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Abstract
The experimental phenomenon of long-term potentiation (LTP) is widely considered to provide a
model of the cellular mechanisms underlying memory formation. NMDA receptor-dependent LTP is
readily induced in a number of pathways within the hippocampal formation, a brain structure known
to be involved in various forms of learning. It is believed that the cellular mechanisms by which
memories are formed within the hippocampus are similar, or identical, to the cellular mechanisms of
LTP. Indeed, treatments that prevent the induction of LTP, such as the blockade of NMDA receptors,
also prevent certain forms of spatial learning.
The aim of the present thesis was firstly to investigate whether the behavioural deficit resulting from
NMDA receptor blockade reflects a genuine learning impairment, rather than a disturbance of some
other aspect of brain functioning. The behavioural test used was a reference memory task in the
watermaze, the learning of which is highly sensitive to hippocampal dysfunction. It has been claimed
that the apparent learning deficits caused by the application of NMDA receptor antagonists may be
secondary to sensorimotor disturbances, or drug-induced brain damage. Behavioural and histological
analysis in the present study was not consistent with either of these two possibilities. However, owing
to the fact that NMDA receptor blockade does indeed cause a number of side effects, subsequent
experiments investigated the role of a novel class of receptor, the metabotropic glutamate receptor
(mGluR), in both LTP and spatial learning. Previous studies have suggested that mGluR activation is
necessary for both LTP induction and the acquisition of spatial memories. However, in the studies
described herein, a broad-spectrum mGluR antagonist, MCPG, caused a modest impairment in spatial
learning, but only under certain circumstances. Moreover, MCPG had no effect on the induction of
LTP in vivo, despite the fact that the application of MCPG successfully blocked the increase in
spontaneous hippocampal activity induced by the application of an mGluR agonist, ACPD. The role
of mGluRs in hippocampal functioning is discussed in the light of these findings.
Finally, electrophysiological experiments were conducted in order to investigate the activity-
dependent reversal of LTP. It was found that the delivery of low frequency stimulation within 2 min
of LTP induction caused a total reversal of LTP, but had little effect on baseline EPSPs when
delivered alone. The ability to selectively erase recently induced potentiation in this way might
provide an alternative to pharmacological intervention in future studies of the role of LTP-like







Table of Contents v
List of Abbreviations xvii
Chapter 1: Thesis overview l
1.1 Memory: a role for hippocampal synaptic plasticity? 2
1.2 Introduction to the experimental work 3
1.2.1 Does pharmacological blockade ofhippocampal NMDA receptors result 3
in a genuine learning impairment?
1.2.2 Does pharmacological blockade of hippocampal NMDA receptors block 4
hippocampal LTP and spatial learning?
1.2.3 Are there alternatives to pharmacological intervention? 4
1.2.4 LTP induction: methodological issues 5
Chapter 2: Hippocampal synaptic plasticity and spatial learning
2.1 Introduction 7
2.2 Hippocampal anatomy 8
2.2.1 Introduction 8
2.2.2 Subfields of the hippocampus proper 8
2.2.3 The dentate gyrus 8
2.2.4 Extrinsic connectivity of the hippocampal formation 9
2.2.5 Intrinsic connectivity of the hippocampalformation: the tri-synaptic 9
circuit
2.2.6 The lamellar hypothesis 10
2.2.7 Efferent projectionsfrom the hippocampus 10
2.2.8 Summary 11
V
2.3 The function of the mammalian hippocampus 13
2.3.1 Introduction 13
2.3.2 Evidence from human case studies 13
2.3.3 Evidence from hippocampal lesions in primates and rats 13
2.3.4 The watermaze task as an index ofhippocampal function 15
2.4 The mechanisms of hippocampal long-term potentiation 17
2.4.1 Introduction 17
2.4.2 The discovery ofhippocampal long-term potentiation 17
2.4.3 Properties ofLTP 18
2.4.4 The mechanisms ofLTP induction 18
2.4.5 Intracellular second messengers involved in LTP induction and 20
expression
2.4.6 The mechanisms and locus ofLTP expression 21
2.4.7 Phases ofLTP 22
2.4.8 The role ofhippocampal theta rhythm in synaptic plasticity 23
2.5 Long-term depression (LTD) of synaptic efficacy 25
2.5.1 Classes ofLTD 25
2.5.2 Induction ofhomosynaptic LTD in area CA1 in vitro 25
2.5.3 Induction ofhomosynaptic LTD in area CA1 in vivo 26
2.5.4 LTD ofperforant-path—dentate gyrus synapses 26
2.5.5 Mechanisms ofLTD induction and expression 27
2.6 The relationship between hippocampal synaptic plasticity and the cellular 29
mechanisms of learning
2.6.1 Introduction 29
2.6.2 Learning-induced changes in synaptic efficacy 29
2.6.3 The effects ofLTP saturation on learning 30
2.6.4 Correlations between the magnitude ofLTP and learning ability 32
2.6.5 Studies involving the use ofperforant path tetanization as a CS 33
2.6.6 Pharmacological modulation ofsynaptic plasticity and learning 34
2.6.7 Targeted disruption ofgenes coding for proteins involved in the 38
induction or expression ofLTP
2.6.8 Summary 41
vi
Chapter 3: Metabotropic glutamate receptors (mGluRs): pharmacology, 42
physiology and function
3.1 Introduction 43
3.2 The discovery of mGluRs 44
3.3 Cloning of the mGluR receptor family 45
3.4 Regional and sub-cellular distribution of mGluRs 46
3.4.1 Group 1 mGluRs 46
3.4.2 Group II mGluRs 47
3.4.3 Group III mGluRs 47
3.5 Transduction mechanisms of mGluRs 49
3.5.1 Group I mGluRs 49
3.5.2 Group II mGluRs 49
3.5.3 Group III mGluRs 50
3.5.4 mGluRs coupled to phospholipase D 50
3.6 mGluR pharmacology 52
3.6.1 mGluR agonists 52
3.6.2 mGluR antagonists 52
3.6.3 The pharmacological properties ofMCPG 55
3.7 Modulation of ion channels and cell excitability 57
3.7.1 Modulation ofpotassium channels 57
3.7.2 Activation ofnon-specific cation currents 57
3.7.3 Inhibition of voltage-sensitive calcium channels (VSCCs) 58
3.7.4 Modulation of ligand-gated ionotropic receptors 58
3.8 Presynaptic actions of mGluRs 59
3.8.1 mGluRs can act as presynaptic autoreceptors 59
3.8.2 A presynaptic mGluR increases glutamate release 60
3.8.3 Summary 61
3.9 The role of mGluRs in synchronized network oscillations 62
vii
3.10 The role of mGIuRs in hippocampal long-term potentiation 64
3.10.1 NMDA receptor activation alone is insufficient to induce LTP 64
3.10.2 The effects ofAP3 and AP4 on LTP induction 64
3.10.3 The effect ofMCPG on LTP induction 65
3.10.4 The "molecular switch" hypothesis 67
3.10.5 The role of tetanus parameters in determining the sensitivity ofLTP to 67
MCPG
3.10.6 mGluR subtype-specific antagonists and the inhibition ofLTP 68
3.10.7 Groups II and 111 mGluR agonists and the inhibition ofLTP 68
3.10.8 mGluR activation can enhance tetanically induced LTP 70
3.10.9 Summary 71
3.11 mGluR agonists and "slow-onset potentiation" 72
3.11.1 Slow-onset potentiation in vitro 72
3.11.2 Slow-onset potentiation in vivo 74
3.12 The role of mGIuRs in learning 76
3.12.1 Effect ofmGIuRs in memory consolidation in chicks and rats 76
3.12.2 mGIiiRs andfear conditioning in rats 76
3.12.3 Anxiolytic actions ofmGluRs 77
3.12.4 mGIuRs and spatial learning 78
3.12.5 mGIuRs may modulate the "signal to noise ratio" during learning 79
3.12.6 Discussion: background to the experimental work of chapters 6 and 7 80
Chapter 4: General methods
4.1 Subjects 82




4.2.2.2 Acquisition training 83
4.2.2.3 Transfer test 83
4.2.2.4 Visually cued task 83
viii
4.3 Electrophysiology 85
4.4 Surgery for intracerebral drug delivery 86
4.4.1 Implantation ofosmotic minipumps 86
4.4.2 Implantation ofacute i.c.v. infusion cannula 86
4.4.3 Implantation of intrahippocampal infusion cannulae 86
4.5 Histology 87
4.6 Statistics 87
Chapter 5: Blockade of spatial learning with D-AP5: "performance" 89
deficits and possible neurotoxicity
5.1 General introduction 90
5.1.1 NMDA receptor antagonists cause "performance" deficits in learning 90
tasks
5.1.2 Attempts to control for NMDA antagonist-induced sensorimotor 92
disturbances
5.1.3 The effects of training protocol on the severity ofsensorimotor 93
disturbances
5.1.4 Neurotoxic effects ofNMDA receptor antagonists 94
5.2 Chronic administration of D-AP5 impairs performance in a spatial, but not a 97






5.2.2.4 Behavioural testing 98
5.2.2.5 Histology 99
5.2.3 Results 99
5.2.3.1 Escape latencies during hidden platform training 99
5.2.3.2 Transfer test performance 100









5.3 Does chronic minipump infusion of 30mM D-AP5 cause neuronal damage? 114
5.3.1 Introduction 1 14
5.3.2 Methods 114
5.3.2.1 Drug treatment and perfusion 114
5.3.2.2 Histological analysis 114
5.3.3 Results 115
5.4 General discussion 118
5.4.1 Overview 118
5.4.2 AP5 does not cause neuronal damage 118
5.4.3 Sensorimotor disturbances 119
5.4.4 Visible platform task 120
5.4.5 Summary 121
Chapter 6: The effects of the mGluR antagonist (/^Sj-a-methyM- 122
carboxyphenylglycine (MCPG) on spatial learning
6.1 General introduction 123
6.2 I.c.v. infusion of (t?,S)-MCPG impairs the performance of rats in a 125




6.2.1.3 Assignment to groups 125




6.2.2.1 Acquisition training 127
6.2.2.2 Swim speeds 127
6.2.2.3 Thigmotaxic swimming 127
x
6.2.2.4 Transfer test and state dependent controls 127
6.2.2.5 Visually cued task 129
6.2.2.6 EPSP slope potentiation 129
6.2.2.7 Population spike potentiation 130
6.2.2.8 Baseline parameters 131
6.2.2.9 Histology 131
6.2.3 Discussion 132
6.2.3.1 Is the impairment mnemonic? 134
6.2.3.2 Does MCPG block LTP? 134
6.2.3.3 Summary 135






6.3.2.3 Behavioural testing 147
6.3.2.4 Histology 148
6.3.3 Results 148
6.3.3.1 Acquisition training 148
6.3.3.2 Transfer tests 148
6.3.3.3 Visible platform task 148
6.3.3.4 Sensorimotor disturbances 148
6.3.3.5 Histology 149
6.3.4 Discussion 149





6.4.1.3 Behavioural testing 153
6.4.1.4 Histology 153
6.4.2 Results 154
6.4.2.1 Acquisition training 154
6.4.2.2 Transfer test 154
XI
6.4.2.3 Visible platform task 154
6.4.2.4 Sensorimotor disturbances 154
6.4.2.5 Histology 154
6.4.2.6 Relationship between histology and watermaze performance 155
6.4.3 Discussion 155
6.5 General discussion 160
Chapter 7: The effect of the mGluR antagonist (/?,S/)-a-methyl-4-
carboxyphenylglycine (MCPG) on dentate LTP in vivo
7.1 General introduction 164
7.2 General methods 165
7.2.2 Drugs 165
7.2.3 Electrophysiology 165
7.3 Does MCPG block dentate LTP in vivo? 168
7.3.1 Methods 168
7.3.2 Results 168
7.3.2.1 EPSP slope potentiation 168
7.3.2.2 Effects of D-AP5 on EPSP slope potentiation 169
7.3.2.3 EPSP slope potentiation across the I/O curve 169
7.3.2.4 Population spike potentiation 170
7.3.2.5 Effect of D-AP5 on population spike LTP 171
7.3.2.6 Baseline stimulation parameters 172
7.3.2.7 Changes in brain temperature 172
7.3.2.8 Rats excluded from analysis 173
7.3.3 Discussion 174
7.4 Does MCPG block dentate LTP in vivo? A two-pathway study. 181
7.4.1 Methods 181
7.4.2 Results 181
7.4.2.1 EPSP slope LTP 181
7.4.2.2 EPSP slope baseline changes 182
7.4.2.3 EPSP slope I/O curves 183
xii
7.4.2.4 Population spike LTP 183
7.4.2.5 Baseline stimulation parameters 184
7.4.2.6 Brain temperature 185
7.4.2.7 Rats excluded from the above analysis 185
7.4.3 Discussion 189
7.5 Does MCPG antagonize the electrophysiological effects of the mGluR agonist 198




7.5.3.1 25 mM (1S,3R)-ACPD 199
7.5.3.2 4mM(lS,3/?)-ACPD 200
Changes in EPSP slope 200
Changes in spontaneous dentate EEC activity 200
7.5.3.3 2mM(lS,3/?)-ACPD 202
Changes in EPSP slope 202
Changes in spontaneous EEG activity 203
7.5.3.4 1 mM(lS,3R)-ACPD 203
Changes in spontaneous EEG activity 203
Spectral analysis ofspontaneous activity 205
Changes in EPSP slope 205
Changes in population spike amplitude 206
Changes in brain temperature 206
7.5.4 Discussion 208





7.6.3.1 1 min 5 Hz 225
Tetanus 1 and depotentiation 225
Drug infusion and tetanus 2 226
7.6.3.2 10 min 5 Hz 227
Tetanus 1 and depotentiation 227






Chapter 8: Reversal of dentate LTP by low frequency stimulation 237
8.1 General introduction 238




8.2.2.1 Reversal of EPSP slope potentiation 241
8.2.2.2 Reversal of population spike potentiation 241
8.2.2.3 Changes in EPSP / spike (E-S) coupling induced by 5 Hz 242
stimulation
8.2.2.4 Epileptiform afterdischarges induced by 5 Hz stimulation 244
8.3 The effect of (/?,S)-MCPG on the reversal of LTP by 5 Hz stimulation. 258
8.3.1 Methods 258
8.3.2 Results 258
8.3.2.1 EPSP slope and population spike LTP 258
8.3.2.2 Comparisons with experiment 8.2 258
8.3.2.3 MCPG and afterdischarge activity 259
8.4 The effect of 1 Hz stimulation on LTP. 261
8.4.1 Methods 261
8.4.2 Results 261
8.4.2.1 Effect of 1 Hz stimulation on LTP 261
8.4.2.2 Effect of 1 Hz stimulation on E-S coupling 262
8.4.2.3 Absence of afterdischarges during 1 Hz stimulation 262
8.5 General discussion 265
8.5.1 The significance of theta frequency stimulation in LTP reversal 265
8.5.2 Changes in E-S coupling 266
8.5.3 The mechanism of time-dependent LTP reversal 267
XIV
8.5.4 LTP reversal by 5 Hz stimulation: physiological mechanism or
experimental tool?
268
Chapter 9: Factors associated with the magnitude of LTP 271
9.1 Introduction 272
9.2 The influence of initial EPSP magnitude on subsequent LTP: further 273




9.3 The effect of tetanus intensity and initial EPSP magnitude on EPSP slope 279
LTP: pilot studies and further analysis of data presented in experiment 7.3
9.3.1 Pilot Studies 279
9.3.2 Further analysis ofdata from experiment 7.3: Effect of tetanus intensity 280
on LTP across the I/O curve
9.3.3 Further analysis ofdata from experiment 7.3: Effect of initial maximum 282
EPSP slope on LTP across the I/O curve
9.4 Other variables associated with LTP magnitude 292
9.4.1 Introduction 292
9.4.2 The use ofnovel tetanus parameters: inter-train interval is only 292
moderately important
9.4.3 The effect ofbaseline test pulse width on the level ofLTP recorded 293
9.4.4 The effect of the strain of rat used on LTP 294
9.4.5 The effect ofstress on LTP induction 295
9.4.6 Seasonal variations in LTP 296
9.5 General Discussion 301
Chapter 10: Summary 303
10.1 Introduction 304
XV
10.2 D-AP5 and spatial learning 304
10.3 The effects ofMCPG on LTP and spatial learning 305
10.4 Time-dependent reversal of LTP 306
10.5 Conclusion 307
References 308
Appendix: published work 345
xvi
LIST OF ABBREVIATIONS
ACPD 1 -aminocyclopentane-1,3-dicarboxylic acid
aCSF artificial cerebrospinal fluid
r-ADA fra/w-acetidine-2,4-dicarboxylic acid
AIDA (R,S)-1 -aminoindan-1,5-dicarboxylic acid
AMPA a-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid








APP (3-amyloid precursor protein
ATP adenosine triphosphate
CA cornu ammonis
CaMKII Ca2+/calmodulin-dependent protein kinase II
cAMP cyclic adenosine monophosphate

















EGTA ethylene-bis (oxyethylenenitrate) tetra-acetic acid
EPSC excitatory postsynaptic current
EPSP excitatory postsynaptic potential
E-S EPSP / spike
fEPSP field excitatory post synaptic potential
GABA y-aminobutyric acid
H + E haematoxylin and eosin
3-HPG 3-hydroxyphenylglycine
HPLC high performance liquid chromatography
HSP72 heat shock protein 72





Ik(sIow) slowly inactivating voltage-dependent potassium conductance
Im slow, non-inactivating voltage-dependent potassium conductance
IP3 inositol triphosphate
IPSC inhibitory postsynaptic current
IPSP inhibitory postsynaptic potential
ITI inter-trial interval
l.f.s. low frequency stimulation
Lat. lateral
l-CCG-i (2S, 1 '5,2'S')-2-(carboxycyclopropyl)glycine
l-csa L-cysteine sulphinate






MAPK mitogen activated kinase
MCCG a-methyl-CCG-I
MCPG a-methyl-4-carboxyphenylglycine
mEPSC miniature excitatory postsynaptic potential
mGIuR metabotropic glutamate receptor
xviii
MK-801 (+)-5-methyl-10,l l-dihydro-5h-dibenzo [a,d] cyclohepten-5,10-imine (dizocilpine)
MPPG a-methyl-4-phosphonophenylglycine
mRNA messenger ribonucleic acid
MSOP (/?,S)-a-methylserine-0-phosphate





PBS phosphate buffered saline
PCCG-IV (2S',l'S,2'S,3'R)-2-(2'-carboxy-3'-phenylcyclopropyl)glycine
PCP phencyclidine
PKA protein kinase A














1.1 Memory: a role for hippocampal synaptic plasticity?
An understanding of the physiological basis of memory remains one of the central goals of
contemporary neuroscience. Many definitions of memory have been proposed, and many different
types of memory have been identified. However, most forms of memory are characterized by a
change in behaviour as a result of prior experience. The process leading to such a change is known as
learning. In order to result in such a behavioural change, mammalian learning must result in a
modification of the central nervous system. The nature and location of this modification has been the
focus of a vast amount of research, much of it centred around a forebrain structure called the
hippocampus.
The hippocampus has attracted particular interest for a number of different reasons. For instance,
hippocampal damage in humans can result in a severe deficit in the formation of memories for facts
and events, an impairment that corresponds well to the everyday notion of a "bad memory".
Furthermore, hippocampal lesions in rodents have suggested that the hippocampus may be
particularly involved in the formation of internal representations of space, or "cognitive maps" (see
O'Keefe and Nadel, 1978). Compared to many other postulated high level cognitive processes, the
suggestion that a structure is involved in the processing of "space" generates a number of
experimentally testable predictions, making the hippocampus an attractive brain region for
experimental psychological research.
In addition, the hippocampus has an apparently rather simple and well-defined anatomical structure.
The principal intrahippocampal connections have been known for some time, and a computational
analysis of the "algorithm" performed by the hippocampal circuitry may ultimately prove possible.
Although such a "circuit level" analysis of hippocampal function is currently beyond our reach, the
discovery of a phenomenon known as long term potentiation (LTP) has provided a huge impetus to
the field of hippocampal research. LTP is an experimentally induced form of synaptic plasticity in
which certain hippocampal glutamatergic synapses exhibit a lasting increase in the efficacy with
which they transmit afferent signals. Such changes in synaptic strength had previously been
postulated on purely theoretical grounds, and the phenomenon displays many of the properties
desirable in a cellular mechanism of associative learning (see chapter 2.4).
Since the discovery of hippocampal LTP over 30 years ago, a considerable experimental effort has
been devoted to the attempt to link memory formation with LTP-like phenomena in the hippocampus.
Indeed, it is widely assumed on a priori grounds that changes in synaptic efficacy must underlie
certain forms of learning. The demonstration that networks of "neuron-like" elements with
modifiable connections between them can exhibit certain forms of learning has added to this view
(Gluck and Rumelhart, 1990). Furthermore, it has been demonstrated that certain simple forms of
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associative learning in invertebrates such as Aplysia, are dependent on the modification of synaptic
strength between pairs of connected neurons (Carew et ah, 1981). However, the evidence suggesting
that synaptic plasticity underlies learning in the mammalian brain, although extensive, is insufficient
to prove such a link definitively.
One conceptual issue concerns the fact that mammalian LTP is an experimental phenomenon,
involving an increase in synaptic efficacy induced by the massive synchronous high frequency
activation of a large population of afferent fibres. Such patterns of activity do not occur naturally,
although limited periods of high frequency bursting are likely to occur in small distributed
populations of afferents. Hence, the hypothesis that LTP is the basis of learning means simply that the
cellular mechanisms artificially engaged during the induction of LTP are the same as those engaged
during learning. LTP cannot, of course, be literally equated with learning, and the LTP / learning
hypothesis should be understood only in the more limited sense proposed.
1.2 Introduction to the experimental work
The experiments described throughout this thesis constitute an attempt to address the LTP / learning
hypothesis as outlined above. In some instances, the mechanistic equivalence of LTP and learning has
been investigated by comparing the effects of a treatment on LTP with its effects in a learning task.
However, in many cases, purely electrophysiological experiments have been carried out in an attempt
to identify ways of modulating LTP that might, if successful, generate alternative approaches to the
investigation of the LTP / learning relationship.
1.2.1 Does pharmacological blockade ofhippocampal NMDA receptors result in a genuine learning
impairment?
Probably the most common approach for testing the LTP / learning hypothesis has been to investigate
the effects of a pharmacological treatment on both long-term potentiation and learning. For instance,
the blockade of hippocampal NMDA receptors impairs learning at a dose equivalent to the dose at
which it blocks LTP (Davis et ah, 1992). However, it has been suggested that NMDA receptor
antagonists impair behaviour by some mechanism unrelated to their effects on LTP. For instance, the
administration of the commonly used NMDA antagonist AP5 causes sensorimotor disturbances and
has also been suggested to cause brain damage (e.g. Cain et al., 1996).
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The first experiments of this thesis, described in chapter 5, represent an attempt to discover whether
the impairment induced by intraventricular infusion of AP5 is consistent with either of the above
possibilities. Rats were tested using a watermaze reference memory protocol similar to that described
by Cain and colleagues. Training was carried out either during AP5 infusion in order to investigate
sensorimotor impairments, or after a period of chronic AP5 infusion in order to assess any residual
deficit attributable to brain damage. A detailed histological analysis was carried out in order to further
investigate the possibility of AP5-induced neurotoxicity.
The results of this study provide evidence to refute some of the arguments for a non-mnemonic
impairment following treatment with an NMDA receptor antagonist. However, the fact that such
drugs do undeniably cause sensorimotor impairments is undesirable. Hence, the remainder of the
thesis represents an attempt to find an alternative way of modulating LTP without the drawbacks
associated with the administration ofNMDA receptor antagonists.
1.2.2 Does pharmacological blockade of hippocampal metabotropic glutamate receptors block
hippocampal LTP and spatial learning?
The metabotropic glutamate receptor provides an attractive alternative target for pharmacological
treatment. Blockade of this class of receptor has been reported either to limit the induction of LTP in
vivo to approximately 2 h, or to block LTP completely, depending on the concentration of antagonist
applied (Riedel et al., 1995a). This result might be exploited in order to probe the relationship
between LTP and learning. Chapter 6 describes a series of experiments designed to characterize the
effects of MCPG on performance in a simple reference memory task. The effects of MCPG on
hippocampal LTP are investigated in chapter 7.
1.2.3 Are there alternatives to pharmacological intervention?
So far, all the experiments described have investigated the effects of the pharmacological antagonism
of receptors believed to be involved in the induction of LTP. However, this approach has a number of
limitations. For instance, no method of drug delivery is ideal, and some may result in substantial drug
concentrations in structures surrounding the hippocampus. Secondly, particular receptors may indeed
be involved in both LTP and learning, but the underling mechanisms may be different in each case.
In an attempt to overcome these problems, I decided to investigate an electrophysiological
phenomenon that might offer the possibility of reversing LTP in potentiated synapses only. Pilot
studies indicated that dentate LTP in vivo could only be reversed by low-frequency stimulation
delivered very soon after tetanization, and a similar result had previously been reported in area CA1
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in vitro (Staubli and Chun, 1996). In order to characterize this phenomenon more fully, a detailed
investigation of the time-dependence of LTP reversal was carried out in the dentate gyrus in vivo (see
chapter 8). The time-dependent reversal of LTP might provide a tool for selectively targeting recently
potentiated synapses after behavioural training, and hence investigating the role of LTP in memory
retention, rather than acquisition. Such a study would be possible, although technically very
demanding for reasons discussed in chapter 8.5.4. Pilot studies have not yet been carried out.
1.2.4 LTP induction: methodological issues
A final methodological chapter is devoted to issues associated with the successful induction of LTP,
or its failure (chapter 9). Throughout the period during which the work described in this thesis was
carried out, intermittent problems were experienced with the induction of lasting LTP. A number of
possible factors were considered, including the initial size of the EPSP, the tetanus intensity used, the
baseline stimulation intensity, the strain of rat, the effects of stress, and the possible influence of
seasonal cycles. A number of these factors, including baseline stimulation parameters were critically
important in determining the level of LTP recorded, a potentially worrying finding considering the
arbitrary nature of the baseline parameters used by most investigators, including myself. The







The aim of this chapter is to provide a broad introduction to the hippocampus, with particular
emphasis on the functions and mechanisms of hippocampal synaptic plasticity. Owing to the vast
scope of this chapter, which could include topics ranging from molecular neurobiology to
psychology, the material presented is necessarily selective. However, an attempt has been made to
provide an integrated view of both the physiological and behavioral levels of analysis, a bridging of
levels that is necessary if the potential role of synaptic plasticity in learning is to be understood.
The first few sections provide a general introduction to the anatomy of the hippocampus and its role
in memory, both in humans and in animals. Following this, the mechanisms and possible significance
of various forms of hippocampal synaptic plasticity are discussed. The final section represents an
attempt to draw together several lines of evidence linking rodent hippocampal synaptic plasticity with
learning. The literature review is by no means exhaustive, but is intended to provide an indication of
the current state of the LTP / learning hypothesis, as well as placing my own experimental work




The mammalian hippocampal formation is located within the forebrain and forms part of the temporal
lobe of the cerebral cortex. It is an elongated structure that lies beneath the corpus callosum and
curves caudally away from the septum, and latero-ventrally around the thalamus. The two
hippocampi are joined at their anterior point by the hippocampal commisure. The hippocampal
formation (often simply referred to as the "hippocampus") is generally considered to consist of the
hippocampus proper, i.e. Amnion's horn (Cornu Ammonis, CA), the dentate gyrus (fascia dentata),
the subicular complex, and the entorhinal cortex (see figure 2.2A). Unlike the 6-layered structure of
the neocortex, the dentate gyrus and Ammon's horn are 3-layered allocortical structures, with one
principal cell type.
2.2.2 Subfields of the hippocampus proper
The hippocampus proper is divided into three subfields on the basis of cell size and distribution,
regions CAI, CA2, and CA3, according to the terminology of Lorente de No (1934). Pyramidal cells
in area CA3 receive a prominent mossy fibre input from the dentate gyrus, a projection absent in
CAI. The CA2 region is less clearly defined, and its very existence has sometimes been debated.
A similar laminar organization is seen in all layers of the hippocampus proper. The pyramidal cell
layer is most prominent, and deep to this layer is a relatively cell-free region called the stratum oriens.
Above the pyramidal cell layer lies the stratum radiatum in which CA3 to CAI Schaffer collateral
connections and CA3 associational connections are located. The most superficial layer is known as
the stratum lacunosum-moleculare, in which perforant path fibres from the entorhinal cortex
terminate.
2.2.3 The dentate gyrus
Like the hippocampus proper, the dentate gyrus is composed of 3 layers. The cell bodies of the
principal neurons, granule cells, form a densely packed V-shaped layer, enclosing the polymorphic
cell layer, and interlocking with the hippocampus proper. The granule cell bodies lie deep to a third
relatively cell free layer, the molecular layer, which comprises the apical dendrites of the granule cells
and various afferent terminals, including the terminals of perforant path fibres from the entorhinal
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cortex. The polymorph layer consists of non-granular interneurons, and is the zone in which granule
cell axons come together to form the mossy fibre projection to area CA3.
The dentate gyrus is often divided into two portions. The suprapyramidal blade refers to the portion
adjacent to area CA1, and the infrapyramidal blade refers to the opposite portion.
2.2.4 Extrinsic connectivity of the hippocampalformation
The major sensory input to the hippocampus is provided by the entorhinal cortex (see figure 2.2A &
B). The entorhinal cortex receives highly processed multimodal information from several regions of
association cortex, as well as direct input from the primary olfactory cortex. This information is
conveyed to the hippocampus via the perforant path. This projection arises in layer II and III of the
entorhinal cortex, and forms the dense "angular bundle" upon entering the hippocampus. The
perforant path can be sub-divided into medial and lateral components, which terminate in the middle
one-third and outer one-third of the dentate molecular layer respectively. Although the dentate gyrus
is the major target of the perforant path, projections to all subfields of Amnion's horn and the
subiculum have been identified.
In addition to the glutamatergic perforant path input, the hippocampus receives a number of
projections from sub-cortical structures. For instance, a serotoninergic projection arises in the raphe
nucleus and projects to the hippocampus via the fornix, and a noradrenergic projection is provided by
the locus coeruleus. A cholinergic / GABA-ergic input arises from the medial septal nucleus, and
nuclei of the diagonal band of Broca and projects to the hippocampus via the fornix. The septal input
is believed to be the source of the hippocampal theta rhythm, a topic discussed in section 2.4.8.
The basolateral nucleus of the amygdala is known to project to the ventral portion of Ammon's horn.
In addition, a noradrenergic projection from this amygdaloid nucleus to the dentate gyrus has been
identified electrophysiologically, but not anatomically (Ikegaya et al., 1996, 1997).
2.2.5 Intrinsic connectivity of the hippocampalformation: the tri-synaptic circuit
The salient features of the intrinsic connectivity are often characterized as a tri-synaptic loop (figure
2.2A). The projections within this loop are almost exclusively unidirectional. The circuit starts with
perforant path afferents which synapse onto granule cells of the dentate gyrus. The axons of these
granule cells form the mossy fibre pathway, which makes en passant synapses with the dendrites of
the CA3 pyramidal cells. The axons of the CA3 pyramidal cells form the Schaffer collateral pathway
which projects to the CA1 pyramidal cells. In addition to forming the Schaffer collaterals, the axons
of CA3 pyramidal cells divide and give rise to associational projections to other CA3 pyramidal cells,
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as well as commissural projections to CAI and CA3 pyramidal cells in the contralateral
hippocampus. The pyramidal cells of CAI project back to the entorhinal cortex, and indirectly via the
subiculum.
As mentioned above, both CAI pyramidal cells receive commissural projections from the
contralateral CA3 region. In addition, the inner third of the molecular layer of the dentate gyrus
receives a projection from both the ipsilateral and the contralateral polymorphic layer, known as the
ipsilateral associational / commissural projection.
2.2.6 The lamellar hypothesis
On the basis of electrophysiological and neuroanatomical studies, it was proposed that the major
excitatory pathways of the tri-synaptic loop run almost exclusively in a direction perpendicular to the
septotemporal axis of the hippocampus, with a highly restricted lateral spread (Andersen et al., 1969,
1971). According to this view, the hippocampus is composed of a large number of semi-autonomous
transverse slices, a structure reminiscent of the columnar organization of neocortex. However,
Amaral and Witter (1989) have challenged this notion on the basis of new neuroanatomical evidence
suggesting that with the exception of the mossy fibre pathway, many of the intrinsic hippocampal
connections are as extensive in the septotemporal direction as in the transverse direction.
Furthermore, different projection systems have distinct and highly topographically organized patterns
of organization in the septotemporal axis.
Hence, the lamellar hypothesis in its original form may be an oversimplification. Nevertheless many
important aspects of hippocampal physiology, including the expression of LTP, are captured in the in
vitro hippocampal slice, a convenient experimental preparation in which transverse hippocampal
sections of approximately 400 pm in thickness are maintained by bath perfusion with artificial CSF.
Proponents of the lamellar hypothesis question whether slice preparations would work if a large part
of the intrinsic circuitry were discontinuous as implied by Amaral and Witter (1989).
2.2.7 Efferent projectionsfrom the hippocampus
The subiculum provides the main output pathway from the hippocampus, giving rise to a prominent
projection back to the entorhinal cortex, as well as projections to a range of neocortical areas. In
addition, subicular efferents project prominently to a number of subcortical areas, including the septal
complex, the mammillary bodies, the nucleus accumbens and the thalamus. As well as projecting via
the subiculum, CAI neurons project directly to a number of cortical areas, as well as the amygdala,
hypothalamus and lateral septum.
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2.2.8 Summary
The hippocampus receives highly processed polysensory information from associational areas of
neocortex, together with various subcortical modulatory inputs, and projections from the amygdala
that may carry informational about the motivational significance of sensory information. The output
pathways of the hippocampus to neocortical, striatal and limbic regions are likely to be involved in
influencing the behaviour of an animal in response to learning. For an extensive recent review of



















(A) Horizontal section through the hippocampus. A schematic diagram of the
intrahippocampal connections comprising the tri-synaptic loop (from O'Keefe and
Nadel, 1978). (B) Major intrinsic connections of the hippocampal formation and
major extrinsic cortical inputs. This diagram summarises current knowledge of both
serial and parallel aspects of the intrinsic hippocampal circuitry such as the direct
entorhinal projections to areas CA3 and CA1 not illustrated in (A). PR Ctx,
perirhinal cortex; Temp Ctx, temporal cortex; Front Ctx, frontal cortex; Vis Ctx,
visual cortex (from Amaral and Witter, 1995).
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2.3 The function of the mammalian hippocampus
2.3.1 Introduction
The role of the hippocampus remains uncertain despite an intensive research effort over recent years,
and the generation of numerous theories of hippocampal functioning. However, the hippocampus is
undeniably involved in certain forms of spatial learning. A major issue in the literature concerns
whether spatial memory represents a particular example of a broader class of declarative memory for
which the hippocampus is required, or whether the hippocampus is preferentially concerned mainly
with navigation and the recall of spatial locations. A systematic review of the literature on this topic is
beyond the scope of this thesis, but a few salient areas will be briefly discussed.
2.3.2 Evidence from human case studies
The critical involvement of temporal lobe structures in memory was first revealed by the study of a
now famous amnesic patient, "H.M." (Scoville and Milner, 1957). H.M. was left with severe amnesia
following bilateral temporal lobe resection as a treatment for intractable epilepsy. The most striking
aspect of H.M.'s impairment is an anterograde amnesia which leaves him unable to retain events in
memory for more than a few minutes. In addition, he exhibits a limited retrograde amnesia extending
back a few years before the surgery. H.M.'s I.Q. is normal, and his memory impairment is limited to
"declarative" memory (see Squire, 1987), particularly the recall of personal events. However, H.M.
exhibits intact "procedural" memory, and is, for instance, able to learn new motor skills (see Milner,
1962).
Evidence from other amnesic patients has confirmed the importance of the hippocampus in memory.
Patient "R.B." became amnesic after an ischaemic episode. Post-mortem histological examination
revealed that the damage was almost exclusively limited to the CA1 subfields of the hippocampus,
suggesting that damage limited to the hippocampus alone can cause amnesia (Zola-Morgan et al.,
1986).
2.2.3 Evidence from hippocampal lesions in primates and rats
The results of behavioural experiments on animals with hippocampal lesions have given rise to a
large number of theories of hippocampal function. According to some of these, the hippocampus is
involved in a particular form of information processing, regardless of the nature of that information.
Such accounts include working memory theory (Olton et ah, 1979; Wan et ah, 1994), declarative
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memory theory (Squire, 1992), and configural association theory (Sutherland and Rudy, 1989). Other
theories have emphasized the type of information learned, for instance spatial (O'Keefe and Nadel,
1978; Morris et al., 1982, 1990b; Gaffan, 1991; Worden, 1992) or contextual (Hirsh, 1974; Honey
and Good, 1993).
Early studies indicated that severe memory impairments in monkeys could be obtained by surgical
removal of the hippocampus, amygdala, and adjacent cortical regions (Mishkin, 1978; Zola-Morgan
et al. 1982; Murray and Mishkin, 1984). The behavioural test used in these studies was a delayed non-
matching-to-sample (DNMS) object recognition task. A deficit in this task is generally characterized
as an impairment of declarative memory (see Squire, 1987, 1992). Combined damage to the
hippocampus, perirhinal and parahippocampal cortices has also been reported to cause a severe
memory impairment (Zola-Morgan et al., 1993). However, lesions of the perirhinal and
parahippocampal cortical areas alone have been found to produce an equally severe deficit,
suggesting that the role of the hippocampus itself may be minimal (Zola-Morgan et al., 1989; Suzuki
et al., 1993).
Nevertheless, radio-frequency lesions limited to the hippocampus, but sparing adjacent cortical areas
have been reported to cause a modest impairment in DNMS performance (Alvarez et al., 1995).
However, it has recently been reported that animals with axon-sparing excitotoxic lesions (see below)
of the hippocampus and amygdala are unimpaired in DNMS performance (Murray and Mishkin,
1998). It is thought that conventional lesions may transect a number of efferent pathways from the
perirhinal and entorhinal cortices. Since these regions are known to play a role in DNMS
performance, it is possible that this inadvertent damage, rather than hippocampal ablation itself, was
responsible for the DNMS deficit observed in earlier studies.
Differences in lesion technique have undoubtedly also contributed to the confusion surrounding the
rodent literature. As in many primate studies, non-axon-sparing lesions have often been used.
Conventional lesion techniques, such as aspiration, electrolytic or radiofrequency, cause damage to
fibres of passage and to adjacent cortical areas, making the contribution of the hippocampus difficult
to judge. However, the injection of small volumes of the excitotoxic agent ibotenic acid at numerous
hippocampal sites results in the selective death of those neurons having their cell bodies within the
dentate gyrus and the CA subfields only (Jarrard, 1989). Using this technique, performance is
unimpaired on a number of tasks formerly thought to be hippocampus-dependent (See Jarrard, 1993
for review). However, robust impairments are still obtained on spatial learning tasks, and in tasks
requiring the use of contextual cues (Jarrard et al., 1987; Morris et al., 1990b; Honey and Good,
1993). This latter result is reminiscent of the finding that fornix transection in primates impairs object
discrimination learning, but only when successful performance depends on the processing of complex
visual scenes (Gaffan and Harrison, 1989). In addition, it has recently been found that monkeys with
14
excitotoxic hippocampal lesions are impaired in a task that requires the animals to learn where to
reach within two-dimensional spatial scenes (Murray et ah, 1998).
The idea that the hippocampus is involved in the mapping of spatial location was first proposed by
O'Keefe and Nadel (1978). The finding that certain principal hippocampal neurons fire selectively
when a rat is in a certain spatial location (O'Keefe and Dostrovsky, 1971) added further evidence in
addition to the hippocampal lesion literature available at the time. A number of studies have since
implicated the activity of such "place cells" in spatial navigation (see Bures et al., 1997). The
consequences of excitotoxic lesions described above would also seem to support the notion that the
hippocampus is preferentially involved in the processing of spatial information.
However, a number of pieces of evidence are not consistent with this limited view of hippocampal
function. To give one example, it was recently reported that rats with ibotenic acid lesions of the
hippocampus are impaired in the learning of non-spatial odour association tasks when the flexible
expression of memory is required (Bunsey and Eichenbaum, 1996). Specifically, rats were impaired
in tests of transitivity (i.e. if A => B and B => C, then A => C), and symmetry (i.e. if B => C then C =>
B). Hippocampal lesioned rats were not impaired in simple paired associate learning. This result has
been interpreted as suggesting that the hippocampus is, after all, a declarative memory structure.
According to this view, spatial tasks are merely one example, albeit a very good one, of a class of
declarative memory tasks for which the hippocampus is required.
2.3.4 The watermaze task as an index ofhippocampal function
Despite the ongoing debate about the precise role of the hippocampus, lesioning this structure results
in a profound spatial learning deficit in the watermaze, a piece of apparatus specifically designed to
study spatial learning in rats (Morris, 1984; Stewart and Morris, 1993).
In a reference memory task in the watermaze, a rat must remember the fixed spatial location of a
hidden escape platform on the basis of cues positioned in the room surrounding the maze. The use of
random starting positions ensures that the platform cannot be located simply by swimming towards
individual cues, or by repeating fixed patterns of body movement. During training, performance is
assessed by measuring the latency to find the hidden platform. At the end of acquisition, a probe trial
or "transfer test" is often carried out, in which the platform is removed and the rat allowed to swim
freely for a limited period of time. Transfer test performance is conventionally assessed by measuring
the percentage time spent in the quadrant of the pool that formerly contained the escape platform.
Whilst the platform may be discovered fairly rapidly during acquisition trials, either by chance or by
adopting a simple strategy such as swimming at a fixed distance from the pool walls, such factors
cannot account for a bias towards the target quadrant during a transfer test. As a result, this measure is
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generally considered to provide a more sensitive index of memory than escape latency. However, a
transfer test is an extinction trial, and as such depends on the persistence of searching in the absence
of reward. For this reason, transfer test performance, although arguably the best measure available,
has the potential to be misleading under some circumstances. This issue is discussed further in
chapter 6.5.
A robust deficit in both escape latency and transfer test performance is obtained in
hippocampectomized rats, whether aspiration lesions or ibotenic acid lesions are used (Morris et al.,
1982, 1986b and 1990b respectively). A number of non-spatial control tasks have been used to
confirm that the deficit is limited to spatial learning. For instance, hippocampal lesions do not impair
the ability of rats to locate and swim towards a visible platform (Morris et al., 1982). In addition,
lesioned rats learn as rapidly as controls to discriminate between two visually distinct platforms, one
of which is rigid and provides a means of escape, and the other of which is floating and will not
support the weight of a rat (Morris et al., 1986b).
Owing to its exquisite sensitivity to the effects of hippocampal lesions, the watermaze has frequently
been used to assess the behavioural effects of treatments designed to modulate putative hippocampal
mechanisms of information storage. For this purpose, it is not important to know whether the role of
the hippocampus is limited to spatial learning, or extends to a wider class of declarative memory
functions. It is in this way, as a behavioural assay, that the watermaze is used in chapters 5 and 6 of
this thesis.
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2.4 The mechanisms of hippocampal long-term potentiation
2.4.1 Introduction
The notion that synaptic changes may underlie the formation of memories was first proposed over a
hundred years ago by Ramon y Cajal, who suggested that learning might involve the experience-
dependent growth of connections between neurons. In the middle of the present century, Konorski
(1948) presented a theoretical proposal concerning the circumstances during which associative
learning might arise. The essence of this proposal was that in order for an increase in associative
strength to occur, activity in an "emitting centre" must be coincident with rising activity in a
"receiving centre". The following year, an explicitly synaptic mechanism for associative learning was
advanced by Hebb (1949). In this scheme, if a presynaptic cell persistently takes part in firing a
postsynaptic target neuron, a change occurs in one or both cells such that the connection between the
two cells is strengthened. Although these two proposals are not identical, both contain the suggestion
that coincident pre- and postsynaptic activity is necessary for the enhancement of connections
between neurons.
The significance of such a proposal is illustrated by the hypothetical case in which one presynaptic
neuron weakly excites a postsynaptic cell at the same time as a second presynaptic afferent strongly
activates and perhaps fires the cell. According to the above condition of coincident of pre- and
postsynaptic activity, the strength of the connection between the initially weak input and its
postsynaptic target should be strengthened. Note that in this case, each input is now able to strongly
activate the postsynaptic cell. Computational modelling of the activity in networks of neuron-like
elements obeying rules similar to the above has given rise to an entire research field in its own right
(see Gluck and Rumelhart, 1990). For examples of hippocampal neural network modelling, see Rolls
et al. (1997) and Treves and Rolls (1994).
2.4.2 The discovery ofhippocampal long-term potentiation
In the late 1960s, an electrophysiological phenomenon was discovered that appeared to fit the
requirements for a cellular learning mechanism such as that postulated by Hebb (1949). The
phenomenon of long-term potentiation was initially discovered by Lpmo in 1966, but was first
reported in detail seven years later (Bliss and Lpmo, 1973).
In these studies, carried out in anaesthetized rabbits, electrical stimulation was delivered to the
perforant path from the entorhinal cortex, and evoked field potentials were recorded from the
synaptic, or molecular, layer of the dentate gyrus. At this point, a negative-going EPSP is recorded,
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reflecting the flow of positive ions into the dendrites in response to the electrical stimulation of
afferent fibres. Superimposed on the EPSP is a positive-going population spike reflecting the
synchronous firing of dentate granule cells.
Bliss and Lpmo (1973) first recorded a "baseline" during which perforant path stimulation was
delivered every 2-3 s, after which a high frequency conditioning train, often known as a tetanus, was
delivered to the perforant path. Upon resuming stimulation at the initial low frequency, the size of the
EPSP was observed to be greater. Both the amplitude of the EPSP and the amplitude of the
superimposed population spike were found to be increased. The population spike latency was also
reduced. These changes lasted up to 10 hours in the acute preparation, and subsequent studies in
animals with chronically implanted electrodes revealed that the phenomenon could last for a period of
several weeks (Bliss and Gardner-Medwin, 1973).
A similar form of LTP was subsequently discovered in the Schaffer collateral-commissural input to
CA1 in vitro (Alger and Teyler, 1976; see section 2.2.6). LTP has since been reported in other brain
regions, including the neocortex (e.g. Artola and Singer, 1987). However, the following discussion is
limited to the properties and mechanisms of hippocampal NMDA receptor-dependent LTP only.
2.4.3 Properties ofLTP
Since its discovery, LTP has been found to have a number of properties that make it an attractive
candidate mechanism for the formation of memories. "Associativity" describes the finding that the
pairing of a weak, sub-threshold input with a strong suprathreshold input can lead to a potentiation of
the weak input (McNaughton et al., 1978; Levy and Steward, 1979). A related property is that of
cooperativity, referring to the mutual facilitation between independent afferent inputs. It has been
reported that the more fibres activated during tetanization, the more LTP is obtained, owing to the
cooperative interaction between inputs (McNaughton et al., 1978; Larson and Lynch, 1986). A third
property, input-specificity, refers to the fact that only those synapses that are active during the LTP
induction event become potentiated (Andersen et al., 1977; Gustafsson et al., 1987; but see Engert
and Bonhoeffer, 1997). Potentiation that exhibits the above properties is sometimes described as
"hebbian".
2.4.4 The mechanisms ofLTP induction
The main excitatory neurotransmitter in the mammalian hippocampus is L-glutamate (Watkins and
Evans, 1981). Fast excitatory transmission is mediated by the action of glutamate on ionotropic
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receptors of the AMPA subtype. When activated, the AMPA receptor allows the passage of sodium
ions through its ionophore, thus depolarizing the cell.
Another class of ionotropic glutamate receptor, the NMDA receptor, consists of a glutamate binding
site and a voltage-gated ionophore. NMDA receptors allow the passage of Ca2+ and Nations into the
cell only during glutamate binding coupled with postsynaptic depolarization. At the normal resting
potential, the ionophore is blocked by the presence of Mg2+ ions. However, postsynaptic
depolarization releases the Mg2+ block, and when paired with glutamate binding, Ca2+ flows through
the ionophore (Nowak et ah, 1984). The dual ligand and voltage gated action of the NMDA receptor
means that Ca2+ entry only occurs under circumstances in which presynaptic glutamate release is
paired with postsynaptic depolarization. Hence, the NMDA receptor embodies at the molecular level
the mechanisms postulated in section 2.4.1.
The involvement ofNMDA receptors in hippocampal LTP was first revealed by the application of the
NMDA receptor antagonist d,l-AP5 to a CA1 slice preparation (Collingridge et ah, 1983; Harris et
ah, 1984). This had little effect on the EPSP evoked by low frequency stimulation of the Schaffer
collateral pathway, but prevented the induction of LTP following a high frequency tetanus. A later
study showed that the application of AP5 after tetanization had no effect on the level of potentiation,
demonstrating that NMDA receptors are required only for the induction, but not the maintenance of
LTP (Davies and Collingridge, 1989). It has since been demonstrated that intraventricular or direct
intrahippocampal infusions of AP5 can block the induction of dentate LTP in vivo (Morris et ah,
1986a; Errington et ah, 1987; Morris, 1989). Note that while the above studies show that NMDA
receptors play a necessary role in LTP induction, they do not address the question of whether NMDA
receptor activation is in itself sufficient. This issue is discussed in chapter 3.10.1.
During low frequency synaptic transmission, glutamate is released and binds to both AMPA and
NMDA receptors. The subsequent AMPA receptor activation causes an inward sodium current, and
cumulative activity at many synapses may result in postsynaptic depolarization, a situation that would
appear to be sufficient to cause NMDA receptor activation. However, the activation of GABA-ergic
interneurons rapidly repolarizes the cell, before the threshold for NMDA receptor activation is
reached. The role of GABAa receptors in LTP induction was first revealed by Wigstrom and
Gustafsson (1983), who found that bathing hippocampal slices in the GABAa antagonist picrotoxin
facilitated the induction of LTP, owing to an increase in postsynaptic depolarization. During
tetanization, a frequency-dependent depression of inhibitory transmission is observed, a result
attributed to a presynaptic GABAb receptor-mediated reduction in GABA release (Davies et al.,
1991). This reduction in inhibition allows further postsynaptic depolarization, and hence the opening
of the NMDA receptor channel, to proceed.
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2.4.5 Intracellular second messengers involved in LTP induction and expression
As mentioned above, the activation of NMDA receptors causes an influx of calcium into the
postsynaptic cell, an event that is believed to trigger a number of intracellular signalling cascades
leading to the expression of LTP. Early evidence that calcium is involved in LTP was provided by the
finding that injection of a calcium chelator, EGTA, into the postsynaptic cell prevented the induction
of LTP (Lynch et al., 1983). Calcium plays a central role in almost all forms of intracellular
signalling, and many of its targets are enzymes that trigger the production of other second
messengers. There is now evidence that the release of calcium from intracellular stores in addition to
calcium influx via the NMDA ionophore is necessary for the induction of LTP (see chapter 3.10).
The calcium activated kinase, protein kinase C (PKC) has been implicated in LTP by a number of
studies indicating that inhibitors of this enzyme block the induction of LTP, whilst sparing a short-
term potentiation lasting 20 to 90 min (Lovinger and al., 1987; Reymann et al., 1988 a, b; Malinow et
al., 1988). Inhibitors of the calcium / calmodulin-dependent protein kinase II (CaMKII) also block
LTP induction (Ito et al., 1991) as do calmodulin inhibitors (Reymann et al., 1988b; Malenka et al.,
1989). Furthermore, mice lacking the gamma isoform of PKC, or the alpha-subunit of CaMKII are
deficient in LTP (Abeliovich et al., 1993a; Silva et al., 1992a).
In addition to its direct actions on PKC and CaMKII, calcium stimulates the production of cAMP in
conjunction with calmodulin, by activating a calmodulin sensitive form of adenylate cyclase
(Chetkovich and Sweatt, 1993). However, the activation of dopaminergic inputs during strong
tetanization is also believed to be necessary in adult animals (Frey and Morris, 1998). The production
of cAMP leads to the activation of protein kinase A (PKA), a kinase implicated in the maintenance of
LTP. The application of PKA inhibitors within 1 hr of tetanization blocks a late phase of LTP that
normally develops 3-4 hr after tetanization (Frey et al., 1993; Matthies and Reymann, 1993). In
addition to a possible role in up-regulating AMPA receptor function (see below), PKA activates a
transcription factor, the cAMP response element binding protein (CREB) that interacts with the
cAMP response elements associated with certain genes, leading to their transcription (Yamamoto et
al., 1988). A role for gene expression in late LTP is suggested by the fact that the persistence of LTP
is substantially reduced by inhibitors of protein and mRNA synthesis (Frey et al., 1988; Abraham and
Otani, 1991; Nguyen et al., 1994; see also Frey and Morris, 1997).
Several other classes of kinase have also been implicated in LTP, such as tyrosine kinases (O'Dell et
al., 1991; Grant et al., 1992) and members of the mitogen activated kinase (MAPK) family (Bading
and Greenberg, 1991), a detailed description of which is beyond the scope of this thesis.
One mechanism by which LTP might be expressed is the up-regulation of postsynaptic glutamale
receptor function by phosphorylation (see section 2.4.6). For instance, CaMKII, and to a lesser extent
PKC, can directly phosphorylate the AMPA receptor (McGlade-McCulloh et al., 1993), and the
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application of PKA has been shown to cause an up-regulation of AMPA receptor functioning
(Greengard et al., 1991). In addition, an up-regulation of NMDA receptor function is believed to
result from phosphorylation by PKC (Ben-Ari et al., 1992).
2.4.6 The mechanisms and locus ofLTP expression
Although the induction of LTP is known to be controlled postsynaptically, and almost certainly
involves the activation of the intracellular signal transduction pathways discussed above, there is still
uncertainty about the locus of expression of LTP. For example, LTP could be expressed simply by an
up-regulation of AMPA receptor functioning, perhaps owing to phosphorylation by protein kinases,
as mentioned above. Alternatively, an increase in the number of AMPA receptors might occur, or
non-functional receptors might be converted from a "silent" to an "active" state (Kullmann, 1994;
Liao et al., 1995). However, it is equally possible that LTP is expressed by a sustained increase in
glutamate from the presynaptic terminal (Dolphin et al., 1992). Despite an intensive research effort
over the past few years, the locus of LTP expression remains uncertain.
Early studies failed to reveal an increase in the postsynaptic response to glutamate application after
tetanization, as was predicted by a postsynaptic locus of expression (e.g. Lynch et al., 1976).
However, Davies et al. (1989) found that the response of CA1 neurons to AMPA gradually increased
after LTP induction, reaching a peak roughly 2 hr after tetanization. The slow onset of this effect may
explain the negative results reported in previous studies. Further evidence suggesting a postsynaptic
locus was provided by the observation that following LTP induction, a selective increase was
obtained in the AMPA receptor-mediated component of the EPSP, whilst the NMDA-receptor
mediated component remained unchanged (Muller and Lynch, 1988; Muller et ah, 1988; Kauer et al.,
1988b; Kullmann, 1994). However, other groups have reported that both NMDA and AMPA-
mediated components of the EPSP can be equally increased following LTP induction, a result that is
consistent either with an identical postsynaptic increase in AMPA and NMDA receptor-mediated
currents, or with a presynaptic locus of expression (e.g. Clark and Collingridge, 1995). It is thought
that differences in the LTP induction protocol (i.e. pairing of presynaptic activity with postsynaptic
depolarization versus tetanization of afferents) may explain the discrepancies in data obtained by
different groups. However, the interpretation of such experiments is further complicated by the
suggestion that NMDA receptors may, under some circumstances, be activated by glutamate "spill¬
over" from adjacent synapses (Kullmann et al., 1996).
An alternative approach is to attempt to measure increases in glutamate release from the presynaptic
terminal, as predicted by a presynaptic locus of LTP expression. Using a variety of techniques, a
number of groups have reported an increase in glutamate release after the induction of LTP (e.g.
Dolphin et al., 1982; Bliss et al., 1986, 1990; Bekkers and Stevens, 1990a; Ghijsen et al., 1992).
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However, for unknown reasons, others have failed to observe an increase in glulamate release after
tetanization (Aniksztejn et al., 1989; Diamond et al., 1998; Liischer et ah, 1998). A further line of
evidence for a presynaptic contribution to LTP has been provided by studies of paired pulse
facilitation (PPF). This is generally regarded as a presynaptic phenomenon in which the response to
the second of a pair of pulses is enhanced when the pulses are delivered in quick succession. This
effect is believed to be caused by an increase in transmitter release in response to elevated presynaptic
calcium levels following the first pulse. Despite negative results in initial studies (e.g. McNaughton,
1982), changes in PPF have been reported during the first hour of LTP, suggesting that the induction
of early LTP, at least, may involve a change in the presynaptic machinery involved in
neurotransmitter release (e.g. Christie and Abraham, 1994; Schultz et al., 1994; Kleschevnikov,
1997). However, the suitability of PPF as an index of presynaptic release probability is questionable.
For instance, the PPF of NMDA receptor-mediated EPSCs has been found to be strongly dependent
on postsynaptic voltage, suggesting the involvement of postsynaptic mechanisms (Clark et al., 1994).
The debate concerning the locus of expression of LTP is far from being resolved. However, an issue
that arises from the possibility of a presynaptic mechanism of LTP expression concerns the need for
retrograde signalling between the postsynaptic terminal at which LTP induction occurs, and the
presynaptic terminal. The nature of this signal, presumed to be chemical, is currently uncertain. While
a number of small molecules have been implicated in this role, including nitric oxide, carbon
monoxide, and arachidonic acid, conclusive evidence is not available for any of these candidates, and
the nature of the retrograde messenger remains a controversial topic (for reviews see Williams, 1996;
Medina and Izquierdo, 1995).
2.4.7 Phases ofLTP
Analysis of the time course of LTP suggests that more than one underlying process is probably
involved. Following a brief tetanus, LTP (or STP; see following paragraph) develops within
approximately 30 s (Gustafsson and Wigstrom, 1990). However, strong tetanic tetanization results in
a superimposed "post-tetanic potentiation" (PTP), believed to be a pre-synaptic phenomenon similar
to paired-pulse facilitation. PTP is thought to result from an increase in release probability in response
to a transient elevation of calcium levels in the presynaptic terminal following tetanization (see
Zucker, 1993).
In parallel with this increase, a longer lasting NMDA-receptor dependent component, usually known
as short-term potentiation (STP) becomes evident. Opinions differ as to the duration of this phase,
and the mechanistic distinction between STP and LTP is similarly unclear. For instance, STP is often
spared by protein kinase inhibitors that block LTP (see section 2.4.7). However, other evidence
suggests that STP might be affected to the same extent as LTP by PKC inhibition (Hanse and
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Gustalsson 1994). It is possible that STP and LTP represent a continuum of plastic changes of
variable duration, depending on the strength of the induction parameters. Nevertheless, it has recently
been reported that STP and LTP do not occlude each other, and have differential effects on paired-
pulse facilitation, suggesting that the two forms of plasticity may indeed be expressed via different
mechanisms (Schulz and Fitzgibbons, 1997). This debate has still not been satisfactorily resolved.
The induction of LTP is, as described above, dependent on the activation of protein kinases.
However, LTP is often defined in more pragmatic terms as potentiation lasting for 1 hr or more.
However, a distinct, late phase of LTP (late LTP or L-LTP) has been identified by studies showing
that the application of protein and mRNA synthesis inhibitors limits the duration of LTP to
approximately 4 hr (Krug et al., 1984; Frey et ah, 1988; Otani and Abraham, 1989; Nguyen et ah,
1994; Frey et ah, 1996). The expression of both early and late forms of LTP may involve structural
changes at potentiated synapses (e.g. Buchs and Muller, 1996; Geinisman et ah, 1996; Voronin et ah,
1995).
2.4.8 The role of the hippocampal theta rhythm in synaptic plasticity
The hippocampal theta rhythm is manifested as a large amplitude, approximately sinusoidal EEG
oscillation of between 5-12 Hz in the behaving rat (see Vanderwolf et ah, 1975; Vinogradova, 1995
for review). Hippocampal complex spike cells have been observed to fire short bursts of action
potentials at a specific phase of the theta rhythm (Fox et ah, 1986). In area CA1 of freely moving rats,
there is evidence that bursting activity is associated with significant behavioural events in an olfactory
discrimination task, and a spatial learning task (Otto et ah, 1991).
A number of studies have reported that LTP is optimally induced using stimulation that mimics the
firing patterns associated with the endogenous theta rhythm. For instance, the delivery of short bursts
of 100 Hz stimulation at intervals of 200 ms results in very robust LTP lasting for several weeks in
vivo (Larson et ah, 1986; Rose and Dunwiddie, 1986; Staubli and Lynch, 1987). It was subsequently
found that a single priming pulse followed 140-200 ms later by a short burst of 2-10 pulses could
induce stable LTP, referred to as "primed burst" potentiation (Diamond et ah, 1988). It has been
suggested that the occurrence of a priming pulse 170-200 ms prior to a burst of high frequency
stimulation suppresses feed-forward inhibition and leads to the prolongation of EPSPs, which in turn
leads to substantial NMDA receptor activation (Arai and Lynch, 1992). A similar mechanism might
explain the robust LTP induced by theta burst stimulation.
It is found that LTP induction is facilitated in the presence of hippocampal theta (Bramham and
Srebro, 1989; Huerta and Lisman, 1993). It has also been reported found that LTP is preferentially
induced by burst stimulation on the positive phase of the theta rhythm in urethane-anaesthetized rats
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(Pavlides et al., 1988). Stimulation on the negative phase of theta had no effect, or resulted in a
depression of population spike amplitude. A similar result has subsequently been reported in CA1
slices bathed in carbachol in order to elicit a theta rhythm. The delivery of trains of single shocks
each locked to a positive theta peak was sufficient to induce LTP, whilst stimulation on the negative
phase had no effect, or occasionally induced LTD (Huerta and Lisman, 1993). It was subsequently
discovered using the same preparation that the delivery of either a single burst or a train of single
pulses phase-locked to the negative phase of theta could reliably induce a depotentiation of existing
LTP (Huerta and Lisman 1995, 1996a, b). Similarly, burst stimulation in CA1 in vivo has been
reported to result either in LTP or depotentiation, depending on its phase relationship to the tail
pinch-triggered theta rhythm (Holscher et al., 1997c).
These results suggest that the hippocampal theta rhythm may be involved in bi-directional
modifications of synaptic strength under physiologically plausible conditions (see chapter 8.5.1).
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2.5 Long-term depression (LTD) of synaptic efficacy
2.5.1 Classes ofLTD
Several forms of hippocampal LTD have been identified, including heterosynaptic LTD.
homosynaptic LTD and associative LTD. Associative LTD has been induced by the "anti-hebbian"
pairing of single pulses in the test pathway with the delivery of short high frequency trains to an
independent input (Stanton and Sejnowski, 1989). However, attempts to replicate these original
findings have generally not been successful (Paulsen et al., 1993; Kerr and Abraham, 1993; but see
Christie and Abraham, 1992). Heterosynaptic LTD is induced in inactive pathways following
activation of the postsynaptic neuron, or orthodromic activation of a separate input to the same
neuron, ft was first observed as a correlate of LTP in area CA1 in vitro (Lynch et al., 1977), but is
readily induced in the dentate gyrus in vivo (Levy and Steward, 1979; Abraham and Goddard, 1983).
The following section will concentrate entirely on homosynaptic LTD, the depression of synaptic
transmission in a single input pathway activated by low frequency stimulation. The related
phenomenon of homosynaptic depotentiation is discussed in chapter 8.1.
2.5.2 Induction of homosynaptic LTD in area CA1 in vitro
A number of studies have revealed that low frequency activation of the Schaffer collateral /
commissural fibres to area CA1 in vitro can lead to a lasting homosynaptic depression of synaptic
efficacy, known as long-term depression (LTD). The effect was first reported by Dunwiddie and
Lynch (1978) using 100 pulses at 1 Hz, although the depression that they observed was only recorded
for 5 min, and was not input specific. Later studies reported that the delivery of 900 pulses at 1-3 Hz
induces a sustained, input specific LTD (Dudek and Bear, 1992, 1993). Similar results have been
reported by many others (e.g. Mulkey and Malenka, 1992; Mulkey et al., 1993, 1994; Bolshakov and
Siegelbaum, 1994; Stevens et al., 1994; Kerr and Abraham, 1995; Wagner and Alger, 1995). Like
LTP. LTD is generally found to be saturable, reversible, and NMDA receptor-dependent.
Despite the fact that homosynaptic LTD was first reported in slices from adult rats (Dudek and Bear,
1992), most subsequent studies have used slices from immature animals. In fact, a number of groups
have reported a failure to induce homosynaptic LTD in slices from adult rats, suggesting that the
phenomenon may be of developmental significance only (Fujii et al., 1991; O'Dell and Kandel, 1994;
Bortolotto et al., 1994; Bashir and Collingridge, 1994; Otani and Connor, 1995). The age-dependence
of CA1 LTD has been attributed to a strengthening of GABAA-mediated inhibition during
development, and hence a reduction in NMDA receptor activation during low frequency stimulation
(Wagner and Alger, 1995).
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2.5.3 Induction ofhomosynaptic LTD in area CA1 in vivo
Considerable controversy surrounds the induction of homosynaptic LTD in area CA1 in adult rats in
vivo using trains of low frequency stimulation. LTD has been successfully induced in this way by two
groups (Heynen et al., 1996; Manahan-Vaughan, 1997; Manahan-Vaughan and Reymann, 1997b; see
chapter 9.4.4), but most report little or no effect (Barrionuevo et ah, 1980; Staubli and Lynch, 1990;
Thiels et ah, 1994; Errington et ah, 1995; Doyere et ah, 1996; Staubli and Scafidi. 1997; Doyle et ah,
1997). In fact, Errington et ah (1995), were only able to obtain LTD and depotentiation in the CA1
region of very young (10-11 day old) animals.
However, Thiels et ah (1994) found that LTD could be induced under urethane anaesthetic in vivo by
the delivery of low frequency (0.5 Hz) trains of paired pulses with a 25 ms inter-pulse interval. This
form of LTD was NMDA receptor-dependent and reversible. It was suggested that the efficacy of the
paired pulse protocol depends on the use of an inter-pulse interval equal to the delay of feedforward
and feedback inhibition. Hence, the EPSP generated by the second pulse of a pair coincides with the
IPSP generated by the first pulse, a circumstance proposed to result in LTD. This protocol has since
been found to induce LTD in area CA1 of freely moving rats (Doyere et ah, 1996).
Another method of successfully inducing LTD in area CA1 of adult rats in vivo has recently been
reported by Xu et ah (1997). The authors found that the exposure of rats to a stressful situation, a
procedure known to inhibit LTP (see chapter 9.4.5), facilitated the induction of LTD. This effect is
thought to be mediated by glucocorticoid receptor activation (Xu et ah, 1998a).
2.5.4 LTD ofperforant path-dentate gyrus synapses
LTD is less readily induced in the dentate gyrus than in area CA1. Low frequency stimulation has
been reported to induce LTD in dentate slices from young rats (O'Mara et ah, 1995a, b; Trommer et
ah, 1996; Huang et ah, 1997; Wang et ah, 1997). This form of LTD has been reported to be NMDA
receptor independent, but dependent on the activation of group II mGluRs (Huang et ah, 1997) and
calcium influx via low voltage activated calcium channels, together with the release of calcium from
intracellular stores (Wang et ah, 1997; O'Mara et ah, 1995b). However, low frequency stimulation
does not generally induce LTD in the dentate gyrus in vivo, either in immature (Errington et ah, 1995)
or adult rats (Abraham et ah, 1996).
In addition to trains of single pulses, the paired pulse protocol used with success in area CA1 in vivo
fails to induce LTD in the dentate gyrus in vivo (Doyere et ah, 1996; Thiels et ah, 1996). However, a
modified protocol involving the delivery of pairs of two-pulse bursts (inter-pulse interval = 2.5-5.0
ms; inter-pair interval = 15-25 ms) at a low frequency (0.5-2 Hz) resulted in a robust and lasting LTD
(Thiels et ah, 1996). The authors suggested that the use of very short inter-pulse intervals might have
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increased the NMDA receptor-mediated component of the EPSP (see Blanpied and Berger, 1992),
without compromising the paired pulse inhibition induced by the inter-pair interval of 15-25 ms. This
form of LTD was investigated in rabbits rather than rats, but could be induced both under anaesthetic
or in the freely moving state, and was NMDA receptor-dependent.
2.5.5 Mechanisms ofLTD induction and expression
Mulkey and Malenka (1992) found that postsynaptic calcium entry via NMDA receptors was
necessary for the induction of LTD. Other suggested sources of calcium entry include mGluR-
mediated calcium release from intracellular stores (Stanton et al., 1991), L-type Ca2+ channels
(Bolshakov and Siegelbaum, 1994) and low voltage-activated Ca2+channels (Wang et al., 1997).
It is well known that a large increase in calcium entry, such as that resulting from a high frequency
tetanus, is necessary for the induction of LTP, perhaps owing to the activation of Ca2+-dependent
protein kinases (see section 2.4.5). It has been proposed that a modest increase in postsynaptic
calcium levels, such as that resulting from low frequency afferent stimulation, causes LTD by the
selective activation of phosphatases (Lisman, 1989; Artola and Singer, 1993). In support of this idea,
the application of protein phosphatase inhibitors has been found to block the induction of LTD
(Mulkey et al., 1993, 1994) and depotentiation (O'Dell and Kandel, 1994).
However, a recent study used the photolysis of caged Ca2+ compounds to investigate the calcium
levels necessary to trigger LTP and LTD. No differences in the threshold for the induction of these
two processes were observed (Neveu and Zucker, 1996b). Nevertheless, fluorescence imaging of
postsynaptic calcium levels has revealed that low frequency stimulation induces a moderate calcium
influx, and causes LTD, whilst high frequency stimulation causes a larger calcium influx and LTP
(Schexnayder et al., 1997). Furthermore, it was found that manipulating the calcium influx shifted the
frequency-dependence of LTP and LTD. For instance, tetanization at 100 Hz normally resulted in
LTP, but in the presence of an L-type Ca2+ channel blocker, or low concentrations of APS, a more
modest increase in intracellular calcium was observed and LTD was obtained.
These contradictory results suggest that another factor is involved in the response to calcium during
afferent stimulation, compared to the situation resulting from intracellular calcium release by the
photolysis of caged chelators. This factor may be the spatial pattern of intracellular calcium changes
in response to afferent stimulation. It is likely that calcium influx and release from intracellular stores
occurs in a highly compartmentalized and regulated fashion. The notion that modest global calcium
increases result in LTD, whereas large increases result in LTP, although supported by
pharmacological and imaging studies, may be a great oversimplification of the truth.
27
One piece of evidence suggesting that the expression mechanisms of LTP and LTP share a common
target is provided by the fact that levels of protein kinase Mc (PKM£, a constitutively active fragment
of PKC) are increased following LTP induction, but decreased following LTD (Hrabetova and
Sacktor, 1996). However, data on the mechanisms and locus of expression of LTD are currently
inconclusive, and will not be discussed further.
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2.6 The relationship between hippocampal synaptic plasticity and the cellular mechanisms of
learning
2.6.1 Introduction
It is now widely assumed that LTP represents a memory mechanism, and numerous neural network
models of learning are based on changes in connection strength between "neuron-like" elements.
However, experimental support for a role of LTP-like processes in learning is mostly indirect and
often inconclusive. The following sections provide a review of some of the approaches that have been
used in an attempt to establish such a connection.
2.6.2 Learning-induced changes in synaptic efficacy
The most direct evidence for a link between LTP and learning would be provided by a demonstration
that learning is accompanied by an increase in synaptic efficacy. However, there are a number of
potential problems with this approach. In particular, it is likely that a learning-related change in
synaptic strength, if such a phenomenon exists, will occur in a small proportion of hippocampal
synapses only. Large changes in synaptic efficacy across whole populations of synapses, such as that
observed after LTP induction, would not represent an efficient mechanism of information storage.
Hence, naturally occurring LTP-like phenomena may be difficult to detect using field potential
recordings.
Early studies reported an apparent transient increase in synaptic strength associated with exploratory
behaviour in rats chronically implanted with stimulation and recording electrodes (Sharp et al., 1989;
Green et al., 1990). During exploration, a rise in EPSP slope was recorded, but values gradually
returned to baseline levels after rats were returned to their home cages. Paradoxically, however, the
population spike amplitude decreased during exploration. Nevertheless, others have failed to observe
learning-related changes in the EPSP (e.g. Cain et al., 1993)
A possible explanation for the initial positive results was suggested by Moser et al. (1993a), who
monitored brain temperature as well as field EPSPs in behaving rats. It was found that exploratory
activity was accompanied by a rise in brain temperature that paralleled the EPSP rise, and the fall in
population spike amplitude. Similar changes could be induced merely by passively warming the rats.
Note that a temperature increase causes a fall in population spike amplitude, a result attributed to the
reduced amplitude of individual action potentials, and a decrease in temporal summation (see
Andersen and Moser, 1995).
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However, after controlling for the temperature artifact, Moser et al. (1993b) identified a small
temperature-independent increase in the fEPSP during exploration. This component increased at the
start of exploratory activity, but fell back to baseline within about 15 min. This residual potentiation
may reflect a true learning-related increase in synaptic efficacy, although the effect was transient, and
may be an artifact of temperature-independent but movement-related neuromodulatory influences.
The measurement of changes in the fEPSP during exploration has not provided a definitive answer to
the question of whether learning results in increases in synaptic strength. An alternative approach has
been to investigate not whether behaviour induces LTP-Iike changes, but whether behaviour can
modulate existing LTP. For instance, Seidenbecher et al. (1995) investigated the effects of drinking 1
hr after a tetanus in water-deprived rats and non-deprived controls. The LTP induced by a strong
tetanus was not affected by drinking. However, the LTP resulting from a weak tetanus, not normally
sufficient to induce lasting potentiation, was facilitated by drinking in the water-deprived group only.
Subsequent work indicates that the hippocampal signal provided by drinking is noradrenergic in
nature (Seidenbecher et al., 1997). This result suggests that a motivationally significant event can
"rescue" LTP that under normal circumstances would have decayed back to baseline. If changes in
synaptic efficacy do indeed underlie learning, then such a mechanism may serve to preserve
motivationally significant information which might otherwise be lost.
2.6.3 The effects ofLTP saturation on learning
If changes in synaptic strength underlie the acquisition of new information, it should be possible to
block learning by driving synaptic strengths throughout the hippocampus to their maximum values.
Numerous studies have attempted to achieve this by saturating hippocampal LTP. It is worth noting,
however, that such an approach may be theoretically impossible. It is likely that the induction of a
large increase in synaptic efficacy will engage mechanisms designed to protect against excessive
excitation and epileptiform activity. Such protective mechanisms might include the occurrence of
LTD at some synapses, in conjunction with LTP at others. As such, a true saturation of LTP may be
unattainable.
It was initially reported that the saturation of dentate LTP with a course of high frequency tetanization
impaired the performance of rats in a circular platform task requiring the learning of a goal location
on the basis of extramaze cues (McNaughton et al., 1986). Similar results were subsequently obtained
in the watermaze (Castro et al., 1989). In this study, an additional group of rats, tested after the decay
of LTP back to baseline, learned normally. This result suggested that the impairment was unlikely to
be a result of permanent damage caused by repeated tetanization.
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However, subsequent attempts to replicate these findings, including one attempt from McNaughton's
own laboratory, have been unsuccessful (McNamara et al., 1992; Cain et al., 1993; Jeffery and
Morris, 1993; Korol et ah, 1993; Sutherland et ah, 1993). The reason for this discrepancy is unknown.
It is possible that the small number of animals used in the Castro et ah (1989) study resulted in a false
positive result.
The failure to obtain a block of learning in the above studies does not necessarily imply that
saturation of LTP has no effect on learning. For instance, tetanization at a single site within the
perforant path may fail to saturate LTP throughout the entire septotemporal extent of the
hippocampus, leaving sufficient residual plasticity for normal learning. Alternatively, the asymptotic
level of LTP regarded as the "saturation" point may not reflect the true maximal level of synaptic
efficacy attainable. The use of different tetanization parameters may result in a different maximal
level of LTP (see Jeffery et ah, 1993).
With respect to the first of the possibilities raised above, it has been reported that LTP saturation
contralateral to a unilateral hippocampal lesion does indeed cause a watermaze spatial learning deficit
(Mumby et ah, 1993). In a recent study, recording electrodes were implanted into the dorsal dentate
gyrus of rats which had previously received a complete hippocampal lesion contralateral to the
recording site (Moser et ah, 1998). A course of tetanic stimulation was delivered via two bipolar
stimulating electrodes straddling the perforant path. Saturation of LTP was assessed by tetanization at
a third stimulating site. In these animals, LTP saturation resulted in an impairment in the acquisition
of a watermaze spatial reference memory task, a result that provides some evidence that driving
synaptic strengths to their asymptote may indeed prevent further learning.
Such results must be interpreted with some caution. A widespread increase in synaptic efficacy
represents a potentially epileptogenic event. It is difficult to dissociate the role of LTP saturation on
learning from the possible role of compensatory responses to repeated tetanization, or the role of
neuroprotective mechanisms engaged by such activity. The demonstration that spatial learning is
normal after the decay of LTP would not provide sufficient evidence to counter such a claim, since
compensatory changes might also have subsided by this time. Hence, although the results of Moser et
al. (1997) provide arguably the strongest evidence to date, the link between LTP capacity and
learning capacity remains controversial.
2.6.4 Correlations between the magnitude ofLTP and learning ability
If both learning and LTP depend on the same mechanisms of synaptic plasticity, it is possible that the
saturated level of LTP in an individual rat may provide a general measure of the modifiability of
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synapses within that animal. On this basis, it might be predicted that the level of LTP would correlate
with learning ability, even if LTP saturation does not actually impair learning.
Such an association has indeed been reported by some researchers. For instance, Barnes (1979) found
a significant positive correlation between the level of dentate LTP induced by three daily sessions of
tetanization, and performance on the circular platform task mentioned in section 2.6.3. Young rats
were found to learn the task faster and with fewer errors than old rats, a difference that paralleled the
greater level of LTP induced in young rats after three days of tetanization. This difference in LTP was
attributed to a faster rate of decay between sessions in old rats. In a subsequent study, it was found
that the decay of LTP in both young and old rats paralleled forgetting as assessed by retention
performance (Barnes and McNaughton, 1985). Young rats remembered the task for longer and
showed more persistent LTP.
Consistent with this result, it was observed that in brain slices taken from rats previously trained in
the watermaze, the amount of CA1 LTP obtained after tetanization correlated with watermaze
performance (Kleschevnikov and Marchbanks, 1993). A similar result was reported by Jeffery and
Morris (1993) who found that the saturated level of dentate LTP in freely moving rats correlated with
subsequent watermaze performance. However LTP saturation did not itself impair learning.
Curiously, the correlation between LTP and performance was positive at high test pulse intensities,
but negative at low test pulse intensities. The reason for this paradoxical result is unknown (but see
Jeffery, 1995, 1997 for discussion).
However, the finding that LTP correlates with spatial learning does not prove that the two phenomena
are causally related. For instance, variability in a third factor that influences both LTP and learning in
a similar way might lead to a spurious correlation between the two variables. An example of such a
third variable is stress, a factor known to impair hippocampal LTP (e.g. Foy et al., 1987; see chapter
9.4.5) and learning (see McEwen and Sapolsky, 1995 for review). Hence, correlational data of the
type presented above provide only circumstantial evidence for the involvement of LTP-like
mechanisms in learning.
A slightly different approach is represented by attempts to identify biochemical changes associated
with both LTP and learning. For instance, an increase in presynaptic glutamate release has been
reported following both LTP (see section 2.4.6) and watermaze learning (Richter-Levin et ah, 1995;
McGahon et ah, 1996). In the latter study, it was found that watermaze training occluded the increase
in glutamate release normally observed after treatment of hippocampal synaptosomes with ACPD and
arachidonic acid (see chapter 3.8.2). This result suggests that an increase in presynaptic inositol
phospholipid metabolism may underlie the increase in glutamate release following learning. A similar
occlusion of the effects of arachidonic acid and ACPD on glutamate release has been observed after
LTP induction (McGahon and Lynch, 1994).
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More direct support for the notion that cellular mechanisms engaged by spatial learning resemble
those engaged by the induction of LTP was provided by the recent study of Richter-Levin et al.
(1997). In this experiment, rats were trained in the watermaze before the induction of LTP. 2 hr after
tetanization, rats were decapitated and dentate synaptosomes were prepared. Spatial training was
found to occlude the increase in glutamate release normally seen after LTP induction, whereas visible
platform training resulted only in a partial occlusion of the tetanus-induced increase in glutamate
release. These results provide additional evidence that LTP and learning activate a common pathway
in the up-regulation of glutamate release. However, such data do not constitute proof that this
common pathway is involved in learning: the finding that glutamate release increases following
spatial learning does not prove that the former phenomenon is necessary for the latter.
Glutamate release is not the only cellular mechanism activated by both spatial learning and LTP
induction. It has been reported that a correlation exists between PKC activity and spatial learning in
different strains of mice (Wehner et al., 1990). It has also been found that watermaze training in rats
causes an increase in presynaptic PKC activation which occludes the increase normally induced by
co-application of ACPD and arachidonic acid (McGahon et al., 1996). Whilst not providing direct
proof of a link between LTP and learning, further data obtained using this approach may ultimately
bring us closer to the conclusion that LTP and learning are indeed supported by similar cellular
mechanisms.
2.6.5 Studies involving the use ofperforant path tetanization as a CS
A number of studies have been conducted in which a perforant path tetanus served as the conditioned
stimulus (CS) in an associative learning task. However, results obtained using this novel approach
have proved difficult to interpret.
In one such study, perforant path tetanization was used as the CS signalling footshock in a
conditioned suppression task (Laroche et al., 1989). In rats that learned the task, robust LTP
developed, but both learning and LTP could be prevented by the application of NMDA receptor
antagonists or by sub-threshold tetanization. A later study revealed that the forgetting of such a task
assessed by retention testing paralleled the decay of LTP; i.e. a rapid decay of LTP was associated
with poor retention performance. However, the induction of LTP in the perforant path may simply
constitute an increase in the salience of the CS, in which case the apparent parallel between LTP and
learning may simply be an artifact of the fact that the level of LTP induced and CS intensity are
confounded (see leffery, 1997 for discussion of this issue).
However, it has also been reported that stimulation at a lower frequency normally not sufficient to
result in a change in synaptic efficacy can induce an increase in EPSP slope when paired with
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footshock (Matthies et al., 1986). In this experiment, a 15 Hz tetanus served as the CS in a shock-
motivated shuttlebox active avoidance task. Good learners showed a greater increase in the EPSP
than poor learners. However, similar criticisms apply to this study as to the correlational studies of
LTP and learning discussed in section 2.6.4. In particular, the fact that poor learners necessarily
received more shocks might have resulted in increased stress, a factor known to impair LTP.
Hence, studies in which the tetanus is used as a CS have so far failed to provide convincing evidence
for the mechanistic equivalence of LTP and learning.
2.6.6 Pharmacological modulation ofsynaptic plasticity and learning
If the cellular mechanisms of LTP are identical to the cellular mechanisms of learning, an obvious
prediction is that the pharmacological blockade of LTP should prevent learning. Almost every
element in the LTP induction cascade has been targeted in order to test this prediction. The
pharmacological modulation of mGluR function is discussed in chapter 3.12. However, the following
section will concentrate only on those studies involving blockade of the NMDA receptor.
Morris et al. (1986a) provided the earliest report that the blockade of NMDA receptors could impair
learning. It was found that chronic intraventricular infusion of the NMDA antagonist AP5 impaired
the acquisition of a watermaze reference memory task, whilst having no effect on the performance of
a visual discrimination task. These results are reminiscent of those obtained following hippocantpa!
lesions (Morris et al., 1982, 1986b) Consistent with previous studies, chronic AP5 infusion was also
found to block dentate LTP.
A subsequent study revealed that the application of AP5 after watermaze training did not affect the
retrieval of previously learned spatial information (Morris, 1989). The results of this study, in
conjunction with those of Morris et al. (1986a), imply that NMDA receptor activation is necessary for
the acquisition, but not the subsequent recall of spatial information. Furthermore, the absence of an
impairment in the expression of previous learning suggests that the acquisition deficit induced by
AP5 application is unlikely to be an artifact of general sensorimotor dysfunction. In a further
experiment, the effect of AP5 on spatial reversal learning was investigated. Rats were trained to a
fixed platform location in the absence of any drug treatment. The animals were then divided into four
groups. Two groups were implanted with osmotic minipumps containing aCSF; the other two were
implanted with pumps containing 30 mM D-AP5. One AP5 group and one aCSF group were tested
for their ability to locate the original platform. The other two groups were trained to locate a platform
in a novel position. AP5-treated rats were unimpaired relative to controls in locating the original
platform position, confirming the absence of an AP5-induced retention deficit. However, AP5 infused
rats learned the novel platform position more slowly than controls (Morris, 1989). At face value,
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these results provide further evidence that under closely matched experimental conditions, NMDA
receptor activation is only necessary for the acquisition of new information. However, it is also
possible that AP5 impaired learning of the new platform location by causing maladaptive and
indexible perseverative searching in the original platform location (see chapter 5.1.2).
The studies discussed above provide evidence that intraventricular AP5 infusion causes a selective
impairment in the acquisition, but not the retrieval, of spatial information. In order to provide
convincing evidence that the blockade of NMDA receptors within the hippocampus itself is
responsible for the AP5-induced deficit, acute intrahippocampal infusions are preferable to chronic
i.c.v. administration of the drug. Owing to its elongated structure, the hippocampus is not an ideal
target for drug injection at a single site. However, fibre tracts that border the hippocampus, e.g. the
alveus, help to prevent drug infusion into adjacent structures (Morris et al., 1989). Moreover, the
dorsal hippocampus appears to be more important for spatial learning than the ventral portion,
suggesting that it may not be necessary to attain high drug concentrations in the relatively
inaccessible ventral region of the structure (Moser et ah, 1993c). In order to estimate the likely spread
of AP5, Morris et al. (1989) injected radiolabeled [3H] D,L-AP4 and [3H] D,L-AP7 directly into the
hippocampus. Diffusion of these drugs was reasonably well confined to the hippocampus, with the
density of the radiolabel falling sharply at the boundaries of the hippocampus. Similar results have
recently been obtained with [3H] D-AP5 (Steele and Morris, 1999).
Consistent with the idea that blockade of hippocampal NMDA receptors is responsible for the
watermaze deficit, animals given acute intrahippocampal infusions of AP5 are similarly impaired to
those given i.c.v. infusions. Morris et al. (1989) tested rats on a standard watermaze reference
memory task, consisting of 8 trials per day for three days, followed 24 hr later by a transfer test with
the platform absent. 15 min prior to each testing session, rats were given an acute infusion of D,L-
AP5. Drug-treated rats took longer than controls to find the platform during acquisition, and
performed at chance in the transfer test. Acute intrahippocampal infusion of D-AP5 has subsequently
been found to impair performance in a delayed matching-to-place task in the watermaze (Steele and
Morris, 1999; see below).
The selective AP5-induced block of memory formation but not expression (Morris et al., 1986a;
Morris, 1989) parallels the effects of AP5 on the induction, but not the expression of LTP (Davies
and Collingridge, 1989). Furthermore, it was reported that the dose response profile of the AP5-
induced learning impairment parallels that of the LTP blockade in vivo, such that no dose of AP5 can
block LTP without also affecting learning (Davis et al., 1992). Estimates of extracellular AP5
concentrations obtained by microdialysis suggested that the effective concentration of AP5 was
similar to that necessary to block LTP in vitro.
Taken as a whole, the results described so far would seem to constitute robust evidence that
hippocampal NMDA receptor-dependent synaptic plasticity is necessary for spatial learning.
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However, such a view is not universally accepted. For instance, AP5 infusion is associated with
sensorimotor disturbances, a finding that has led some researchers to question whether the argument
for a learning impairment is valid, despite the variety of control tasks carried out (e.g. Keith and
Rudy, 1990; Cain et al., 1996). This issue is discussed in some detail in chapter 5.1.
However, even if the AP5 distribution could be limited exclusively to the hippocampus, at a
concentration sufficient to block LTP, and without causing sensorimotor deficits, the possibility
remains that a learning impairment might result from NMDA receptor-mediated actions which are
separable from the role of NMDA receptors in LTP. For instance, AP5 has been reported to decrease
hippocampal theta, although this effect is only seen at high doses that cause marked sensorimotor side
effects (Leung and Desborough, 1988). However, moderate doses of AP5 have been found to reduce
cell excitability as indicated by the population spike of the extracellularly recorded evoked potential
(Errington et al., 1987; Abraham and Mason, 1988; S. J. Martin, unpublished observations). In
addition, it has been reported that hippocampal complex cell firing is impaired by NMDA receptor
antagonists (Abraham and Kairiss, 1988). This raises the possibility that NMDA receptors may be
involved in the routine functioning of the hippocampal circuitry, in addition to their role in synaptic
plasticity (see Bekkers and Stevens, 1990b). This possibility can never be ruled out in behavioural
studies involving pharmacological NMDA receptor blockade. The aim of most such studies is merely
to confirm that NMDA receptor antagonists impair performance in tasks such as the watermaze by
selectively disrupting learning, whilst sparing all other behavioural processes.
In addition to the critical interpretation of existing data, new experimental evidence has further
complicated the story. Bannerman et al. (1995) found that when rats were given spatial pre-training in
one watermaze prior to minipump implantation and postoperative spatial training in a second maze,
the delivery of AP5 had almost no effect on postoperative learning. However, rats given non-spatial
pre-training were still impaired when tested in the second watermaze during AP5 infusion. In
contrast, rats given hippocampal lesions after training in the first watermaze were severely impaired
postoperatively, regardless of the type of pre-training given. These results suggest that the activation
of NMDA receptors is not necessary simply for the learning of a single platform location, once other
task demands have been learned. Note that the integrity of the hippocampus is still required under
these circumstances. The nature of these "other task demands" remains unclear. Saucier and Cain
(1995) have reported that merely training undrugged rats on a non-spatial task results in unimpaired
spatial learning in the same pool after administration of AP5. The interpretation of these data is
difficult and controversial (see Morris et al., 1996). Nevertheless, it is clear that NMDA receptor
activation is not, as previously thought, required for all forms of place learning.
However, spatial reference memory tasks may not provide a very sensitive index of learning ability.
A more conventional way to assess memory impairments, and to dissociate memory from non-
mnemonic performance factors, is to look for a delay-dependent effect of the treatment in question.
Cole et al. (1993) studied the effects of the competitive NMDA receptor antagonist CPP and the non-
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competitive antagonist MK-801 in an operant delayed matching-to-position task, with delays between
0 and 30 s (see Dunnett, 1985). Administration of CPP caused a delay-dependent impairment in
matching-to-position performance, with no deficit at the 0 s delay. However, MK-801 produced a
delay-independent impairment. These results suggest that whereas CPP genuinely impairs memory,
MK-801 causes a performance deficit at all delays. Furthermore, a perseverative deficit can be ruled
out in the case of CPP, since such a deficit would be expected to affect all delays equally. However,
impaired performance under MK-801 was associated with an increased speed of responding,
consistent with either a perseverative deficit, or a stimulant action of the drug.
Similar results have been obtained with MK-801 and the competitive NMDA receptor antagonist
CGS 19755 in a spatial working memory task carried out in the 8-arm radial maze (Li et al., 1997).
All arms were baited, and rats were trained to a predetermined criterion for collecting all rewards
without re-visiting arms. At this point drug treatment was started. In one session, a 5 min delay was
imposed between the third a fourth arm choices; in a subsequent session, no delay was introduced.
Application of both drugs resulted in a deficit in the delay condition only, with no impairment in the
non-delay task.
The recent development of a novel task has enabled the investigation of delay-dependent effects in
the watermaze. Steele and Morris (1999) trained rats to find a novel platform position on each day of
training; the platform position remained constant within each daily session. Hence the performance
on trial 2 of each day constitutes a matching-to-place task, in which the rat must remember the
location of the platform presented on trial 1 after variable delays. It was found that rats infused with
D-AP5 via chronic i.e.v. minipumps were unimpaired at the shortest delay of 15 s between trials 1 and
2. However, if 20 min or 2 hr were allowed to intervene, AP5-treated rats were amnesic. This result is
hard to interpret as anything other than a memory impairment, although one possible criticism of both
the above study and that conducted by Cole and colleagues concerns the treatment of animals during
the delay period. Cole et al. (1993) returned the rats to their home cages during the 5 min delay
period, whereas no equivalent manipulation occurred in the non-delay period. In an attempt to control
for such factors, Steele and Morris (1999) returned rats to their home cages after trial 1 at all delays.
However, the cages were returned to the animal room during the 20 min and 2 hr delay periods, but
obviously not during the 15 s delay. This change in context between different delays might account
for an apparent delay-dependent effect. However, a subsequent study was carried out using 15 s and 2
hr delays only. During each of these delay periods, rats remained in the watermaze room. Under these
circumstances, a delay-dependent effect was still observed, ruling out the possibility that the result
might be an artifact of a change in context between delays (Steele and Morris, 1999).
It is not immediately obvious how these results can be reconciled with the findings of the two-pool
study carried out by Bannerman et al. (1995). In the matching-to-place study, rats received extensive
spatial pretraining in the same pool in which they were tested during AP5 infusion. However, a deficit
in matching-to-place performance was still observed, despite the fact that, before minipump
37
implantation, rats had clearly learned all aspects of the task except the daily requirement to remember
a novel location. This result apparently contradicts that of the two-pool study in which spatial pre-
training in one environment was sufficient to allow NMDA receptor-independent place learning in a
novel environment. The reason for this apparent discrepancy is unclear, although the demands of the
two tasks are very different. For instance, in the matching-to-place task, single trial leaning of a novel
location is required on each day, compared to the one trial per day learning of a fixed location
required in the postoperative phase of the two pool study. It is possible that the former task makes
considerably greater demands on hippocampal synaptic plasticity than the latter task, which simply
requires the gradual cumulative learning of a single platform location.
Despite this apparent discrepancy, the results of Steele and Morris (1999) provide strong evidence
that NMDA receptor activation is necessary for the formation of spatial memories, at least under
some circumstances. Furthermore, it is very unlikely that non-mnemonic factors such as sensorimotor
or motivational effects of AP5 infusion can account for the delay-dependent deficit observed. As
mentioned above, a role of NMDA receptors in learning does not necessarily imply that synaptic
plasticity is involved in learning. The inference is merely correlational. However, whilst not proving
the hypothesis, the finding that NMDA receptor antagonists cause a delay-dependent deficit in spatial
learning provides some of the strongest current evidence suggesting a link between hippocampal
synaptic plasticity and learning.
2.6.7 Targeted disruption ofgenes coding for proteins involved in the induction or expression ofLTP
Recent advances in transgenic technology have provided the possibility of targeted gene disruption as
an alternative to pharmacological intervention in studies of LTP and learning. For instance, mice
lacking the a subunit of CaMKII (see section 2.4.5) showed a spatial learning deficit in the
watermaze, and a deficit in LTP in vitro (Silva et al., 1992a, 1992b). Normal synaptic transmission
was unaffected, and although mutant mice were initially impaired on a visible platform task, they
eventually caught up with wild-type animals by the fifth block of training trials. Similar behavioural
and electrophysiological results have been obtained with mice deficient in thtfyn gene which codes
for a non-receptor tyrosine kinase (Grant et al., 1992).
A large number of gene knockout mice have now been produced, and many have undergone
electrophysiological and behavioural testing. For instance, mice deficient in the y subunit of PKC
show a very mild impairment in spatial learning, but show a profound impairment in CA1 LTP
(Abeliovich et al., 1993a and b). However, further investigation revealed that if preceded by the
delivery of priming stimulation consisting of 900 pulses at 1 Hz, normal LTP was obtained following
tetanization. The mechanism of this priming effect is unknown. Similarly, mice deficient in Th.y-1, a
neuronal cell adhesion molecule, are unimpaired in the watermaze, but are severely deficient in
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dentate LTP in vivo under anaesthetic (Nosten-Bertrand et al., 1996). However, it was found that
local disinhibition restored the capacity for normal LTP. A subsequent study revealed that dentate
LTP, although still impaired, could be obtained without disinhibition in freely moving Thy-1 mutant
mice (Errington et al., 1997). These results illustrate a serious difficulty in drawing parallels between
LTP and learning after an experimental manipulation. If a treatment results in a block of LTP, there is
always a possibility that under another set of circumstances such a block might not be obtained. The
converse is, of course, also true (see chapter 3.10.5). Hence, the question of whether synaptic
plasticity is available to a behaving animal may be very difficult to answer on the basis of
conventional LTP experiments.
In addition to the general problem outlined above, there are a number of problems specific to the use
of genetic techniques. For instance, none of the mutations described above is restricted to the
hippocampus, and all are present throughout development. Hence, the possibility that learning
impairments, if found, are not hippocampal in origin cannot be ruled out. For instance, it has been
reported that fyn mutant mice tend to spend much of their time floating in the watermaze without
swimming, a behaviour which increases escape latencies. However, lightly touching the hind feet of
the mutants at the start of a trial resulted in improved swimming, and normal spatial learning (Huerta
et al., 1996; note, however, that this study was based on a sample of only 6 mice per group).
An additional complication concerns the possibility that the absence of a gene product throughout
development may result in unpredictable structural and functional changes in the brain. For instance,
fyn mutant mice have an increased number of dentate granule cells and CA3 pyramidal cells, resulting
in abnormalities in hippocampal morphology, the functional significance of which is unknown.
It is possible that abnormalities in transgenic animals may result either from the absence of some
function performed by the normal gene product during development, or from compensatory changes
occurring in response to the absence of this protein. With respect to the latter possibility, it is likely
that during development in the absence of a gene coding for a specific protein, upregulation of genes
coding for related proteins or alternative isoforms may occur. It has often been remarked that the
deficits resulting from gene knockouts are surprisingly mild considering the apparent importance of
the gene deleted. For instance, the CaMKII protein constitutes approximately 2 % of the total
hippocampal protein context, yet the effects of its deletion are comparatively subtle. It is possible that
compensatory changes of the sort proposed may explain this finding. If such compensatory changes
are routinely induced by gene knockouts, the absence of a deficit cannot be taken as conclusive
evidence that the deleted gene normally plays no role in the function investigated. Conversely, the
presence of an abnormality in a mutant may reflect the activation of compensatory mechanisms,
rather than the absence of the gene under investigation. For a discussion of such issues, together with
the addition problem of genetic background, see Gerlai (1996a and b) and Routtenberg (1995).
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Recent technological advances have overcome the problem of developmental defects to some extent.
A transgenic mouse has recently been developed in which the aCaMKII gene is mutated resulting in
a Ca2+-independent CaMKII enzyme. Expression of this mutation results in a systematic shift in the
relationship between tetanus frequency and LTD / LTP, such that LTP is deficient at low frequencies
(Mayford et al., 1995). A further transgenic strain was developed in which expression of the CaMKII
transgene could be temporarily suppressed. These mice exhibited deficient LTP at low tetanus
frequencies, and were impaired in spatial learning. However, these deficits were reversed after the
transgene was turned off (Mayford et ah, 1996). These results suggest that the abnormalities in
hippocampal function do not result from developmental disturbances caused by the mutation.
Subsequent experiments have revealed that these activated CaMKII mice have less well-defined CA1
place fields, with lower peak firing rats than wild-type animals, a fact which might contribute to the
spatial learning deficit (Rotenberg et ah, 1996).
By combining the Cre-loxP recombination system with embryonic stem cell targeting technology, a
knockout mouse has recently been created in which the gene coding for the NMDAR1 subunit is
selectively deleted in CA1 pyramidal cells and only from the third week of postnatal life onwards,
thus avoiding most potential developmental changes (Tsien et al., 1996a). These mice lack an NMDA
receptor-mediated EPSC and do not exhibit CA1 LTP or LTD, although dentate LTP is unimpaired.
Furthermore, mutant mice fail to show a bias towards the training quadrant in a watermaze transfer
test following reference memory training (Tsien et al., 1996b). A subsequent study revealed that CA1
place fields in these mice were larger than those in controls and tended to have multiple peaks. In
addition, cells with overlapping place fields failed to show normal temporal firing correlations
(McHugh et al., 1996).
To conclude, studies involving the disruption of genes thought to be involved in synaptic plasticity
have generally provided ambiguous evidence about the role of synaptic plasticity in learning, and in
some cases have highlighted methodological difficulties in demonstrating such a relationship.
However, the so-called "second generation" knockouts of Mayford et al. (1996) and Tsien et al.
(1996a) offer a glimpse of the possibilities of this new technology. The arrival of fully inducible and
regionally specific gene knockouts is likely to provide an extremely powerful tool for future studies
of LTP and learning.
2.6.8 Summary
Despite all the evidence presented in this section, it is still impossible to provide a definitive answer
to the question of whether the processes engaged by the induction of LTP are the same as those
involved in learning. While pharmacological and gene targeting studies have provided fairly
convincing evidence that elements of the cellular machinery, such as NMDA receptors, are necessary
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for both LTP and learning, the problem remains that such evidence is merely correlational, and does
not imply a causal relationship between the mechanisms of LTP and those of learning. A similar
problem applies to demonstrations that the level of LTP that can be induced in an animal correlates
with its learning ability.
The observation of LTP-like changes in synaptic efficacy during learning would constitute stronger
proof of a causal relationship. However, attempts to identify learning-related increases in fEPSPs
have met with little success, and may be doomed to failure on a priori grounds. The possibility of
identifying LTP between pairs of individual neurons in vivo with unit recording techniques, whilst
technologically daunting, may provide one way forward. Alternatively, it may be possible to devise
an experimental manipulation that selectively targets recently potentiated synapses, then test the
effects of this manipulation on memory recall (see chapter 8). At present, however, despite its
theoretical plausibility, the hypothesis that memories are stored as changes in synaptic strength has
proved impossible either to confirm or to refute.
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Chapter Three
Metabotropic glutamate receptors (mGluRs):
pharmacology, physiology and function
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3.1 Introduction
The role of the NMDA receptor in hippocampal synaptic plasticity and spatial learning was
discussed in the previous chapter (see sections 2.4.4 and 2.6.6). However, much of the experimental
work described in this thesis concerns the role of the more recently identified metabotropic glutamate
receptor (mGIuR).
The experiments described in chapter 6 represent an attempt to characterize, in our hands, the effects
of mGIuR blockade on performance in a standard behavioural paradigm, the watermaze reference
memory task. The effects of mGIuR antagonism on LTP are then assessed in chapter 7. The mGIuR
antagonist used throughout, (R,S)-MCPG, is not ideal for reasons discussed in sections 3.6.3, 3.10.6,
and 3.10.7. However, few other selective mGIuR antagonists were available at the time when the
experimental work was started, and a small literature concerning the effects of this drug on spatial
learning tasks other than the watermaze already existed. In addition, the use of MCPG was
considered preferable to newer drugs with higher apparent subtype specificity and potency in
expression systems, but whose pharmacological properties in vivo were even less well characterized
than those of MCPG.
The following chapter provides an overview of the role of mGluRs in hippocampal functioning,
synaptic plasticity and learning. Basic aspects of mGIuR physiology and pharmacology are
introduced in sections 3.2-3.8 of this chapter. The remaining sections cover aspects of the literature
which are more directly related to the experimental work described later in this thesis. For instance,
section 3.9 on the role of mGIuR activation in various forms of synchronous hippocampal activity,
and section 3.11 on slow-onset potentiation, have been included to provide a background to the work
with the mGIuR agonist (lS^RFACPD in chapter 7.5. The sections on mGluRs and synaptic
plasticity and learning (3.10 and 3.12) are directly relevant to work carried out in chapters 6 and 7.
Particular emphasis is placed on studies involving the mGIuR antagonist, (/?,S)-MCPG, a drug used
throughout a large part of this thesis.
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3.2 The discovery of mGluRs
Fast excitatory synapses in the mammalian central nervous system use L-glutamate as a
neurotransmitter. The receptor-mediated actions of glutamate were until recently thought to be
confined to the direct gating of cation channels, although glutamatergic transmission was known to
be modulated by the release of neurotransmitters such as dopamine, serotonin, acetylcholine, and
noradrenaline from extrinsic afferent projections. These compounds exert their effects by activating
G-protein-coupled receptors linked to intracellular second messenger cascades. However, Sladeczek
et al. (1985) discovered that glutamate could itself stimulate inositol 1,4,5-trisphosphate (IP3)
formation in cultured striatal neurons. A similar glutamate-mediated stimulation of IP3 synthesis was
subsequently demonstrated in the Purkinje cells of the cerebellum (Nicoletti et al., 1986a) and many
other parts of the brain, including the hippocampus (Nicoletti et al., 1986b). Experiments in which
Xenopus oocytes were injected with rat brain mRNA confirmed that this effect is dependent upon the
direct activation of an expressed receptor, and not simply a consequence of membrane depolarization
or calcium influx (Sugiyama et al., 1987). Activation of the glutamate receptor in these oocytes
induced a calcium-dependent chloride current. This is known to be characteristic of G-protein-linked
receptors which couple to phospholipase C and cause the breakdown of phosphoinositides, resulting
in the formation of the protein kinase C activator diacylglycerol (DAG), and IP3 which promotes the
release of intracellular calcium. This new class of G-protein-coupled glutamate receptor became
known as the "metabotropic glutamate receptor" or mGluR.
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3.3 Cloning of the mGluR receptor family
The mGluR family consists of a number of subtypes, 8 of which have been cloned to date
(Nakanishi, 1992; Pin and Duvoisin, 1995). The first mGluR, now known as mGluR la (or oc), was
independently cloned by two groups (Masu et ah, 1991; Houamed et al., 1991). The deduced amino
acid sequence revealed a receptor much larger than previously identified G-protein-coupled
receptors, and sharing little sequence homology with them. Seven other genes encoding mGluRs
have since been identified, together with a number of splice variants. (Note that the splice variants of
all mGluR subtypes are hereafter identified by Roman characters only, despite the common practice
of using Greek letters to identify splice variants of mGluRl.) In common with other G-protein-
coupled receptors, mGluRs consist of 7 transmembrane domains. However, ligand binding does not
occur in this region, but on an uncharacteristically large N-terminal extracellular domain (Takahashi
ct al., 1993).
mGluRs can be classified into 3 groups according to their amino acid sequence homology. Group I
comprises mGluRs 1 and 5, group 2 comprises mGluRs 2 and 3, and group 3 comprises mGluRs 4,
6, 7 and 8. Within group sequence identity is roughly 70 %, whilst between group identity is about
45 % (Pin and Duvoisin, 1995). The mGluRs have little sequence homology with most other G-
protein-coupled receptors, although they do show significant homology with the GABAb receptor
(Kaupmann et al., 1997) and a parathyroid Ca2+-sensing receptor (Garret et al., 1995).
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3.4 Regional and sub-cellular distribution of mGluRs
Metabotropic glutamate receptors are heterogeneously distributed throughout the brain. In situ
hybridization and immunolabelling studies have revealed that the various mGluR subtypes show
distinct but overlapping profiles of regional and sub-synaptic localization, consistent with the
different roles which members of the mGluR family are believed to play. The approximate sub¬
cellular localization of the three mGluR groups is illustrated in figure 3.5.
3.4.1 Group I mGluRs
In adult rats, the mRNA for mGluRl is most prominently expressed in cerebellar Purkinje cells.
However, while numerous moderately labelled cells are found in the dentate gyrus, expression in
CA1 is weak (Masu et al., 1991; Shigemoto et al., 1992). Similar results have been obtained by
immunoblotting with an anti-mGluRla antibody (Martin et ah, 1992). Hippocampal labelling was
localized to non-pyramidal cells, particularly those in the polymorph layer of the dentate gyrus, and
the stratum oriens of CA1. Subsequent studies have confirmed that mGluRla immunoreactivity is
largely confined to somatostatin-containing GABAergic interneurons (Baude et ah, 1993; Lujan et
ah, 1996).
However, the alternative splice variants mGIuRlb and / or c have been detected on principal cells of
the hippocampus: the pattern of immunoreactivity for an antibody which binds to all three splice
variants included pyramidal cells of CA3 and dentate granule cells, in contrast to mGluRla labelling
which was confined to interneurons. CA1 pyramidal cells were not labelled, even by the pan
mGluR 1 antibody (Lujan et ah, 1996).
In situ hybridization with an mGluR5 mRNA-specific probe has revealed high expression in many
brain areas, including pyramidal cells throughout Ammon's horn, and dentate granule cells. Hence,
group I mGluR actions in CA1 are likely to be mediated by mGluR5, rather than mGluRl, which is
largely absent. Immunohistochemical studies have confirmed this pattern of distribution (Shigemoto
et ah, 1993). Overall levels of mGluR5 receptor protein correlate well with developmental changes in
agonist-stimulated PI turnover in brain slices, suggesting that this receptor mediates the major
component of the phosphoinositide response (Casabona et ah, 1997b).
Electron microscopic examination of immunogold-labelled hippocampal slices has revealed that
group I mGluRs are localized postsynaptically on dendritic spines. mGluRs 1 and 5 are concentrated
at perisynaptic sites, adjacent to the postsynaptic specialization (Baude et ah, 1993; Nusser et ah,
1994; Lujan et ah, 1996). However, some pre-synaptic immunoreactivity for mGluR5 was reported
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by one group (Romano et al., 1995). Biochemical evidence also suggests the existence of a
presynaptic group I-like mGluR (Herrero et al., 1992; see section 3.8.2)
3.4.2 Group II mGluRs
mGluR2 is most heavily expressed in the Golgi cells of the cerebellar cortex. Within the
hippocampus, mGluR2 mRNA is prominent in the dentate gyrus, but is absent in Ammon's horn.
Pyramidal cells of the entorhinal cortex are also heavily labelled (Ohishi et al., 1993a; Fotuhi et al.,
1994). Immunoreactivity to the mGluR2 receptor protein is localized to perforant path fibres from
the entorhinal cortex to the stratum lacunosum-moleculare of the dentate gyrus and CA1-CA3, and
the mossy fibres from dentate granule cells to the stratum lucidum of CA3, consistent with the
suggested role of mGluR2 as a presynaptic autoreceptor in these pathways (Neki et al., 1996;
Shigemoto et al., 1997).
hi situ hybridization signals for mGluR 3 have been detected not only in neurons, but also in many
glial cells throughout the brain. In the hippocampus, dentate granule cells are weakly labelled, but
mGluR3 is absent in Ammon's horn; moderate to weak expression is also seen in the entorhinal
cortex (Ohishi et al., 1993b; Tanabe et al., 1993).
Curiously, electron microscopic examination of group II mGluR immunogold-labelled sections
reveals an extrasynaptic concentration of reactivity, with little labelling within the pre-synaptic
membrane specialization, suggesting that group II mGluRs may only be activated after the
accumulation of glutamate during, for instance, repeated stimulation of afferents (Shigemoto et al.,
1997).
3.4.3 Group III mGluRs
Of the four members of group III, only mGluRs 4, 7, and 8 are expressed in the hippocampus:
mGluR 6 is preferentially localized to retinal ON bipolar cells (Masu et al., 1995). mGluR4 is most
highly expressed in cerebellar granule cells, but weak expression has been reported in a number of
hippocampal areas (Kristensen et al., 1993; Tanabe et al., 1993; Ohishi et al., 1995).
Immunolabelling for mGluR4a is generally weak in the hippocampus, but prominent in the inner
third of the dentate molecular layer, corresponding to the termination zone of the associational /
commissural fibres, suggesting an autoreceptor role for mGluR4a in this pathway (Shigemoto et al.,
1997). A second splice variant, mGIuR4b, has recently been characterized, but its pattern of
expression is currently unknown (Thomsen et al., 1997).
In contrast to mGluR4, prominent expression of mGluR7 has been reported in dentate granule cells
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and in the pyramidal cell layer throughout Amnion's horn (Ohishi et al., 1995; Kinzie et al., 1995).
Two splice variants of mGluR7 have been identified. Immunolabelling has revealed that mGluR7a is
prominent on interneurons in the stratum oriens, radiatum and lacunosum-moleculare of both CA1
and CA3. No labelling is observed on pyramidal cells. In the dentate gyrus, labelling is intense in the
middle third of the molecular layer, corresponding to the termination zone of the medial perforant
path, consistent with an autoreceptor role for mGluR7a in this pathway.
Expression of mGluR8 mRNA is weak in the hippocampus (Duvoisin et al., 1995; Saugstad et al.,
1997). However, prominent immunolabelling of mGluRS protein has been reported in the outer third
of the dentate molecular layer, and the superficial portion of the CA3 stratum lacunosum moleculare,
both of which correspond to terminal zones of the lateral perforant path, suggesting an autoreceptor
role for mGluR8 (Shigemoto et al., 1997).
In contrast to group II mGluRs, group III immunolabelling is concentrated at axon terminals, within
the presynaptic membrane specialization (Shigemoto et al., 1997).
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3.5 Transduction mechanisms ofmGluRs
The classification of mGluRs based on sequence homology is supported by the transduction
mechanisms of the individual subtypes. Figure 3.5 shows a schematic view of the transduction
mechanisms of the three mGluR sub-groups at a generic hippocampal synapse.
3.5.1 Group I mGluRs
Studies of mGluRs expressed in various cell lines have consistently revealed that group I mGluRs
stimulate phospolipase C and phosphoinositide hydrolysis. Similar results have been obtained in
native systems (for review, see Sudzak et al., 1994; Pin and Duvoisin, 1995; Conn and Pin, 1997).
Activation of group I mGluRs has also been reported to stimulate cAMP formation in expression
systems (Aramori et al., 1992; Pickering et al., 1993; Joly et al., 1995), although it is not known
whether this coupling is present in real neurons, where levels of mGluR expression are lower than
those obtained in artificial expression systems. Nevertheless, co-activation of group I and II mGluRs
causes a synergistic potentiation of the cAMP response to agonists of Gs-coupled receptors in
neonatal rat hippocampal slices (Schoepp et al., 1996). However, this effect is mediated by the
activation of group II mGluRs in adult slices; activation of group I and III mGluRs is ineffective
(Winder and Conn, 1995).
3.5.2 Group II mGluRs
Group II mGluRs inhibit forskolin-stimulated cAMP formation in mammalian cell lines. This effect
is sensitive to pertussis toxin treatment, indicating that the Gj type of G-protein is involved (Tanabe
et al., 1992; Tanabe et al, 1993). Similar results have been obtained in native systems, such as cell
cultures from various brain regions (Prezeau et al., 1994), and hippocampal slices (Wright and
Schoepp, 1996). However, it is possible that the effect of group II mGluR activation on cAMP
accumulation in response to the adenylate cyclase activator forskolin does not provide an accurate
index of the response under normal circumstances. As mentioned above, group II mGluRs can
potentiate increases in cAMP formation in response to agonists of Gs-coupled receptors (Winder and
Conn, 1995). Hence, the natural physiological response to group II mGluR activation may be
opposite to that assayed in the presence of forskolin.
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3.5.3 Group III mGluRs
Group III mGluRs are also negatively coupled to adenylate cyclase, although more weakly than
group II. However, this may not be the preferred coupling of group III mGluRs in their native
environments (see Pin and Duvoisin, 1995; Conn and Pin, 1997 for reviews). In contrast to the
findings described above for group II mGluRs, the selective group III agonists L-AP4 and L-SOP
have been found to inhibit Gs-coupled receptor agonist-induced increases in cAMP formation in
hippocampal slices, in addition to inhibiting the increase caused by the application of forskolin
(Wright and Schoepp, 1996).
3.5.4 mGluRs coupled to phospholipase D
There is evidence that some mGluRs may be coupled to the activation of phospholipase D (PLD)
(Boss et al., 1994; Holler et al., 1993). The pharmacological profile of this response is not consistent
with that of any known mGluR subtype, and may therefore represent a novel, currently uncloned
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3.6 mGluR pharmacology
3.6.1 mGluR agonists
Pharmacological studies of the role of mGluRs have consistently been hampered by the lack of
selective agonists and antagonists. Whilst AMPA and NMDA are inactive at mGluRs, ibotenate (an
NMDA receptor agonist) and quisqualate (an AMPA / kainate receptor agonist) are effective mGluR
agonists, although their actions at ionotropic glutamate receptors make them unsuitable for use in
native systems. However, numerous mGluR-selective agonists have been developed in the last few
years.
The earliest selective mGluR agonist was a conformationally restricted form of glutamate, trans-1-
aminocyclopentane-l,3-dicarboxylic acid (frans-ACPD; but see Schoepp et al. (1991b) for
discussion of nomenclature), a racemic mixture of (\R,3S)- and (lS,3ft)-enantiomers, the latter of
which is now known to be the active form (Palmer et al., 1989; Irving et al., 1990). In heterologous
expression systems, (1S,3R)-ACPD activates both group I and group II receptors, but has higher
affinity for the latter group (Saugstad et al., 1995 see table 3.6.2). Many more mGluR agonists have
since been synthesized, several of which are listed in table 3.6.1
3.6.2 mGliiR antagonists
Early studies suggested that D,L-AP4 could antagonize the agonist-induced increase in
phosphoinositide hydrolysis in adult hippocampal slices (Nicoletti et al., 1986a), an action mediated
by the L-isomer of the drug (Schoepp and Johnson, 1988). However, L-AP4 is at best a weak
antagonist of PI hydrolysis, and has been found to be inactive in many preparations, such as slices
from immature rats (Nicoletti et al., 1986b), and in cultured neurons (e.g. Patel et al., 1990).
Moreover, L-AP4 is inactive at group I Pi-coupled mGluRs, although it has been found to be a
selective agonist at group III mGluRs, as discussed above. The reason for the reported effects of L-
AP4 on PI hydrolysis are unknown, although cross-talk between receptor subtypes, or the existence
of an unknown AP4 sensitive Pi-coupled mGluR may explain these findings. Nevertheless, L-AP4 is
clearly an unsuitable antagonist for use in physiological studies of mGluR function.
Another putative mGluR antagonist used in many early studies is L-amino-3-phosphonopropionate
(L-AP3). This compound was found to inhibit mGluR agonist-induced effects, including the increase
in PI hydrolysis, in many different preparations (Schoepp et al., 1991b). However, L-AP3 does not
antagonize the depolarization and inhibition of slow afterhyperpolarization induced by trans-ACPD
application in CA1 pyramidal cells (Stratton et ah, 1990). A similar failure to antagonize the ACPD-
52
induced depolarization in rat thalamic neurons has been reported (Salt and Eaton, 1991). These
findings, together with the low potency and non-competitive action of L-AP3, limit its usefulness as
an mGluR antagonist.
More recently, a family of phenylglycine derivatives has been described, some exhibiting antagonist,
and others agonist properties at mGluRs, such as (S)-DHPG mentioned above (see Watkins and
Collingridge, 1994 for review). (S)-4-carboxyphenylglycine ((S')-4CPG) and the racemic form of its
cc-methyl derivative (R,S)-a-methyl-4-carboxyphenylglycine ((R,S')-MCPG) were reported to block
(1S,3R)-ACPD stimulated PI hydrolysis in rat cerebral cortical slices. In contrast to L-AP3, these
antagonists were found to inhibit the ACPD-induced depolarization in rat thalamic neurons and
neonatal rat motor neurons (Eaton et al, 1993). The (+)- or (S)-isomer of MCPG has since been
identified as the active form (see table 3.2). Since the discovery of the properties of phenylglycines,
several more selective mGluR antagonists have been characterized. A range of commonly used
mGluR antagonists are listed in table 3.6.1
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Table 3.6.1 mGluR agonists and antagonists (data taken from Jane et al., 1994, 1995; Pin and
Duvoisin, 1995; Pelliciari et al., 1995; Gomeza et al., 1996; Toms et al., 1996; Conn and Pin, 1997;
Roberts, 1998). The results are based mainly on biochemical measurements, e.g. phosphoinositide
hydrolysis and cAMP formation, in heterologous expression systems. Full drug names are included
in the list of abbreviations on page xvii.



















































These compounds are believed to be selective agonists or antagonists for the particular mGluR
group in which they are listed.
b
This compound also acts as an NMDA receptor agonist.
1
This compound is both a group I mGluR antagonist, and a group II agonist.
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3.6.3 The pharmacological properties ofMCPG
Unlike (S)-4CPG, which has agonist properties at group II mGluRs, MCPG antagonizes both group I
and group II mGluRs in cellular expression systems (Hayashi et al., 1994; Thomsen et al., 1994).
However, it has been reported that (+)-MCPG does not inhibit the ACPD-induced reduction in
forskolin-stimulated cAMP accumulation in adult hippocampal slices, despite inhibiting ACPD-
induced PI hydrolysis in a competitive manner, suggesting a functional selectivity for group I
mGluRs (Riedel et al., 1995a). Nevertheless, MCPG has been found to inhibit the ACPD-induced
reduction in forskolin-stimulated cAMP accumulation in guinea pig cortical slices (Kemp et al,
1994), as well as antagonizing a number of group II-mediated electrophysiological responses in the
hippocampus, an issue which will be discussed later. In addition, recent studies have revealed that
(+)-MCPG acts as an agonist at a group II-like receptor (or receptors) in slices taken from
hippocampal area CA1 (Breakwell et al., 1998), or basolateral amygdala (Keele et al., 1995). The
recent finding that (+)-MCPG can stimulate phospolipase D activation in the hippocampus raises the
possibility that it acts as an agonist at an unidentified mGluR subtype (Pelligrini-Giampietro et al.,
1996).
One further complication concerning the use of MCPG as an antagonist of Pl-coupled mGluRs
concerns the fact that MCPG antagonizes the trans-ACPD-induced increase in PI turnover far more
potently than the increase in PI turnover induced by glutamate application in both hippocampal and
cerebellar slices (Littman and Robinson, 1994). Similar results have recently been described in rat
visual cortical slices (Huber et al., 1998). These findings are in agreement with data from non-
neuronal cells expressing either mGluRla or mGluR5a. (+)-MCPG was found to potently inhibit the
effect of (1S,3R)-ACPD on both subtypes. However, (+)-MCPG exhibited lower potency as an
antagonist of glutamate-mediated effects on mGluR la, and was almost completely ineffective
against the actions of glutamate on mGluR5a (Joly et al., 1995; Brabet et al, 1995). On the basis of
these results, Brabet et al. (1995) suggested that glutamate and (1S,3R)-ACPD bind to different sites
on the mGluR receptor. The high expression of mGluR5 within the hippocampus and cortex would
explain the failure of MCPG to block glutamate-stimulated PI hydrolysis in these regions.
Alternatively, it is possible that much of the response to glutamate is mediated by unidentified
ACPD-insensitive mGluR subtypes. These results imply that the mere demonstration of an MCPG-
induced inhibition of the effects of ACPD application cannot be taken as conclusive evidence that a
physiologically relevant blockade of mGluRs has been achieved.
Despite these potential problems, MCPG was the best mGluR antagonist available at the time when
the work described in this thesis was started. The main drugs used in chapters 6 and 7 are (R,S)-
MCPG and (1 S,3R)-ACPD. (-)-MCPG was used on one occasion as a control. A detailed
pharmacological characterization of (-) and (+)-MCPG, and (IS,3/?)-ACPD is presented in table
3.6.2.
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Table 3.6.2 Potency (EC50, IC50, or Kb values in pM) of MCPG and ACPD determined in cell lines
expressing a particular mGluR subtype (values taken front Conn and Pin, 1997; Saugstad et al.,
1997; Hayashi et al., 1994), or in the case of ionotropic receptors, from cultured striatal neurons
(ACPD: Manzoni et al., 1990), and cerebral cortical membranes (MCPG: Thomsen et al., 1994).
(-)-MCPGa (+)-MCPG (1S,3R)-ACPD
AMPA receptor — > 1000 >1000b
NMDA receptor — > 1000 >1000b
mGluRla n.e. 40-200 10-80
mGluR5a — >200 5-7
mGluR2 n.e 100-1000 18
mGluR3 — >1000 8
mGluR4a n.e. n.e. »300
mGluR6 — — 300
mGluR7 — n.e. —




(-)-MCPG has also been reported to be ineffective in antagonizing the ACPD-induced
depolarization of neonatal rat motoneurones and the excitation of thalamic neurons (Jane et al.,
1993), as well as the ACPD induced increase in phosphoinositide metabolism in cortical slices
(Eaton cl al., 1993). It has also been found to be ineffective in blocking LTP (Riedel et al.,
1995).
''
trans-ACPD was used in these cases.
c
The racemic form, (/?,S)-MCPG was used in this case.
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3.7 Modulation of ion channels and cell excitability
3.7.1 Modulation ofpotassium channels
Metabotropic glutamate receptors are involved in the modulation of several potassium conductances,
with consequent effects on cell excitability (see figure 3.5). Early studies indicated that mGIuR
activation could induce a slow membrane depolarization of hippocampal CA1 neurons, associated
with an increase in membrane resistance; stimulation of mGluRs was also reported to block the slow
after-hyperpolarization current (Iahp) in CA1 pyramidal cells, a phenomenon known to be mediated
by Ca2+-activated potassium channels (Stratton et al., 1989; Charpak et al., 1990; Baskys et ah,
1990). It has been reported that application of mGIuR agonists causes an inhibition of spike
frequency adaptation in hippocampal neurons, an effect consistent with an mGluR-mediated
blockade of IAHP (Stratton et ah, 1989; Desai and Conn, 1991). Activation of mGluRs in hippocampal
pyramidal cells has also been reported to block several other potassium currents, such as a leak
potassium conductance (I|eak). active at the resting membrane potential (Guerineau et ah, 1994), a
slow, non-inactivating, voltage-dependent potassium conductance (IM) (Charpak et ah, 1990), and a
slowly inactivating voltage-dependent current (Ik(Siow)) (Luthi et ah, 1996). The inhibition of these
potassium currents is thought to underlie the slow depolarization and increase in membrane
resistance associated with mGIuR activation.
Pharmacological studies suggest that the postsynaptic depolarization and blockade of spike
frequency adaptation are mediated by the activation of group I mGluRs. Davies et ah (1995) found
that these electrophysiological effects could be elicited in CA1 pyramidal neurons by the selective
group I agonist (5)-DHPG. In contrast, DCG-IV and L-AP4, agonists at group II and III mGluRs
respectively, had no effect on the passive membrane properties, or spike frequency adaptation.
Furthermore, both (+)-MCPG (a group I and II antagonist) and (S)-4CPG (a group I antagonist)
inhibited the postsynaptic actions of (15',3I?)-ACPD. (+)-MCPG was also found to antagonize the
actions of (5,R)-DHPG. (The effects of (S)-4CPG were not tested.) Since (lS,3/?)-ACPD elicits
normal postsynaptic excitatory effects in mGluRl knockout mice (Aiba et ah, 1994; Conquet et ah,
1994), Davies et ah (1995) tentatively suggest that these effects are most likely to be mediated by the
mGluR5 subtype of group I, although a role ofmGluRl in normal animals cannot be excluded.
3.7.2 Activation ofnon-specific cation currents
Stimulation of postsynaptic mGluRs can also increase cell excitability by the activation of non¬
specific cation currents. These currents can be generated in a number of ways, such as activation of a
Na+ / Ca2+ exchanger (McBain et ah, 1994), a calcium independent, non-specific cation channel
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(Pozzo Miller et al., 1995), or a calcium-activated non-specific cation (CAN) current (Crepel et al.,
1994).
3.7.3 Inhibition of voltage-sensitive calcium channels (VSCCs)
A number of studies have demonstrated that application of inGluR agonists can inhibit voltage-
sensitive Ca2+ channels (VSCCs) (see figure 3.5). This effect has been reported in many different cell
types, including hippocampal, striatal, cortical and cerebellar granule cells. The pharmacological
profile of this effect, and the susceptibility of N- and L-type calcium currents depends on the cell
type or tissue studied (see Pin and Duvoisin, 1995; Conn and Pin, 1997 for review).
3.7.4 Modulation of ligand-gated ionotropic receptors
GABAa, NMDA and AMPA receptors can all be regulated by mGluRs. (15,3/?)-ACPD inhibits
GABAa receptor-mediated currents and potentiates AMPA-mediated responses in neurons of the rat
tractus solitarus nucleus (Glaum and Miller, 1993). The profile of antagonism of these effects with
phenylglycine derivatives suggests the involvement of group I mGluRs (Glaum et al., 1993).
In CA1 hippocampal slices, (15,3/?)-ACPD application has been reported to induce an NMDA
receptor-independent potentiation of the AMPA receptor-mediated field EPSP (Bortolotto and
Collingridge, 1993). (15,3/?)-ACPD has also been found to cause an acute enhancement of NMDA
receptor-mediated currents in CA1 pyramidal cells, without affecting the AMPA-mediated
component (Harvey et al., 1991; Anisztejn et al., 1992; Harvey and Colingridge, 1993). Anisztejn et
al. (1992) reported that this upregulation of NMDA receptors was sensitive to PKC inhibitors, but
negative results were obtained by Harvey and Collingridge (1993). This discrepancy may reflect the
use of different PKC inhibitors by the two groups. The involvement of group I mGluRs is suggested
by the finding that application of (/?,S)-DHPG results in an acute enhancement of NMDA currents,
whereas group II and III agonists are ineffective (Fitzjohn et al., 1996). The agonist-induced
upregulation of NMDA receptor function in the above studies was limited to the period of ACPD
application only. However, a long-term potentiation of NMDA receptor-mediated responses has been
described in the dentate gyrus (O'Connor et al., 1994).
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3.8 Presynaptic actions of mGIuRs
3.8.1 mGIuRs can act as presynaptic autoreceptors
A commonly observed effect of trans-ACPD application in hippocampal slice preparations was first
reported by Baskys and Malenka (1991a). They found that a brief application of trans-ACPD
decreased the initial slope of the CA1 field EPSP in a reversible and dose-dependent fashion. These
findings have since been replicated by others (Pacelli and Kelso, 1991). Similar results had been
obtained several years earlier using l-AP4 (Collingridge and Lester, 1989), a compound now known
to be a selective mGluR group III agonist. Curiously, the presynaptic depression induced by the
application of trans-ACPD is far more marked in neonatal rat brain slices than in adult slices (Baskys
and Malenka, 1991b). In the same study, evidence was presented suggesting that the receptor
mediating this depression in synaptic transmission is located pre-synaptically. Firstly, both the
NMDA and AMPA receptor-mediated components of the EPSC were depressed by mGluR agonists.
Secondly, responses to exogenous AMPA were unaffected, even when the EPSC was very strongly
depressed. Thirdly, paired pulse facilitation, a pre-synaptic phenomenon, was enhanced during
depression.
Manzoni and Bockaert (1995) have since shown that application of the group I selective agonist
(R,S)-DHPG can induce a presynaptic depression of synaptic transmission at CA3-CA1 pyramidal
cell synapses. The authors report that the application of the selective group II agonists l-CCG-I and
4-C3HPG had no effect on synaptic transmission. (D>,3R)-ACPD induced a similar presynaptic
inhibition to DHPG, which was not blocked by the mGluRl subtype preferring antagonist (S)-4CPG,
suggesting that the effect is mediated by mGluR5. In a later study (Gereau and Conn, 1995a), the
group II mGluR antagonist MCCG failed to inhibit the depressant actions of DHPG or l-AP4,
confirming that group II mGIuRs are not involved in this effect. In contrast, the mixed group I and II
antagonist, (+)-MCPG blocked the depressant actions of DHPG, but was ineffective against the
depression induced by l-AP4. Additional experiments confirmed that these agonist-induced
depressant actions were indeed presynaptic in origin. These results suggest that the presynaptic
autoreceptor-mediated actions of mGluR agonists in adult CA1 pyramidal cells are mediated by
group I and III mGIuRs, but not by group II.
Pharmacological studies of the neonatal hippocampal slice have revealed that, in contrast to the
findings in adult slices, group II mGIuRs can also act as presynaptic autoreceptors at an early
developmental stage (Vignes et al., 1995). This result is consistent with the finding that the
presynaptic depressant action of rrans-ACPD is more pronounced in neonatal slices (Baskys and
Malenka, 1991b).
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It is curious that a group I mGluR, postulated to be mGluR5, should act as a presynaptic
autoreceptor, since most immunolabelling studies have reported a postsynaptic location for this class
of mGluR (e.g. Shigemoto et al., 1997). However, some immunoreactivity for mGluR5 has been
reported at presynaptic terminals (Romano et al., 1995). Alternatively, an unidentified presynaptic
mGluR5-like receptor may act as a group I autoreceptor (see section 3.8.2).
Group I and II agonists do not cause a reduction in synaptic transmission at lateral perforant path-
dentate gyrus synapses. However, l-AP4 causes a marked depression which is blocked by the group
III selective antagonist MAP4 (Bushell et al., 1995; Macek et al., 1996). The sensitivity of lateral
perforant path synapses to micromolar concentrations of l-AP4, together with recent
immunolabelling studies (Shigemoto et al., 1997), suggests that mGluR8 may act as the major
autoreceptor in this pathway. Consistent with this possibility, (R^-MCPG has been reported to
antagonize the presynaptic depression induced by l-AP4 in the lateral perforant path (Johansen et al.,
1995), despite the fact that it is inactive at mGluRs 4 and 7 (Thomsen et al., 1994; Hayashi et al.,
1994). However, a recent study suggests that MCPG acts as an antagonist of mGluR8 (Saugstad et
al., 1996).
l-AP4 also depresses synaptic transmission at medial perforant path-dentate gyrus synapses, but
with lower potency than in the lateral perforant path, consistent with the involvement of mGluR7
(Ugolini and Bordi, 1995; Macek et al., 1996). Group i selective agonists have no effect. However,
application of selective group ii agonists such as l-CCG-I and APDC causes a marked depression,
which is blocked by antagonists of group II receptors. These results indicate that different receptor
subtypes serve as autoreceptors at medial and lateral perforant path synapses.
3.8.2 A presynaptic mGluR increases glutamate release
In addition to acting as inhibitory autoreceptors, a presynaptic mGluR has been identified which
increases glutamate exocytosis in cerebrocortical nerve terminals. Co-application of (15,3R)-ACPD
and arachidonic acid increased the 4-aminopyridine (4-AP)-induced release of glutamate form
cerebrocortical synaptosomes (Herrero et al., 1992). This effect was sensitive to inhibition of PKC,
suggesting that the increase in glutamate release is mediated by the synergistic activation of PKC by
arachidonic acid and DAG generated by mGluR activation. Since arachidonic acid is a possible
retrograde messenger (Lynch et al., 1991), mGluR-mediated increases in glutamate release may
contribute to the expression of LTP. Indeed, Collins et al. (1995b) found that co-perfusion of
(15',3R)-ACPD and arachidonic acid in hippocampal slices evoked a rapid and long-lasting
enhancement of synaptic transmission in CA1 hippocampal slices. The mGluR subtype which




The studies reviewed in this section reveal that all groups of mGluRs can modulate presynaptic
glutamate release. At CA3-CA1 synapses, group I and III mGluRs, but not group II, act as inhibitory
presynaptic autoreceptors. However, group II and III receptors, but not group I, act as presynaptic
autoreceptors in the medial perforant path-dentate gyrus projection. In addition to these inhibitory
effects, there is evidence that the activation of a presynaptic group I-like mGluR in conjunction with
arachidonic acid application results in an increase in glutamate release. The presynaptic actions of
mGluRs are summarized in figure 3.5.
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3.9 The role of mGluRs in synchronized network oscillations
In addition to their role in the oscillatory activity of individual neurons (e.g. McBain et al., 1994),
there is evidence that mGluRs may be involved in the generation of synchronized neuronal network
oscillations. Krieger et al. (1994) examined the effects of (1S,3R)-ACPD perfusion on both the single
cell and network properties of the lamprey spinal cord. They found that (1S,3R)-ACPD induced a
transient depolarization in all grey matter neurons tested, which could be reduced by the application
of (+)-MCPG. The membrane depolarization was accompanied by an increase in synaptic noise
attributed to an increase in the activity of presynaptic interneurons. Perfusion of the lamprey spinal
cord preparation with NMDA results in burst firing of the neurons involved in the generation of
locomotor activity, a phenomenon known as "fictive locomotion". Application of ACPD during
perfusion with NMDA was found to increase the frequency of this locomotor rhythm, presumably
due to an increase in the excitability of individual neurons within the network.
I.p.s.c. oscillations have also been seen in the hippocampus. Whittington et al. (1995) made
intracellular recordings from CA1 pyramidal cells in a hippocampal slice preparation. In the presence
of CNQX and D-AP5, single electrical stimuli evoked i.p.s.c.s oscillating at 40 Hz. Application of
(+)-MCPG completely blocked these i.p.s.c. oscillations, but had no effect on monosynaptic i.p.s.c.s.
Application of (15,3R)-ACPD elicited 40 Hz i.p.s.c. oscillations similar to those evoked electrically;
these oscillations were also blocked by MCPG. Similar ACPD-induced oscillations were seen in
neocortical slices. The authors propose that tonic activation of mGluRs can provide the excitatory
input to drive network oscillations of inhibitory interneurons, resulting in a 40 Hz oscillatory rhythm
in pyramidal cells, which can entrain their firing.
The synchronous firing of hippocampal or cortical cells has been proposed as a solution to the
problem of how information carried by different populations of cells, located at some distance from
each other, can be associated to form a coherent percept, the so-called "binding problem".
Whittington et al. (1995) propose that the long-range coupling necessary to achieve this oscillatory
coherence could occur via intercortical interconnections or via the thalamocortical loop.
A slightly different approach was taken by Boddeke et al. (1997), who recorded spontaneous field
potential activity close to the CA1 pyramidal cell layer. Application of (15,3/?)-ACPD or quisqualate
caused a large increase in spontaneous activity. Analysis of power spectra revealed a mean dominant
frequency of roughly 20 Hz. This rhythm was distinct from the 9 Hz "theta-like" rhythm induced by
application of the muscarinic agonist carbachol. The firing of individual CA1 pyramidal cells in
response to ACPD was phase-locked to the 20 Hz cycle, but the firing rates of single cells increased
to only 8.2 Hz after drug infusion. However, multiple unit firing rates increased to frequencies
between 15 and 25 Hz, indicating that the dominant 20 Hz rhythm is an emergent network property,
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rather than a simple reflection of unit activity. Synchronized activity persisted in the presence of
ionotropic glutamate receptor antagonists. However, application of the GABAa antagonist
bicuculline strongly reduced the rhythmic activity induced by ACPD, suggesting a prominent role of
GABAergic interneurons in the generation of these oscillations. In contrast, the cholinergic theta
rhythm is enhanced after administration of bicuculline (Konopacki et al., 1987). The authors suggest
that the 20 Hz oscillations described are generated by a similar GABAa receptor-dependent
mechanism to that described by Whittington et al. (1995). mGluR agonist-induced rhythmic activity
was inhibited by (-t-)-MCPG. The potency rank order of the two agonists was quisqualate > (15,3/?)-
ACPD. Since quisqualate is a more potent agonist at group I mGluRs than (15,3/?)-ACPD, but a
considerably weaker agonist than (15,3/?)-ACPD at group II mGluRs, it is likely that synchronous
the 20 Hz activity is induced by the activation of group I mGluRs.
Another form of oscillatory activity was described by Taylor et al. (1995) in rat hippocampal CA3
pyramidal cells. Application of a high concentration of (15,3/?)-ACPD induced trains of
depolarizations with superimposed action potentials. Individual trains lasted for several seconds, and
depolarization frequencies slowed from an initial maximum of 27 Hz to a frequency of 8 Hz towards
the end of the train. This activity was found to be synchronous throughout the CA3 pyramidal cell
population. Oscillations were blocked by the application of the mGluR antagonists (+)-MCPG, (5)-
4C3HPG and (5)-4CPG. Since the latter two drugs are group I mGluR antagonists, but group II
agonists, it is likely that Pi-coupled mGluRs are responsible for the oscillatory activity. However,
unlike the rhythmic activity described previously, these oscillations persisted in the presence of
GABAa antagonists, but were blocked by the application of CNQX. The authors speculate that this
form of rhythmic activity could be mediated by recurrent excitation, and may be more relevant to the
pathophysiology of epileptiform discharges, than the generation of physiological rhythmic activity.
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3.10 The role of mGluRs in hippocampal long-term potentiation
3.10.1 NMDA receptor activation alone is insufficient to induce LTP
It is well established that NMDA receptor activation during a tetanus is necessary for the induction
of LTP in the dentate gyrus and area CA1 of the rodent hippocampus, since potentiation is
completely blocked, both in vivo and in vitro, by the application of the selective NMDA receptor
antagonist, AP5 (Collingridge et al., 1983; Harris et ah, 1984; Morris et ah, 1986a; Errington et al.,
1987). However, direct iontophoresis of NMDA in hippocampal slice preparations induces only a
short-lasting potentiation which decays back to baseline values within about 30 min (Collingridge et
ah, 1983; Kauer et ah, 1988a). In contrast, potentiation induced by a high frequency tetanus consists
of a short-lasting decremental phase similar to that induced by NMDA, followed by a stable increase
in synaptic efficacy which may remain above baseline values for hours or even days (see chapter
2.4.2).
Early studies demonstrated that perfusion of a conditioning solution containing glutamate, low Mg2+
and high K+ could induce a non-tetanic form of LTP in guinea pig CA1 slices (Izumi and Kato,
1987a). If glutamate was replaced by NMDA, LTP was not observed, suggesting that activation of
NMDA receptors alone is not sufficient for the induction of LTP. However, if quisqualate was
administered prior to NMDA application, LTP was again induced (Izumi et ah, 1987a). It has been
shown that tetanization of an afferent pathway leads to an elevation of intracellular calcium in
hippocampal slices which lasts for several minutes (Kudo et ah, 1987). Perfusion of a low Ca2+
medium starting immediately after tetanization and lasting for 5 min blocks LTP (Izumi et ah,
1987b). However, other studies have found that the voltage dependent Ca2+ influx (via NMDA
receptors and VSCCs) is not sufficient to account for the duration of the elevation of intracellular
calcium following a tetanus (Kudo et ah, 1987; Krnjevic et ah, 1986). The necessity for an additional
Ca2+ source was further suggested by the finding that tetanization did not result in LTP in the
presence of an inhibitor of Ca2+ release from intracellular stores (Izumi et ah, 1990). On the basis of
these results, it was proposed that activation of the newly identified quisqualate metabotropic
receptor, known to stimulate IP3 synthesis and the release of intracellular Ca2+, might provide the
extra trigger necessary for the induction of stable LTP (Izumi et ah, 1990).
3.10.2 The effects ofAP3 and AP4 on LTP induction
Early studies were carried out with the putative antagonist of PI turnover, AP4 (see section 3.6.2).
Reymann and Matthies (1989) reported that, in hippocampal CA1 slices, a late phase of LTP is
reportedly blocked by the application of this drug. However, D-AP4, which does not inhibit PI
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turnover, was found to be as effective as l-AP4, the active isomer, a result which raised serious
doubts as to the selectivity of the drug. Furthermore, d-AP4 applied shortly after the tetanus was
almost as effective as when applied before tetanization. l-AP4 is now known to be a selective
agonist of group III mGluRs, although the mechanism by which it inhibits PI hydrolysis is unknown.
The weak partial mGluR antagonist AP3 has also been used in a number of studies. Izumi et al.
(1991) found that d,l-AP3 blocked both PTP and LTP in CA1 slices. The application of AP3
immediately after tetanization was also found to limit the duration of LTP. Bchnisch et al., (1991)
found that d,l-AP3 could block late LTP, and was effective even when applied after the tetanus.
However, the d-isomer of AP3 is a weak NMDA receptor antagonist, so these results must be viewed
with caution. Nevertheless, a subsequent study revealed that a dose of l-AP3 demonstrated to have
no effect on ionotropic receptor-mediated EPSCs could nevertheless block the late phase of EPSP
slope potentiation (Behnisch and Reymann, 1993). Since similar results had been obtained with the
application of PKC inhibitors (Reymann et al., 1988a, b), it was postulated that the action of AP3
was mediated by inhibition of PKC resulting from the blockade of PLC-coupled mGluRs.
Similar results were presented by Zheng and Gallagher (1992), who found that moderate doses of
AP4 and AP3 produced a stereoselective block of LTP in the dorsolateral septal nucleus, a region
that has the highest density of mGluR-like binding sites in the rat brain (Cha et al., 1990), and in
which LTP induction is not affected by the application of d-AP5. In contrast, Stanton et al. (1991)
reported that l-AP3 blocked the induction of homosynaptic LTD induced by the out of phase pairing
of test and conditioning inputs to CA1 pyramidal cells (see chapter 2.5.1). The induction of
homosynaptic LTP by an in phase pairing protocol was not blocked. However, LTP was assessed 30
min after induction, and the late phase of LTP found to be blocked by Behnisch and Reymann (1993)
was not assessed.
3.10.3 The effect ofMCPG on LTP induction
Despite its inhibition of PI turnover, l-AP3 does not affect certain electrophysiologically determined
mGluR-mediated responses in the hippocampus (Stratton et al., 1990; Charpak and Gawiler, 1991;
Hu and Storm, 1992; Desai et al., 1992). This problem was resolved following the characterisation of
a weak, but selective and competitive antagonist, (R.Sfa-methyl^-carboxyphenylglycine (MCPG)
(see sections 3.6.2 and 3.6.3).
MCPG has been widely used since its discovery, but studies of its effects on the induction of LTP
have often yielded contradictory results. The first report of the ability of MCPG to block
hippocampal LTP was published soon after the initial characterization of the drug. It was found that
500 pM (/?,5)-MCPG was sufficient to block LTP in CA1 hippocampal slices, sparing only a short-
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term potentiation lasting about 30 min (Bashir et al., 1993). In this study, application of L-AP3
produced no such block, even after 3 hours. The efficacy of (R,5j-MCPG as an mGluR antagonist
was demonstrated when calcium-mobilizing responses to (15,3R)-ACPD in isolated mGluRla-
transfected cells devoid of ionotropic glutamate receptors were found to be reversibly abolished.
MCPG was also shown to reverse the ACPD-induced inhibition of action potential accommodation
and after-hyperpolarization in hippocampal CA1 pyramidal cells. A similar result was reported by
Sergueeva et al. (1993) who found that 500 pM (R,S)-MCPG limited the duration of LTP to little
more than an hour, as well as preventing the tetanus-induced increase in AMPA receptor sensitivity.
(R,S)-MCPG has been found to block both NMDA receptor-dependent and NMDA-receptor
independent LTP in CAI slices (Little et al., 1995). The latter form of LTP is dependent on VSCC
activation. Recently, Breakwell et al. (1996) reported that (+)-MCPG could block EPSP slope,
population spike, and E-S LTP in rat hippocampal slices. A large STP remained, which decayed to
baseline within 30 min.
MCPG has been found to limit LTP induction in vivo. Riedel and Reymann (1993) reported that an
i.c.v. injection of MCPG could limit the duration of LTP to 2-3 hr in freely moving rats. In a later
paper, the same authors reported a complete block of both STP and LTP by a tenfold higher
concentration of MCPG (Riedel et al., 1994a). The (-)-form of MCPG was found to be ineffective.
Richter-Levin et al. (1994) reported a reduction in EPSP slope potentiation 1 hr after tetanization
following bilateral i.c.v. infusions of (/?,.S)-MCPG under urethane anaesthesia. However, continuous
perfusion of (R,S)-MCPG via a push-pull cannula for 30 min prior to tetanization resulted a complete
block of both EPSP slope and population spike LTP 2 hr after induction.
Despite these positive reports, Chinestra et al. (1993) reported a failure of (R,S)-MCPG to block
LTP in CAI hippocampal slices. However, the authors also found that MCPG failed to antagonize
the block of slow after-hyperpolarization and action potential accommodation induced by (IS,3R)-
ACPD (see Bashir et al., 1993). Furthermore, no blockade of the ACPD-induced slow inward current
thought to result from the inhibition of potassium conductances, or the depression in field potentials
induced by a higher concentration of (IS,3/?)-ACPD was observed. These latter results have led to
considerable scepticism concerning the reported absence of an effect on LTP. However, others have
reported that MCPG has no inhibitory effect on LTP in areas CAI and CA3 of the guinea-pig
hippocampus (Manzoni et al., 1994). Nevertheless, contrary to the findings of Ben-Ari's group,
MCPG was able to antagonize the blocking action of ACPD on slow after-hyperpolarization in CA1,
as well as reducing the presynaptic inhibitory actions of ACPD on field EPSPs in both CAI and
CA3. Other workers have found that MCPG does not block LTP in the dentate gyrus of urethane-
anaesthetized rats (Bordi and Ugolini, 1995).
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3.10.4 The "molecularswitch" hypothesis
The reasons for the contradictory findings on the ability of MCPG to block LTP are not yet
understood, although it is likely that differences in experimental procedure may account for some of
the discrepancies. One potential explanation for the mixed results is provided by the findings of
Bortolotto et al. (1994) who reported that in CA1 slices, (R,S)-MCPG failed to block LTP in
pathways which had previously undergone sub-maximal potentiation. The same result was obtained
if the first "conditioning" tetanus was delivered in the presence of D-AP5 which completely blocks
LTP, or if the conditioning tetanus was replaced by the application of (1 .S,3.R)-ACPD. These data
suggest that the activation of mGluRs turns on a "molecular switch" which eliminates the
requirement for further mGluR activation in the induction of LTP. Activation of the switch could be
prevented by the application of MCPG or a protein kinase inhibitor, K-252b during the conditioning
train. The conditioning effect was found to last up to 6 hr. However, low-frequency stimulation
which induced depotentiation following the conditioning tetanus was found to re-establish the ability
of MCPG to block LTP after a second tetanus. This "deconditioning" effect was also mGluR-
mediated, since application of MCPG during low frequency stimulation abolished the re-setting of
the switch.
It has been suggested that certain techniques for cutting hippocampal slices may effectively tetanize
the slice prior to the start of an experiment, thus rendering mGluR activation unnecessary for
subsequent LTP. Consistent with this possibility, it was reported that in dentate slices, (R,S)-MCPG
was only able to block LTP of the AMPA-mediated EPSC in response to tetanization of the
associational / commissural pathway after the delivery of low frequency stimulation resulting in LTD
(Wang et al., 1995). Negative results have, however, been reported by Selig et al. (1995) and Thomas
and O'Dell (1995), who failed to see a block of LTP in CA1 slices in the presence of (R,S)-MCPG,
even after low frequency stimulation of afferents, although in the latter study, MCPG was found to
inhibit the LTP induced with a weak induction protocol.
3.10.5 The role of tetanus parameters in determining the sensitivity ofLTP to MCPG
It seems that the molecular switch hypothesis cannot account for all failures of MCPG to block LTP.
However, Thomas and O'Dell's result suggests that tetanization strength may be critical. This
possibility is consistent with the finding that the LTP induced in area CA1 by certain tetanization
protocols such as theta burst stimulation is not blocked by MCPG (Brown et al., 1994). Furthermore,
it has recently been reported that MCPG only results in a block of LTP induced by weak tetanization,
owing to the requirement for calcium release from intracellular stores under these circumstances.
After strong tetanization, this requirement is bypassed by calcium influx via voltage-dependent
calcium channels (Wilsch et al., 1998).
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The issue of tetanization strength may also explain why MCPG fails to block LTP under urethane
anaesthesia (Bordi and Ugolini, 1995; Martin and Morris, 1997), but not in freely moving rats
(Riedel et al., 1995a). For instance, it has been found that stronger tetanization parameters are
required to induce LTP in area CA1 of urethane-anaesthetized rats, compared to the freely moving
state (Riedel et al., 1994b). Similarly, Thy-1 knockout mice show a complete block of dentate LTP
under urethane anaesthesia, but express significant LTP in the freely moving state (Nosten-Bertrand
et al., 1996; Errington et al., 1997). The weaker tetanization parameters necessary to induce LTP in
freely moving animals may unmask a modulatory role of mGluRs. Nevertheless, studies involving
MCPG do not support an obligatory role for mGluRs in LTP induction, despite the fact that there
may be circumstances in which a modulatory function is revealed. However, there are a number of
problems with the use of MCPG as an mGluR antagonist; some these were discussed in section
3.6.3, and others will be addressed in the following two sections.
3.10.6 mGluR subtype-specific antagonists and the inhibition ofLTP
MCPG is not a subtype-selective antagonist, and several newer compounds with subtype-specific
actions have now been tested. Nevertheless, such studies have mostly generated negative results. For
instance, Bordi and Ugolini (1995) found that, in addition to MCPG, the preferential mGluR 1
antagonist (S)-4CPG had no effect on the induction of LTP in vivo. A similar result has been
obtained with the recently synthesized group I-selective agonist AIDA (Holscher et al., 1997b;
McCaffery et al., 1998). The group II antagonists MSOPPE (Manahan-Vaughan, 1997) and MCCG
(Holscher et al., 1997b) also fail to block LTP in vivo, as does the group III antagonist MAP4 in vitro
(Breakwell et al., 1998). In the same study, it was found that CA1 LTP could be induced in the
presence of a cocktail of (S)-4CPG, MCCG and MAP4, antagonists at groups I, II and III
respectively. No biochemical assays for the antagonism of mGluR-mediated second messenger
systems were carried out in the above studies. Nevertheless, the data suggest that mGluR antagonists
do not prevent the induction of LTP. However, currently available antagonists are rarely selective for
all members of a group. Hence, although it is likely that the activation of mGluRl is not obligatory
for the induction of LTP, the role of mGluR5 is currently uncertain, since MCPG and 4CPG are
inactive at mGluR5 (Joly et al., 1995), and AIDA has been found to a much weaker antagonist at
mGluR5a compared to mGluR la (Moroni et al., 1997).
3.10.7 Group II and 111 mGluR agonists and the inhibition ofLTP
It has been reported that the selective group III mGluR agonist L-AP4 blocks LTP in the dentate
gyrus and CA1 of 12-week-old rats; by this age, L-AP4 has no effect on baseline synaptic
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transmission in either region (Manahan-Vaughan and Reymann, 1995c). The authors suggest that L-
AP4 may exert its effects by inhibiting glutamate release during tetanization. These results are
consistent with earlier reports that L-AP4 could limit the duration of LTP, originally attributed to the
inhibition of PI turnover.
Curiously, the group II mGluR agonist (1S,3S)-ACPD has also been reported to block both dentate
and CA1 LTP in vivo (Holscher et al., 1997a, b). However, (15,3S)-ACPD also acts as a less potent
agonist at group I and III mGluRs. Nevertheless, a block of LTP has been reported even with low
concentrations of (lS^SFACPD, an effect which was prevented by co-perfusion with MCCG,
suggesting that an agonist action at group II mGluRs may indeed be responsible for the block of LTP
(Holscher et al., 1997b). Surprisingly, the block of LTP with (+)-MCPG was also prevented by the
group II ntGluR antagonist MCCG in CA1 slices (Breakwell et al., 1998): since antagonists of
mGluR groups I, II and III were completely ineffective in blocking LTP, it was proposed that MCPG
blocks LTP via an agonist action at a group II, or group II-like, mGluR.
Independent studies have suggested that MCPG may have agonist properties at one or more mGluR
subtypes. It was found that MCPG activated a presynaptic mGluR autoreceptor in the basolateral
amygdala, although pharmacological characterization of the subtype involved was not carried out
(Keele et al., 1995). Application of MCPG in rat dentate slices has been reported to induce a
depression in field EPSPs, an effect which was attributed to an agonist action at group II mGluRs
(Huang et al., 1997). However, several lines of evidence suggest that MCPG does not have agonist
actions at any known group II mGluR subtype. For example, MCPG antagonizes the presynaptic
depression induced by (lS^iO-ACPD in the dentate gyrus and neonatal CA1, an effect thought to be
mediated by the activation of presynaptic group II mGluRs. Moreover, mGluRs 2 and 3 are largely
absent in adult area CA1, suggesting that the block of LTP by putative group II agonists in this
region is unlikely to be mediated by a known subtype (see section 3.4.2). In addition, MCPG has not
been found to be an agonist of cloned group II mGluR subtypes studies in expression systems
(Hayashi et al., 1994; Emile et al., 1996). However, (S)-4CPG, which does act as an agonist at
mGluR2, in addition to antagonizing mGluR 1, has no effect on LTP (Bordi and Ugolini, 1995). The
pharmacological characterization of mGluR3 is currently poor, but this receptor is absent in CA1 and
only weakly expressed in the dentate, making it an unlikely modulator of LTP (see section 3.4.2).
Hence, it is possible that MCPG blocks LTP via an action at an unidentified mGluR subtype with
group Il-like pharmacology. It is likely that the cloning of additional mGluR subtypes together with
the arrival of new pharmacological tools will help to resolve this issue in the near future.
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3.10.8 mGluR activation can enhance tetanically induced LTP
Early studies revealed that the magnitude of tetanus-induced LTP in area CA1 in vitro could be
greatly increased by prior application of trans-ACPD (McGuinness et al., 1991a, b; Otani and Ben-
Ari, 1991). It was also reported that a weak tetanus, normally resulting only in STP, induced LTP
when delivered after frans-ACPD application (Aniksztein et ah, 1991; Behnisch and Reymann,
1993). In the former study, application of ACPD was found to potentiate NMDA, but not AMPA-
mediated EPSCs, suggesting a possible mechanism for the enhancement of tetanic LTP: this up-
regulation of NMDA receptor was blocked by the application of a PKC inhibitor. In a later study,
coupling of a weak tetanus with ACPD application was found to result in a transient elevation of
cytosolic PKC activity, consistent with previous suggestions that PKC activation may be involved in
the induction of lasting LTP (Otani et ah, 1993).
A similar facilitation of LTP induction has been seen with the putative group I-selective mGluR
agonist r-ADA in the dentate gyrus of freely-moving rats (Riedel et ah, 1995c). However, negative
results were obtained in the dentate gyrus of rat hippocampal slices with both f-ADA, and DHPG
(Brown and Reymann, 1995). The reasons for this discrepancy are unknown, but differences between
in vivo and in vitro preparations may be relevant. A later study from the same laboratory revealed
that the activation of mGluRs with f-ADA could overcome an AP5-induced block of LTP in the
dentate gyrus of freely-moving rats, in addition to facilitating the induction of lasting LTP with a
weak tetanus in the absence of AP5 (Manahan-Vaughan et ah 1996). Furthermore, it was found that
application of f-ADA or DHPG could still facilitate the induction of LTP when applied up to 25 min
after tetanization (Manahan-Vaughan and Reymann, 1996). In view of these findings, it is unlikely
that an mGluR-mediated upregulation of NMDA receptors underlies this form of LTP enhancement.
However, the discrepancy between these results and those of other studies remains unresolved.
Nevertheless, the ability of mGluR activation within a limited time window after tetanization to
extend the duration of LTP is reminiscent of similar findings following the activation of
dopaminergic or (3-adrenergic receptors, a phenomenon which is consistent with the "synaptic
tagging" theory of late LTP induction (Frey and Morris, 1998).
The proposed role of group I mGluRs in the facilitation of LTP induction is difficult to reconcile
with the failure of group I-selective antagonists to block LTP. It is possible that the activation of
mGIuR5, for which few mGluR antagonists have significant affinity, may explain the discrepancy:
DHPG has been reported to be an effective mGluR5 agonist (Brabet et al., 1995; Gereau and Conn,
1995b), and f-ADA has 10-fold greater potency at mGluR5 than mGluR 1 (Manahan-Vaughan et al.,
1996). Alternatively, the mGluR-mediated blockade and facilitation of LTP may be mechanistically
distinct, perhaps involving different subtype populations. It is likely that new mGluR ligands
selective for individual subtypes will provide answers to these questions.
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3.10.9 Summary
These results suggest that mGluRs play a non-obligatory modulatory role in the induction of LTP,
but that the nature and mechanism of this role may vary between brain regions and between
experimental preparations. Methodological issues such as tetanus strength and anaesthesia have been
suggested to explain discrepancies between studies. In addition, the molecular switch hypothesis
describes circumstances in which mGluR activation is not involved in the induction of LTP. These
issues will be revisited in chapter 7, in which a series of experiments concerning the effect ofMCPG
on dentate LTP in vivo are described.
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3.11 mGluR agonists and "slow-onset potentiation"
3.11.1 Slow-onset potentiation in vitro
Several groups have reported that co-activation of mGluRs and NMDA receptors induces a lasting
potentiation. For instance, Izumi et al. (1987b) found that co-application of quisqualate and NMDA
in CA1 slices caused a lasting LTP, not induced by NMDA application alone, a result which was
later interpreted as suggesting a role for quisqualate-activated mGluRs in LTP (Izumi et al. 1990).
Radpour and Thomson (1992) subsequently found that co-application of trans-ACPD and NMDA
could induce a slowly developing potentiation in CA1 slices, but only when accompanied by low
frequency stimulation of afferents. This effect was not dependent on postsynaptic depolarization, or a
block of synaptic inhibition.
However, other groups have found that activation of mGluRs may in itself be sufficient to induce a
form of long-term potentiation, equivalent to the maintenance phase of tetanic LTP without the prior
occurrence of STP or PTP. Bortolotto and Collingridge (1992, 1993) reported that the application of
(15,3/?)-ACPD could induce a slow-onset potentiation in area CA1 which totally occluded tetanus-
induced LTP, but was not itself dependent on NMDA receptor activation. The dose of ACPD used to
produce this effect had no effect on the baseline EPSP, suggesting that presynaptic depression of
glutamate release, and postsynaptic depolarization resulting from the inhibition of K+ currents were
minimal. (15.3/?)-ACPD-induced LTP was prevented by the application of protein kinase inhibitors
or the intracellular Ca2+ ATPase inhibitor thapsigargin, suggesting that both arms of the
phosphoinositide second messenger system may be involved. Interestingly, removal of CA3
prevented ACPD-induced slow-onset potentiation, suggesting that some form of ongoing synaptic
activity may be necessary.
The necessity for intact connections to CA3 may explain the negative results obtained by other
groups, since CA3 is often removed during preparation of a CA1 slice. For instance, Collins and
Davies (1993) found that co-application of NMDA and (15,3/?)-ACPD was necessary to induce
slow-onset potentiation in CA1 slices from which CA3 had been removed. A subsequent study
revealed that ACPD alone was sufficient if intact CA3-CA1 connections were preserved (Collins et
al., 1995a). However, it was found that infusion of ACPD was associated with an increase in the
excitability of CA3 neurons, the appearance of spontaneous burst firing in CA3, and an increase in
the presynaptic fibre volley. A similar form of "slow-onset potentiation" had previously been
reported by Chinestra et al. (1994), and attributed to an increase in the presynaptic fibre volley.
Collins et al. (1995a) found that the effects of ACPD on CA3 excitability and the afferent fibre
volley to CA1 - together with slow-onset potentiation itself - were blocked by the application of D-
AP5, in contrast to the findings of Bortolotto and Collingridge (1993). These results suggest that
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ACPD-induced slow-onset potentiation is not mediated by an increase in synaptic efficacy such as
that induced by a high frequency tetanus, but may be an indirect effect of an increased presynaptic
fibre volley from CA3. However, it is also possible that burst firing originating from CA3 might
constitute a physiological tetanus resulting in NMDA receptor-dependent LTP at synapses in CA1
(see Collins et al., 1995a).
Additional evidence against a postsynaptic mechanism for the induction of slow-onset potentiation
was provided by Liu et al. (1993) who found that application of (lS,3/?)-ACPD could induce an LTP
of AMPA-receptor mediated EPSPs which was secondary to an LTD ofGABAergic IPSPs.
These issues were addressed in a series of experiments by Bortolotto and colleagues, who provided a
detailed characterization of the effect they had originally described (Bortolotto and Collingridge,
1995). Firstly, the addition of picrotoxin did not prevent slow-onset potentiation, suggesting that the
effect is not secondary to a depression of synaptic inhibition. Secondly, ACPD-induced potentiation
was not associated with an increase in the presynaptic fibre volley. In addition, the expression of
slow-onset potentiation was found to be mediated entirely by an increase in AMPA receptor
mediated EPSPs. In contrast to the findings of O'Connor et al. (1994), no potentiation of the
pharmacologically isolated NMDA receptor EPSP was observed. It was found that the delivery of a
high-frequency tetanus in the presence of AP5 could substitute for the presence of CA3, suggesting
that high frequency burst activation is necessary for the induction of ACPD-mediated slow-onset
potentiation, although the mechanism involved is NMDA receptor-independent. These findings
demonstrate that the slow-onset potentiation observed by Bortolotto and colleagues is
mechanistically distinct from that described by Chinestra et al. (1994), and Collins and Davies
(1994). The former class of slow-onset potentiation is clearly more similar to the maintenance phase
of tetanic LTP than the latter, but the extent to which the two forms of potentiation are
mechanistically equivalent remains unknown.
Methodological considerations may explain some of the discrepancies between the effects of
(IS^ftpACPD in different laboratories. One such possibility concerns the use of interface slice
chambers by some groups, and submersion chambers by others. For instance, Bortolotto et al. (1995)
found that switching from an interface to a submerged slice configuration prevented the occurrence
of slow-onset potentiation. A slight acidification of the tissue found to occur after submersion of the
slice was suggested as a possible explanation. However, this does not explain why other groups have
obtained a mechanistically different form of slow-onset potentiation using submersion slice
chambers (e.g. Chinestra et al., 1994). In fact, the use of an interface chamber has been criticised by
Chinestra et al. (1994) for being "less than physiological", since slices are exposed to oxygenated air
rather than perfused with aCSF.
Although these issues remain largely unresolved, recent experiments have provided evidence for a
form of mGluR-induced potentiation which, though not identical to that reported by Bortolotto and
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colleagues, appears to be postsynaptic in origin and may be mechanistically related to the
maintenance phase of tetanically-induced LTP. For instance, (IS,3/?)-ACPD was found to induce a
transient depression, followed by a fairly rapid potentiation of both AMPA and NMDA receptor-
mediated EPSCs in rat dentate granule cells in vitro (O'Connor et al., 1995). This effect was found to
be AP5-sensitive. A similar result was reported by Breakwell et al. (1996), who found that bath
application of (lS,3/?)-ACPD induced a transient depression, followed by a fairly rapid EPSP slope
and E-S potentiation in submerged rat CA1 slices. Potentiation was prevented by the application of
AP5, and was only observed when an intact CA3 connection was present. However, no increase in
the presynaptic fibre volley was seen following ACPD application. This suggests that a change in the
excitability of CA3 neurons does not underlie the present result, although the exact role of CA3 is
unknown. E-S potentiation was blocked by the application of picrotoxin, whilst synaptic potentiation
was spared, suggesting that ACPD induced E-S potentiation, but not EPSP slope potentiation, may
result from a depression of GABAergic inhibitory transmission such as that reported by Liu et al.
(1993). Application of (+)-MCPG blocked the EPSP slope and E-S potentiation induced by both
ACPD application and high frequency tetanization. A similar, but NMDA receptor-independent,
form of potentiation has recently been described following the application of the selective group I
mGluR agonist (S)-DHPG in dentate slices (O'Leary and O'Connor, 1997). This potentiation
occluded tetanically-induced LTP, and vice versa. No change in the presynaptic fibre volley was
seen after (S)-DHPG application.
It is possible that the potentiation observed in the above studies, particularly the final one, may be
mechanistically similar to that reported by Bortolotto et al. (1995). The initial depression and faster
time course of potentiation in these later studies may result from the use of slices from immature rats.
The choice of hippocampal region, i.e. CA1 or dentate, is also likely to be relevant. However, there is
still no consensus regarding the induction of LTP by the activation of mGluRs. For instance, a recent
study found that application of (15,3/?)-ACPD in immature rat CA1 slices resulted in LTD, whereas
effects in adult rats were variable, ranging from minimal change to slow-onset potentiation
(Overstreet et al., 1997). In fact, there are currently almost as many forms of slow-onset potentiation
described in the literature as there are laboratories investigating the phenomenon.
3.11.2 Slow-onset potentiation in vivo
Slow-onset potentiation following the infusion of mGluR agonists has sometimes been described in
vivo. Manahan-Vaughan and Reymann (1995a) found that i.e.v. infusion of (1S,3R)-ACPD induced a
slow onset potentiation in the dentate gyrus of freely-moving rats. This effect was completely
blocked by the application of D-AP5 or (R,S)-MCPG. A similar result was obtained in area CA1 of
freely moving rats using either (15,3R)-ACPD (Manahan-Vaughan and Reymann, 1995b), or the
putative group I mGluR agonists DHPG and r-ADA (Manahan-Vaughan and Reymann, 1997a). No
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alterations in EEG such as epileptiform activity, or behavioural changes such as "wet dog shakes"
were found after ACPD infusion in the former study. An independent report confirmed that (15,3/?)-
ACPD can induce a slow onset potentiation in area CA1 of urethane-anaesthetized rats, which was
found to occlude tetanus-induced LTP (Davis and Laroche, 1996). No changes in the afferent fibre
volley were induced by ACPD. In the same study, however, a dose-dependent biphasic effect was
obtained in the dentate gyrus, consisting of a short-term potentiation induced by both low and high
doses of ACPD, followed by a lasting depression of the response in the high-dose group only. Since
(15,3/?)-ACPD is a broad spectrum agonist acting at both group I and group II mGluR sub-types, it is
possible that the potentiation of the EPSP is mediated by class I mGluRs coupled to PI hydrolysis,
whereas the depression is mediated by presynaptically located class II mGluRs. However, this
interpretation is difficult to reconcile with the fact that (15,3/?)-ACPD has a higher affinity for group
II mGluRs than group I. Nevertheless, the differential effects of ACPD in the dentate versus CAI
might reflect the fact that group II receptors are not prominently expressed in CAI, and do not play a
role as autoreceptors in this region (see sections 3.4.2 and 3.8.1, respectively). Consistent with this
possibility, the group I mGluR-selective agonist (/?,5)-DHPG induced only a potentiation of synaptic
transmission in the dentate, whereas the mixed group II agonist / group I antagonist (5)-4CPG caused
only a depression. Interestingly, application of a high dose of (15,3/?)-ACPD and (5)-4CPG blocked
the subsequent induction of tetanic LTP, providing further evidence that activation of a receptor or
receptors with group II-like pharmacology can block LTP.
Despite the fact that the in vivo data described above provide some support for the in vitro reports of
slow-onset potentiation, such data must be interpreted with caution. Although no evidence of a
presynaptic excitability or epileptiform activity was reported in these studies, other confounding
factors not monitored, such as brain temperature, may contribute to an apparent slow-onset
potentiation (c.f. Erickson et al., 1993). In fact, a number of glutamate receptor agonists, including L-
glutamate, NMDA and (15,3/?)-ACPD have been reported to cause a dose-dependent dilation of
hippocampal microvessels (Fergus and Lee, 1997). The increase in local blood flow resulting from
this phenomenon would very likely lead to a temperature rise, an effect which may contribute to
reports of slow onset potentiation induced by ACPD.
In summary, there is considerable evidence that activation of mGluRs, sometimes in conjunction
with NMDA receptors, can cause a potentiation of hippocampal evoked responses via a pre- or
postsynaptic mechanism, depending on the preparation used. However, it remains unknown whether
these effects have any physiological relevance in the intact animal.
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3.12 The role of mGluRs in learning
A number of groups have reported that the manipulation of mGluR function by pharmacological or
genetic means can cause learning deficits, a result which is not surprising considering the wide
regional distribution and diverse physiological roles of mGluRs. A satisfactory account of mGluR
function would require a detailed understanding of the role of the individual mGluR subtypes within
a particular brain structure during the performance of a specific behavioural task. For example, it has
been demonstrated that the activation of mGluR2 in the accessory olfactory system in mice can lead
to the induction of an olfactory memory (Kaba et al., 1994). However, such unambiguous results are
rare, particularly when more complex forms of learning are studied.
3.12.1 Effect ofmGluRs in memory consolidation in chicks and rats
Initial work revealed that injection of MCPG into the chick IMHV region prior to the acquisition of
an inhibitory avoidance task could prevent long-term memory consolidation (1-2 hr) without
affecting retention at shorter intervals. The onset of amnesia was dose dependent, with higher
concentrations of drug resulting in faster forgetting (Holscher, 1994; Rickard and Ng, 1995). MCPG
has also been found to impair the long-term consolidation of a visual discrimination task in young
chicks, a task in which NMDA receptor antagonists have no effect (Tiunova et ah, 1996). In addition,
Bianchin et al. (1994) found that bilateral intrahippocampal infusion of MCPG immediately after
training produced a retention deficit in a step-down inhibitory avoidance task in rats. No amnesia
was seen when MCPG was administered 180 min after acquisition, indicating that mGluR activation
immediately after, or during training is critical for memory formation. Application of (15,3R)-ACPD
together with MCPG resulted in normal retention of the task, whereas ACPD alone caused an
enhancement of memory. These results suggest that the level of mGluR activation immediately after
learning can modulate the strength of the ensuing memory trace.
3.12.2 mGluRs andfear conditioning in rats
Aiba et al. (1994) reported that mice lacking mGluRl were moderately impaired in contextual fear
conditioning. However, intraventricular infusion of MCPG has subsequently been found to have no
effect in this task, in comparison with the NMDA receptor antagonist D-AP5 which caused a
significant deficit (Bordi et al., 1996). Nevertheless, application of the selective group I mGluR
antagonist AIDA has recently been found to cause a selective deficit in contextual conditioning,
while hippocampal independent cue conditioning was unaffected (Nielsen et al., 1997). Lu et al..
76
(1997) have since reported that mice lacking mGluR5 exhibit a contextual conditioning impairment.
Further evidence for a role of mGluR5 in contextual fear conditioning has recently been provided by
Casabona et al., (1997a) who found that mGluR5 protein levels were markedly increased in area
CA3 24 hr after contextual fear conditioning. 10 days later, CA3 expression had diminished, but
protein levels were elevated in area CA1. Little change in mGluR5 protein was observed in the
dentate gyrus, however.
Intraperitoneal injection of the group II selective mGluR agonist APDC prior to the acquisition of
fear conditioning caused a severe deficit in freezing to a context, but not to a simple cue. This deficit
could be eliminated by increasing the salience of the context by placing black and white stripes on
the walls of the conditioning chamber and introducing the odour of eucalyptus oil. Increasing the
salience of the US by raising the shock intensity also abolished the APDC-induced deficit (Riedel et
al., 1997). These data are interpreted as evidence that excessive mGluR activation constitutes "noise"
which prevents efficient learning. It is proposed that an increase in the "signal", in this case the CS or
US, can overcome the increase in noise, thus permitting learning to occur normally. However, it
could also be argued that activation of presynaptic group II mGluRs might cause a reduction in
glutamate release at afferent terminals. Increasing the salience of the CS or US may cause sufficient
afferent activation to overcome this autoreceptor action and permit normal learning. The idea that
mGluRs modulate the signal to noise ratio in hippocampal dependent learning is discussed in section
3.12.5.
3.12.3 Anxiolytic actions ofmGluRs
Before considering the role of mGluRs in spatial learning, it is worth noting that certain mGluR
ligands have anxiolytic properties, a factor that may contribute to the apparent learning impairments
seen after pharmacological manipulation of mGluR function. For instance, the novel group II mGluR
agonist (+)-2-aminobicyclo[3.1.0]hexane-2,6-dicarboxylic acid (LY354740) has been reported to
increase open arm activity in the elevated plus maze test, indicating a reduction in anxiety (Monn et
al., 1997). It is postulated that this effect results from the suppression of excitatory pathways within
the limbic system, consistent with the postulated autoreceptor actions of group II mGluRs.
LY354740 has also been found to attenuate the enhancement of the auditory startle response
following nicotine withdrawal in rats (Helton et al., 1997). Independent studies have demonstrated
that antagonists of group I mGluRs ((S)-4C3HPG) and group III mGluRs (MSOP) reduce anxiety in
rats, as measured using the conflict drinking Vogel test (Chojnacka-Wojcik et al., 1997). Since
MCPG antagonizes group I and II mGluRs in expression systems, and has been reported to have
agonist properties at group II mGluRs in vivo, application of MCPG might be expected to have
anxiolytic effects.
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However, MCPG has been shown to have little effect on the open field behaviour of rats, and the
effects of MCPG and AIDA on shock-reinforced tasks do not indicate that these drugs have
anxiolytic properties (Riedel et al., 1994a, 1995d; Nielsen et ah, 1997). Nevertheless, the possibility
that MCPG might have anxiolytic actions has never been directly tested, and the issue will be
discussed further in section 6.5.
3.12.4 mGluRs and spatial learning
A number of studies have indicated that mGluRs are involved in various forms of hippocampus-
dependent spatial learning. For example, watermaze studies involving mGluR knockout mice have
revealed a spatial learning deficit in mice lacking mGluRl (Conquet et ah, 1994) and mGluR5 (Lu et
ah, 1997). However, most studies have involved pharmacological manipulations. Riedel et ah
(1994a) found that an i.e.v. injection of MCPG prior to training in a foot-shock reinforced Y-maze
spatial alternation task, resulted in a deficit when rats were later tested for retention. Paradoxically,
the mGluR agonist f-ADA also caused a deficit when administered prior to training in the same task
(Riedel et ah, 1995b). However, application of f-ADA immediately post-training facilitated memory
formation (Riedel et ah, 1995c). Neither MCPG nor f-ADA had any effect on brightness
discrimination learning. The differential effects of this putative group I mGluR agonist are
interpreted by the authors according to the signal to noise ratio theory ofmGluR function.
Using a slightly different approach Ohno and Watanabe (1996) found that blockade of mGluRs with
MCPG could aggravate the working memory deficit in a three panel runway task resulting from
NMDA receptor blockade. A subsequent study revealed that application of the selective group I
mGluR antagonist AIDA alone could increase working memory errors in this task. However,
concurrent administration of D-cycloserine, a partial agonist at the glycine site of the NMDA
receptor, significantly reduced the impairment induced by AIDA (Ohno and Watanabe, 1998). These
results suggest that mGluRs interact with NMDA receptors in memory formation: this interpretation
is consistent with reports that group I mGluR activation can potentiate responses to NMDA (see
section 3.7.4) and enhance tetanic LTP induced by a weak tetanus (see section 3.10.8). In Ohno and
Watanabe's (1998) study, upregulation of NMDA receptors with D-cycloserine may bypass the
necessity for mGluR activation, and allow normal learning in the presence of AIDA.
Curiously, application of AIDA has been reported to facilitate memory under certain circumstances.
In a recent study study, the effects of AIDA were investigated in a delayed-matching-to-position task
with fixed reward location in a three choice maze. Pre-training application of AIDA resulted in
enhanced within session performance, but retention between sessions (separated by 24 hr) was
equivalent to that of controls. This result differs from that obtained with a contextual fear
conditioning task, in which AIDA caused only a slight and non-significant facilitation of within
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session performance, but caused a pronounced retention deficit (G. Riedel, personal communication).
These results suggest that blockade of group I mGluRs may have differential effects on short and
long-term memory formation, manifested in a task-dependent fashion. Nevertheless, the reason for
this dissociation is currently unknown.
The first investigation of the role of mGluRs in watermaze performance was published by Richter-
Levin et al. (1994). A bilateral i.e.v. infusion of (R.SyMCPG prior to training was found to cause
little impairment in latency to reach the platform, but a severe deficit in transfer test performance.
This deficit was observed regardless of whether MCPG was re-administered prior to the transfer test,
ruling out the possibility of state-dependent or performance deficits. However, it has subsequently
been reported that MCPG induces a slight increase in latency to find the hidden platform, but only
causes a transfer test deficit when re-administered prior to testing; rats infused with MCPG
throughout testing, but given saline prior to the transfer test performed as well as controls (Bordi et
al„ 1996). This result is hard to reconcile with that of the earlier study. Furthermore, in contrast to
the positive results reported following acute i.e.v. injection ofMCPG, chronic i.e.v. infusion of either
MCPG or AIDA via an osmotic minipump does not disrupt watermaze performance (Riedel et' al.,
1998). These issues will be explored further in the experimental work described in chapter 6.
Application of mGluR agonists prior to training has also been reported to impair watermaze
performance. Pettit et al. (1994) found that i.e.v. infusion of a subtoxic dose of (1S,3R)-ACPD
increased latency to find the hidden platform, and resulted in a trend towards a transfer test deficit.
Similar results have been obtained with L-CCG-I, although transfer test performance was unaffected
(Van der Staay et al., 1995). However, the effective dose of this drug caused convulsions during
infusion, post-infusion sedation, and increased floating in the pool. Hence, the "mnemonic" effects of
this drug must be viewed with some caution. Holscher et al. (1996) reported that i.e.v. infusion of L-
AP4, an agonist at group III mGluRs, caused a deficit in both watermaze and radial maze tasks.
Despite the fact that injection of the group III mGluR antagonist MAP4 alone caused a spatial
learning deficit, co-administration of MAP4 and L-AP4 resulted in normal performance on both
behavioural tasks. In addition to acting as a group III mGluR agonist, L-AP4 has also been found to
antagonize the (15,3f?)-ACPD-induced increase in transmitter release thought to be mediated by an
uncloned receptor (Herrero et al., 1994). Holscher et al. (1996) have suggested that the effects of L-
AP4 on spatial learning may be mediated by this mGluR subtype.
3.12.5 mGluRs may modulate the "signal to noise ratio" during learning
It is notable that whereas pre-training administration of mGluR agonists has been found to impair
memory formation (Pettit et al., 1994; Riedel et al., 1995b), post-training application has been found
to facilitate memory (Bianchin et al., 1994; Riedel et al, 1995c). These findings are interpreted by
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Riedel (1996) as evidence that abnormal pre-training activation of mGluRs constitutes noise, and
prevents efficient learning. It is suggested that mGluRs involved in a learning event may be use-
dependently primed, leading to enhanced second messenger stimulation when activated by the
application of an agonist. Hence, post-training mGluR agonist application may enhance memory
formation since the greatest increases in signal transduction will be coupled to those mGluRs
activated during the learning event, i.e. the signal to noise ratio will be increased.
Whilst this hypothesis is currently formulated in rather general terms, it provides a framework for the
interpretation of a number of results, as well as generating testable predictions. However, a number
of physiological mechanisms would be consistent with the signal-to-noise ratio hypothesis. For
instance, "noise" could consist of a literal increase in spontaneous neuronal activity following
mGluR activation (see Boddeke et al., 1997; Martin and Morris, 1997). However, a reduction in the
statistical efficiency of a conjunction detection mechanism during excessive mGluR activation would
also constitute the introduction of "noise" to a learning system. Unfortunately, these issues are
difficult to address when the nature of the neuronal "signals" underlying learning are largely
unknown.
3.12.6 Summary
The studies reviewed in this final section illustrate the diverse effects that the modulation of mGluR
activity has been reported to have on behaviour. However, there is no overall consensus concerning
the mechanisms by which mGluR blockade affects the performance of learning tasks, and the effects
of an mGluR ligand on learning and its effects on LTP are often far from clear. A large part of the
experimental work described in this thesis was conducted in an attempt to address these issues. This






Adult male Lister-hooded rats (250-500g) obtained from the breeding colony in the Department of
Pharmacology, University of Edinburgh, were used as subjects in most experiments. However,
differences in strain, sex or supplier will be mentioned as appropriate. Animals were individually
housed with ad libitum access to food and water, and maintained on a 12 hr light / 12 hr dark cycle.
4.2 Watermaze training
4.2.1 Apparatus
Testing was carried out in an open-field watermaze (Morris 1981, 1984; figure 4.2), 2 m in diameter
and 0.6 m deep, filled with water at 25 ± 1°C to a depth of 0.3 m. The pool was located in the centre
of a room containing prominent extra-maze cues such as wall posters, a metal rack, cupboards etc.
The room was diffusely illuminated by floodlights placed in the 4 corners. Rats were placed into the
water facing the sidewalls and learned to escape onto a submerged platform, 11 cm in diameter. (On
some occasions, however, a visible platform with prominent vertical black and white stripes
protruding 1-1.5 cm above the water surface was used instead.) In order to obscure the submerged
platform, the water was made opaque by the addition of cempolatex liquid (Cementone-Beaver Ltd.).
A recessed video camera was placed directly above the centre of the pool to monitor the paths taken
by the rats during swimming. The video signal was relayed to a video recorder for both on- and off¬
line analysis and fed to an image analyser (HVS VP112). Co-ordinates were sampled at 10 Hz by an
Acorn Archimedes 3000 computer running the "Watermaze" software package written by R.
Spooner. This program records the swim path of a rat, and calculates a number of behavioural
measures, such as the latency to reach the escape platform and the percentage time spent within a
specified area of the pool.
4.2.2 Procedure
Details of the behavioural methodology and data analysis differ between experiments, and will be
described in subsequent chapters as necessary. However, the standard spatial reference memory task
described below was used, with minor modifications, for all the experiments described in chapter 6.
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4.2.2.1 Pre-training
Prior to spatial acquisition training, rats received one session of non-spatial pre-training consisting of
4 trials of 60 s each, during which curtains were drawn about the pool in order to obscure extra-maze
cues. Both platform position and starting position were varied according to pseudo-random schedules.
Rats which failed to find the platform within 60 s were guided to the correct location. A 30 s stay on
the platform was allowed between each trial. This pre-training provided an introduction to the
procedural aspects of the task, such as the need to avoid the side-walls and the existence of an escape
platform, whilst keeping the spatial component to a minimum.
4.2.2.2 Acquisition training
For the following three days, rats were given daily blocks of 6 trials to a fixed platform location with
the curtains drawn back to reveal extra-maze cues. Starting positions were randomized and animals
that failed to find the platform within 120 s were guided to the correct location. Rats were allowed to
remain on the platform for 30 s following the end of each trial, after which the next trial was started
immediately. In order to control for positional biases, half of the rats were trained to a platform
position in the centre of the NE quadrant of the pool, whilst the remainder were trained to a position
in the SW quadrant. Platform positions were counterbalanced across all groups.
4.2.2.3 Transfer test
24 hr after the final acquisition training session, the rats' memory of the platform location was tested
in a transfer test during which the platform was removed and the animal allowed to swim freely for
60 s. This test was analysed by dividing the pool into four quadrants centred around the NE, NW, SE
and SW platform positions. The percentage time spent in each of these quadrants during the trial
constituted the primary measure of task performance.
4.2.2.4 Visually cued task
At the end of training, rats received six visually cued trials that required the location of a black and
white striped platform, protruding 1 cm above the water surface. Both platform and starting positions
were randomized between trials and curtains were drawn about the pool in order to minimise















Fig. 4.2 Watermaze apparatus
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4.3 Electrophysiology
Rats were anaesthetized with urethane (1.5g/kg i.p.), and mounted in a stereotaxic frame (Kopf) with
skull horizontal. All co-ordinates described below, and in future chapters, were measured relative to
bregma unless otherwise stated. Temperature was monitored by a rectal probe and maintained at 36.2
+ 0.2 °C using an isothermic heating blanket (Harvard Instruments). A teflon-coated, bipolar,
platinum / iridium stimulating electrode (consisting of two wires twisted together, each wire having
external diameter = 0.112 mm and bare wire diameter = 0.075 mm) was lowered into the angular
bundle of the perforant path (AP = 7.5 mm; Lat. = 4.0 mm; DV = 2.5 mm from the dura) and a
monopolar recording electrode (a single wire of same diameter and material as the stimulation
electrode) was positioned in the hilus of the dentate gyrus (AP = 3.5 mm, Lat. = 2.0 mm; DV = 3.0
mm) in order to record positive-going field potentials.
Test stimulation was delivered using a NeuroLog stimulation system (Digitimer Research
Instrumentation) at either 0.1 Hz or 0.05 Hz, and consisted of biphasic pulses with 100 ps half-pulse
duration. Waveforms were amplified using a polygraph (Grass Instruments); the initial slope of the
field EPSP (measured by linear regression between two fixed time points), and the population spike
amplitude (the distance between the minimum of the negative-going spike and a tangent subtending
the two local maxima of the field potential), were monitored on-line by an Acorn A5000 computer
running specialized software. Deviations from this procedure, including the implantation of
thermistors and / or infusion cannulae will be described in later methods sections.
After implantation of the electrodes, stimulation was turned off for at least half an hour in order to
allow the brain tissue to settle. After this period a number of test pulses were delivered and the
stimulation intensity was adjusted to elicit a population spike of the required amplitude. Several
different sets of baseline stimulation parameters were used in the course of this thesis. Similarly, a
number of different tetanization protocols were tested. These details are described wherever
necessary.
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4.4 Surgery for intracerebral drug delivery
4.4.1 Implantation ofosmotic minipumps
Rats were placed in a stereotaxic frame (Kopf) under tribromoethanol anaesthesia (Avertin; 0.29
g/kg). The skull was exposed and a burr hole was made to allow the insertion of an L-shaped stainless
steel cannula into the right lateral ventricle (co-ordinates from bregma: AP = 0.9 mm; Lat. = 1.3 mm;
DV = 4.5 mm from skull surface). The cannula was attached to an osmotic minipump (Alzet 2002)
via plastic tubing and secured in place with dental acrylic and three jeweller's screws. The minipump
was inserted into a subcutaneous pocket above the shoulder blades. Alzet 2002 minipumps infuse
continuously for 14 days at a rate of 0.5 pi / hr.
4.4.2 Implantation ofacute i.e.v. infusion cannula
Animals were placed in a stereotaxic frame and anaesthetized with Avertin as above. The skull was
exposed and a burr hole was made to allow the insertion of a stainless steel guide cannula (23 gauge)
into the right lateral ventricle (co-ordinates from bregma: AP = 0.9 mm; Lat. = 1.3 mm; DV = 4.0
mm from skull surface). The cannula was fixed in place with dental cement and two jeweller's
screws, one anterior and one posterior, provided further anchorage. After implantation, the guide
cannula was blocked by the insertion of a stainless steel dummy cannula, protruding 0.5 mm below
the tip of the guide cannula. Both guide and dummy cannulae were made in the laboratory from
stainless steel tubing.
Prior to infusion, the dummy cannula was removed from the guide cannula and replaced by an
injection needle of the same length connected, via plastic tubing, to a microsyringe. The rat was then
given a 5 pi intraventricular infusion, over a period of 2 min. The injection needle was left in place
for approximately 1 min after the end of infusion, to allow diffusion of the drug away from the
injection site.
4.4.3 Implantation of intrahippocampal infusion cannulae
The methods used were similar to those described above. However, commercially available guide
cannulae (23 gauge), dummy cannulae, and injection needles were used (Plastics One). Dummy
cannulae consisted of a length of steel tubing attached to a plastic cap which could be screwed onto
the guide cannula, resulting in a more effective barrier against infection than that provided by the
dummy cannulae described above.
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Guide cannulae were implanted bilaterally above the dorsal hippocampi (co-ordinates from bregma:
AP = -4.5 mm; Lat. = ± 3.0 mm; DV = -3.0 mm from the dura) Four jeweller's screws were used to
provide anchorage after cementing.
Prior to infusion, the dummy cannulae were removed from the guide cannulae and replaced by
injection needles protruding approximately 0.2 mm below the base of the guide cannulae. These were
connected, via plastic tubing, to microsyringes held in a syringe drive. A volume of 1 pi was infused
into each hippocampus over a period of 5 min. The injection needles were left in place for
approximately 1 min after the end of infusion.
4.5 Histology
After behavioural testing, rats implanted with electrodes, cannulae, or minipumps were either
perfused transcardially with physiological saline followed by 10 % formol saline or sacrificed
without perfusion. In both cases, the brains were removed and placed in formol saline solution. When
adequately fixed, the relevant section of a brain was frozen, cut into 30 pm sections, and stained with
cresyl violet. Sections were then examined under the light microscope to determine the position of the
cannulae, and to assess the amount of tissue damage and / or infection. Other histological techniques
will be detailed wherever relevant.
4.6 Statistics
Unless otherwise stated, statistical comparisons were carried out using analysis of variance
(ANOVA). In ANOVA designs involving one between subject variable and one within subject
variable, the effect of the between subject factor was sometimes calculated for just one level of the
within subject factor (analysis of "simple effects"). For instance, in a watermaze experiment, the
effect of drug group might be investigated on individual acquisition trials. Such an analysis was only
carried out after a main effect of the between subject factor had been established. Conversely, the
effect of the between subject variable was sometimes calculated for just one level of the between
subject factor (i.e. for just one group). In the former case, the error term for the between subject factor
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was calculated using the pooled error term, rather than using just one level, of the within subject
variable. The number of degrees of freedom of this pooled error term was calculated using
Satterwaite's approximation. In circumstances requiring multiple post hoc comparisons, Newman-
Keuls individual pairwise comparisons were always used.
In cases where the distribution of values was suspected to deviate substantially from normality and /
or the variance between experimental conditions was grossly non-homogeneous, a Shapiro-Wilk test
for significant deviations from normality, and a Levene test for homogeneity of variance, were
carried out. If necessary, a non-parametric analysis was then conducted.
Most data were analysed using "CLR ANOVA" and "SPSS" statistical packages. Correlation
coefficients were calculated using "Cricket Graph" and "SPSS". Numerical values are stated as mean
± standard error throughout.
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Chapter Five
Blockade of spatial learning with D-AP5:
"performance" deficits and possible neurotoxicity
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5.1 General Introduction
The application of NMDA receptor antagonists has consistently been found to impair the
performance of rats in spatial learning tasks (see chapter 2.6.6). However, it is still not entirely clear
that these drugs cause a pure memory impairment, rather than interfering with other behavioural
processes. Sensory, motor, and / or motivational deficits following the administration of NMDA
receptor antagonists may all impair spatial "learning". Distinguishing between genuine learning
impairments and "performance" factors such as these is one of the central challenges of behavioural
pharmacology. In addition, it has recently been suggested that the impairment observed after
application of NMDA receptor antagonists might be secondary to the neurotoxic effects of these
drugs, rather than the blockade of NMDA receptors. The following sections will provide a review of
the relevant literature, followed by an experimental study designed to address some of these issues.
5.1.1 NMDA receptor antagonists cause "performance" deficits in learning tasks
NMDA receptors are widely distributed in the brain (Monaghan and Cotman, 1985); hence, any mode
of drug administration other than local infusion into the target structure will lead to the blockade of
NMDA receptors in a number of brain regions. Intraventricular drug infusion is preferable to
systemic injection as a mode of drug delivery to the hippocampus. Moreover, it is necessary for the
delivery of drugs that do not readily cross the blood-brain barrier, such as D-AP5. However, this route
of administration results in a widespread distribution of the drug throughout the forebrain (Butcher et
al., 1991; Davis et ah, 1992).
The possibility of NMDA receptor blockade in structures such as the striatum and thalamus is a
serious problem. For instance, there is evidence that NMDA receptors in the lateral geniculate
nucleus (LGN) are involved in the normal relaying of visual information (Sillito et ah, 1990), rather
than synaptic plasticity per se. Indeed, i.e.v. infusion of the competitive NMDA receptor antagonists
CPP and AP7 has been found to impair brightness discrimination in the rat (Tang and Ho, 1988). This
result is potentially worrying considering the importance of vision in tasks such as the watermaze, in
which rats must navigate towards a hidden platform using information provided by distal cues. A
similar role of NMDA receptors in normal synaptic transmission of somatosensory information in the
ventrobasal thalamus has been identified (Salt, 1986, 1987). Furthermore, it has been reported that
infusion of the competitive NMDA receptor antagonist CPP into the thalamus antagonizes the
nocioceptive responses of single neurons to noxious thermal stimuli in anaesthetized rats (Eaton and
Salt, 1990). It is possible that a blockade of thalamic NMDA receptors following the i.e.v. infusion of
an antagonist might result in a reduction in the aversive qualities of immersion in cold water, and
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hence a reduced motivation to learn a watermaze task.
In addition to the possibility of sensory impairments, NMDA receptor antagonists have been reported
to cause a range of motor deficits. Injection of AP5 into the spinal cord has been found to result in
analgesia and locomotor paralysis of the hindquarters (Cahusac et al., 1986). Although such effects
are unlikely after ventricular drug infusion, NMDA antagonists can also cause motor deficits by
actions at higher brain centres, such as the thalamus (Klockgether et al., 1984). Both competitive and
non-competitive NMDA receptor antagonists, including AP5, are frequently observed to cause ataxia,
characterized by a slowing of the righting reflex, an abnormal gait, and a loss of balance (Koek et al.,
1987; Leung and Desborough, 1988; Contreras et al., 1988; Hiramatsu et al., 1989). During
watermaze training rats are often observed to fall off the platform whilst performing a "wet-dog
shake" (Morris et al., 1986a; Morris 1989). As well as tiring the animals, this phenomenon may
reduce the value of the platform as an escape from the aversive properties of immersion in water.
Hence, drug-treated animals may be less motivated to search for the platform, and may look for other
means of escape, for instance by swimming around the walls of the pool (Cain et al., 1996; R. G. M.
Morris, R. J. Steele, S. J. Martin, and J. E. Bell, unpublished observations).
However, there may be other reasons for such maladaptive behavioural patterns. In addition to
causing ataxia, non-competitive NMDA receptor antagonists such as dizocilpine (MK-801) produce
stereotypical behaviours at comparatively low doses. These behaviours consist of stylized movement
patterns such as head weaving, sniffing, and grooming (Koek et al., 1988; Tiedke et al., 1990). Such
behaviour is also observed after treatment with competitive NMDA receptor antagonists including
AP5 (Schmidt, 1986; Koek et al., 1987). It is likely that these effects are mediated by the blockade of
striatal NMDA receptors. In fact, stereotypical behaviours can be induced by direct striatal infusions
of d,l-AP5 (Schmidt, 1986). Rats given chronic i.e.v. minipump infusions of d-AP5 sometimes
display stereotypical behaviours in the watermaze, such as swimming continuously around the
perimeter of the pool (thigmotaxic swimming), or swimming in apparently aimless circles.
Occasionally, AP5-treated rats are observed to "swim over" the escape platform owing to a failure to
inhibit swimming movements upon contact. These swimming movements sometimes continue even
after a rat has been removed from the pool. For a detailed description of such impairments, see Cain
et al. (1996).
Consistent with the stereotypical behaviour patterns associated with the administration of NMDA
receptor antagonists, MK-801 has been reported to cause perseverative arm entries in an 8-arm radial
maze spatial alternation task (Holter et al., 1996), and perseverative lever pressing in an operant task
(Cohn and Cory-Slechta, 1993). It is not clear whether non-competitive NMDA receptor antagonists
also cause perseverative deficits. However, chronic minipump infusion of d,l-AP5 has been reported
to cause a deficit in the "differential reinforcement of low rates" (DRL) task, in which rats must delay
lever pressing in order to obtain a reward (Tonkiss et al., 1988). AP5-treated rats tended to respond
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too early, a result interpreted as an impairment in temporary memory storage. Alternatively, however,
this result may be an illustration of AP5-induced perseverative lever pressing similar to that observed
after administration ofMK-801.
In addition to the deficits described above, NMDA receptor antagonists have been found to have
direct effects on motivation. For instance, application of AP5 increases open arm exploration time in
the elevated plus maze test, indicating that the drug has anxiolytic actions (Dunn et al., 1989). A
reduction in the anxiety experienced by a rat upon immersion in the watermaze may reduce the
incentive to escape, and hence impair learning. It has been speculated that the AP5-induced
watermaze impairment may result from such a motivational deficit (Keith and Rudy, 1990).
5.1.2 Attempts to control for NMDA antagonist-induced sensorimotor disturbances
A number of control tasks have been carried out in order to rule out the contribution of sensorimotor
and motivational disturbances to watermaze performance. In the simplest of these paradigms, rats are
simply required to locate a visible platform in the absence of distal cues. AP5 does not generally
cause a deficit when tested in this task (Morris, 1989; Butcher et al., 1990; Steele and Morris, 1999;
but see Cain et al., 1996). However, the task is clearly very easy: escape latencies of a few seconds
are generally observed from the start of testing. Hence, a ceiling effect might obscure any subtle
impairment. Nevertheless, in an earlier study, Morris et al. (1986a) carried out a visual discrimination
task, in which rats had to discriminate between two randomly located but visually distinct platforms,
only one of which would support the rat and offer refuge. No impairment was observed in AP5-
treated rats, despite the obvious difficulty of the task (rats took between 40-120 trials to reach a
criterion of 90 % correct in one 10-trial session). However, the demands of this task are very different
to those of the spatial reference memory task, in which distal cues must be used. For instance, a slight
visual impairment might be obscured by the fact that visual discrimination performance is likely to
require a lower level of acuity than the spatial task.
Nevertheless, the recent report that D-AP5 causes a delay dependent impairment in a watermaze
delayed matching-to-place task provides strong evidence that the AP5-induced impairment is not
merely a sensorimotor side-effect, unrelated to learning (Steele and Morris, 1999; see chapter 2.6.6).
If this were the case, performance would be equally affected at all delays.
5.1.3 The effects of training protocol on the severity ofsensorimotor disturbances
Variations in experimental protocol between laboratories may contribute to differences of opinion
concerning the contribution of sensorimotor disturbances to the watermaze deficit caused by NMDA
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antagonists. For instance, massed trials result in greater sensorimotor disturbances under AP5 than
spaced trials. Davis et al. (1992) gave rats 6 trials per day for 5 days; the performance of animals
treated with AP5 tended to deteriorate over trials, suggesting that fatigue might exacerbate the drug-
induced deficit. Consistent failure to find the platform during massed trials may also exacerbate
stereotypical behaviour patterns such as circling the sidewalls. It was subsequently found that
implantation of minipumps containing 15 mM D-AP5 failed to cause a deficit in a one trial per day
watermaze paradigm (D. M. Bannerman, unpublished observations). This dose of AP5 results in a
hippocampal concentration known to impair watermaze performance when massed trial protocols are
used (e.g. Davis et ah, 1992). Hence, under conditions that minimize sensorimotor impairments, a
higher dose of AP5 may be needed to disrupt performance.
The sensorimotor disturbances induced by NMDA antagonists are strongly influenced by watermaze
experience. The importance of prior experience in watermaze tasks is illustrated by the findings of
Bannerman et al. (1995) and Saucier and Cain (1995) (see chapter 2.6.6). Similarly, the sensorimotor
disturbances following AP5 infusion can be reduced by pre-training consisting of six trials to a visible
platform with distal cues obscured (see Bannerman et al., 1995; experiment 1). Despite increasing in
the course of a massed-trial training session, sensorimotor deficits associated with chronic AP5
infusion tend to diminish between testing days. AP5-treated rats are often found to fall off the
platform on the first day of watermaze training, but this problem disappears in subsequent sessions. In
a recent study conducted in this laboratory, the severity of a number of sensorimotor disturbances,
both negative and positive, over several daily test sessions. By day 4, AP5-treated rats were
indistinguishable from controls in terms of the behavioural symptoms of sensorimotor disturbance,
yet they still showed a robust spatial learning deficit (R. G. M. Morris, R. J. Steele, S. J. Martin, and
J. E. Bell, unpublished observations).
Nevertheless, it has recently been claimed that acute infusion of D-AP5 causes sensorimotor deficits
in the watermaze that are severe enough to account for the failure to locate the platform (Cain et al.,
1996). The disturbances reported include periphery swimming, contacting the platform without
climbing on, "swimming" over the platform, and the continuation of hind-limb swimming movements
after removal from the pool. Furthermore, AP5-treated rats swam more slowly relative to controls as
testing progressed, and were impaired in the performance of a visually cued control task. However,
rats were given a single session of hidden platform training, consisting of 10 trials in close
succession, followed by 10 trials to a visible platform. This is a protocol likely to exacerbate
sensorimotor disturbances, as well as inducing considerable fatigue in animals failing to find the
platform rapidly. This may explain the impairment found in the visible platform task, a result that has
not been obtained in other studies (Morris, 1989; Butcher et al., 1990). Furthermore, it is not clear
whether sensorimotor disturbances were evident from the start of testing, or whether they became
worse as testing progressed, perhaps as the result of a failure to learn. In order to investigate these
issues, it was decided to repeat the study presented by Cain and colleagues, subject to minor
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modifications (see experiment 5.2).
5. 1. 4 Neurotoxic effects ofNMDA receptor antagonists
In addition to the contribution of sensorimotor disturbances, Cain et al. (1996) suggested that the
behavioural deficit caused by chronic infusion of NMDA receptor antagonists might be secondary to
the neurotoxic actions of these drugs in the retrosplenial and cingulate cortices, brain regions known
to be involved in spatial learning (Sutherland et al., 1988).
The neuroprotective effects of NMDA receptor antagonists following insults such as hypoxia and
ischaemia are well established, and have been the subject of considerable clinical interest. It is known
that the high synaptic concentrations of glutamate which follow a number of insults are excitotoxic,
probably owing to excessive calcium influx via NMDA receptors (see Bruno et al., 1993; Choi, 1992
for review). Application of non-competitive and competitive NMDA receptor antagonists, including
d,l-AP5 has been found to protect neurons in rat hippocampal slices from hypoxic damage (Grigg
and Anderson, 1990). However, most research has been carried out with the non-competitive
antagonists dizocilpine (MK-801), phencyclidine (PCP) and ketamine. The most potent of these
compounds, MK-801 has been found to prevent excitotoxic neuronal damage in animal models of
ischaemia (Gill et al., 1987) and epilepsy (Clifford et al., 1990). However, non-competitive NMDA
receptor antagonists have clinically undesirable psychotomimetic properties. In addition, these drugs
have recently been discovered to be neurotoxic themselves.
Olney et al. (1989) found that subcutaneous injection of relatively low doses MK-801, PCP, or
ketamine in female Sprague-Dawley rats caused cytoplasmic vacuolation in neurons of the
retrosplenial and posterior cingulate cortices. This reaction first became evident 2 hr after injection,
and became increasingly more prominent at 4, 8, and 12 hr. However, 24 hr after drug administration,
most neurons appeared normal. A similar acute vacuolation was obtained following injection of d-
AP5 into a site bordering on the cingulate cortex (Labruyere et al., 1989). A number of other
competitive NMDA receptor antagonists have since been found to induce the same reaction
(Hargreaves et al., 1993; Ellison, 1994). In addition to vacuolation, injured neurons of the
retrosplenial cortex have been found to express a 72k Da heat shock protein (HSP72). This response
was maximal 24 hr after treatment with MK-801, but was still detectable for up to 2 weeks (Sharp et
al., 1991; Lan et al., 1997).
Despite the fact that vacuolation was initially thought to be reversible, subsequent studies have
demonstrated that higher doses of MK-801 can cause necrosis in the retrosplenial cortex, evident
several days after a single drug treatment (Allen and Iversen, 1990; Fix et al., 1993). Curiously,
female rats are found to be more susceptible to neuronal damage than males (Fix et al., 1995). It has
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been suggested that after doses of MK-801, vacuolated neurons may become irreversibly injured,
leading to necrosis (Fix et al., 1993). However, the relationship between vacuolation, HSP72
expression and necrosis is currently unclear.
Application of NMDA receptor antagonists for an extended period has been reported to cause a more
widespread pattern of neuronal damage. Repeated administration ofMK-801 (i.p. injection every 8 hr
for 2 days) resulted in neuronal degeneration in the pyriform cortex, entorhinal cortex, amygdala, and
the ventral two thirds of the dentate gyrus, as well as the cingulate and retrosplenial cortices (Horvath
et ah, 1997). Damaged neurons, axon terminals and activated microglia were labelled using silver
staining techniques. A similar, but less severe pattern of damage was obtained following single high
doses of MK-801. In most brain regions, the highest density of silver impregnation was observed
within the first day or two after injection. An extended pattern of degeneration has also been found
following the chronic administration of PCP by osmotic minipump (Ellison and Switzer 1993).
Chronic minipump infusion of the competitive NMDA receptor antagonist LY235959 has been
reported to induce a similar pattern of limbic degeneration, as revealed by silver staining techniques,
to that induced by non-competitive antagonists (Ellison, 1994).
The mechanism by which NMDA receptor antagonists cause neuronal damage is unclear. Olney et al.
(1991) proposed that glutamatergic neurons in the posterior cingulate cortex give rise to collateral
axons which feed back to NMDA receptors on GABAergic neurons and exert tonic inhibitory control
over the release of acetylcholine onto cingulate neurons. The disinhibition of cholinergic afferents
following NMDA receptor blockade thus leads to neurotoxic damage. This scheme is consistent with
reports that the neurotoxic effects of MK-801 can be attenuated by application of the cholinergic
antagonist, scopolamine (Olney et al., 1991; Wozniak et al., 1995), or by anaesthetic agents which
facilitate GABAa receptor-mediated neurotransmission (Olney et al., 1991; Ishimaru et al., 1995;
Jevtovic-Todorovic et al., 1997). However, it is possible that disinhibition of other excitatory
pathways may be involved (Corso et al., 1997). It has recently been reported that the protein synthesis
inhibitor cycloheximide almost completely prevents neuronal damage caused by injection of MK-801
(Zhang et al., 1996). This suggests that the neuronal death caused by NMDA receptor antagonists
may be apoptotic, rather than necrotic, as had previously been assumed.
Administration of MK-801 has been reported to cause an acute impairment in a number of spatial
learning tasks, attributed to a deficit in memory function (Butelman, 1989; Caramanos and Shapiro,
1994; Pitkanen et al., 1995). However, the potential neurotoxic effects of the drug have rarely been
considered. In a recent study by Wozniak et al. (1996), mice given a single i.p. injection of a high
dose of MK-801 were impaired in the performance of a hole board food search task for a period up to
at least 5 months after treatment. Mice injected with a lower dose of MK-801 showed only an acute
impairment. The performance of high-dose MK-801-injected mice did not differ from that of
untreated animals in a range of sensorimotor control tasks carried out 2 weeks after injection.
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Histological analysis confirmed that treatment with high-dose MK-801 resulted in the death of a
small number of neurons in the cingulate and retrosplenial cortices. These results demonstrate that an
acute dose of an NMDA receptor antagonist can lead to a chronic spatial learning impairment,
probably due to drug-induced neuronal death.
However, the possibility of neuronal death following chronic i.c.v. infusion of the competitive
NMDA receptor antagonist D-AP5 has never been investigated. Consequently, the purpose of
experiment 5.3 was to investigate the possible neurotoxic effects of i.c.v. minipump infusion of D-
AP5, in comparison to the effects of acute systemic injections of MK-801 which reliably cause
neuronal damage. In addition, the spatial learning abilities of rats were assessed both during and after
the period of AP5 infusion (experiment 5.2), in order to determine the contribution of chronic
neuronal damage, if found, to the AP5-induced behavioural deficit.
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5.2 Chronic administration of D-AP5 impairs performance in a spatial, but not a cued version
of the watermaze task, only during the period of drug infusion
5.2.1 Introduction
The purpose of this study was to replicate the behavioural protocol used by Cain et al. (1996), subject
to minor modifications. Owing to the suggestion that AP5 infusion might cause brain damage,
different groups of rats were tested either during or after the period of drug infusion. The latter group
was included in order to investigate the possibility of persistent deficits attributable to AP5-induced
neuronal damage.
An additional aim of this experiment was to assess whether sensorimotor disturbances might be
exacerbated by the testing protocol used by Cain et al. (1996), in comparison to the protocols
routinely used in this laboratory (see section 5.1). Of particular interest was the question of whether
the visible platform deficit reported by Cain and colleagues could be obtained using chronic i.e.v.
minipump infusions of D-AP5.
5.2.2 Methods
5.2.2.1 Animals
Adult male Lister-hooded rats (250-500g) obtained from the breeding colony in the Department of
Pharmacology, University of Edinburgh, were used as subjects.
5.2.2.2 Drugs
All drug solutions were made up in pyrogen free water. A 100 mM stock solution of D-2-amino-5-
phosphopentanoate (D-AP5; Tocris) was made up in equimolar NaOH. A final concentration of 30
mM D-AP5 was attained by dilution with the appropriate volume of artificial cerebrospinal fluid
(aCSF), made up according to the Alza methodology (final ionic concentrations (mM): Na+ = 150.0;
K+ = 3.0; Ca2+ = 1.4; Mg2+ = 0.8; P043" = 1.0; CI" = 155.0; pH = 7.3 ± 0.1). Solutions were stored at -
20°C in small aliquots before use.
5.2.2.3 Surgery
Since D-AP5 does not readily cross the blood-brain barrier, AP5 was infused directly into the brain
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via a surgically implanted osmotic minipump (see chapter 4.4.1 for details). 13 rats received
minipumps filled with 30 mM D-AP5; a further 12 received aCSF. The Alza 2002 minipump infuses
continuously at 0.5 pi / hr for 14 days, after which the pump is exhausted.
5.2.2.4 Behavioural testing
Testing was carried out in an open-field watermaze, as described in chapter 4.2.1. After surgery, rats
were divided into 2 groups. In one group, "pumps on", behavioural testing was carried out during the
period of drug infusion, starting 5 days after minipump implantation (30 mM D-AP5: n = 7; aCSF: n
= 6). In the second group, "pumps off', testing was carried out after exhaustion of the minipumps,
starting 25 days after implantation (30 mM D-AP5: n = 6; aCSF: n = 6). Both groups received
identical watermaze training. All rats were given pre-training one day before testing was started,
consisting of 6 trials to a totally random platform location with curtains drawn about the pool to
obscure extra-maze cues. Trials lasted for a maximum of 1 min each; rats which failed to find the
platform within this time were guided to the correct location. Animals were allowed to remain on the
platform for 30s following each trial, after which the next trial was begun immediately.
The main phase of watermaze training followed a protocol similar to that described by Cain et al.
(1996). On day 1, rats were given spatial training consisting of a 60 s "transfer test" (escape platform
absent), then 10 trials to a fixed hidden platform position in 5 blocks of 2 trials each (inter-trial
interval = 2 min; inter-block interval = 5 min), and finally a second 60 s transfer test to assess the
rats' memory for the position of the escape platform. During transfer tests, rats were simply allowed
to swim freely for 60s with the escape platform absent. These trials were analysed by dividing the
pool into 4 quadrants, one of which, the "training quadrant", was centred about the position of the
now absent platform. The percentage time spent within this quadrant provides a more sensitive and
less variable measure of memory for the platform position than latency scores alone. A 5 min interval
separated each transfer test from the regular training trials. Starting positions were moved pseudo-
randomly between trials (N, S, E or W). The goal platform was located either in the centre of the NE
or the SW quadrant of the pool. These positions were counterbalanced across groups in order to
control for positional biases. Rats were allowed to remain on the platform for 15s after completion of
each training trial.
On the following day, rats were given a visually cued task (in contrast to the Cain et al. study in
which both spatial and cued tasks were carried out on the same day). Testing consisted of 10 trials (5
blocks of 2) to a visible, striped platform, 10 cm in diameter and protruding 1-1.5 cm above the water
surface. White curtains were drawn about the pool to obscure extra-maze cues. Rats were always
placed in the water at N, and the platform was moved pseudo-randomly between each trial to 1 of 4
locations (N, S, E and W). Rats were allowed to remain on the platform for 15 s after each trial, and
the schedule of inter-trial intervals was identical to that described for the hidden platform training.
98
5.2.2.5 Histology
At the end of training, rats were injected i.p. with Euthatal (sodium pentobarbitone; 1 ml) and
perfused transcardially with physiological saline followed by 10 % formol saline. Brains were then
removed, and a coronal wedge of tissue was taken from the region immediately adjacent to the
cannula site. This section was placed in formol saline solution. The rest of the brain was preserved for
later histological investigation of the possible neurotoxic effects of AP5 infusion (see experiment
5.3). However, the wedge of tissue surrounding the cannula site was frozen, cut into 30 pM sections,
and stained with cresyl violet in order to determine the cannula position and to assess any mechanical
damage and / or infection caused by cannula implantation.
5.2.3 Results
AP5-treated animals trained in the spatial task during the period of drug infusion were grossly
impaired relative to controls, and showed severe sensorimotor deficits which became progressively
worse as training continued. AP5-treated animals in the "pumps off' condition displayed
sensorimotor deficits such as impairment of the righting reflex during the period of AP5 infusion, but
when tested after exhaustion of the minipumps, these rats performed as well as aCSF-treated controls,
with minimal sensorimotor impairments.
5.2.3.1 Escape latencies during hidden platform training
Latencies to reach the escape platform in the spatial task are shown in figure 5.2.1. An ANOVA of
performance in the "pumps on" condition (figure 5.2.1A), in which all trials were entered as within
subject factors, revealed a significant overall improvement across trials [F(9,99) = 2.07; p < 0.05],
and also a highly significant group difference, indicating that AP5-treated animals were impaired
[/*"( 1,11) = 104.32; p < 0.0001]. A significant drug group x trial interaction was found [F(9,99) =
5.74; p < 0.0001]. Subsequent analysis of simple effects revealed that AP5 treated animals showed no
significant change in escape latency over trials [f(9,99) = 1.70; p > 0.05], compared to controls
whose improvement was highly significant [E(9,99) = 5.79; p < 0.001]. No impairment was seen on
trial 1, at which point neither group had any knowledge of the platform's location [Mean aCSF
latency = 48.5 ± 5.5 s; mean AP5 latency = 40.0 ±8.1 s; f(l,94) = 1.26; p > 0.2]. This result is
consistent with the notion, discussed in depth later, that sensorimotor disturbances are initially
minimal, but develop as training progresses.
However, on a substantial number of trials, AP5-treated rats failed to reach the platform within the
maximum allowed time of 60 s. Owing to this, it was suspected that the data were likely to violate the
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criteria for parametric analysis. A Shapiro-Wilk test for normality and A Levene test for homogeneity
of variance were carried out. The tests revealed that the data failed to meet either of these criteria for
parametric analysis, and so a non-parametric Kruskal-Wallis test was performed instead. This test
revealed that AP5-treated animals showed equivalent escape latencies to controls on trial 1 [Chi-
square - 0.68; p > 0.4], but were impaired on all subsequent trials [trials 2 and 8: Chi-Square > 4.0; p
< 0.05; trials 3,4,5,6,7,9,10: Chi-Square >l\p< 0.01].
An ANOVA of performance in the "pumps off" condition (figure 5.2.IB) did not reveal an overall
group difference [F < 1], However, the overall decrease in escape latencies over trials failed to reach
significance [F(9,90) = 1.75; 0.05 < p < 0.1]. In fact, performance of both AP5 and aCSF-treated rats
in the "pumps off' condition was noticeably worse than that of aCSF-treated rats in the "pumps on"
condition. A separate ANOVA of the aCSF groups from each condition only revealed a significant
impairment in the "pumps off' animals [F(l,10) = 5.91; p < 0.05], The reason for this impairment is
unknown, although it is possible that the presence of an intracerebroventricular cannula for 25 days
prior to testing may have impaired performance in some way. Nevertheless, transfer test performance
was unaffected, as described below.
5.2.3.2 Transfer test performance
Figure 5.2.2A shows the performance of rats in the "pumps on" condition in transfer tests given
before and after the 10 acquisition trials. The graph displays percentage time spent in the quadrant of
the pool in which the platform was located during acquisition training (the "training" quadrant). AP5-
treated rats performed at, or slightly below chance, both before and after training. However, aCSF-
treated rats improved from 18.5 ± 3.1 % initially, to 48.9 ± 3.7 % after training. An ANOVA of
percentage time within the training quadrant, in which each transfer test was entered as a within
subject factor, revealed a significant overall effect of group [F(l,ll) = 12.12; p < 0.01], and a
significant group by transfer test interaction [F(l,l 1) = 30.28; p < 0.001].
Conversely, both AP5 and aCSF-treated rats showed an equivalent improvement between the first and
second transfer test when trained after exhaustion of minipumps (figure 5.2.2B). Performance on the
second transfer test was well above chance in both groups (percentage time in training quadrant:
aCSF = 50.0 ± 5.4 %; AP5 = 43.1 ± 7.2 %). An ANOVA of percentage time in the training quadrant
in pre- and post-training transfer tests (entered as within subject factors) showed neither a group
difference [F < 1] nor a group x trial interaction [F(l,10) = 1.19\p> 0.3],
aCSF-treated rats in the "pumps off' condition performed worse than aCSF-treated rats in the "pumps
on" condition in terms of latency to reach the platform during acquisition training. However, a
separate ANOVA comparing aCSF performance on the post-training transfer test across the two
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conditions, revealed no group difference [% time in training quadrant: aCSF, "pumps off' = 50.0 ±
5.4 %; aCSF, "pumps on" = 48.9 ± 3.7 %; F< 1],
5.2.3.3 Sensorimotor disturbances
The above analysis reveals that rats infused with 30 mM D-AP5 are severely impaired in the
acquisition of a spatial reference memory task, but only during the period of drug infusion. Flowever,
sensorimotor disturbances may have contributed significantly to this impairment. During training,
AP5-treated rats displayed many of the deficits noted by Cain et al. (1996), such as swimming around
the periphery of the pool, "swimming" over the platform rather than climbing on, making contact
with the platform without climbing on, loss of balance whilst standing on the platform (especially
after a "wet-dog" shake), and in extreme cases, continuing to make swimming movements after
removal from the pool. It was apparent that the AP5-treated rats showed an increase in all of these
indices of impairment as testing progressed. A number of such sensorimotor impairments have been
investigated in detail with the aid of a side-mounted video camera in a later experiment conducted in
this laboratory (R. G. M. Morris, R. J. Steele, S. J. Martin, and J. E. Bell, unpublished observations).
However, in the present study, only two indices of sensorimotor disturbance could be satisfactorily
analysed: percentage time spent within 15 cm of the pool wall (an index of thigmotaxis), and mean
swim speed.
5.2.3.4 Thigmotaxis
Figure 5.2.3A shows the time spent within 15 cm of the sidewalls during all trials. Data from the
transfer tests are plotted together with regular training trials. An ANOVA in which all trials were
entered as within subject factors revealed a significant main effect of trial [F(l 1,121) = 3.39; p <
0.001], a significant group difference [F(l,l 1) = 37.90; p < 0.001], and a significant group x trial
interaction [F(l 1,121) = 8.10; p < 0.0001]. Analysis of simple effects showed that the trend towards a
decrease in percentage time within 15 cm of the sidewalls in the aCSF group, from greater than 20 %
on trial 1, to a stable value of less than 10 % from trial 4 onwards, was not significant [F < 1], In
contrast, AP5-treated rats showed a highly significant progressive increase in thigmotaxis over trials
[F(l 1,121) = 11.32; p < 0.001], However, a group difference in thigmotaxis did not emerge until the
third acquisition trial [F(l,101) = 4.17; p < 0.05; ANOVA, simple effects], at which point the search
strategy of AP5-treated animals abruptly began to deteriorate. Note, however, that on trial 2 of
acquisition training, AP5-treated rats were no more thigmotaxic than controls, but took more than
twice as long to find the platform (see figure 5.2.1). This result illustrates the fact that thigmotaxis is
not a necessary consequence of AP5 infusion, but that it develops after repeated trials.
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Figure 5.2.3B shows the percentage time within 15 cm of the sidewalls after exhaustion of the
minipumps. A significant main effect of trial was found [F(l 1,110) = 3.03; p < 0.01], but no overall
group difference was revealed [F(l,10) = 1.90; p > 0.1].
Figure 5.2.4 shows representative sample swim paths of rats in the "pumps on" condition. The rat
infused with aCSF searched randomly during the first transfer test, but after training it spent
approximately half its time within the training quadrant (figure 5.2.4A). The first AP5-treated rat
shown (little thigmotaxis) simply searched randomly during both transfer tests, indicating that no
learning had occurred (figure 5.2.4B). The paths taken by the second AP5-treated rat (severe
thigmotaxis) were perhaps more typical (figure 5.2.4C). In this case, searching was random on the
first transfer test, but thigmotaxic swimming was not evident at this point. By the second transfer test,
however, swimming was limited almost completely to the periphery of the pool.
Figures 5.2.5A and B show examples of transfer test performance in the "pumps off' condition. Both
aCSF and AP5-treated rats searched randomly during the first transfer test, but showed a strong bias
towards the platform position after training.
5.2.3.5 Swim speed
Figure 5.2.6A shows swim speeds on all trials, including transfer tests, in the "pumps on" condition.
An ANOVA revealed a significant main effect of trial [/^(l 1,121) = 3.48; p < 0.001], a significant
overall group difference [F(l,ll) = 9.03; p < 0.02], and a significant group x trial interaction
[F(l 1,121) = 4.53; p < 0.0001], Analysis of simple effects revealed that AP5-infused rats slowed
significantly as testing progressed [F(l 1,121) = 7.73; p < 0.001], whilst no change in swim speed was
seen in the aCSF-infused group [F < 1], Note that both groups swam equally fast during their first
exposure to the pool on the first transfer test [simple effects: F < 1]. Apart from an anomalous point
on the first acquisition trial, the difference in swim speeds did not become significant until trial 8
[simple effects: F(l,46) = 12.07; p < 0.01]. However, the deficit in escape latency was apparent from
trial 2 onwards, well before swim speed began to fall. This pattern of results is similar to that found
during the analysis of thigmotaxis, i.e. latency to find the platform was impaired before sensorimotor
disturbances became evident.
Nevertheless, swim speed tends to fall gradually in the course of an individual trial, as rats become
fatigued. It might therefore be expected that the longer the escape latency on a given trial, the lower
the mean swim speed would be. Hence, it could be argued that the apparent group difference in swim
speeds between AP5-treated rats and controls is simply an artifact of the difference in escape
latencies. This is unlikely for a number of reasons. Firstly, escape latencies did not change over trials
in the AP5 group, yet swim speeds were still found to decrease. Secondly, as mentioned above, the
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group difference in swim speeds is not apparent until trial 8, whereas latencies are impaired from as
early as trial 2. Thirdly, swim speeds differ considerably on the second transfer test, during which all
rats swim for exactly 60 s. Hence, it is probable that AP5-treated rats simply became fatigued over the
course ofmultiple trials lasting close to 60 s.
Figure 5.2.6B shows swim speeds for the "pumps off' condition. There was a significant main effect
of trial [F(l 1,110) = 2.44; p < 0.01], but no significant group difference [F < 1],
5.2.3.6 Visually cued task
Figure 5.2.7 shows escape latencies during the visible platform task. Latencies were considerably
shorter than those seen in the hidden platform task, and rats from all groups swam straight towards
the platform on most trials. Significant main effects of trial were obtained in both "pumps on" and
"pumps off' conditions [F(9,99) = 5.37; p < 0.0001; and F(9,90) = 5.07; p < 0.0001 respectively], but
no group differences were found in either the "pumps on" [F(l,ll) = 1.17; p > 0.3] or "pumps off"
condition [F(l,10) = 3.93; p > 0.05],
The absence of an impairment in the AP5 "pumps on" group was particularly striking considering the
gross impairment observed in the hidden platform task. AP5-treated rats displayed greatly reduced
sensorimotor disturbances during the cued task, and rarely fell off the platform, even during "wet-
dog" shakes. Figure 5.2.8 shows thigmotaxic swimming during visible platform testing. In the
"pumps on" condition, there was a significant main effect of trial [figure 5.2.8A; F(9,99) = 8.01; p <
0.0001], but no significant overall group difference was found [F(l,l 1) = 1.91; p> 0.1].
Note that in accordance with the protocol described by Cain et al. (1996), the same sequence of
platform positions was used in all rats, and N was always used as the starting point. Hence, trials in
which the platform was located in the centre of the N quadrant, such as trial 4, necessarily generate
high "thigmotaxis" values, especially if performance is optimal. It is significant that AP5-treated rats
reached the visible platform in under 3 s on trial 4, faster than controls. It is therefore not surprising
that a large proportion of this time was spent close to the sidewalls. The "thigmotaxis" peak on trial 6
likewise corresponds to a target location in the N quadrant.
In the "pumps off' condition (figure 5.2.8B), there was a significant main effect of trial [F(9,90) =
5.04; p < 0.0001], but no significant group difference in thigmotaxis [F < 1],
Figure 5.2.9 shows the swim speeds of rats during the visible platform task. A significant main effect
of trial was obtained in the "pumps on" condition [figure 5.2.9A; F(9,99) = 8.94; p < 0.0001], but no
group difference [F(l,l 1) = 1.60; p > 0.2], In the "pumps off' condition, the main effect of trial was
likewise significant [figure 5.2.9B; F(9,90) = 3.97; p < 0.001], but no significant group difference
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was found [F < 1],
5.2.3.7 Histology
The infusion cannula was correctly sited in the right lateral ventricle in all cases. Little or no evidence
of ventricular enlargement and / or brain infection was observed in any of the brains examined.
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Fig. 5.2.1
(A) Minipump infusion of 30 mM D-AP5 impairs acquisition of a spatial
reference memory task in the watermaze. (B) No such impairment is seen
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Fig. 5.2.2
Percentage time spent in the training quadrant during transfer tests given
before (TT1) and after (TT2) spatial acquisition training. AP5 impaired
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Fig. 5.2.3
(A) Percentage time spent within 15 cm of the sidewalls during each
trial. Rats infused infused with 30 mM D-AP5 become progressively
more thigmotaxic as testing continues. Data from transfer tests (TT1
and TT2) are plotted together with regular trials. (B) No group difference
in thigmotaxis is seen when rats are tested after exhaustion of minipumps.
107






Transfer test performance before and after 10 acquisition trials to the platform
position indicated. The swim paths of one rat trained to the NE position have
been rotated 180° to aid comparisons between figures. aCSF-treated rats showed
a clear bias towards the target quadrant after training (A). However, 30 mM
D-AP5-treated rats never showed such a bias (B), and many were extremely
thigmotaxic during the second transfer test (C).
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BEFORE TRAINING AFTER TRAINING
Fig. 5.2.5
Transfer test performance before and after 10 acquisition trials to the platform
position indicated (pumps exhausted). Both groups showed an equivalent bias
towards the training quadrant in the second transfer test.
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Fig. 5.2.6
(A) Mean swim speeds throughout training. Transfer tests (TT1 & TT2)
are plotted together with regular trials. Rats infused with 30 mM D-AP5
swam more slowly as testing progressed. Controls, however, swam at
roughly the same speed throughout. (B) No differences in swimming
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(A) Minipump infusion of 30 mM D-AP5 does not impair performance of a
visually-cued task in the watermaze. (B) No impairment is seen when testing
is carried out after the minipumps are exhausted.
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(A) Percentage time spent within 15 cm of the sidewalls during visible
platform testing. No group difference was seen. (B) No group difference
in thigmotaxis was seen in rats tested after exhaustion of minipumps.
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(A) Mean swim speeds throughout visible platform training. No group
differences in swimming speed were found. (B) No group differences




5.3 Does chronic minipump infusion of 30 mM D-AP5 cause neuronal damage?
5.3.1 Introduction
The aim of this study was to determine whether chronic AP5 infusion causes neuronal damage. For
comparison with those rats tested in experiment 5.2, separate groups of rats were infused with the
non-competitive NMDA receptor antagonist, MK-801, a drug whose neurotoxic effects have been
extensively studied. Neuronal damage was assessed by conventional staining, as well as
immunostaining for heat shock protein 72 (HSP72) (see section 5.1.4). Histological analysis of
perfused brains was carried out by J. E. Bell, F. Brannan, and J. Knox at the Department of
Neuropathology, Western General Hospital.
5.3.2 Methods
5.3.2.1 Drug treatment and perfusion
As described in experiment 5.2, rats were perfused intracardially with 0.9 % saline and 10 % buffered
formalin at the end of behavioural testing. Animals in the pumps on condition were sacrificed 4-6
days after the end of behavioural testing, i.e. before exhaustion of the minipumps. Animals in the
pumps off condition were sacrificed approximately 7 days after the end of training. In addition to
those animals that took part in experiment 5.2, an extra 4 rats were implanted with minipumps
containing 30 mM D-AP5. Two of these animals were sacrificed during the period of drug infusion, at
an equivalent time to those in the pumps on condition above. The remaining two were sacrificed after
exhaustion of the minipumps, at an equivalent time to those in the pumps off condition.
In order to provide a positive control, 8 rats were given acute systemic injections of MK-801 (2 mg /
kg). Instead of male Lister-hooded rats, female Cob Wistars were used, owing to the greater
susceptibility of female rats to the neurotoxic actions of NMDA receptor antagonists (see section
5.1.4). Rats were sacrificed and perfused either 4-5 hr after MK-801 injection (n = 4), or 24 hr later (n
- 4).
5.3.2.2 Histological analysis
After removal, the brains were further fixed in 10 % buffered formalin. Coronal sections were cut and
processed using a VIP tissue processor, before being embedded in paraffin wax. Sections were cut at
5 pm and stained with haematoxylin and eosin (H & E) and Luxol fast blue in order to assess the
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condition of neurons after drug application, and to select areas of the brain for immunohistological
investigation. Coronal sections at the level of the posterior cingulate gyrus and posterior hippocampus
were stained with monoclonal antibodies to HSP72 using a standard avidin-biotin complex method.
Antibodies to HSP72 (Amersham, Little Chalfont, UK) were applied at a dilution of 1 in 100, and
sections were pre-treated by microwaving in citric acid (pH = 6) for 15 min. The reaction product was
visualized with diaminobenzidine, and the sections were counterstained with haematoxylin.
All brain sections were examined independently by two observers who were blind to the experimental
history of the samples. Examination of brain sections was generally confined to sections at the level
of the posterior cingulate cortex and hippocampus. However, in two of the AP5-treated brains from
the pumps on condition, sections were examined throughout the entire rostrocaudal extent of the
brain.
5.3.3 Results
Figure 5.3.1 A shows an H & E stained section of posterior cingulate cortex taken from an AP5-
treated rat in the pumps on condition. All cells are of normal appearance, and show neither
vacuolation nor necrosis. In fact, no signs of neuronal damage were seen in any of the brains treated
with either AP5 or aCSF, either in the pumps on or pumps off conditions. This was true throughout
the entire rostrocaudal extent of the brains taken from two AP5-treated animals in the pumps on
condition.
However, all rats injected with MK-801 showed evidence of neuropathology. Examination of H & E
stained sections revealed prominent cytoplasmic vacuolation in layer 3 posterior cingulate neurons of
those brains removed 4-5 hr after injection. An example is shown in figure 5.3.IB: the cytoplasm is
shrunken and vacuolated in a large number of neurons. In brains removed 24 hr after MK-801
injection, vacuolation was no longer observed, but a number of necrotic neurons were evident,
suggesting an ongoing process of vacuolation, followed either by recovery or by cell death (figure
5.3.1C).
Immunolabelling for HSP72 was never detected in any of the sections prepared from brains treated
with either AP5 or aCSF. Figures 5.3.2 A & B show cingulate neurons negative for HSP72 in sections
taken from an AP5 rat in the pumps on condition, and an aCSF rat in the pumps off condition,
respectively). No immunolabelling for HSP72 was found in brains removed 4-5 hr after MK-801
injection, although vacuolated neurons were prominent at this stage (figure 5.3.2C). However,
immunoreactivity for HSP72 was observed in a number of posterior cingulate neurons 24 hr after
MK-801 infusion (figure 5.3.2D).
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H & E stained sections from the cortex of the posterior cingulate gyrus
photographed at x 400. (A) D-AP5 pumps on condition: all neurons
appear normal. (B) 4-5 hr after MK-801 injection: vacuolated neurons
are seen in layer 3. (C) 24 hr after MK-801 infusion: necrotic neurons




Sections taken from the cortex of the posterior cingulate gyrus stained with
antibodies to HSP72 (200 x magnification) (A) AP5 pumps on: HSP72
negative. (B) aCSF pumps off: HSP72 negative (C) 4-5 hr after MK-801
injection: neurons vacuolated but HSP72 negative. (D) 24 hr after MK-801




The main finding of this study is that rats infused with 30 mM D-AP5 exhibit an impairment in
watermaze reference memory performance during the period of drug infusion only, ruling out the
possibility that lasting neuronal damage might account for the AP5 deficit. Nevertheless, it could still
be argued that reversible neuronal injury might have contributed to the deficit in the pumps on
condition. However, a detailed histological analysis of the brains of AP5-treated rats revealed no
evidence of neuronal damage in either the pumps off or pumps on conditions. This result rules out the
possibility that AP5 impairs learning by inducing transient neuronal damage, and confirms the
absence of lasting neuropathology.
No impairment was found on a visually cued task carried out on the day following spatial training,
suggesting that the behavioural impairment is limited to spatial learning. AP5-treated rats did display
sensorimotor abnormalities in the course of spatial training, but a failure to learn was observed even
on early trials when sensorimotor disturbances were minimal. The fact that sensorimotor
abnormalities were minimal or absent at the start of training, but became progressively more severe as
testing progressed, suggests that such impairments are not a necessary consequence of AP5 infusion,
but may be uncovered by the use of a massed-trial training protocol, such as that used by Cain et al.
(1996).
5.4.2 AP5 does not cause chronic neuronal damage
Acute intracerebral infusion of AP5 has previously been reported to cause neuronal vacuolation
(Labruyere et al., 1989). However, no evidence of neuronal damage was seen in any of the AP5-
treated brains in the present study. Although the chronic infusion of D-AP5 is not exactly comparable
to the acute injection of MK-801, it is likely that in the pumps on condition at least, any neurotoxic
effects of AP5 would be manifested by an ongoing process of vacuolation and necrosis, such as that
seen in the 4-5 hr and 24 hr MK-801 groups. The absence of such pathology confirms that chronic
infusion of 30 mM D-AP5 at a rate of 0.5 |il / hr is not neurotoxic.
In contrast, systemic injection of MK-801 (2 mg / kg) in female rats resulted in neuronal vacuolation
in the cingulate cortex after 4-5 hr, and necrosis 24 hr later. The former result is similar to that
obtained by Olney et al. (1989), and the latter confirms the finding that MK-801 induced damage may
not always be reversible (Allen and Iversen, 1990; Fix et al., 1993). Consistent with previous reports
(see section 5.1), 24 hr after MK-801 injection, a number of neurons within the posterior cingulate
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cortex were found to be immunopositive for HSP72.
5.4.3 Sensorimotor disturbances
Rats tested in the "pumps on" condition displayed severe sensorimotor impairments, which were
slight at the start of training, but grew considerably worse as testing progressed. These impairments
were worse than those typically observed with the testing protocols regularly used in this laboratory,
such as one trial per day (e.g. Bannerman et al., 1995), or four trials per day with a total ITI of 45 s
between trials (e.g. Steele and Morris, 1999). In fact, AP5-treated rats became so fatigued towards the
end of the testing session that any assessment of their learning abilities was impossible. Many rats
were unable to balance on the platform at all after several trials, a situation which robs the platform of
any reward value. Behavioural abnormalities included falling off the platform during a "wet-dog
shake", thigmotaxic swimming around the side-walls, failure to climb onto the platform after
contacting it, "swimming" over the platform, and occasionally continuing to make swimming
movements even after removal from the pool. These disturbances are similar to those reported by
Cain et al. (1996).
The percentage time spent within 15 cm of the sidewalls, an index of thigmotaxic swimming, was
equivalent in AP5- and aCSF-treated rats at the start of testing. However, AP5-treated rats spent an
increasing amount of time at the sidewalls as testing progressed (figure 5.2.3A). A striking illustration
of this deterioration in search strategy is provided in figure 5.2.4C. The rat in question searched
efficiently for the platform in the initial probe test with the platform absent, but after 10 trials the rat
did little more than aimlessly circle the walls of the pool. Similarly, AP5-treated rats initially swam at
the same speed as controls, but gradually slowed down as testing progressed, indicating increasing
fatigue.
The fact that AP5-treated rats were initially unimpaired according to the above criteria, but
deteriorated as testing progressed, is consistent with the suggestion that the testing protocol is
responsible for the extreme levels of sensorimotor impairment obtained. It is possible that a genuine
learning deficit during the initial trials leads to increasing fatigue which exacerbates the sensorimotor
side effects of AP5 and hence leads to an even greater decline in performance. Hence, there is no
reason to assume that sensorimotor disturbances are the cause of the "learning" impairment, it is
equally likely that an initial learning impairment, coupled with the massed-trial training protocol, may
have caused the severe sensorimotor disturbances.
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5.4.4 Visible platform task
Despite the fact that thigmotaxis and swim speed were normal in AP5-treated rats at the start of
testing, other behavioural abnormalities such as falling off the platform were evident from the start.
However, falling from the platform decreases over days in protocols involving a number of testing
sessions (R. G. M. Morris, R. J. Steele, S. J. Martin, and J. E. Bell, unpublished observations),
another reason why a single session of 10 trials may be inappropriate.
Considering the severe sensorimotor impairments evident during hidden platform training, I fully
expected AP5-treated rats to be unable to stand on the platform during visible platform training, and
an impairment on this task, such as that reported by Cain et al. (1996) seemed inevitable. However, I
was surprised to find that AP5-infused rats were totally unimpaired on the visually cued task. Rats
which had never managed to balance satisfactorily on the hidden platform, stood on the visible
platform with ease. No deficits were seen in latency to reach the platform, thigmotaxic swimming, or
swimming speed. However, Cain et al. (1996) tested rats on the visible platform task on the same day
as the hidden platform task, whereas I carried out the visible platform task on the following day.
Hence, an improvement in performance over days, such as that described above, may explain the
discrepancy between these results and those reported by Cain and colleagues. However, this assertion
cannot be tested by exactly replicating the latter study, owing to Home Office regulations concerning
the number of permissible watermaze trials per day.
The nature of this "overnight improvement" in performance is unclear. The new-found ability to stand
on the platform may reflect a form ofmotor learning. It is often found that distributed training is more
efficient than massed training in the acquisition of motor skills (e.g. Carron, 1969), a result which
holds for a number of different procedural learning tasks. The overnight improvement in one such
task (a form of visual discrimination carried out with human subjects) has been found to be dependent
on REM sleep (Carni et al., 1994). If the reduction in the sensorimotor deficits associated with AP5
infusion involves procedural learning of some kind (i.e. learning to "compensate" for drug induced
disturbances in performance) then the 24 hr interval between spatial and cued tasks may provide an
explanation for the radical reduction in sensorimotor disturbances. Incidentally, the mere inhibition of
"wet-dog shakes" is not responsible, since AP5-treated rats have a tendency to shake more than
controls throughout training. In fact, the number of "wet-dog" shakes performed by drug-treated
animals actually increases over days, whereas the tendency to fall off the platform very rapidly
diminishes (R. G. M. Morris, R. J. Steele, S. J. Martin, and J. E. Bell, unpublished observations).
Alternatively, it is possible that the normal performance of AP5-treated rats on early trials of the
visible platform task may have prevented fatigue and the associated sensorimotor deficits observed
during hidden platform training. The visible platform deficit reported by Cain et al. (1996) may have
resulted from fatigue effects being carried over from one task to the other, since both were conducted
on the same day. Other explanations include the possibility that a reduction in the stress associated
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with exposure to the watermaze may occur between days. Additionally, AP5-treated rats may, in fact,
have learned about the "procedural" demands of the watermaze during hidden platform testing.
Whilst this learning was not expressed at the time, perhaps owing to severe fatigue, it is possible that
latent knowledge may have resulted in unimpaired performance on the visually cued task. Whatever
the explanation, the absence of an impairment on the visible platform control task when carried out 24
hr after hidden platform testing provides a further illustration that sensorimotor deficits are not an
inevitable consequence of AP5 infusion, but only become apparent under certain testing conditions.
5.4.5 Summary
The experiments described above do not provide conclusive evidence that NMDA receptors are
involved in spatial learning per se, rather than other aspects of watermaze performance. Indeed, the
behavioural abnormalities induced by the interaction of testing protocol and drug treatment are so
severe that the possibility of a learning deficit cannot be assessed. Some behavioural disturbances,
such as thigmotaxis, abnormally slow swimming, and making swimming movements after removal
from the water, were not evident at the start of spatial training, but became worse as testing
progressed. Other disturbances, such as falling off the platform, were evident from the start of spatial
training, but declined between testing days. Hence, the severe sensorimotor disturbances observed in
the current study, and that of Cain et al. (1996), cannot be used as evidence that the spatial learning
deficit obtained by others, using different testing protocols, is secondary to a sensorimotor deficit. As
emphasized above, severe sensorimotor disturbances result from an interaction of drug treatment and
training protocol. Severe sensorimotor disturbances are not an inevitable consequence of AP5
infusion.
Rats tested after the end of a two-week period of AP5 infusion performed equally well as controls in
both spatial and cued watermaze tasks, ruling out the possibility that lasting neuropathology
contributes to the spatial learning deficit. In addition, a thorough histological examination of the
brains of rats given chronic i.e.v. infusion of 30 mM D-AP5 failed to reveal any evidence of neuronal
damage either during or after a two-week period of drug infusion. Hence, the spatial learning deficit









The results of the previous chapter support the hypothesis that NMDA receptors play a role in
learning. Firstly, chronic AP5 infusion did not result in neurotoxic damage. Secondly, severe
sensorimotor disturbances were not a necessary consequence of AP5 infusion, but were readily
observed after multiple training trials carried out in a single day. The recent finding that
intrahippocampal infusion of AP5 causes a delay-dependent deficit in a watermaze matching-to-place
task (Steele and Morris, 1999) provides fairly strong evidence that a sensorimotor or motivational
account cannot adequately explain the AP5 deficit.
However, the role ofNMDA receptors in hippocampal functioning may extend beyond a role in LTP-
like processes. Moderate doses of AP5 have been found to reduce cell excitability and to impair
complex cell firing (see chapter 2.6.6). It has been suggested that NMDA receptors may be involved
in the routine functioning of the hippocampal circuitry, in addition to their role in synaptic plasticity
(see Bekkers and Stevens, 1990b). Hence, the finding that AP5 impairs learning does not necessarily
imply the involvement of LTP-like processes in learning.
The fact that NMDA receptor antagonists cause sensorimotor disturbances, and may interfere with
normal hippocampal functioning independently of their effects on synaptic plasticity, introduces
inevitable confounds in all studies of the role of NMDA-receptor dependent plasticity in learning.
Whilst these problems do not necessarily invalidate the conclusions of previous reports, the use of a
pharmacological tool without these drawbacks would clearly be desirable. In this respect,
metabotropic glutamate receptors provide an attractive alternative target for pharmacological
intervention (see chapter 3.12).
Comparatively few studies of the role of mGluR antagonism in spatial learning have been carried out.
Riedel et al. (1994a) found that an i.e.v. injection of MCPG (5pl, 200 mM) prior to training in a foot-
shock reinforced Y-maze spatial alternation task, resulted in a deficit when rats were later tested for
retention. At the time when experiment 6.2 was started, this remained the only study of the role of
mGluRs in spatial learning: the role of mGluRs in watermaze performance was unknown.
In the course of this investigation, however, it was reported that a bilateral i.e.v. infusion of (R,S)~
MCPG (5 pi / ventricle; 20 mM) could produce a deficit in the watermaze reference memory
performance of rats (Richter-Levin et al., 1994). A further study of the effects of i.e.v. MCPG
infusions on reference memory performance has since been published (Bordi et al., 1996), although
the results of this experiment differ somewhat from those of Richter-Levin et al. (1994).
Nevertheless, both studies report that MCPG causes a deficit in transfer lest performance, but has
little or no effect on latency to locate a hidden platform.
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The aim of the present series of experiments was to characterize the impairment induced by MCPG in
a spatial reference memory task, similar to the tasks subsequently carried out by Richter-Levin et al.
(1994) and Bordi et al. (1996). The protocol consisted of 3 days of acquisition training followed by a
transfer test and visible platform control task. MCPG was delivered either acutely via an
intraventricular cannula (experiment 6.2), chronically via an intraventricular osmotic minipump
(experiment 6.3) or acutely via intrahippocampal cannulae (experiment 6.4).
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Intraventricular cannulae were implanted as described in chapter 4.4.2.
6.2.1.2 Drugs
Solutions were prepared by first dissolving the solid, crystalline form of each drug in 1M sodium
hydroxide to form an equimolar solution, then diluting with 0.9% saline to achieve the desired
concentration (20 and 200 mM (R,S)-MCPG; 100 mM (-)-MCPG). Drug solutions were stored in
small aliquots at -20 °C when not in use.
6.2.1.3 Assignment to groups
Animals were randomly assigned to one of three groups, each of which received a different infusion
during the acquisition phase of training. Two different concentrations of (J?,S)-MCPG were tested:
200 mM (n = 13) and 20 mM (J?,Sj-MCPG (n = 9). A control group (n = 11) received 100 mM (-)-
MCPG. The minus form of MCPG is reported to be the inactive enantiomer (Jane et al., 1993; Riedel
et al. 1995a) and was given in preference to vehicle injections in order to control for possible non¬
specific effects of MCPG, not associated with the blockade of metabotropic glutamate receptors. A
concentration of 100 mM was chosen because this matches the concentration of (-)-MCPG present in
a 200 mM (R,S)-MCPG solution.
6.2.1.4 Behavioural testing
The watermaze reference memory task was carried out as described in chapter 4.2.2. Pre-training was
carried out without prior drug infusion, but on all other days testing was carried out 30 min after the
end of infusion.
Prior to the transfer test, most animals were infused with the same drug as on previous days.
However, a subset of rats from the 200 mM (/?,S)-MCPG group (n = 4) were instead given (-)-MCPG
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in order to control for a possible state-dependent effect. Similarly, a subset of the (-)-MCPG control
group (n = 4) were injected with 200 mM (/?,5)-MCPG in order to test for the existence of retention
or performance deficits in control subjects exposed to the active isomer lor the first time.
Visible platform testing was carried out 2 days after the transfer test. Each rat received the same drug
as during acquisition 30 min prior to this session.
6.2.1.5 Electrophysiology
Following behavioural testing, a number of rats from each group (200 mM (7?,5j-MCPG: n = 5; 20
mM (/?,.S)-MCPG: n = 6; 100 mM (-)-MCPG: n = 9) were prepared for electrophysiology under
urethane anaesthesia as described in chapter 4.3. Stimulation and recording were both carried out on
the left-hand side of the brain, and hence contralateral^ to the cannulated right ventricle.
Half an hour or more after implantation of the electrodes, a number of 700 pA test pulses were
delivered to the perforant path at 20 s intervals in order to evaluate the stability of baseline responses.
As soon as the fEPSP appeared to be stable, an input-output curve consisting of six pulses (whose
values were averaged) at each of 11 stimulation intensity values ranging from 0-1000 pA, was
recorded. From this I / O curve, the stimulation current required to elicit a population spike with an
amplitude 40 % of the maximum obtained was calculated, and stimulation intensity was set at this
value before a trial baseline was started; the intensity was later adjusted, if necessary, in order to
maintain the desired population spike amplitude. A 25 min baseline period of 0.05 Hz stimulation
was then recorded, although if at any time during this period the EPSP slope or population spike
amplitude showed a systematic drift away from its initial value, the session was restarted. After 25
min, a 5 pi drug infusion was given over a period of 5 min, in the same way as described for
behavioural testing. Each rat was injected with the same drug as that received during the acquisition
phase of spatial learning. Tetanic stimulation (10 trains of 15 pulses at 200 Hz with 10 s between
trains, and an intensity double that used for test pulses) was delivered 30 min after the completion of
the injection (i.e. the moment equivalent to the start of a watermaze testing session). Field potentials
were recorded for a further 2 hr after tetanization. In order to assess the efficacy of the tetanus
parameters in the absence of any drug treatment, LTP was measured in an additional four rats that
received no drug infusion prior to testing.
6.2.1.6 Histology
At the end of the experiment, each rat's brain was removed and preserved in 10 % formalin, before




All groups showed a progressive reduction in escape latency during acquisition training (figure 6.2.1)
and there was no visible sign of any sensorimotor disturbance during either swimming or climbing
onto the platform. An ANOVA of escape latencies over the 3 days of spatial training revealed a
highly significant overall improvement across trials [F(17,510) = 6.26; p < 0.0001] but no significant
group difference [F(2,30) = 1.86; p > 0.1]. Inspection of figure 6.2.1 suggests that 200 mM MCPG-
treated rats took slightly longer to reach the platform on the very first training trial. A separate
ANOVA of trial 1 performance only, revealed a non-significant trend towards a group difference on
this trial [F(2,30) = 2.58; p < 0.1].
6.2.2.2 Swim speeds
An ANOVA of swim speeds over the three days of acquisition training revealed a significant effect of
trial, since rats tended to slow down within each testing session, particularly on the first day [figure
6.2.2; F( 17,510) = 2.11; p < 0.01]. However, no significant overall group difference was seen
[F(2,30) = 1.30; p > 0.2].
6.2.2.3 Thigmotaxic swimming
An ANOVA of the percentage time spent within 15 cm of the side-walls throughout training revealed
a significant decrease in this index of thigmotaxis over successive trials [figure 6.2.3; F(17,510) =
4.27; p < 0.0001]. However, there was no group difference in thigmotaxic swimming [F < 1].
6.2.2.4 Transfer test and state dependent controls
An ANOVA of time spent in different quadrants of the pool during the transfer test revealed a
significant overall bias towards the quadrant in which the platform was situated during acquisition
training (the "training quadrant") [figure 6.2.4A; F(3,90) = 27.2; p < 0.0001] as well as a significant
group by quadrant interaction [F(6,90) = 3.68; p < 0.01]. Analysis of simple effects revealed that both
(-)-MCPG and 20 mM (F,S)-MCPG groups showed a significant bias towards the training quadrant
[(-)-MCPG: F(3,90) = 20.3; p < 0.001; 20 mM (F,.S)-MCPG: F(3,90) = 11.2; p < 0.001]. However, no
such bias was evident in the 200 mM (F.VfMCPG group, who performed at chance [F(3,90) = 1.72;
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p > 0.1]. A separate ANOVA of percentage time spent in the training quadrant only, revealed a
significant overall group difference [F(2,30) = 5.44; p < 0.01], Post hoc Newman-Keuls pairwise
comparisons indicated that the 200 mM (R.Sj-MCPG group performed significantly worse than both
the (-)-MCPG group [p < 0.01] and the 20mM (/?,5j-MCPG group [p < 0.05]. No significant
difference was found between (-)-MCPG and 20 mM (/?,5j-MCPG groups. Examples of the swim
paths taken by rats in each group are shown in figure 6.2.5.
Breakdown of the data into state dependency groups revealed that the subset of 200 mM (R,S)-MCPG
rats injected with (-)-MCPG during the transfer test showed no significant difference, in terms of time
spent in the training quadrant, to the majority injected with 200 mM (R.Sj-MCPG [figure 6.2.4B; post
hoc Newman-Keuls pairwise comparison; NS]. The group of control rats injected with 200 mM
(/?,.S)-MCPG during the transfer test also showed no significant difference to those injected with (-)-
MCPG [post hoc Newman-Keuls pairwise comparison; NS]. Sample swim paths are shown in figure
6.2.6.
Richter-Levin et al. (1994; p856) stated that "most MCPG-treated rats swam initially towards the
location where the platform had been in the same way as did control or vehicle-injected rats.
Subsequently, the MCPG-treated animals spent more time away from this location than control or
vehicle-injected animals, leading to the significant differences observed in the quadrant analysis." In
order to test this possibility, a measurement of latency to reach the previous position of the platform
was taken (figure 6.2.7). However, the increase in mean latency shown by the MCPG high group was
not found not to be significant: An ANOVA showed no overall differences between the three groups
[F(2,30) = 2.42; p > 0.1].
To address the issue in more detail, the amount of time spent in the training quadrant during the 60 s
transfer test was re-analysed by division into four 15 s time windows (figure 6.2.8). Owing to the
small size of the state dependent control groups (n = 4), and the absence of state dependent effects in
the overall analysis, data from sub-groups were pooled for the following analysis. An ANOVA
comparing time spent in the training quadrant only at each time interval revealed, as expected, a
significant effect of group [F(2,30) = 5.42; p < 0.01] as well as an effect of time interval [E(3,90) =
2.82; p < 0.05], suggesting that an overall change in spatial bias did occur over the course of the
transfer test. In fact, overall performance was marginally worse between 45-60 s than between 30-45
s, probably due to extinction [post hoc Newman-Keuls pairwise comparisons; p < 0.05]. However, no
significant group by interval interaction was found [F < 1], This last result does not support the idea
that MCPG-treated rats searched initially in the correct location, then subsequently spent more time
in other areas of the pool. Indeed, an ANOVA of performance in the first 15 s of the transfer test still
revealed a highly significant difference between the 200 mM MCPG group and (-)-MCPG-treated
controls [Newman-Keuls post hoc pairwise comparison; p < 0.01],
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6.2.2.5 Visually cued task
On the day of visible platform testing, the cannula became detached from the skull of one rat in the
200 mM (/?,S)-MCPG group during infusion; a second rat in the (-)-MCPG group became ill and was
dropped from the study. Hence, data from these animals was not available for the following analysis.
An ANOVA of the escape latencies of the remaining animals (n = 31) revealed a significant overall
improvement across trials [figure 6.2.9A; F(3,84) = 3.02; p < 0.05], but also a significant effect of
group [F(2,28) = 3.46; p < 0.05]. However, the group x trial interaction did not reach significance
[F(6,84) = 1.23; p > 0.2]. Individual post hoc pairwise comparisons (Newman-Keuls) revealed a
significant difference between the 200 mM (/?,Sj-MCPG and (-)-MCPG groups [p < 0.05], The 20
mM (F,5)-MCPG group did not differ significantly from either of the other two groups. However, an
analysis of simple effects revealed that all groups had reached an equivalent level of performance by
trial 4.
It was noticed during testing that whilst control animals almost always swam directly to the platform,
200 mM (F.SpMCPG-treated rats often appeared to orient themselves towards the visible platform
and maybe even begin an approach, before turning away, searching briefly elsewhere, then finally
heading for the platform again. An example of the path taken by an (/?,.S)-MCPG-treated rat behaving
in this way is shown in figure 6.2.9B. This result would tend to indicate a possible attentional or
motivational deficit in MCPG-treated animals, rather than a simple visual or motor impairment.
6.2.2.6 EPSP Slope Potentiation
The EPSP slope potentiation data are shown in figure 6.2.10A. All values were normalized to the
mean EPSP slope over the 10 min immediately prior to tetanization. PTP was defined as the mean
slope value over the 4 min immediately following tetanization. LTP was calculated as the mean EPSP
slope value measured over one of two 10-min periods: 50-60 min post-tetanus, and 110-120 min post-
tetanus. Separate ANOVAs of the normalized EPSP slope at these different time intervals after
tetanization failed to reveal a significant group difference at any point (table 6.2.1; 200 mM (R,S)-
MCPG: n = 5; 20 mM (/?,S)-MCPG: n = 6; 100 mM (-)-MCPG: n = 9). However, no group exhibited
EPSP slope LTP lasting for 2 hr, hence the absence of a group difference cannot be taken as evidence
against a role of mGluRs in LTP. In order to rule out the possibility that the failure to induce LTP
was caused by an undocumented action of the minus form of MCPG, LTP was measured in 4 rats,
selected randomly from the remaining subjects of the behavioural study, in which no infusion was
given prior to telanization. Figure 6.2.10B shows EPSP slope potentiation data from the (-)-MCPG
group alongside data from the non-infused controls. No difference in potentiation was observed at
any time point, and neither group showed lasting LTP 2 hr after tetanization (EPSP slope 1 10-120
min post tetanus: non-injected group = 103.9 ± 3.2 %; (-)-MCPG group = 101.8 + 3.4 %).
129
Table 6.2.1 EPSP Slope Potentiation
% PTP 0-4 min
post-tetanus




100 mM (-)-MCPG 130.6 ±4.8 % 110.2 ±2.9 % 101.8 ±3.4 %
20 mM («,S)-MCPG 130.2 ±4.2% 106.6 ± 1.3 % 101.0 ±2.4 %
200 mM (,R,S)-MCPG 126.3 ±2.3 % 105.2 ±2.7 % 96.8 ±3.9 %
ANOVA result F < 1 F< 1 F < 1
6.2.2.7 Population spike potentiation
A similar analysis of population spike data revealed no significant group differences at any point after
letanization, including 110-120 min; the apparently reduced population spike LTP at this point did
not reach significance (Fig. 6.2.11; Table 6.2.2; 200 mM (F,S)-MCPG: n = 5; 20 mM (F,S)-MCPG: n
= 5; 100 mM (-)-MCPG: n = 8; the reduced numbers result from the omission of data from two rats
owing to the fact that values had fallen very nearly to zero prior to tetanization). However, very little
lasting LTP was induced in either the 100 mM (-)-MCPG or 20 mM (/?,.S)-MCPG groups, making it
impossible to draw any strong conclusions from these results. In two animals tested, the population
spike amplitude prior to tetanization was very close to zero, one from the (-)-MCPG group and one
from the 20 mM (/?,S)-MCPG group; these cases were excluded from the above analysis of
population spike LTP.
Table 6.2.2 Population Spike Potentiation
% PTP 0-4 min
post-tetanus




100 mM (-)-MCPG 257.3 ±38.0 165.1 ±24.7 140.8 ±26.6
20 mM (fl,S)-MCPG 326.8 ±43.1 193.7 ±20.7 138.4 ± 8.5
200 mM (/?,S)-MCPG 211.8 ±25.2 135.5 ±21.1 78.4 ± 11.0








Table 6.2.3 shows initial EPSP slope and population spike amplitude values, averaged over the 10
min prior to tetanization. No significant group differences were found in either measure. Baseline
stimulation intensities likewise did not differ across groups. However, for a discussion of factors
which were found to influence the magnitude of LTP in this study, see chapter 9.2.









100 niM (-)-MCPG 346.0 ±32.2 4.36 ±0.42 2.19 ±0.54
20 mM (fl,S)-MCPG 441.7 ±57.4 5.16 ±0.43 2.61 ±0.68
200 mM (fl,S)-MCPG 336.0 ±36.7 3.93 ± 0.46 2.21 ±0.45






Coronal sectioning of the preserved brains revealed that cannulae were correctly sited in the right
lateral ventricle in all cases. Slight evidence of infection at the base of the cannula was present in
several of the brains, but was often particularly severe in rats that became ill and were dropped from
the experiment. Infection was characterized by enlargement of the right lateral ventricle and
infiltration of white blood cells. The use of isotonic saline as the vehicle for drug delivery was not
ideal, since it has been reported to act as an irritant (see Urquart et al., 1984). Infection may have
been caused by bacterial contamination of the injection needles or stylets. A subjective assessment
was made of the severity of infection in rats that remained healthy throughout testing: all groups were
equally affected, and the degree of infection was not correlated with watermaze performance (data
not shown). Hence, the presence of infections around the cannula site cannot account for the effects
of (.ft.Sj-MCPG on spatial learning.
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6.2.3 Discussion
These experiments reveal that i.e.v. infusion of MCPG disrupts the performance of rats in a spatial
learning task. Although performance during acquisition was not significantly affected (figure 6.2.1),
the 200 mM (R,Sj-MCPG group showed a clear deficit when tested for retention in a subsequent
transfer test (figure 6.2.4A). This deficit remained similar whether or not the active isomer was re-
administered prior to testing, suggesting the absence of state-dependent effects (figure 6.2.4B).
Furthermore, control animals injected for the first time with 200 mM (R,Sj-MCPG prior to the
transfer test, showed no impairment relative to controls which again received the minus form. This
suggests that MCPG neither causes an impairment in the recall of previously learned spatial
information, nor does it induce a detectable sensorimotor or motivational deficit in control animals
under these circumstances.
These results are broadly consistent with those reported by Richter-Levin et al. (1994), who found
only a marginal effect of (/?,5j-MCPG on escape latency during acquisition, but a severe impairment
in transfer test performance. As in the present study, (/?,5)-MCPG infusion during acquisition training
resulted in a transfer test deficit 24 hr later, regardless of whether or not rats were injected with a
further dose beforehand.
However, the effective dose found in the present study was 5 pi of 200 mM (R,S)-MCPG, whereas
Richter-Levin et al. report a similar behavioural impairment with a bilateral injection of 20 mM
(/?,5)-MCPG, 5 pi per ventricle, a five-fold lower concentration. However, the unimpaired 20 mM
(R,S)-MCPG group in the current study received only half this dose, i.e. a 5pl unilateral infusion.
Little is known about the mobility and binding properties of MCPG within the brain, but it is possible
that differences between unilateral and bilateral infusion may also contribute to this apparent
discrepancy. Unilateral infusion of 20 mM MCPG may cause a blockade of mGluRs ipsilateral to the
infusion site only, without significantly affecting the contralateral forebrain.
Richter-Levin et al. (1994) made an anecdotal claim that MCPG-treated rats "swam initially towards
the location where the platform had been in the same way as did control or vehicle-injected rats."
Consistent with this possibility, 200 mM (R,S)-MCPG-treated rats in the present study were certainly
able to learn something about the platform position, as the decrease in escape latency during spatial
acquisition demonstrates. Furthermore, although the 200 mM (/?,i>)-MCPG group took, on average,
roughly twice as long to reach the original platform position as both other groups, this difference was
found not to be significant (figure 6.2.7).
However, escape latency is a more variable measure of performance than the time spent in each
quadrant during a transfer test. A breakdown of the 60 s transfer test data into four 15 s time windows
failed to reveal a pattern of good performance early on, followed by more rapid extinction in the 200
mM (/?,5j-MCPG group (figure 6.2.8). In fact, rats treated with 200 mM (/?,5)-MCPG performed best
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in the interval between 30-45 s after the start of the transfer test. (Note that the transfer test carried
out by Richter-Levin et al. lasted only 30 s.) Hence, the MCPG-induced deficit in the present study
cannot be accounted for by differences in the rate of extinction, or persistence in searching.
The findings of a later study by Bordi et al. (1996) differ more substantially from those of the present
study. Intraventricular infusion of 5pl 20 mM (+)-MCPG (20.8 pg) was found to cause a modest
impairment in escape latencies during watermaze acquisition training, relative to vehicle-injected
controls, as was reported by Richter-Levin et al. (1994). However, in contrast to the results of the
latter study, a transfer test deficit was only seen when a further infusion of (+)-MCPG was given prior
to testing. Rats unilaterally infused with (+)-MCPG throughout acquisition training, but infused with
vehicle prior to the transfer test performed as well as controls infused with vehicle throughout.
In order to explain this discrepancy, Bordi et al. (1996) argue that, "Because MCPG-treated animals
initially swim towards the correct quadrant, but subsequently spend more time away from this
location (Richter-Levin et al., 1994), the difference between the two studies can be explained by the
fact that we allowed the animals less time (20 vs. 30 sec) to search for the platform in the probe trial."
However, the argument is far from compelling. It must be supposed that MCPG given only during
acquisition simply decreases the persistence of searching in a drug-free transfer test; hence the
absence of a deficit with a 20 s transfer test (Bordi et al., 1996), but the presence of a deficit with a 30
s transfer test (Richter-Levin et al., 1994).
This issue could potentially be settled by analysis of the change in transfer test performance over time
in the present study for the group given 200 mM (/?,5)-MCPG during acquisition, but 100 mM (-)-
MCPG before the transfer test. Unfortunately, the small state-dependent group sizes used, and the
increase in variability associated with division of the transfer test data into distinct time windows,
mean that this analysis is not feasible.
However, Bordi et al., (1996) also found that rats infused with vehicle during acquisition training, but
infused with (+)-MCPG prior to the transfer test, were impaired relative to rats infused with saline
throughout. This impairment was as severe as that seen in the group given (+)-MCPG throughout. It
was suggested that MCPG might impair memory retention, rather than acquisition. However, it is
difficult to reconcile such an interpretation with the results of the present study, in which MCPG
given during acquisition impaired transfer test performance regardless of whether the drug was re-
administered beforehand. The pattern of results reported by Bordi et al. (1996) is, in fact, equally
consistent with the possibility of an MCPG-induced performance deficit, unrelated to learning.
One methodological factor that may be relevant is the time interval between drug infusion and
behavioural testing. Bordi et al. (1996) gave infusions 5 min prior to testing, compared to the 20 min
interval used by Richter-Levin et al. (1994), or the 30 min interval used in the present study.
Nevertheless, it is not clear how this factor could explain the differences between studies, and the
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issues raised above remain unresolved (see section 6.1).
6.2.3.1 Is the impairment mnemonic?
Rats injected with 200 mM (/?,5)-MCPG showed no obvious sensorimotor deficits, and an analysis of
swim speeds and thigmotaxic swimming revealed no significant differences between groups (figures
6.2.2 and 6.2.3). Furthermore, the transfer test performance of control rats was not impaired by the
prior injection of 200 mM (R.Sj-MCPG in place of the minus form, and (R,,S)-MCPG-injected rats
showed no signs of the ataxia often associated with D-AP5 treatment. However, the 200 mM (R,S)-
MCPG-treated rats did show a trend towards longer escape latencies on trial one of acquisition
(figure 6.2.1), when nothing is known about the platform position, and a final testing session in which
rats were required to locate a randomly-positioned prominent visible platform, with extra-maze cues
obscured, revealed a significant overall impairment in the 200 mM (R,.S)-MCPG group (figure 6.2.9),
although (R,S)-MCPG-treated rats did reach the same level of performance as controls by trial 4.
Nevertheless, considering the apparent ease of the task - control rats reach the platform within
seconds - this is a rather surprising result. No other reports of such a deficit exist. Richter-Levin et al.
(1994) did not carry out a visible platform task, but Bordi et al. (1996) found no effect of 20 mM (+)-
MCPG on performance in a visually-cued watermaze task. Nevertheless, it may be significant that the
effective dose of MCPG used by Bordi et al. (1996) was five-fold lower than the 200 mM (R,S)-
MCPG used in the present study.
This impairment may represent a visual or sensorimotor deficit. MCPG has been reported to inhibit
the transmission of nocioceplive information in the ventrobasal thalamus (Salt and Eaton, 1994), and
impairs contrast adaptation in cat striate cortical cells (McLean and Palmer, 1996). It is also possible
that MCPG causes attentional or motivational changes. For instance, the group I mGluR antagonist
(S)-4C3HPG has anxiolytic properties (Chojnacka-Wojcik et al., 1997). It is not known whether
MCPG shares these anxiolytic actions, but a reduction in the anxiety induced by exposure to the
watermaze might reduce the motivation to locate the platform rapidly. Hence, at this stage, the
possibility of non-mnemonic contributions to the poor performance of 200 mM (R.^-MCPG treated
rats cannot be ruled out.
6.2.3.2 Does MCPG block LTP?
The electrophysiological results presented here are inconclusive, partly because little LTP was seen in
the control group. The drug concentrations and tetanus parameters used were originally chosen to
match those of a previous electrophysiological study by Riedel et al. (1994a), in which it was
reported that the 200 mM concentration caused a complete block of both STP and LTP, whereas a 20
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mM concentration spared a short-term potentiation which fell to baseline within 1-2 hours. This study
was carried out in freely moving animals, rather than under terminal urethane anaesthesia, and pulse
width, rather than stimulation current was doubled during tetanization. The doubling of stimulus
intensity in the present study, rather than stimulus duration, may have contributed to the poor LTP
obtained.
The absence of differences in LTP between drug groups may simply have reflected a general failure
to activate nrGluRs. Immunocytochemical studies have revealed that group I mGluRs are
perisynaptically located, outside of the postsynaptic membrane specialization (Lujan et al., 1996),
whilst an extrasynaptic location has been reported for group II mGluRs (Shigemoto et al., 1997). A
weak tetanus may not induce sufficient glutamate release to activate mGluRs in the periphery of (or
outside) the synaptic cleft, and hence a blockade of these receptors with MCPG will have no effect
under these circumstances.
However, Riedel et al. (1995a) reported a block of both STP and LTP with 200 mM (R,S)-MCPG.
The failure of this dose of MCPG to block STP in this study is difficult to reconcile with the fact that
tetanization was, if anything, weaker, judging by the lack of lasting LTP. Unidentified factors, such
as differences in electrophysiological equipment, or the strain of rat used, may also have contributed
to the differences between the two studies. For instance, Riedel et al. (1995) used Wistar rats
throughout. This strain has recently been found to express LTD more readily than Lister-hooded rats
(Manahan-Vaughan and Reymann, 1997b), and it is possible that strain differences may also be found
in the induction of LTP.
These problems were overcome in a subsequent series of experiments by the use of a stronger tetanus
that reliably induces lasting LTP in controls (see chapter 8).
6.2.3.3 Summary
The results of the present study confirm that i.e.v. administration of (R.S)-MCPG impairs
performance in a spatial reference memory task in the watermaze. However, the slight deficit on the
visible platform control task means that it cannot conclusively be argued that the impairment in
"spatial learning" is genuinely mnemonic in nature.
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★ 200 mM (R,S)-MCPG
A 20 mM (R,S)-MCPG
O 100 mM (-)-MCPG
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Day 1 Day 2 Day 3
Trial Number
Fig. 6.2.1
Mean latency to find the hidden escape platform during acquisition of a
reference memory task in the watermaze. Rats infused with 200 mM
(R,S)-MCPG prior to each daily testing session were slightly impaired
on the first day of testing only.
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Fig. 6.2.2
Mean swim speeds during acquisition of a reference memory task in the
watermaze. Swim speeds did not differ across groups.
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★ 200 mM (R,S)-MCPG
A 20 mM (R,S)-MCPG
O 100 mM (-)-MCPG
0 1 2 3 4 5 6 1 8 9 10 11 12 13 14 15 16 17 18
Day 1 Day 2 Day 3
Trial Number
Fig. 6.2.3
Percentage time within 15 cm of the side-walls during acquisition of a
spatial reference memory task. All groups were equally thigmotaxic
according to this measure.
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100 mM (-)-MCPG
AL Tr AR Op
20 mM (R,S)-MCPG
AL = Adjacent left
Tr = Training
AR = Adjacent right
Op = Opposite
AL Tr AR Op
200 mM (R,S)-MCPG
AL = Adjacent left
Tr = Training
AR = Adjacent right
Op = Opposite
AL Tr AR Op AL Tr AR Op
(-)-MCPG in TT (R,S)-MCPG in TT
100 mM (-)-MCPG during Acquisition
AL Tr AR Op AL Tr AR Op
(-)-MCPG in TT (R,S)-MCPG in TT
200 mM (R,S)-MCPG during Acquisition
Fig. 6.2.4
(A) Mean percentage time spent within each quadrant of the pool during the
transfer test. Labels below the x-axis indicate the drug infused during acquisition.
(B) Transfer test performance of rats infused with 200 mM (R,S)-MCPG and
100 mM (-)-MCPG during acquisition, divided into state dependent control
sub-groups according to the drug delivered prior to the transfer test (TT).










Representative swim paths during the transfer test. Rats infused with 200 mM
(R,S)-MCPG failed to show a significant bias towards the training quadrant.
In all examples shown, rats were infused with the same drug prior to the transfer
test as during acquisition training. The swim path of one rat trained to the SE











Examples of the transfer test performance of state dependent control
animals. Performance was determined by the drug given during
acquisition training, not the drug infused prior to retention testing.
The swim path of one rat has been rotated 180° in order to aid




























Mean latencies to reach the original position of the now absent
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Transfer test performance broken down into four 15 s time intervals
Data for each quadrant are displayed separately (AL = adjacent left,







★ 200 mM (R,S)-MCPG
A 20 mM (R,S)-MCPG
O 100 mM (-)-MCPG
Trial Number
Fig. 6.2.9
(A) Latency to reach the visible escape platform. Rats infused with 200 mM
(R,S)-MCPG were significantly impaired relative those infused with (-)-MCPG.
(B) Sample swim paths taken on trial 1 of visible platform testing. A subset
of rats treated with 200 mM (R,S)-MCPG, such as the example shown here,
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(A) EPSP slope potentiation, measured for 2 hr after tetanization. Lasting LTP
was not induced in any group. (B) The failure to induce LTP was not due to
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Fig. 6.2.11
Infusion of 200 mM (R,S)-MCPG appears to limit the induction of population
spike LTP. However, very little lasting LTP was induced in rats infused with
(-)-MCPG or 20 mM (R,S)-MCPG, and the group difference did not reach
significance, even 2 hr after tetanization.
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6.3 Chronic niinipump infusion of (/?,S)-MCPG has no effect on spatial reference memory
6.3.1 Introduction
It was originally planned to carry out a watermaze matching-to-place task using MCPG, since the
finding of a delay-dependent deficit on such a task would provide strong evidence for genuine a role
of mGluRs in learning. However, it was first decided to test animals chronically infused with MCPG
via osmotic minipumps, a procedure which has been used many times in this laboratory in the past,




Osmotic minipumps were implanted as described in chapter 4.4.1. Minipumps contained either 100
mM (/?,5')-MCPG (n = 10) or aCSF (n = 10). Rats were allowed 4 days to recover before the start of
pre-training, throughout which they were handled and weighed daily.
6.3.2.2 Drugs
A 100 mM solution of (R,5)-MCPG was prepared as described in experiment 6.2, except that aCSF
was used as the vehicle.
6.3.2.3 Behavioural testing
The protocol for reference memory training is detailed in chapter 4.2.2. However, rats were trained to
platform positions either in the NW or SE quadrants of the pool, rather than NE and SW. In addition,
a second transfer test was carried out 6 days after the first in order to investigate the longer term
retention of spatial information during continuous drug infusion. The visible platform task was
carried out on the same day as the second transfer test.
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6.3.2.4 Histology
Histological verification of cannula sites was carried out as described in chapter 4.5.
6.3.3 Results
6.3.3.1 Acquisition training
Latencies to reach the hidden platform are shown in figure 6.3.1A. The overall reduction in escape
latencies over training was highly significant [T(17,306) = 7.47; p < 0.0001], but the two groups did
not differ [T< 1],
6.3.3.2 Transfer tests
Transfer test performance is shown in figure 6.3.2A. An ANOVA of the time spent in different
quadrants of the pool during the initial transfer test revealed a significant overall bias towards the
training quadrant [f(3,54) = 56.8; p < 0.0001], but no group by quadrant interaction [F < 1]. A
separate analysis of the time spent in the training quadrant only failed to reveal a difference between
groups [F< I]. Representative sample swim paths recorded during transfer tests are shown in figure
6.3.2B.
No significant forgetting occurred between the first and second transfer tests. MCPG-treated rats
again performed as well as controls (data not shown).
6.3.3.3 Visible platform task
Latencies to reach the visible platform are shown in figure 6.3.IB. No main effect of trial was
obtained [F(3,54) = 1.0; p > 0.3] and no group difference [F(l,18) = 1.77; p > 0.2],
6.3.3.4 Sensorimotor disturbances
There was no evidence of sensorimotor or behavioural abnormalities in rats implanted with
minipumps containing MCPG. MCPG-treated rats swam equally fast and were no more thigmotaxic
than controls (data not shown).
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6.3.3.5 Histology
Cannulae were found to be correctly located in the right lateral ventricle in all cases.
6.3.4 Discussion
Continuous infusion of 100 mM (f?,.S)-MCPG had no noticeable behavioural effects of any kind,
whether learning-related or sensorimotor. Similarly, no behavioural abnormalities were revealed upon
examination of the rats.
It is possible that the dose of MCPG used was simply too low. The Alzet 2000 osmotic minipumps
used in the present study infuse continuously for 14 days at 0.5 pi / hr. Hence, a dose equivalent to
the 5 pi of 200 mm MCPG used in experiment 6.3 was delivered every 20 hr. However, the relative
hippocampal concentrations resulting from these two modes of delivery are unknown, and depend
critically on the rate at which MCPG leaves the brain and / or is metabolized.
According to Davis et al. (1992). implantation of minipumps containing 30 mM D-AP5 results in a
hippocampal tissue concentration of 0.27 nmol.mg1 wet weight. Subsequent studies have reported
concentrations two-fold or even four-fold higher than this (D. M. Bannerman, PhD thesis; Steele and
Morris, 1999). However, taking the lowest figure as a guide, and assuming that 1 mg is equivalent to
1 ml, a 30 mM D-AP5 minipump results in a hippocampal concentration of roughly 0.3 mM D-AP5,
i.e. a 100-fold reduction in concentration. The pharmacokinetics of MCPG binding and diffusion in
vivo are unknown, but (/?,S)-MCPG has a similar molecular weight to D-AP5 (209.2 compared to
197.1). Assuming that the two drugs are comparable, a 100 mM MCPG minipump should result in a
tissue concentration of approximately 1 mM. This figure is double the concentration routinely used to
block LTP in CA1 slices (see chapter 3.10.3), and as mentioned above, may be a substantial
underestimate.
Nevertheless, the assumption that MCPG and AP5 can be treated as equivalent in the above
calculation is almost certainly wrong. It has been found that a substantial amount of AP5 is
unavailable to NMDA receptors owing to a "trapping" phenomenon (Davis et al., 1992). It is not
known whether MCPG behaves in the same way, but if so, the true extracellular concentration of
MCPG could be a fraction of that suggested above. In the absence of a reliable assay for the presence
of MCPG, these issues remain unresolved.
Assuming that adequate hippocampal MCPG levels were achieved in both cases, the ability of acute
but not chronic infusions of MCPG to impair watermaze performance might be due to receptor up-
regulation in the latter case. It has been reported that chronic infusion of NMDA receptor antagonists
causes an increase in the number of NMDA receptors, but no changes in affinity (Mennini et al.,
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1994). It is possible that changes in either affinity or number of mGlu receptors during chronic
infusion of MCPG may have compensated for the presence of the antagonist, and resulted in
unimpaired performance. Note that minipumps were implanted 5 days before the start of spatial
acquisition training, allowing considerable time for receptor up-regulation to occur. Such changes
may not have been induced after the single acute infusions of MCPG delivered in experiment 6.2.
If the above suggestion is correct, MCPG will only impair learning if delivered acutely. However, the
intraventricular route is not ideal owing to the range of brain structures reached in addition to the
hippocampus, and hence the possibility of sensorimotor side-effects such as the slight impairment in
the visible platform task observed in experiment 6.2. In order to overcome these problems, it was
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Fig. 6.3.1
Mean latency to find the escape platform during both hidden (A) and
visible platform training (B). Rats implanted with minipumps
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Fig. 6.3.2
(A) Mean percentage time spent within each quadrant of the pool during
the transfer test. MCPG-treated rats spent an equal amount of time in the
training quadrant to controls. (B) Sample swim paths of rats treated with
aCSF or MCPG.
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6.4 Acute intrahippocampal infusion of (R,S)-MCPG has no effect on spatial reference memory.
6.4.1 Methods
6.4.1.1 Surgery
Bilateral intrahippocampal cannulae were implanted as described in chapter 4.4.3. Rats were allowed
1-2 weeks to recover before the start of pre-training, throughout which they were handled and
weighed daily.
6.4.1.2 Drugs
A 200 mM solution of (R,S)-MCPG was prepared as described in experiment 6.3. Rats were infused
with lpl aCSF (n = 10) or 1 pi (R,S)-MCPG (n = 10).
State dependent and performance control conditions were not included in the present study. Hence,
rats were infused with the same drug throughout acquisition training and the transfer test.
6.4.1.3 Behavioural testing
Reference memory training was carried out as detailed in chapter 4.2.2. Pre-training was carried out
without prior infusion. Spatial acquisition training, transfer tests, and visible platform training were
started 30 min after the end of drug infusion. The visible platform task was carried out 4 days after
the transfer test.
6.4.1.4 Histology
The histological procedures used are described in chapter 4.5. The co-ordinates of infusion sites were




Latencies to reach the hidden platform are shown in figure 6.4.1 A. The overall reduction in escape
latencies over training was highly significant [F( 17,306) = 11.8; p < 0.0001], but the two groups did
not differ [F < I].
6.4.2.2 Transfer test
Transfer test performance is shown in figure 6.4.2A. Although performance was worse than that
obtained in experiments 6.2 and 6.3, an ANOVA of the time spent in different quadrants of the pool
revealed a highly significant overall bias towards the training quadrant [F(3,54) = 6.26; p < 0.01], but
no group by quadrant interaction [F < 1]. A separate analysis of the time spent in the training
quadrant only failed to reveal a difference between groups [F < 1 j. Representative sample swim paths
recorded during the transfer test are shown in figure 6.4.2B.
6.4.2.3 Visible platform task
Latencies to reach the visible platform are shown in figure 6.4.IB. The overall improvement across
trials was significant [F(3,54) = 4.04; p < 0.05], but no difference was found between groups [F < 1].
6.4.2.4 Sensorimotor disturbances
4 of the rats infused with MCPG exhibited a slight ataxia and failure to groom when examined 1-2 hr
after drug infusion. These symptoms were not evident at the time of behavioural testing, and no
abnormal behaviours such as falling off the platform were observed. MCPG-treated rats were no
more thigmotaxic than controls, and swam equally fast throughout training (data not shown).
6.4.2.5 Histology
Figure 6.4.3 shows infusion sites for the 20 rats included in the above analysis, All infusion sites were
located within the hippocampus. In some cases, hippocampal damage extended for several hundred
pm below the site of the guide cannula (see below). In these cases, the infusion site was estimated
based on guide cannula position.
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6.4.2.6 Relationship between histology and watermaze performance
In 8 rats (3 aCSF and 5 MCPG), hippocampal damage extended ventrally as far as the wall of the
ventricular layer situated beneath the inferior blade of the dentate gyrus. Of the 5 MCPG-treated rats
in which such damage was observed, 3 exhibited sensorimotor disturbances.
In order to assess any possible impact on behaviour, both aCSF and MCPG groups were sub-divided
according to whether damage extended as far as the ventricular wall or not ("intact" or "damaged"
groups). Figure 6.4.4 shows the percentage time spent in the training quadrant during the transfer lest
re-analysed in this way. Rats infused with aCSF performed equally well, regardless of the extent of
hippocampal damage. However, MCPG-infused rats in the "damaged" group performed at chance,
whilst those in the "intact" group performed as well, or better than controls, with no hint of the slight
mean impairment evident in the overall analysis (figure 6.4.2A). A modest impairment in escape
latencies on the final day of acquisition training was also observed in the MCPG "damaged" group
(data not shown). Despite the above findings, MCPG-treated rats in the "damaged" condition were
normal in terms of thigmotaxis, swimming speed, and performance in the visible platform task (data
not shown).
However, owing to the small and uneven group sizes, a statistical analysis of the above data was not
attempted, and any attempt to draw conclusions from these findings is necessarily speculative.
6.4.3 Discussion
In contrast to the effects of acute intraventricular infusion of MCPG, acute intrahippocampal infusion
does not cause a deficit in watermaze performance. As in experiment 6.3, it is possible that the dose
of MCPG used was simply too low. However, the concentration used is close to the solubility limit of
MCPG. This problem might be overcome by continuous inlrahippocampal minipump infusion of
MCPG, but if receptor up-regulation occurs during chronic infusion as suggested in experiment 6.3,
this method of drug administration would be unlikely to produce an impairment.
It is interesting that a deficit was observed in MCPG-treated rats whose hippocampal damage
extended ventrally as far as the wall of the ventricular layer that links the dorsal third ventricle with
the lateral ventricles. It is possible that MCPG was not limited to the hippocampus in these cases, but
leaked into the ventricles to some extent, thus mimicking the effects of i.e.v. infusion. MGPG-treated
rats in the "damaged" group showed a similar watermaze deficit to that obtained after acute
ventricular infusion in experiment 6.2. Possible reasons for the success of acute i.e.v. infusions, but
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Mean latency to find the escape platform during both hidden (A) and
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(A) Mean percentage time spent within each quadrant of the pool during
the transfer test. MCPG-treated rats spent an equal amount of time in the
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Percentage time spent within the training quadrant during the transfer
test sub-divided into "intact" and "damaged" groups (see text).
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6.5 General discussion
The results of experiment 6.2 are broadly consistent with those of existing reports (see section 6.1),
i.e. i.c.v. infusion of MCPG causes a watermaze deficit that is almost exclusively limited to the
transfer test. However, experiment 6.3 revealed that chronic infusion of MCPG by the same route has
no effect on performance. Surprisingly, the same was found to be true of acute intrahippocampal
infusion (experiment 6.4). Nevertheless, there was an indication in this last experiment that MCPG-
treated rats were impaired when hippocampal damage extended ventrally towards the ventricular
layer, suggesting that in these cases, infusion may have been effectively more intraventricular than
intrahippocampal.
There are at least two alternative explanations for the success of acute i.c.v. infusions of MCPG, but
the failure of acute intrahippocampal infusions. Firstly, MCPG may induce a watermaze deficit by
actions on structures other than the hippocampus. Secondly, intrahippocampal infusions may lead to
blockade of mGluRs within a very limited portion of the hippocampus, whilst leaving sufficient drug-
free tissue for normal task performance. These possibilities are discussed below.
This first possibility is consistent with the fact that MCPG causes a deficit in the percentage time
spent within the target quadrant during the transfer test, but little or no deficit in latency to reach the
platform during acquisition training, and no deficit in swimming initially to the correct location in the
transfer test. It is true that transfer test performance is a more sensitive and less variable measure of
spatial learning than escape latency. However, a transfer test is essentially an extinction trial, during
which persistent searching is required in the absence of reward. It is possible, for example, that a
decreased motivation to escape resulting from an anxiolytic action of MCPG outside of the
hippocampus might result in a selective transfer test deficit owing to the requirement for persistent
searching, as well as spatial memory.
Nevertheless, such an interpretation is hard to reconcile with the finding that rats infused with vehicle
throughout training were not impaired when given MCPG for the first time during the transfer test in
experiment 6.2. However, this result is based on a very small sample (n = 4). It is worth noting that
Bordi et al. (1996) reported a modest but significant deficit in this condition using a larger sample of
rats (n = 9). Hence, it is possible that the "learning" impairment seen after i.c.v. infusion of MCPG is
in fact a performance deficit, perhaps caused by the blockade of mGluRs outside the hippocampus.
This interpretation is also consistent with the finding in experiment 6.2 that acute i.c.v. infusion of
MCPG causes a slight impairment on a visually cued control task.
As discussed in section 5.1.1, intraventricular infusion of a drug results in a fairly widespread
distribution of drug throughout the forebrain. It is likely that i.c.v. infusion of MCPG in experiment
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6.2 resulted in appreciable blockade of mGluRs in many brain areas, including the thalamus, striatum,
and frontal cortex. Thalamic mGluRs, in addition to NMDA receptors, are known to be involved in
the transmission of sensory information (Salt and Eaton, 1996), and hence the blockade of mGluRs in
this structure might be expected to cause a performance deficit, rather than a genuine learning
impairment.
mGluRs are also highly expressed in the striatum, a structure reported to play a role in watermaze
place learning (Devan et al., 1996). The blockade of striatal mGluRs results in the inhibition of long-
term depression in vitro (Calabresi et ah, 1993), although no studies of the role of striatal mGluRs in
spatial learning have been conducted. The medial prefrontal cortex is another region that has been
implicated in spatial learning, and in which mGluRs are expressed. MCPG has been found to block
LTP in isolated slices of medial frontal cortex (Vickery et ah, 1997). The role of frontal mGluRs in
spatial learning has not been studied, but medial prefrontal cortex lesions have been reported to
impair the acquisition of a spatial reference memory task in the watermaze (Kolb et ah, 1982).
However, others have failed to find such a deficit on acquisition, but report an impairment of spatial
reversal learning (deBruin et ah, 1994). This latter finding is consistent with other reports that the
medial prefrontal cortex is necessary for successful watermaze navigation under changing task
conditions (Granon and Poucet, 1995; Compton et ah, 1997). The above discussion illustrates the fact
that there are a number of different ways in which intraventricular MCPG infusion might impair
watermaze performance, in addition to its actions in the hippocampus.
The second possibility mentioned earlier concerns the likelihood that a single point infusion of
MCPG will result in a limited distribution of the drug along the septotemporal axis of the
hippocampus. It has been reported that an island of dorsal hippocampal tissue comprising only 26 %
of the total volume is sufficient for normal performance of a watermaze reference memory task
(Moser et ah, 1995). Hence, the blockade of mGluRs within a restricted region of the dorsal
hippocampus might be insufficient to impair learning. This problem is not likely to occur after
ventricular drug infusion, since the hippocampus is surrounded by ventricular structures, allowing
access to its entire septotemporal length. However, the superior distribution of drug within the
hippocampus is achieved at the cost of allowing substantial quantities of drug to enter surrounding
structures.
Unfortunately, the data obtained in the present series of experiments cannot distinguish between the
two possibilities discussed above. A pessimistic conclusion, however, might be that MCPG is a
questionable choice of mGluR antagonist for use in such tasks. MCPG is a rather weak mGluR
antagonist with an uncertain profile of subtype selectivity (see chapter 3.6.3). It produces a modest
watermaze impairment when injected intraventricularly at the highest concentration possible, and
then only under certain circumstances. It is likely that antagonists with considerably greater potency
and subtype selectivity than MCPG will be necessary to produce an unambiguous resolution of all the
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issues raised in the present study. Watermaze experiments involving the preferential group I mGluR
antagonist AIDA are currently underway.
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Chapter Seven
The effect of the mGluR antagonist
(/^S)-oc-methyl-4-carboxyphenylglycine (MCPG)
on dentate LTP in vivo.
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7.1 General introduction
The effect of the putative group I and II mGluR antagonist MCPG on hippocampal NMDA receptor-
dependent LTP is currently a controversial topic, and the literature contains several conflicting reports
(see chapter 3.10). At the time when the current study was carried out, three laboratories had
published reports concerning the ability ofMCPG to block LTP in vivo.
Riedel and colleagues found that unilateral i.c.v. infusion of 200 ntM (/?,S)-MCPG 30 min before
tetanization completely blocked both STP and LTP in freely moving rats. A lower dose of 20 mM
(R.S^-MCPG limited the duration of LTP to 2-3 hr (Riedel and Reymann, 1993; Riedel et al., 1995a).
It was subsequently reported that continuous perfusion of the dentate with 5 mM (R.S)-MCPG via a
push-pull cannula limited the duration of LTP to 2 hr in urethane-anaesthetized rats. Acute bilateral
i.c.v. infusion of 10 pi (R,5)-MCPG (5 pi per ventricle) 40 min before tetanization reduced the
magnitude of LTP, but did not cause a total block (Richter-Levin et ah, 1994). However, LTP was
recorded for less than 1 hr after tetanization in this part of the study. Despite these positive results, it
was reported elsewhere that unilateral i.c.v. infusion of 5 pi 200 mM (R.SVMCPG had no effect on
LTP in urethane-anaesthetized rats (Bordi and Ugolini, 1995).
The reasons for the discrepancies in results obtained in different laboratories are unknown (see
chapter 3.10.5 for discussion). The experiments conducted below were carried out in order to
determine, initially, whether or not a blockade of LTP with MCPG could be obtained in this
laboratory (experiments 7.3 and 7.4), and whether MCPG reverses the electrophysiological effects of
the mGluR agonist (1 S,3/?)-ACPD (experiment 7.5).
One possible explanation for the negative results obtained in many laboratories concerns the position
of the mGluR-activated molecular switch described by Bortolotto et al. (1994). Hence, additional
experiments were conducted in order to address the possibility that an mGluR-activated molecular
switch must be reset before a block of LTP with MCPG can be demonstrated (see Bortolotto et al.,
1994; Wang et al., 1995; but also Selig et al., 1995; Thomas and O'Dell, 1995; experiment 7.6).
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7.2 General methods
The procedures described below constitute methods that were common to all experiments in the
current series, but not covered in chapter 4. Aspects of the methodology unique to a particular
experiment will be introduced later, as necessary.
7.2.2 Drugs
Two different concentrations of (/?,S)-MCPG were tested: 200 mM and 20 mM. Solutions were
prepared as described in chapter 6.2.1.2, except that phosphate buffered saline (PBS) was used as the
vehicle. Despite the high concentration of NaOH present in the 200 mM (I?,.Sj-MCPG solution, the
pH was found to be 7.28, i.e. very nearly neutral. A 100 mM stock solution of D-2-amino-5-
phosphopentanoate (D-AP5) was made up in equimolar NaOH. Spiking with small aliquots (l-2pl) of
5M NaOH was sometimes required to ensure that the drug dissolved fully. A final concentration of 30
mM was attained by dilution with the appropriate volume of aCSF. Solutions were stored at -20 °C in
small aliquots before use.
7.2.3 Electrophysiology
Experiments were conducted under urethane anaesthesia as described in chapter 4.3. In addition, two
stainless steel injection cannulae, connected by plastic tubing to microinfusion syringes, were lowered
into the left and right lateral ventricles (AP = -0.9 mm; Lat = ± 1.3 mm; DV = -4.5 mm from the skull
surface). Miniature thermistors (Fenwell Electronics Ltd.) were glued to the end of a length of
insulated copper tubing, such that the total diameter of the thermistor and shaft was approximately 0.5
mm (although early attempts were slightly thicker). Each thermistor was calibrated by measuring the
resistance of the device (in arbitrary units recorded by computer) whilst the tip was immersed to a
depth of approximately 3 mm in a beaker of water. The water was stirred constantly (using a magnetic
stirrer), and its temperature, as determined with a mercury thermometer, was varied over an
appropriate range. An example of the relationship between thermistor reading and temperature thus
derived is shown in figure 7.2. The equation describing the best linear fit to these data was used, off¬
line, to convert arbitrary thermistor readings into temperature expressed in degrees centigrade. In each
rat, a thermistor was lowered into the right dentate gyrus (AP = -3.5 mm; Lat. = 2.0 mm; DV = 3.0
mm from dura), and thermistor readings were sampled every 20 s for the duration of an experiment.
Throughout the experiment, perforant path test stimulation consisted of biphasic pulses of 100 ps
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half-pulse duration delivered at 0.05 Hz, except during input / output curves when pulses were
delivered at 0.1 Hz.
Half an hour or more after implantation of electrodes a number of test pulses were delivered and the
stimulation intensity was adjusted to elicit a population spike of 2-4 mV. At this point, a test baseline
was recorded. Once potentials had stabilized (typically 30-60 min later), the main experiment was
started. High frequency tetanization consisted of 5 trains of 20 pulses at 250 Hz, with 10s between
trains; the stimulation intensity was set at twice the baseline level.
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According to linear fit:
Thermistor reading = 2979.0 - (41.85 x temperature)
=> Temperature = (thermistor reading - 2979.0) / -41.85
Fig. 7.2
Sample thermistor calibration data. Thermistor readings were
converted into temperature data according to the equation
described above.
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7.3 Does MCPG block dentate LTP in vivo?
7.3.1 Methods
Once potentials assessed during the test baseline period had been stable for at least 20 min, an input /
output (I / O) curve consisting of 4 pulses at each of 10 stimulation intensities over the range 0.1-1.0
mA was recorded. Immediately afterwards, a 20 min baseline period was started, followed by a 10 pi
bilateral drug infusion (i.e. 5 pi per ventricle) of either 200 mM (/?,.S)-MCPG (n = 7), 20 mM (R,S)-
MCPG (n = 6), or vehicle (n = 7), delivered over a period of 10 min. Half an hour after the end of the
infusion, a second, partial, I / O curve, consisting of 4 pulses at 200 pA, 400 pA, and 600 pA only,
was recorded. Following this, animals received a high frequency tetanus. Field potentials were
recorded for a further 2 hr after tetanization. Finally, a third I/O curve was recorded over the full
intensity range.
In order to test the drug infusion system, a further control group was infused with 30 mM D-AP5 (n =
6). In two of these animals, stimulation and recording electrodes were implanted bilaterally; only one
pathway received a high-frequency tetanus.
7.3.2 Results
7.3.2.1 EPSP slope potentiation
Figure 7.3.1A shows the amount of EPSP slope potentiation in the three main groups, normalized to
the mean value obtained during the 10 min prior to tetanization; neither dose of MCPG caused a block
of LTP. Sample EPSPs recorded before and after LTP induction in a vehicle-infused rat are
illustrated. Separate ANOVAs of the mean slope potentiation over different 10 min time periods
revealed no significant group differences in EPSP slope LTP 50-60 min or 110-120 min post-tetanus;
no group differences were found in percentage PTP (table 7.3.1). No significant group differences in
EPSP slope LTP were observed at any time point after tetanization when the results were re-
normalized to the 10 min prior to drug infusion, rather than tetanization (data not shown).
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Vehicle 144.2 ±2.7 123.3 ±2.4 116.9 ±2.4
20 mM (fl,S)-MCPG 146.9 ±3.6 121.8 ± 3.5 116.3 ±4.6
200 mM (/?,5)-MCPG 143.7 ±2.7 119.9 ±3.2 109.9 ±4.0
ANOVA results F < 1 F< 1 E(2,17)= 1.21;
p > 0.3
7.3.2.2 Effect of D-AP5 on EPSP slope potentiation
Infusion of 10 pi 30 mM D-AP5 caused a complete block of LTP. Figure 7.3.IB shows pooled EPSP
slope data from the 6 rats infused with AP5 compared to the vehicle-infused controls. Mean non-
tetanized control pathway data from the two rats in which recordings were made bilaterally are plotted
alongside data from the six tetanized pathways. Curiously, infusion of AP5 caused a slight increase in
EPSP slope, an effect noticeable in both tetanized and control pathways, and associated with a
transient temperature rise of approximately 0.5 °C (see below). However, the elevated pre-tetanus
slope magnitude appears to be maintained throughout the experiment. Inspection of figure 7.3.IB
suggests that this is most likely due to the superposition of an EPSP slope increase induced by AP5,
upon a slight chronic baseline rise. (A similar slight baseline rise was found in later experiments: see
figure 7.4.1 A, control pathways.) Nevertheless, equivalent changes were seen in both tetanized and
non-tetanized pathways. In the two rats which received bilateral stimulation and recording, no
differences were found between tetanized and non-tetanized EPSP slope values 2 hr after tetanization,
relative to the pre-tetanus baseline, indicating that LTP was completely blocked (tetanized pathways
110-120 min post tetanus: 109.7 % and 103.0 %; corresponding non-tetanized pathways: 111.3 %;
98.1 %). Hence, in these two animals at least, the possibility that a residual potentiation was masked
by baseline changes can be ruled out.
7.3.2.3 EPSP slope potentiation across the I / O curve
Figure 7.3.2 shows the mean EPSP slope I / O curves for all groups. Data are normalized to the
maximum EPSP slope value recorded during the first I/O curve, prior to drug infusion and
tetanization. The initial and final I / O curves, which span the full range of stimulation intensities, are
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plotted as line graphs. The three points of the shortened I/O curve carried out immediately prior to
tetanization are superimposed upon the full I/O curves. The proximity of these points to the
corresponding points on the pre-infusion I/O curve suggest that drug-induced baseline changes were
minimal, even in the 200 mM (/?,S)-MCPG group, when assessed in this way (but see discussion).
Inspection of figure 7.3.2 suggests that there is little difference in the potentiation induced across the 1
/ O curve in the three drug groups. This was examined more formally by measuring the percentage
potentiation occurring between the initial and final I/O curves at each test pulse intensity (i.e. [initial
value / final value] x 100). The results of this analysis are shown in figure 7.3.3. An ANOVA in
which stimulation intensity was entered as a within subject factor revealed no significant overall
group difference [F < 1], or group x stimulation intensity interaction [F < 1], indicating that the slight
reduction in LTP seen in the 200 mM (/?,5j-MCPG group was not significant. The result also
confirms that the failure to find a block of LTP with MCPG is not an artifact of the test pulse
stimulation intensities chosen for sampling during the main experiment.
7.3.2.4 Population spike potentiation
No significant differences in the percentage population spike potentiation were found at any time
point after tetanization (figure 7.3.4; table 7.3.2).
















Vehicle 511.8 ±207.9 449.7 ±213.5 330.7 ± 138.8
20 mM (/?,S)-MCPG 388.3 ± 11.6 298.4 ± 30.8 231.1 ±32.2
200 mM (7?,S)-MCPG 430.4 ± 26.2 347.6 ±67.7 250.3 ±55.6
ANOVA results F< I F< 1 F < 1
However, the percentage increase in population spike amplitude is dependent on the initial baseline
amplitude. This can lead to misleading results especially if baseline values fall to very low levels prior
to tetanization, as sometimes happened in the present experiment. For instance, the large standard
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errors in the vehicle group are due largely to a baseline fall in one animal, leading to an artificially
high value for population spike LTP. Under these circumstances, it is more appropriate to compare
absolute changes in amplitude. Accordingly, the mean absolute spike amplitude over the 10 min prior
to letanization was subtracted from the spike amplitude at each individual time point, resulting in a
measure of population spike potentiation which is independent of the initial baseline value (figure
7.3.5A). Nevertheless, no significant group differences in the mean absolute population spike increase
were found at any time point after tetanization (table 7.3.3)
















Vehicle 4.76 + 0.69 3.60 ±0.76 2.51 ±0.58
20 mM (R,S)-MCPG 5.03 + 0.36 3.46 ±0.36 2.25 ± 0.48
200 mM (fl,S)-MCPG 4.25 ±0.53 3.10 ±0.29 1.81 ±0.48
ANOVA results F < 1 F < 1 F< 1
7.3.2.5 Effect of D-AP5 on population spike LTP
Infusion of 30 mM D-AP5 caused a dramatic fall in population spike amplitude (figure 7.3.5B), far
greater than that predicted by the modest temperature rise induced by D-AP5 infusion (see below).
Furthermore, the fall in population spike amplitude is far more rapid in onset than the temperature
rise. This effect of AP5 has been noted in previous studies in vivo (Errington et al., 1987; Abraham
and Mason, 1988; Bordi and Ugolini, 1995) and has been attributed to the influence of an extrinsic
afferent pathway (Abraham and Mason, 1988). However, data from the two non-tetanized control
pathways reveal that the population spike depression was transient, lasting little more than 1 hr after
drug infusion. Figure 7.3.5B shows the absolute increase in population spike amplitude following D-
AP5 infusion and tetanization, normalized to the 10 min prior to drug infusion owing to the baseline
changes described above. Data from vehicle-infused controls, analysed in the same way, are shown
for comparison. Infusion of D-AP5 caused a complete block of population spike LTP.
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7.3.2.6 Baseline stimulation parameters
The mean absolute slope of the pre-infusion baseline field EPSP and population spike amplitude
recorded over the 10 min prior to drug infusion did not differ across groups; no significant group
differences in stimulation intensity were found (table 7.3.4).










Vehicle 318.6 ± 39.8 3.61 ±0.33 2.51 ±0.20
20 mM (7?,S)-MCPG 291.7 ±24.1 3.61 ±0.28 2.92 ±0.23
200 mM (/?,S)-MCPG 282.9 + 39.7 3.48 ±0.37 2.46 ±0.18
ANOVA results F < 1 F < 1 F(2,17)= 1.55;
p > 0.2
7.3.2.7 Changes in brain temperature
Figure 7.3.6A shows brain temperature changes throughout the experiment normalized to the mean
temperature over the 10 min before infusion. An ANOVA of the mean temperature rise over the 30
min after drug infusion revealed a significant effect of group [F(2,17) = 6.04; p < 0.05]. Post hoc
Newman-Keuls pairwise comparisons revealed significant temperature rises in both the 20 mM and
200 mM (/?,5)-MCPG groups relative to vehicle-infused controls (table 7.3.5). However, these
increases rarely exceeded 0.5 °C, and no significant group differences were seen over the final 30 min
of the experiment [f< 1; table 7.3.5].
No significant differences were found in the absolute baseline brain temperature recorded over the 10
min prior to drug infusion (table 7.3.5). The difference between these values and the body
temperature maintained by the heating blanket (36.2 °C) is most likely due to heat loss through the
burr hole made to allow insertion of the thermistor, as well as through the surrounding skull. The non¬
significant trend towards a group difference is explained by the slightly lower initial temperature
recorded in the vehicle group. However, this difference is an artefact of thermistor design: the
thermistor used for the first three vehicle-injected rats consistently gave lower temperature readings
than those used subsequently. This thermistor was slightly thicker in diameter than later ones (see
section 7.2.3), and is likely to have caused a greater amount of damage upon insertion.
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Vehicle 32.34 ±0.80 0.01 ±0.09 0.14 ± 0.18
20 mM 0R,S)-MCPG 33.59 + 0.16 0.47 ±0.14 0.35 ±0.33
200 mM (fl,S)-MCPG 34.16 ±0.42 0.30 ±0.04 0.46 ±0.11





Figure 7.3.6B shows the temperature increase induced by infusion of 30 mM D-AP5, normalized to
the 10 min prior to drug infusion. Data from vehicle-infused rats are shown for comparison. An
ANOVA of the mean temperature change over the 30 min following drug infusion in vehicle and AP5
groups revealed that the temperature increase caused by AP5 infusion was significant (table 7.3.6).









final 30 min of
recording (°C)
Vehicle 32.24 ±0.80 0.01 ±0.09 0.14 ± 0.18
30 mM D-AP5 30.95 ±0.10 0.34 ±0.12 0.31 ±0.31
ANOVA results F(l,ll) = 1.24;
p > 0.2
F(l,l 1) = 4.95;
p < 0.05
F < 1
7.3.2.8 Rats excluded from analysis
Data from one member of the 200 mM (F.S)-MCPG group were not included in the above analysis. In
this rat, the EPSP slope had fallen to less than 70% of the baseline value 2 hr after tetanization; the
EPSP amplitude fell by a similar amount. This dramatic fall was never seen in any of the other
MCPG-infused rats. At the end of the experiment, the recording electrode was lowered slightly and
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the signal recovered to its pre-tetanus level, or slightly above. It is probable that the recording
electrode shifted upwards slightly during the course of the experiment.
One rat infused with AP5 and implanted bilaterally with stimulation and recording electrodes was
excluded from analysis on the basis of baseline criteria described in experiment 7.4.
7.3.3 Discussion
These results indicate that MCPG does not have any effect on LTP. Nevertheless, although not
significant, the mean potentiation after 2 hr was smallest in the 200 mM (7?,S)-MCPG group.
However, inspection of Figure 7.3.1A suggests that the EPSP slope baseline of this group, following a
slight rise after the drug infusion (possibly an effect of the small temperature increase described
above), was falling throughout the 20 min before tetanization. This decline was slight, and did not
result in a reduction in slope potentiation measured 2 hr after tetanization, even when normalized to
the pre-infusion, rather than pre-tetanus baseline (data not shown). Nevertheless, a baseline fall was
consistently observed in rats infused with 200 mM (ft.SO-MCPG. This phenomenon may reflect a
small metabotropic contribution to normal synaptic transmission. It has been reported that MCPG
infusion into the basolateral amygdala causes a transient depression of baseline responses (Keele et
al., 1995). Similarly, MCPG perfusion has recently been found to cause a lasting EPSP slope
depression in dentate slices (Huang et al., 1997). A gradual chronic baseline fall induced by MCPG
might give rise to an apparent block of LTP, particularly when followed for several hours after
tetanization. In order to detect and, if necessary, control for such a chronic baseline fall, the above
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Fig. 7.3.1
(A) Infusion of (R,S)-MCPG did not significantly reduce EPSP slope
LTP. Representative sample EPSPs recorded immediately before
tetanization and 30 min afterwards are shown. (B) Infusion of D-AP5
caused a complete block of EPSP slope LTP. Data from the 6 animals
infused with D-AP5 are plotted against the vehicle-infused control
data from figure A. Of the 6 rats infused with D-AP5, 2 underwent
bilateral stimulation and recording; mean data from the 2 control













EPSP slope input / output curves recorded before and after drug
infusion and 2 hr after tetanization. Rats treated with 20 mM
(R,S)-MCPG (B) or 200 mM (R,S)-MCPG (C) showed equivalent













Percentage increase in EPSP slope before and 2 hr after tetanization
measured across the full range of the I/O curve. Infusion of MCPG























Infusion of MCPG did not significantly reduce the percentage
population spike potentiation. The large standard errors were
caused by falling baselines, which resulted in artificially high
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(A) An equivalent increase in population spike amplitude was seen in all
groups after tetanization. (B) D-AP5 infusion caused a transient fall in
population spike amplitude, and LTP was completely blocked relative to
vehicle-infused controls. Data are normalized to 10 min prior to infusion
owing to the AP5-induced fall in population spike. Mean non-tetanized
control pathway data from the 2 rats in which bilateral recordings were
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Fig. 7.3.6
(A) Infusion of both 20 mM 200 mM (R,S)-MCPG caused a slight
temperature rise relative to vehicle-infused controls. (B) A similar
temperature increase was seen after infusion of 30 mM D-AP5.
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7.4 Does MCPG block dentate LTP in vivo? A two-pathway study
7.4.1 Methods
Most procedures were identical to those described for experiment 7.3. However, stimulating and
recording electrodes were positioned in the right hippocampal formation in addition to the left, and
the thermistor was positioned approximately 2 mm posterior and 1 mm lateral to the right-hand
recording electrode. Test pulse stimulation intensity was adjusted in each pathway to give a
population spike of 2-4 mV as before. The two pathways were stimulated alternately, but only the left
perforant path was given a high frequency tetanus. Rats received infusions of either 200 mM (R,S)-
MCPG or vehicle. Data from animals in which a seizure had occurred in either pathway during
positioning of the electrodes were discarded. Likewise, if the final normalized slope baseline
[(tetanized/control) xlOO] changed by more than 10 % during the hour before tetanization, the results
were not included in the final analysis. Examples of such failed experiments are described in section
7.4.2.7.
7.4.2. Results
7.4.2.1 EPSP Slope LTP
MCPG infusion again failed to block LTP. Figure 7.4.1 A shows the data for both control and
tetanized pathways, normalized to the mean value ten minutes prior to tetanization (MCPG: n = 5;
aCSF: n = 7). Separate ANOVAs at different time points, in which tetanized and control pathway
values were entered as sub-groups within each drug treatment group, revealed no significant group by
pathway interaction in the amount of PTP or LTP after 1 or 2 hr (see table 7.4.1). The tetanized
pathways were still significantly potentiated overall relative to the control pathways 110-120 min
post-tetanus [F(l,20) = 14.2; p < 0.01]. Post hoc pairwise comparisons at this time point (Newman-
Keuls) revealed that tetanized pathways were significantly potentiated relative to control pathways in
both individual groups [200 mM (R,S>MCPG: p < 0.05; vehicle: p < 0.05]. Pairwise comparisons
between tetanized pathways in the 200 mM (R,5j-MCPG and vehicle groups failed to reveal a
significant group difference 0-4 min, 50-60 min, or 110-120 min post-tetanus. Similarly, no
significant group differences were found between non-tetanized control pathways at any of these time
points.
As in experiment 7.3, I/O curves were recorded 20 min before drug infusion and 2 hr after
tetanization. No difference in the amount of EPSP slope LTP induced in the tetanized pathways of
MCPG and vehicle groups was observed at any point on the I / O curve (data not shown).
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Table 7.4.1 Two-pathway study: EPSP slope potentiation
EPSP slope PTP 0-
4 min post-tetanus
(% baseline)







































ANOVA Drug group x Drug group x Drug group x
results pathway interaction pathway interaction pathway interaction
NS [F < 1], NS [F< 1], NS \F< 1],
In figure 7.4.IB the EPSP slope data are plotted using the non-tetanized pathway as a within subject
control at each lime point throughout the experiment, i.e. normalized value = [(tetanized / control) x
100]. Equivalent LTP was seen in both groups. No significant group differences were found 0-4 min
post-tetanus, 50-60 min post-tetanus, or 110-120 min post-tetanus (table 7.4.2).













Vehicle 145.2 ±4.9 112.7 ±2.8 110.3 ± 1.8
200 mM (/?,S)-MCPG 145.7 ±4.7 116.6 ± 1.3 109.8 ±3.6
ANOVA results F< 1 E(l,10)= 1.22;
p > 0.2
F< 1
7.4.2.2 EPSP slope baseline changes
The slight baseline changes noted in the previous experiment were observed in all animals infused
with MCPG. However, no significant differences in EPSP slope were found between vehicle and
MCPG control pathways at any lime point after tetanization (see analysis above), indicating that these
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changes were transient and could not affect the level of LTP obtained. Comparison of the baseline
period in figure 7.4.1A and B demonstrates that normalization of tetanized to control values smoothes
out these baseline fluctuations since both pathways are affected in the same way by MCPG infusion
(but see section 7.4.2.7).
7.4.2.3 EPSP slope I/O curves
Analysis of the EPSP slope 1 / O curves before and after tetanization revealed similar results to those
described in experiment 7.3 (data not shown). The failure ofMCPG to block LTP cannot be explained
as an artifact of the test pulse stimulation intensities chosen.
7.4.2.4 Population spike LTP
For similar reasons to those described in experiment 7.3, population spike LTP was expressed as an
absolute change in millivolts, rather than as a percentage increase. Figure 7.4.2A shows the
population spike increase for both control and tetanized pathways, relative to the mean value over the
10 min prior to tetanization: MCPG had no effect on the induction of spike LTP. An ANOVA in
which control and tetanized pathways were entered as sub groups revealed no group by pathway
interaction 0-4 min, 50-60 min, or 110-120 min post tetanus (table 7.4.3).















































ANOVA Drug group x Drug group x pathway Drug group x
results pathway interaction interaction NS [F< 1], pathway interaction
NS [F < 1], NS [F< 1],
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At each time point, the population spike change in a control pathway was subtracted from the
corresponding change in the tetanized pathway; the normalized data are plotted in figure 7.4.2B.
When analysed in this way, no significant differences were found in the amount of potentiation at any
time point after tetanization (table 7.4.4)













Vehicle 4.0 ±0.66 2.65 ± 0.46 1.67 ±0.35
200 mM (R,S)- MCPG 4.53 ± 1.20 2.94 ±0.71 2.0 ± 0.94
ANOVA results F < 1 F < 1 F< 1
7.4.2.5 Baseline stimulation parameters
An ANOVA of absolute mean EPSP slope values over the 10 min before drug infusion, in which
tetanized and control pathways were entered as sub-groups revealed no significant differences in
initial slope values between drug groups, or between tetanized and control pathways (table 7.4.5). A
similar ANOVA of mean absolute population spike amplitudes over the 10 min before drug infusion
revealed no significant differences between groups or pathways (table 7.4.5). Analysis of test-pulse
stimulation intensities revealed no significant differences between groups or between pathways (table
7.4.5).














Vehicle 330.0 ± 39.0 395.7 + 39.9 3.18 + 0.34 2.68 ±0.17 2.70 ±0.32 2.49 ±0.21
200 mM MCPG 380.0 ±58.3 420.0 + 51.5 3.72 + 0.31 3.24 ±0.30 2.63 ± 0.55 2.48 ±0.43
ANOVA results Effect of pathway: Effect of pathway: Effect of pathway: F < 1
F(l,20) = 1.30; F(l,20) = 3.02;
p > 0.2 p > 0.05 Effect of drug group:
Effect of drug group: Effect of drug group: F < 1




Infusion of MCPG caused a slight increase in brain temperature, relative to vehicle-infused controls,
similar to that described in experiment 7.3. Figure 7.4.3 shows changes in temperature relative to the
mean value over the 10 min prior to drug infusion. However, an ANOVA of the mean temperature
increase over the 30 min after drug infusion, failed to reveal a significant group difference on this
occasion (table 7.4.6).
No group differences in the mean temperature change obtained over the final 30 min of recording
were found (table 7.4.6), but a slight increase in temperature over the course of the experiment was
seen in both groups. Curiously, the difference in absolute pre-infusion baseline temperature reached
significance (table 7.4.6). The reason for this difference is unknown, since an identical design of
thermistor was used in each group, and MCPG-infused rats were interleaved with vehicle-infused rats
over days. However, the difference is slight, and the result is based on a rather small sample of
animals.














Vehicle 32.21 ±0.57 0.12 ±0.08 0.35 ±0.07
200 mM (fl,S)-MCPG 30.21 ±0.26 0.36 ±0.15 0.38 ±0.21





7.4.2.7 Rats excluded from the above analysis
Seizures were induced in the right hippocampus of the first three animals prepared for bilateral
recording (all vehicle-infused controls); these animals were excluded. Figure 7.4.4 shows the EPSP
slope data from one such rat. The tetanized left-hand pathway shows a relatively stable baseline and
normal, if modest, LTP. However, the non-tetanized right-hand pathway continues to rise throughout
the experiment (figure 7.4.4A). The result when the tetanized pathway is normalized to the control is
shown in figure 7.4.4B. Whilst the baseline change in this graph does not reach the criterion for
rejection described below, it is clear that the apparent absence of LTP is due entirely to the seizure-
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induced rise in the control pathway.
The problem was caused by the shape and position of the thermistor, which was positioned in the
right hippocampus. It was found that an improved design, and a position roughly 2 mm posterior and
1 mm lateral to the right-hand recording electrode allowed the thermistor to be inserted without
inducing a seizure. (After this change, only one further rat had to be excluded owing to a seizure in
the right hippocampus.)
The bilateral design is intended to control for baseline changes, which might otherwise go unnoticed.
However, if both pathways rise or fall to different extents during the baseline period before
tetanization, then normalizing one to the other will be meaningless, since under these circumstances
the control pathway does not provide any evidence about likely baseline changes in the tetanized
pathway. Hence if normalization of the pathway to be tetanized to the control pathway resulted in a
baseline which changed by more than 10 % over the hour prior to tetanization (i.e. a difference
between the mean of the first 10 min and the last 10 min of greater than 10 %), then data from the
animal concerned was excluded from further analysis.
This criterion led to the rejection of one vehicle and four MCPG-infused animals. The fact that four
MCPG-infused animals had to be rejected on these grounds is potentially worrying; figure 7.4.5
shows an example. The control pathway was typically more depressed by MCPG infusion than the
tetanized pathway. This may be partly because initial slope values in control pathways tended to be a
little smaller in absolute terms than those in primary pathways (see table 7.4.5). However, it is
possible that MCPG infusion interacted with damage caused by the nearby thermistor, resulting in a
greater fall in baseline than that caused by drug infusion alone. (Note also that the baseline fall in the
control pathway appears to have been fairly abruptly reversed following tetanization of the
contralateral hemisphere. This phenomenon is considered in the discussion.)
Whatever the explanation, it could be argued that animals which showed the greatest baseline changes
after drug infusion were those in which the infusion had been most successful. Since large changes in
the baseline of each pathway increase the probability of divergence, it is possible that by applying a
10% change criterion to the final normalized result, those animals with the highest hippocampal
concentrations of MCPG may be selected against. Nevertheless, it is meaningless to include data such
as that shown in figure 7.3.4B, since the baseline rise in the normalized slope is merely an artefact.
In order to check that the selection criteria had not excluded those rats showing the greatest block of
LTP, the primary pathway EPSP slope data from all animals studied were analysed, including those in
which a seizure had been induced in the right hippocampus during electrode placement, but excluding
one vehicle-infused rat in which an additional seizure was induced in the left hippocampus. Figure
7.4.6A shows the mean slope data for both MCPG and vehicle-infused groups, normalized to the pre-
tetanus baseline. No significant group differences were observed 0-4 min, 50-60 min, or 110-120 min
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post-tetanus (table 7.4.7).
However, as control pathway data from the original analysis suggest that the baseline change induced
by MCPG infusion is transient (see figure 7.4.1A), it may be more appropriate to normalize all data to
the pre-infusion baseline. Figure 7.4.6B shows the above results plotted in this way, calculated
relative to the mean value over the 10 min before drug infusion. Both groups show almost identical
levels of LTP (table 7.4.8).
The population spike increase was also equivalent in both groups whether normalized to the pre-
tetanus baseline (table 7.4.9; figure 7.4.7A) or the pre-infusion baseline (table 7.4.10; figure 7.4.7B).
This analysis confirms that MCPG genuinely fails to block LTP under the current circumstances, and
this failure cannot be an artifact of the criteria used to reject data from the main analysis.
Table 7.4.7 Two-pathway study: EPSP slope LTP data from tetanized pathways of all rats tested.













Vehicle 142.0 ±4.2 115.9 ± 1.9 111.9 ± 1.7
200 mM (fl,S)-MCPG 144.7 ±4.7 121.1 ±3.1 115.5 ±3.0
ANOVA results F < 1 F (1,18) = 2.02;
p > 0.1
F( 1,18) = 1.24;
p > 0.2
Table 7.4.8 Two-pathway study: EPSP slope LTP data from tetanized pathways of all rats tested.













Vehicle 144.9 ±5.5 118.1 ±2.8 114.0 ±2.5
200 mM (T?,S)-MCPG 141.4 ± 6.1 118.0 ±3.4 1 12.7 ±3.6
ANOVA results F < 1 F < 1 F < 1
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Table 7.4.9 Two-pathway study: population spike LTP in tetanized pathways of all rats tested. Values
















Vehicle 4.48 ± 0.49 2.76 ±0.39 1.81 ±0.33
200 mM (/?,S)-MCPG 4.57 ± 0.70 2.88 ±0.45 2.37 ±0.51
ANOVA results F< 1 F< 1 F < 1
Table 7.4.10 Two-pathway study: population spike LTP data from tetanized pathways of all rats
















Vehicle 4.41 ±0.50 2.69 ± 0.36 0.33 ± 1.74
200 mM (K,S)-MCPG 3.82 ±0.70 2.13 ±0.44 1.62 ±0.50
ANOVA results F< 1 F( 1,18) = 1.01;
p > 0.3
F < 1
Despite some of the problems described above, the bilateral set-up worked well much of the time.
Figure 7.4.8A shows both tetanized and control pathways from one such experiment (200 mM (R,S)-
MCPG infusion). Fluctuations in EPSP slope are broadly paralleled by temperature changes (figure
7.4.8B) suggesting a possible explanation for these irregularities. When the tetanized pathway is
normalized to the control pathway [(tetanized / control) x 100, at each time point; figure 7.4.8C],
gradual changes are smoothed out.
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7.4.3 Discussion
These results confirm the original finding that MCPG is ineffective in blocking LTP. Furthermore, the
slight baseline changes caused by MCPG appear to be transient, and hence unlikely to affect a
measure of LTP recorded 1-2 hr later. However, the baseline fall in the control pathway following
MCPG infusion appears to reverse quite abruptly after contralateral tetanization (see figures 7.4.1 A,
7.2.5 and 7.2.8), suggesting that control and tetanized pathways may not be strictly independent. A
similar effect was observed in rats infused with buffered saline. One complication with the use of the
contralateral perforant path-dentate gyrus projection as a control pathway is that each hippocampus
receives a commissural projection from the contralateral dentate gyrus. Hence, the possibility of
heterosynaptic potentiation of the control pathway after contralateral tetanization may provide an
explanation for the slight rise in control pathways seen after tetanization. However, whilst a
heterosynaptic depression of the contralateral response has been found following tetanization of the
ipsilateral perforant path, heterosynaptic potentiation of the ipsilateral projection following
contralateral potentiation has not been observed (Levy and Steward, 1979; Krug et al., 1985).
Nevertheless, even if the two pathways used in the current experiment were not strictly independent,
the analysis of all tetanized pathways presented in figure 7.4.5 demonstrates very clearly that MCPG
has no effect on LTP under these circumstances.
The reason for the apparent slight reduction in LTP after 200 mM (f?,Sj-MCPG infusion in
experiment 7.3 is unknown. However, this reduction was not significant, and did not occur in the
present experiment; the original result might simply have been the result of chance variation in the
level of LTP.
A further potential problem concerns the unknown concentration of MCPG reaching the hippocampus
after i.e.v. infusion. The failure to find an effect of a drug on LTP without any positive control
constitutes a very weak result. Unlike D-AP5 which causes a characteristic fall in population spike
amplitude and, of course, blocks LTP, MCPG does not cause any obvious indication of its presence,
except for a slight fall in EPSP slope baseline. Furthermore, MCPG is not readily detected, at least in
our hands, by HPLC. In order to overcome these problems, the experiment described below was
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Fig. 7.4.1
(A) Infusion of 200 mM (R,S)-MCPG (n = 5) failed to block EPSP
slope LTP relative to vehicle-infused controls (n = 7). Tetanized
pathways in each group showed equivalent LTP; control pathways
did not diverge during the course of the experiment, indicating that
MCPG infusion did not result in a chronic baseline fall.
(B) Tetanized pathways normalized to control pathways at each time
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Fig. 7.4.2
(C) Equivalent increases in population spike amplitude were seen in
rats infused with 200 mM (R,S)-MCPG (n = 5) or vehicle (n = 7). Non-
tetanized pathways likewise did not differ. (D) Tetanized pathways
normalized to control pathways at each time point. Equivalent LTP




Mean change in brain temperature during bilateral stimulation and
recording. Infusion of 200 mM (R,S)-MCPG caused a slight increase
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Fig. 7.4.4
(A) EPSP slope data for both the tetanized and the non-tetanized pathway
in an individual rat infused with PBS. Data from this animal were not
included in the main analysis owing to the fact that a seizure was induced
in the non-tetanized pathway during positioning of the recording electrode
and thermistor. Note the subsequent chronic rise in this pathway. (B) The
apparent absence of LTP in the normalized slope data is an artifact of the
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Fig. 7.4.5
(A) EPSP slope data for both the tetanized and the non-tetanized pathway
in an individual rat infused with 200 mM (R,S)-MCPG. Data from this
animal were not included in the main analysis owing to the fact that the
normalized baseline shown in (B) changed by more than 10% over the
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Fig 7.4.6
EPSP slope LTP data from the tetanized pathways of all rats tested,
including those rejected from the main analysis. (A) Data normalized
to the pre-tetanus baseline. (B) Data normalized to the pre-infusion.
baseline. The failure ofMCPG to block LTP cannot be an artifact of
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Fig 7.4.7
Population spike LTP data from the tetanized pathways of all rats
tested, including those rejected from the main analysis. (A) Data
normalized to the pre-tetanus baseline. (B) Data normalized to the
pre-infusion basline. The failure of MCPG to block LTP cannot
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Fig. 7.4.8
(A) EPSP slope data for both the tetanized and the non-tetanized pathway
in an individual rat infused with 200 mM (R,S)-MCPG. Data from this
animal were included in the main analysis. (B) Changes in brain temperature
throughout the experiment. Note that the fluctuations are broadly parallelled
by changes in EPSP slope in the figure above. (C) Normalization of tetanized
to control values smoothes out fluctuations in the data.
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7.5 Does MCPG antagonize the electrophysiological effects of the mGluR agonist (1S,3R)-1-
aminocyclopentane-l,3-dicarboxylic acid (ACPD) in vivo?
7.5.1 Introduction
In order to check whether the i.e.v. infusion of 200 mM (R.VJ-MCPG in the previous experiments was
sufficient to cause a functional blockade of mGluRs in the dentate gyrus, the ability of MCPG to
inhibit the actions of the broad spectrum mGluR agonist (IS,3/?)-ACPD was tested. However, it was
first necessary to establish the existence of a suitable ACPD-mediated response. Application of
(1S,3R)-ACPD has been reported to have a wide range of physiological effects in a number of
different experimental preparations (see chapter 3), although few studies have addressed the effects of
ACPD in the dentate gyrus in vivo.
Manahan-Vaughan and Reymann (1995b) reported that (IS,3/?)-ACPD induced a slow-onset
potentiation in dentate field EPSPs in vivo. However, others have found only a transient potentiation,
followed by depression at higher doses (Davis and Laroche, 1996). Brain temperature was not
monitored in these studies, although the slow-onset potentiation of population spike amplitude in
addition to EPSP slope obtained by Manahan-Vaughan and Reymann (1995b) would suggest that the
effect is not merely a temperature artifact. (Population spike amplitude is usually observed to fall after
a temperature increase; see chapter 2.6.2). However, application of ACPD has been found to cause an
increase of almost 1° C in the temperature recorded at the brain surface (R. C. Heath, unpublished
observations). This temperature rise persisted for the duration of the experiment (1.5 hr) and may be
an underestimate of the true increase in hippocampal temperature. The highest dose of ACPD tested
caused a transient EPSP slope potentiation of roughly 20 %, which fell almost to baseline levels
within 1.5 hr after the start of infusion. This dose of ACPD did not cause a potentiation of population
spike amplitude; in fact a fall in population spike was sometimes observed. As discussed below, a
temperature rise of 1° C would be sufficient to account for the observed increase in EPSP slope. The
dissociation between EPSP slope and population spike is also consistent with the possibility of a
temperature artifact.
However, as mentioned above, a potentiation of population spike amplitude was reported by
Manahan-Vaughan and Reymann (1995a). Hence, even if the increase in EPSP slope after ACPD
infusion is purely a temperature artifact, the population spike increase may be due to different
mechanisms, such as an increase in neuronal excitability, or a reduction in inhibitory tone (see chapter
3.9 & 3.11).
Studies in vivo have concentrated on the role of mGluR activation on evoked field potentials.
However, application of ACPD has been reported to cause an increase in the spontaneous
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synchronous activity of CA1 pyramidal cells, attributed to mGluR-driven network oscillations of
inhibitory interneurons (Whittington et al., 1995; Boddeke et al., 1997). The change in spontaneous
dentate activity provides a further possible assay for mGluR activation, and its blockade by MCPG.
The aim of the following experiments was firstly to characterize the effects of i.e.v. infusion of
(IS,3/?)-ACPD on dentate EPSP slope, population spike amplitude, spontaneous activity, and
temperature. The ability ofMCPG to block these effects was then assessed.
7.5.2 Methods
The recording set-up was identical to that described in chapter 4. A range of doses of (1S,3R)-ACPD
were tested: 25 mM, 4 mM, 2 mM and 1 nrM. Brain temperature was monitored in the 1 mM and 2
mM groups only. In these animals, a thermistor was placed in the dentate gyrus contralateral to the
stimulation and recording electrodes. Spontaneous hippocampal activity was monitored by polygraph,
and recorded for off-line analysis using an FM reel-to-reel tape recorder (Racal-Thermionic Ltd.).
Following a 20 min baseline period, rats received a bilateral i.e.v. infusion of lOpI (5pl per ventricle)
of either phosphate buffered saline or 200 mM (/?,S)-MCPG over 10 minutes. Thirty minutes later, a
10 pi infusion of 1 mM (1S,3R)-ACPD was given, again over 10 min. In all cases except the 25 mM
group, a second infusion of (IS,3/?)-ACPD was given 2 hr after the start of the first infusion of this
drug in order to investigate the "wash-out" of (R,S)-MCPG. Recording was continued for a further 50
min after the end of this infusion.
7.5.3 Results
7.5.3.1 25 mM (1S,3R)-ACPD
In an initial pilot study, two rats were infused with PBS followed by ACPD; two more were first
infused with 200 mM (R,S)-MCPG. Only one infusion of 25 mM (1S,3R)-ACPD was given to each
animal. The 25 mM dose was chosen to match that used in a previous study carried out in this
laboratory (R. C. Heath, unpublished observations). ACPD infusion caused a marked rise in EPSP
slope of almost 20 %, which fell back to baseline within about 30 min of the end of infusion (data not
shown). This transient increase was not blocked by MCPG. ACPD also caused a slight rise in
population spike that was not blocked by MCPG (data not shown). Brain temperature and
spontaneous dentate activity were not monitored in these animals.
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7.5.3.2 4mM (lS,3/?)-ACPD
The possibility that MCPG might block the rise in EPSP slope induced by a lower concentration of
ACPD was tested by reducing the dose from 25 mM to 4 mM. Spontaneous dentate activity was also
recorded as an alternative index of mGluR activation. On this occasion, a second infusion of ACPD
was delivered 2 hr after the start of the first. Four animals were infused with 200 mM (R,S)-MCPG
before ACPD; another four were initially infused with PBS.
Changes in EPSP slope
Figure 7.5.1A shows the EPSP slope data throughout the experiment, normalized to the 10 min
immediately before the infusion of PBS / MCPG. In figure 7.5.IB, data are shown over the range
starting 20 min before, and ending 40 min after, the start of each ACPD infusion. Data are normalized
to the mean value over the 10 min before each individual infusion; i.e. each portion of the data is
normalized to its own, separate baseline. This eliminates variation due to the MCPG-induced baseline
fall, as well as chronic baseline changes that may have occurred over the course of an experiment.
Both infusions of ACPD caused a transient increase in the EPSP slope, the increase being slightly
more pronounced after the second infusion. The maximum increase in slope was similar to that
obtained after 25 mM (IS,3/?)-ACPD infusion, although the onset of the rise was slightly slower, and
the fall back towards baseline values was a little more rapid. As before, the increase in EPSP slope
was not blocked by prior infusion of MCPG.
Figure 7.5.2 shows the change in population spike throughout the experiment, analysed in the same
way as the EPSP slope data. Despite the variability of the data, and the severe fall in baseline caused
by MCPG infusion, it appears that ACPD caused a slight transient increase in population spike
amplitude of up to 1 mV, which was not prevented by the prior infusion of MCPG.
Changes in spontaneous dentate EEG activity
Spontaneous EEG activity was recorded via the same electrode used to monitor field potentials.
Recording was carried out over a period starting 2 min before ACPD infusion and finishing 10 min
after the end of infusion. For an example of this form of recording, see figure 7.5.3A (The data are
taken from the 1 mM ACPD experiment detailed below). The figure is a representative polygraph
trace recorded during and after the infusion of ACPD in a rat previously infused with buffered saline.
The large downward deflections represent positive-going EPSPs, spaced at 20 s intervals; upward
deflections reflect the subsequent hyperpolarization. The continuous low amplitude noise recorded
between EPSPs represents spontaneous hippocampal neuronal activity in the absence of afferent
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stimulation. ACPD reliably caused an increase in the amplitude of this spontaneous activity. An
equivalent polygraph trace from a rat previously infused with 200 mM (7?,5)-MCPG is shown in
figure 7.5.3B. On this occasion, the increase in noise was completely blocked.
The amplitude of spontaneous activity was measured directly from the trace, samples being taken
every 2 min. The mean change in amplitude of spontaneous activity is presented in figure 7.5.4. In
part A, the change in spontaneous noise is plotted relative to the 2 min prior to each ACPD infusion.
Spontaneous activity was not routinely recorded during infusion of PBS or MCPG since pilot studies
indicated that no changes in spontaneous activity resulted from the infusion of these drugs (PBS: n =
3; 200 mM (7?,5)-MCPG: n = 5; data not shown). The first infusion of ACPD caused a marked rise in
spontaneous activity, which was completely blocked by the prior infusion of 200 mM (7?,5)-MCPG. A
partial blockade of the increase in spontaneous activity induced by the second ACPD infusion 2l/i hr
later was also observed, indicating that washout of MCPG was incomplete. Two of the rats initially
infused with PBS showed evidence of epileptiform activity during the second ACPD infusion; such
activity was never observed in rats initially infused with MCPG (data not shown).
The increase in spontaneous activity following the first ACPD infusion is plotted in expanded form in
figure 7.5.4B. The effects of ACPD infusion appear to be biphasic. MCPG infusion unmasks a
depression induced by ACPD, but blocks the rise in spontaneous activity. These effects may reflect
the different affinities of MCPG and ACPD for individual mGluR subtypes (see discussion). An
ANOVA of the data presented in figure 7.5.4B, in which time points were entered as a within subject
factor, revealed a significant overall group difference between MCPG and PBS treated rats [7^(1,6) =
12.01; p < 0.05], together with a significant group by time point interaction [T^ 10,60) = 2.58; p <
0.05]. Significant group differences at individual time points are indicated by asterisks. This analysis
demonstrates that MCPG significantly antagonizes the ACPD-induced rise in spontaneous dentate
activity. The mean peak increase in spontaneous activity following each infusion of ACPD is
summarized in table 7.5.1. No significant group differences were found in absolute pre-infusion levels
of spontaneous activity measured over the 2 min prior to drug infusion (table 7.5.2).
Table 7.5.1 Maximum mean increase in the amplitude of spontaneous dentate activity induced by of 4
mM (15,37?)-ACPD, in the presence or absence of 200 mM (7?,5)-MCPG.
Maximum mean increase in amplitude of
spontaneous activity (mV)
1st ACPD infusion 2nd ACPD infusion
PBS + 4 mM ACPD 0.81 ±0.44 1.60 ±0.89
200 mM MCPG + 4mM ACPD 0.14 ±0.25 0.48 ± 0.02
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Table 7.5.2 Initial amplitude of spontaneous dentate activity over the 2 min prior to ACPD infusion.





PBS + 1 mM ACPD 1.15 ± 0.11 1.24 ±0.10




Difference between first and
second ACPD infusion:-
F < 1
7.5.3.3 2 mM (15,3/?)-ACPD
Despite the finding that MCPG can block the rise in spontaneous dentate activity induced by 4 mM
ACPD, it was decided to reduce the dose of ACPD in order to investigate whether MCPG might also
reduce the rise in EPSP slope under these circumstances. However, it was also decided to monitor
brain temperature in order to determine to what extent the rise in slope could be accounted for by an
increase in temperature. A second reason for lowering the dose concerned the fact that epileptiform
discharges were sometimes observed during the second infusion of 4 mM ACPD, suggesting that this
concentration may be excessively high.
Before starting the I mM experiment, however, two rats were infused with 2 mM ACPD; one
received an initial infusion of PBS, the other received 200 mM (/?,S)-MCPG. Although essentially
pilot data, the findings from these animals are included since they provide clear individual examples
of the parallel rise in brain temperature and EPSP slope following ACPD infusion.
Changes in EPSP slope
Figure 7.5.5 shows the change in EPSP slope analysed in the same way as in figure 7.5.1. Infusion of
ACPD induced an EPSP slope increase that was only slightly smaller that that induced by infusion of
4 mM ACPD. As before, this increase was not blocked by prior infusion of MCPG. Owing to the
baseline variability of the data, it was impossible to judge whether population spike amplitude was
also increased (data not shown). Figure 7.5.6 shows the increase in brain temperature induced by
ACPD infusion, analysed in the same way as the EPSP slope data, i.e. normalized to the baseline
immediately prior to each infusion of ACPD. ACPD infusion caused a marked temperature rise of
202
approximately 1 °C in controls, a rise that was little affected by prior infusion of MCPG. It is notable
that the time course of this transient temperature rise was closely paralleled by the rise in slope plotted
in figure 7.5.5.
Changes in spontaneous EEC activity
The change in spontaneous activity in the two rats infused with 2 mM ACPD is plotted in figure 7.5.7,
analysed in the same way as the data shown in figure 7.5.4. However, the ACPD-induced increase in
noise is rather modest in the PBS-infused animal, and the pre-infusion baseline noise is unstable in the
MCPG-infused rat. Hence, few conclusions can be drawn about the effect of MCPG on ACPD-
induced noise from these individual examples.
7.5.3.4 1 mM (15,3/?)-ACPD
In the final experiment, rats were infused with 1 mM ACPD. The experimental set-up was identical to
that described above. However, at the end of the experiment, 7 rats from each group infused with
ImM (lS,3f?)-ACPD were passively warmed, and regression lines were calculated relating EPSP
slope to brain temperature.
Changes in spontaneous EEG activity
Figure 7.5.3A shows a representative polygraph trace recorded during and after the first 1 mM ACPD
infusion in a rat previously infused with buffered saline. An equivalent polygraph trace recorded from
a rat previously infused with 200 mM MCPG is shown in figure 7.5.3B. On this occasion, the increase
in noise was completely blocked.
Figure 7.5.8A shows the mean increase in amplitude of spontaneous activity in each group analysed
in the same way as in figure 7.5.4A. As before, an expanded figure of the rise in spontaneous activity
following the first ACPD infusion is shown in part B. The maximum increase in spontaneous activity
from baseline values is shown in table 7.5.3. An ANOVA of all data points from 60-80 min after the
start of the experiment, in which lime was entered as a within subject factor, revealed a significant
group difference [F(l,14) = 7.39; p < 0.05], and a significant group by time point interaction
[/*"( 10,140) = 2.37; p < 0.05], Subsequent analysis of simple effects revealed that spontaneous activity
levels were significantly higher in the PBS / ACPD group than in the MCPG / ACPD group for a
period 6 min after the start of ACPD infusion until 2 min after the end of infusion (see graph legend).
However, inspection of figure 7.5.8B suggests that prior infusion of MCPG unmasked a slight initial
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depression in spontaneous activity induced by ACPD.
The second infusion of 1 mM ACPD resulted in a slightly greater, but still transient, increase in
spontaneous activity which was only partially blocked by prior infusion of MCPG 180 min earlier,
suggesting incomplete washout of the drug (figure 7.5.8A; table 7.5.3).
Table 7.5.3 Maximum mean increase in the amplitude of spontaneous dentate activity induced by of 1
mM (15,3/?)-ACPD, in the presence or absence of 200 mM (F,5j-MCPG.
Maximum mean increase in amplitude of
spontaneous activity (mV)
1st ACPD infusion 2nd ACPD infusion
PBS + 1 mM ACPD 0.96 ± 0.22 1.11+0.18
200 mM MCPG + 1 mM
ACPD
0.18 ±0.29 0.54 ±0.22
In order to check for chronic effects of ACPD application that might have carried over from the first
to the second infusion, an ANOVA of the baseline pre-inlusion spontaneous activity levels was
carried out. Values prior to the first and second ACPD infusions were entered as within subject
factors. An ANOVA revealed neither an overall group difference between MCPG and PBS-treated
rats, nor an overall difference between baselines prior to the first ACPD infusion and prior to the
second (table 7.5.4). A separate ANOVA of baseline spontaneous activity in the PBS pre-treated
group alone also failed to reveal a significant difference between these two baseline periods [F < 1],
confirming that the effects of 1 mM ACPD infusion are indeed transient.
Table 7.5.4 Initial amplitude of spontaneous dentate activity over the 2 min prior to ACPD infusion.





PBS + 1 mM ACPD 1.15 ±0.11 1.24 ±0.10





Difference between first and
second ACPD infusion:-
F( 1,14) = 1.34;
p > 0.2
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Spectral analysis ofspontaneous activity
A preliminary spectral analysis of the polygraph record before and after 1 mM ACPD infusion
indicates that the increase in amplitude of spontaneous dentate activity consists of a selective increase
in frequencies between 20 and 50 Hz (data not shown). The significance of this result will be
discussed later.
Changes in EPSP slope
Infusion of ACPD was again associated with a transient rise in EPSP slope; an effect not blocked by
MCPG (figure 7.5.9; data analysed as in figure 7.5.1). The increase in EPSP slope following each
infusion of 1 mM ACPD was measured as the percentage change in mean value from the baseline
recorded over the 10 min immediately prior to that infusion, to the mean value over the 10 min
following the end of infusion (table 7.5.4). An ANOVA in which the first and second infusions of
ACPD were entered as within subject factors revealed no overall difference between the increase in
slope following the first ACPD infusion compared to that following the second infusion; animals
previously infused with MCPG showed equivalent increases to rats previously infused with PBS
(table 7.5.4). However, the increase in slope caused by ACPD infusion was transient and always
returned to baseline within 20 min of the end of infusion.
Table 7.5.4 Mean increase in EPSP slope averaged over the 10 min following each infusion of
ACPD.






PBS + 1 mM ACPD 5.23 ±2.12 9.00 ± 1.54
200 mM MCPG + 1 mM ACPD 5.39 ± 1.75 6.02 ± 1.56
ANOVA result Overall difference
between PBS and MCPG groups:
F < 1
Overall difference between first
and second infusion of ACPD:
F(l,14) = 2.10;
p > 0.1
Drug group x infusion interaction: F(l,14) = 1.08;
p > 0.3
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Changes in population spike amplitude
Figure 7.5.10 shows the change in population spike throughout the experiment, analysed in the same
way as the EPSP slope data. Despite the variability of the data, and the severe fall in baseline caused
by MCPG infusion, it appears that ACPD caused a very slight transient increase in population spike
amplitude, which was not blocked by prior infusion of MCPG. The increase was most evident after
the second ACPD infusion, possibly owing to the stable pre-infusion baseline at this point. Population
spike changes following the second ACPD infusion are considered in greater detail in connection with
the increase in brain temperature associated with ACPD infusion (see below).
Changes in brain temperature
The increase in EPSP slope described above was typically accompanied by a slight transient rise in
brain temperature whose time course paralleled that of the increase in EPSP slope (figure 7.5.11).
Owing to baseline changes in temperature occurring in both groups before the first infusion of ACPD,
meaningful quantification of the data was impossible at this time point. However, temperature
readings were fairly stable prior to the second ACPD infusion, allowing an estimate to be made of the
expected rise in EPSP slope resulting from the observed increase in temperature.
The following analysis was carried out only on the 7 rats from each group that were passively warmed
during the recording of evoked potentials. The increase in brain temperature, measured as the absolute
change in mean value from the baseline recorded over the 10 min immediately prior to the second
ACPD infusion, to the mean value over the 10 min following the end of infusion, did not differ
between groups [PBS = 0.39 ± 0.09°C; MCPG = 0.34 ± 0.07°C; F < 1],
Figure 7.5.12 shows scatter plots relating EPSP slope to brain temperature, derived from the passive
warming of rats at the end of each experiment. The slope of the function relating slope to temperature
was fairly consistent across animals. Regression lines were calculated from each of the data sets
shown in figure 7.5.12. The rise in EPSP slope expected following a temperature rise of 1 °C did not
differ significantly between groups, indicating that EPSP slopes in both groups were equally sensitive
to temperature changes [PBS = 19.75 ± 2.06 %; MCPG = 19.37 ± 2.29 %; F < 1], It is worth noting
that a previous study reported an EPSP slope increase of roughly 20 %, associated with a 1 °C
increase in brain temperature (R. C. Rowan, unpublished observations). This is exactly the result that
would be predicted based on the relationship between EPSP slope and brain temperature in the
present study.
Based on the above data, the EPSP slope value expected to result from the observed temperature
increase after the second ACPD infusion was calculated for each rat. No significant difference was
found between the predicted rise in EPSP slope and the actual increase recorded (table 7.5.5). These
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data are consistent with the possibility that the transient increases in EPSP slope after ACPD infusion
are simply temperature artifacts. As expected, no significant overall effect of drug group (i.e. PBS vs.
MCPG) was observed; no significant drug group x EPSP slope increase (i.e. observed or expected)
was found (table 7.5.5).
Table 7.5.5 Increase in EPSP slope after the second ACPD infusion. Values expected on the basis of
the temperature increase are compared with actual values recorded.
Mean percentage increase in EPSP slope over
the 10 min following the end of the 2nd ACPD
infusion
Expected increase Observed increase
PBS + 1 mM ACPD 7.60 ± 1.57 9.24 ± 1.76
200 mM MCPG + 1 mM ACPD 6.20 ± 1.33 6.06 ± 1.80
ANOVA result Overall





observed and expected slope
increases
F < 1




A similar analysis was carried out on changes in population spike amplitude following the second
infusion of ACPD. As before, the analysis was carried out only on the 7 rats from each group that
were passively warmed during the recording of evoked potentials. Figure 7.5.13 shows scatter plots
relating population spike amplitude changes to brain temperature, derived from the passive warming
of rats at the end of each experiment. Regression lines were calculated from each of the data sets
shown. The expected fall in population spike amplitude following a temperature rise of 1 °C did not
differ significantly between groups [PBS = -0.97 ± 0.31 mV; MCPG = -0.59 ± 0.07mV; F(l,12) =
1.38; p > 0.2], The fall in population spike amplitude expected to result from the observed
temperature increase after the second ACPD infusion was calculated for each rat. However,
population spike amplitudes in fact increased slightly after ACPD infusion. The difference between
the expected fall in population spike amplitude and the observed rise was highly significant,
indicating that the increase in population spike amplitude after ACPD infusion is not merely a
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temperature artifact (table 7.5.6).
The overall difference between PBS and MCPG treated groups almost reached significance.
However, no significant drug group by population spike change (i.e. observed or expected) was
found. In fact, the observed population spike was approximately 0.7 mV larger than expected in both
groups (table 7.5.6). The trend towards a group difference is merely an artifact of the slightly lower
sensitivity of population spike amplitude to temperature changes in the 200 mM MCPG group (see
above), coupled with the slightly lower temperature rise occurring in this group.
Table 7.5.6 Increase in population spike amplitude after the second ACPD infusion. Values expected
on the basis of the temperature increase are compared with actual values recorded.
Mean absolute change in population spike
amplitude over the 10 min following the end of
the 2nd ACPD infusion (mV)
Expected change Observed change
PBS + 1 mM ACPD -0.44 ±0.17 0.22 ± 0.25
200 mM MCPG + 1 mM ACPD -0.20 ± 0.04 0.51 ±0.19
ANOVA result Overall
difference between PBS and
MCPG groups:
F(l,12) = 4.59;






Drug group x population spike




The finding that 10 pi 200 mM (7?,S)-MCPG inhibits the rise in spontaneous activity induced by
infusion of 1 nrM and 4 mM (15,3/?)-ACPD confirms that the drug does indeed inhibit mGIuRs
whose activity increases spontaneous dentate noise. The blockade was equally effective at both 1 nrM
and 4 mM concentrations of ACPD. Note that the application of 4 mM (15,3R)-ACPD / 200 mM
(/?,5)-MCPG reflects an agonist / antagonist ratio commonly used in vitro (e.g. 10 pM (15,31?)-ACPD
/ 500 pM (/?,5)-MCPG: Bashir et al., 1993). It therefore seems unlikely that the failure to block LTP
in the two previous experiments was due to the failure ofMCPG to inhibit mGluR activation.
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Previous studies have demonstrated that mGluR activation can give rise to synchronized network
oscillations within the hippocampus (see chapter 3.9.2). For instance, Whittington et al. (1995) found
that application of (15',3R)-ACPD elicited 40 Hz i.p.s.p. oscillations in area CA1. It was proposed that
mGluR activation drives network oscillations of inhibitory interneurons, resulting in a 40 Hz rhythm
that entrains the firing of pyramidal cells. Since the work presented in this chapter was carried out,
Boddeke et al. (1997) have described a similar increase in CA1 spontaneous activity, with a dominant
frequency of roughly 20 Hz. This rhythm was also found to be dependent on the activation of
GABAergic interneurons. Although pharmacological characterization of the increase in spontaneous
activity was not carried out in the present study, owing to the difficulties associated with such
experiments in vivo, it is likely that the 20-50 Hz rhythm induced by ACPD in the dentate gyrus
reflects a similar network oscillation to that described by Boddeke et al. (1997).
Although MCPG successfully antagonized the increase in spontaneous activity induced by ACPD, it
unmasked a small dose-dependent depression (see figures 7.5.4B and 7.3.8B). This may reflect the
action of ACPD at a subtype of mGluR not antagonized by MCPG. It is interesting that in cat visual
cortex, ACPD either reduces or increases the level of spontaneous activity, depending on the cortical
layer from which recordings are made (Reid and Daw, 1997). However, since the subtypes
responsible for changes in spontaneous activity are unknown, and considering the controversy
surrounding the actions of MCPG (see chapter 3.6.3 & 3.10), further speculation would be premature.
Infusion of ACPD caused only a transient increase in EPSP slope in the present study; lasting slow-
onset potentiation of the kind described by Manahan-Vaughan and Reymann (1995a) was not
observed. A slight rise in brain temperature was also associated with ACPD infusion (see chapter
3.11.2). Neither of these effects was blocked by the prior infusion of MCPG. In the 1 mM ACPD
condition, at least, the increase in brain temperature was sufficient to account entirely for the observed
slope increase. However, in contrast to the population spike decrease predicted by a temperature rise,
ACPD infusion caused a clear increase in population spike after infusion of 4 mM ACPD (figure
7.5.2B). Although the rise in population spike was minimal after 1 mM ACPD infusion (figure
7.5.10B), spike amplitudes were still significantly larger than predicted by the temperature rise.
Hence, whilst the increase in EPSP slope may be simply a temperature artifact, the rise in population
spike cannot be accounted for in this way. This finding may be explained by an ACPD-induced
decrease in the firing threshold of dentate granule cells, without an enhancement of fast synaptic
transmission. Consistent with this possibility, it has been reported that application of ACPD can cause
a depression of GABAergic transmission, resulting in an increase in CAI pyramidal cell excitability.
However, pharmacological isolation of AMPA receptor-mediated responses revealed that the fast
EPSP was unaffected by ACPD application (Liu et al., 1993). It is possible that similar mechanisms
underlie the transient increase in population spike in the present study.
The mGluR subtypes responsible for the various effects of ACPD are unknown, as is the subtype
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responsible for the modulation of LTP. Hence, whilst these results demonstrate that MCPG blocks at
least one subtype of (probably) hippocampal mGluR when infused intraventricularly, it is possible
that actions on a different subtype explain the ability of MCPG to block LTP under some
circumstances. This problem could potentially be solved by the use of subtype-specific antagonists. A
further problem with the above assay is that MCPG exhibits greater potency in antagonizing ACPD-
mediated responses, compared to those of glutamate (Littman and Robinson, 1994; Brabet el al.,
1995; Huber et al., 1998). Again, this problem requires the use of novel antagonists that were not
available when the present series of experiments was started.
Having established that MCPG does indeed antagonize mGluRs using the current experimental set-up
(despite the qualifications raised above), the possibility that the mGluR activated molecular switch
(see chapter 3.10.4) might provide an explanation for the failure of MCPG to block LTP was tested.
This work is described in the following section.
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Fig. 7.5.1
Effect of 4 mM (1S,3R)-ACPD infusion on EPSP slope following
the application of 200 mM (R,S)-MCPG or PBS. Data are
normalized either to the 10 min prior to MCPG / PBS infusion (A),
or to separate 10 min periods prior to each infusion of ACPD (B).
Prior application ofMCPG did not block the transient ACPD-
induced rise in EPSP slope.
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Effect of 4 mM (1S,3R)-ACPD infusion on population spike
amplitude after application of 200 mM (R,S)-MCPG or PBS. Data
are normalized either to the 10 min prior to MCPG / PBS infusion
(A), or to separate 10 min periods prior to each infusion of ACPD
(B). Prior application ofMCPG did not block the slight ACPD-
induced rise in population spike amplitude.
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200 mM (R,S)-MCPG + ImM (1S,3«)-ACPD
Fig. 7.3.3
Infusion of 1 mM (1S,3^)-ACPD induces a transient increase in spontaneous
dentate activity when applied after buffered saline (A). This increase was
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Fig. 7.5.4
(A) Mean increase in amplitude (peak to trough) of spontaneous activity
resulting from infusion of 4 mM (1S,3R)-ACPD. Values were measured
directly from polygraph chart records at 2 min intervals and normalized
to the baseline level 0-2 min prior to the start of each individual infusion
of ACPD. (B) Expanded display of the rise in spontaneous activity
following the first infusion of ACPD. Prior application of 200 mM (R,S)-
MCPG significantly reduced this effect (*p < 0.05; **p < 0.01).
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Fig. 7.5.5
Effect of 2 mM (1S,3R)-ACPD infusion on EPSP slope following
the application of 200 mM (R,S)-MCPG (n = 1) or PBS (n = 1).
Data are normalized either to the 10 min prior to MCPG / PBS
infusion (A) or to separate 10 min periods prior to each infusion
of ACPD (B). Application of MCPG did not block the transient
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Fig. 7.5.6
Effect of 2 mM (1S,3R)-ACPD infusion on brain temperature.
Data were normalized either to the 10 min prior to MCPG / PBS
infusion (A), or to separate 10 min periods prior to each infusion
of ACPD (B). Application of MCPG (n = 1) did not block the
transient ACPD-induced temperature rise compared to the
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Fig. 7.5.7
(A) Mean increase in amplitude of spontaneous activity resulting from
infusion of 2 mM (1S,3R)-ACPD. (B) Expanded display of the rise in
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Fig. 7.5.8
(A) Mean increase in amplitude (peak to trough) of spontaneous activity
resulting from infusion of 1 mM (1S,3R)-ACPD. (B) Expanded display
of the rise in spontaneous activity following the first infusion of ACPD.
Prior application of 200 mM (R,S)-MCPG significantly reduced this
effect (*p < 0.05; **p < 0.01).
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Fig. 7.5.9
Effect of 1 mM (1S,3R)-ACPD infusion on EPSP slope following
the application of 200 mM (R,S)-MCPG or PBS. Data are
normalized either to the 10 min prior to MCPG / PBS infusion (A),
or to separate 10 min periods prior to each infusion of ACPD (B).
Application of MCPG did not block the transient ACPD-induced
rise in EPSP slope.
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Fig. 7.5.10
Effect of 1 mM (1S,3R.)~ACPD infusion on population spike
amplitude after application of 200 mM (R,S)-MCPG or PBS. Data
are normalized either to the 10 min prior to MCPG / PBS infusion
(A), or to separate 10 min periods prior to each infusion of ACPD
(B). Application of MCPG did not block the slight ACPD-induced
rise in population spike amplitude.
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Fig. 7.5.11
Effect of 1 mM (1S,3R)-ACPD infusion on brain temperature.
Data were normalized either to the 10 min prior to MCPG / PBS
infusion (A), or to separate 10 min periods prior to each infusion
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Change in brain temperature (°C)
Fig. 7.5.12
Relationship between EPSP slope and brain temperature during passive
warming of animals (1 mM (1S,3R)-ACPD study). Data from the PBS-
treated group are plotted in part (A). Data from the 200 mM (R,S)-MCPG-
treated group are plotted in part (B). The different symbols correspond






































Change in brain temperature (°C)



































Change in brain temperature (°C)
Fig. 7.5.13
Relationship between population spike amplitude and brain temperature
during passive warming of animals (1 mM (1S,3R.)-ACPD study). Data
from the PBS-treated group are plotted in part (A). Data from the
200 mM (R,S)-MCPG-treated group are plotted in part (B). Symbols
correspond to data obtained from individual rats.
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7.6 Does prior depotentiation reveal an MCPG-sensitive component of LTP in vivo?
7.6.1 Introduction
One potential explanation for the mixed results obtained with MCPG is provided by the results of
Bortolotto et al. (1994), who postulated that mGluR activation turns on a molecular switch that
eliminates the requirement for further mGluR activation in the induction of LTP. This switch was
found to be turned off by the delivery of low frequency stimulation. Wang et al. (1995) subsequently
reported that even without deliberate activation of mGluRs (e.g. by tetanic stimulation or agonist
application), a block of LTP with MCPG was only obtained after low frequency stimulation of
afferents. It is possible that under some circumstances, the mGluR-activated molecular switch may be
turned on prior to the start of an experiment, thus abolishing the ability of MCPG to block LTP, a
possibility that has not previously been investigated in vivo.
The following experiments were conducted in an attempt to address this issue. However, rather than
delivering low frequency stimulation under baseline conditions, it was decided to follow the
Bortolotto et al. (1994) protocol in which LTP is first induced, then depotentiated using low
frequency stimulation prior to drug infusion and further tetanization. This allows the efficacy of low
frequency stimulation in reversing LTP to be judged, in addition to its actions on the putative
molecular switch.
It has been reported that the percentage reversal of LTP in CA1 slices declines steeply as the interval
between tetanus and low-frequency stimulation is increased (Staubli and Chun, 1996). Owing to this
finding, and since low-frequency stimulation does not readily reverse stable LTP in the dentate gyrus,
it was decided that the depotentiating train should be delivered very soon after tetanization. Hence,
low frequency stimulation was started 2 min after the final tetanus train. A range of different
frequencies have been reported to induce long-term depression or reverse LTP, but 5 Hz stimulation
(the frequency chosen in the present study) has generally been found to be optimal for inducing
depotentiation in vivo (see chapter 8).
7.6.2 Methods
The recording set-up was identical to that used in experiment 7.3. A 20 min baseline period was
recorded, followed by a high frequency tetanus. However, 2 min after tetanization, a 1 min period of 5
Hz stimulation was applied to most rats. One hour after the first tetanus, these animals were infused
with either 200 mM (/?,S)-MCPG (n = 7) or vehicle (n = 8). Half an hour after the end of drug
infusion, a second tetanus was given, and LTP was followed for 1 hr. A control group (n = 8) also
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received the first tetanus, but no depotentiating stimulation. LTP was followed for one hour in these
animals, and their experiment ended at the point when drug infusion would have begun for the other
groups.
In a follow-up study, the period of 5 Hz stimulation was increased to 10 min. All groups consisted of
6 animals in this experiment.
7.6.3 Results
7.6.3.1 1 min 5 Hz
Tetanus 1 and depotentiation
Figure 7.6.1A shows EPSP slope data recorded throughout the experiment, normalized to the mean
value over the 10 min prior to the first tetanus. The change in population spike amplitude is shown in
figure 7.6.IB. Significant depotentiation was induced by 5 Hz stimulation given 2 min after
tetanization. An ANOVA of the amount of EPSP slope potentiation 50-60 min after the first tetanus,
in which all depotentiated animals were compared with controls, revealed a significant reduction in
LTP. A non-significant trend towards a reduction in population spike amplitude was also observed
(table 7.6.1). However, the depotentiation was incomplete: only 2 of the 15 rats receiving 5 Hz
stimulation showed less than 5 % EPSP slope LTP after 1 hr, in contrast to control rats, all of which
showed more than 5 % LTP.
Owing to the 2 min interval between tetanus and 5 Hz stimulation, PTP was measured over the period
between 0-2 min after tetanization (rather than 0-4 min as in 7.3 & 7.4). No significant group
differences were found in the amount of EPSP or population spike PTP 0-2 min post-tetanus (table
7.6.1).
Table 7.6.1 Percentage potentiation induced by a high frequency tetanus followed by a 1 min period
of 5 Hz stimulation.










Tetanus only 151.2 ±2.4 120.2 ±3.4 4.71 ±0.62 2.78 ± 0.35
Tetanus + 5 Hz 150.4 ±2.4 111.5 ± 1.9 5.21 ±0.41 2.02 ±0.21
ANOVA results F< 1 F(l,21) = 5.87;
p < 0.05
F< 1 F(l,21) =3.84;
0.1 > p > 0.05
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No significant group differences were found in baseline stimulation intensity, initial spike amplitude
over the 10 min prior to tetanus 1, and absolute slope magnitude prior to tetanus 1 (table 7.6.2).








Tetanus only 288.8 ± 34.5 3.18 ± 0.12 2.86 ±0.21
Vehicle 300.0 ± 26.6 3.40 ± 0.23 2.79 ±0.13
200 mM (/?,S)-MCPG 255.7 ± 11.7 3.77 ± 0.27 3.18 ±0.23




Drug infusion and tetanus 2
Infusion of MCPG caused a marked fall in baseline slope values (see section 7.6.4), but failed to
block LTP after the second tetanus (see figure 7.6.1 A). Similarly, MCPG infusion did not affect
population spike LTP following the second tetanus.
However, since depotentiation was not completely effective, it was considered more appropriate to re-
normalize the data to the elevated baseline after the first tetanus. The baseline fall induced by MCPG
infusion introduces a further complication: should data be normalized to the baseline immediately
prior to the second tetanus, or to the baseline prior to drug infusion? Since the MCPG induced
baseline fall appears to be transient (see experiment 7.4), the pre-infusion baseline would seem to be
most appropriate. Table 7.6.3 shows the amount the amount of EPSP slope and population spike LTP
50-60 min after the second tetanus, relative to both pre-infusion and pre-tetanus baselines. When
normalized to the pre-infusion baseline, no group differences in EPSP slope or population spike LTP
were found.
However, when normalized to baseline immediately prior to the second tetanus, MCPG-treated
animals displayed significantly more LTP than vehicle-infused controls. This result is an artifact of
falling pre-tetanus baselines in the former group, leading to an artificially elevated measure of LTP. It
is curious that the baseline fall in EPSP slope appears more pronounced when MCPG is infused
during the recording of a potentiated baseline (figure 7.6.1 A) compared to that obtained in a non-
potentiated baseline (figures 7.3.1A and 7.4.1A). This phenomenon is discussed in section 7.7.
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Table 7.6.3 Potentiation following a second tetanus delivered after infusion of 200 mM (/?,S)-MCPG
or PBS.
















PBS 114.1 ±4.2 114.2 ±2.6 2.17 ±0.40 1.89 ±0.46
200 mM (/?,S)-MCPG 125.0 ±5.6 114.5 ±6.2 3.61 ±0.25 2.77 ± 0.24
ANOVA results F (1,13) =
3.21;/? <0.05




The above results demonstrate that MCPG does not block LTP after significant depotentiation has
previously been induced. However, depotentiation was only partial, suggesting that deconditioning of
the molecular switch, if induced, may also have been incomplete (see section 7.6.4). It remains
possible that a more effective depotentiation protocol might produce a different result. Hence, the
period of 5 Hz stimulation was increased from 1 min to 10 min.
7.6.3.2 10 min 5 Hz
Tetanus 1 and depotentiation
Figure 7.6.2A shows EPSP slope data recorded throughout the experiment normalized to the mean
value over the 10 min prior to the first tetanus. The change in population spike amplitude is shown in
figure 7.6. IB. An ANOVA of the amount of EPSP slope LTP 50-60 minutes after tetanus 1, in which
all depotentiated animals (n = 12) were compared with controls (n =6), revealed a highly significant
reduction in the depotentiated group (table 7.6.4). No significant differences in the amount of PTP 0-2
min post-tetanus were found. An analysis of population spike depotentiation gave similar results.
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Table 7.6.4 Percentage potentiation induced by a high frequency tetanus followed by a 10 min period
of 5 Hz stimulation.












Tetanus only 150.5 ±4.6 119.3 ± 1.4 4.86 ± 0.67 2.84 ±0.19
Tetanus + 5 Hz 150.6 ±2.4 105.6 + 2.5 5.39 ±0.56 0.87 ± 0.20
ANOVA results F < 1 F(l,16)= 13.3;
p< 0.01
F < 1 E(l,16) = 38.6;
p < 0.0001
No group differences were found in baseline stimulation intensity, initial spike amplitude over the 10
min before tetanus 1, and absolute slope magnitude over the 10 min before tetanus 1 (table 7.6.5).







Tetanus only 283.3 ±45.9 3.83 ±0.27 3.15 ±0.40
Vehicle 313.3 ±38.8 4.08 ± 0.25 2.85 ±0.20
200 mM MCPG 241.7 ±30.0 3.66 ± 0.24 3.25 ± 0.24
ANOVA results F < 1 F < 1 F < 1
This protocol was slightly more effective than that used previously. A comparison of the amount of
EPSP slope LTP following 5 Hz stimulation for I min and the amount following 10 min revealed a
trend towards greater EPSP slope depotentiation in the latter (table 7.6.6). Furthermore, population
spike depotentiation was considerably more effective after 10 min of 5 Hz, compared to 1 min of 5 Hz
(table 7.6.6). EPSP slope values returned to within 5 % of baseline or less in 7 of the 12 rats given 10
min of 5 Hz, compared to only 2 out of 15 given 1 minute of low frequency stimulation. No
significant differences in non-depotentiated control LTP were seen between the 1 min of 5 Hz and 10
min of 5 Hz studies (table 7.6.6); all controls showed more than 5 % LTP.
228
Table 7.6.6 Residual LTP after 1 min of 5 Hz compared to that remaining after 10 min of 5 Hz.
EPSP slope LTP 50-60 min
after first tetanus (%
baseline)
Increase in population spike
amplitude 50-60 min after
first tetanus (mV)
1 min 5 Hz 111.5 ±1.9 2.02 ±0.21
10 min 5 Hz 105.6 ±2.5 0.87 ±0.20
ANOVA results E(l,25) = 3.59; 0.1 >p> 0.05 F(l,25)= 14.6; p < 0.001
Drug infusion and tetanus 2
MCPG did not block LTP of either the EPSP slope (figure 7.6.2A) or population spike (figure 7.6.2B)
following the second tetanus, despite substantial depotentiation of previously induced LTP. This was
true even in individual cases where 5 Hz stimulation returned EPSP slope levels to the original
baseline, prior to drug infusion and further tetanization. An example of such a recording is shown in
figure 7.6.3.
MCPG still did not block LTP as measured relative to the 10 min prior to drug infusion, or the 10 min
prior to the second tetanus (table 7.6.7). In fact, whereas EPSP slope LTP did not differ between
MCPG and PBS groups when normalized to the pre-infusion baseline, the population spike increase
was significantly higher in the MCPG group. The reason for this finding is unknown, although the
small group sizes may provide an explanation. As in the 1 min of 5 Hz study, both EPSP slope and
population spike LTP were significantly higher in the MCPG group when normalized to the baseline
immediately before the second tetanus. This result is explained by falling baselines induced by MCPG
infusion.
These above results confirm the original finding that the inability of MCPG to block LTP is
unaffected by prior depotentiation.
Table 7.6.7 Potentiation following a second tetanus delivered after infusion of 200 mM (/?,S)-MCPG
or PBS.









PBS 110.0 ±3.9 108.3 ±5.5 2.44 ± 0.33 2.03 ± 0.22













Depotentiating stimulation was successful in reversing LTP, but did not re-establish an ability of
MCPG to block LTP following a second tetanus. It is conceivable that LTP reaches a ceiling after the
second tetanus thus masking differences in potentiation between the groups. However, this
explanation is unlikely. The EPSP slope 1 hr after tetanus 2 in figure 7.6.2A was a mere 20 % above
the initial baseline level recorded prior to tetanus 1, an implausibly low level for an LTP "ceiling".
The failure of prior depotentiation to restore the ability of MCPG to block LTP is consistent with the
findings of Selig et al. (1995) and Thomas and O'Dell (1995) who failed to replicate the molecular
switch findings of Bortolotto and Collingridge (1994) in area CA1 in vitro. However, there may be
important differences between the reversal of established LTP in vivo with 1 Hz stimulation, and the
"destabilization" of potentiation within minutes of its induction in vivo, using 5 Hz stimulation (see
chapter 8.5.3). For instance, although not routinely recorded, there was evidence of epileptiform
activity during 5 Hz stimulation in the present study, a finding not associated with stimulation at 1 Hz
(see experiment 8.4). However, the mechanistic relationship between depotentiation and
"deconditioning" of the mGluR activated molecular switch is unclear, although both are induced by
low-frequency stimulation (Bortolotto and Collingridge, 1994). Under these circumstances, the
importance of possible differences between the form of depotentiation described here and that
typically induced in slice preparations is hard to assess. Furthermore, differences between the CAI in
vitro and dentate gyrus in vivo preparations may contribute to the difference in results obtained.
Hence, although providing no support for the hypothesis, the results of the present study do not rule
out the possibility that the sensitivity of LTP to MCPG may, under certain circumstances, be







Low frequency stimulation (5 Hz for 1 min) resulted in a significant
reduction in both EPSP slope LTP (A), and population spike LTP (B),
relative to controls receiving only a high frequency tetanus. Infusion
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Fig. 7.6.2
10 min of 5 Hz stimulation resulted in a slightly more effective reversal
of LTP than 1 min of 5 Hz. However, MCPG still did not block LTP of
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Fig 7.6.3
MCPG failed to block EPSP slope LTP even in animals showing
complete depotentiation, such as the example given here.
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7.7 General discussion
The experiments described in this study have consistently revealed that intraventricular infusion of a
high dose of (R,S)-MCPG in urethane-anaesthetized rats does not result in a block of LTP in the
dentate gyrus. This result holds whether LTP is assessed relative to a pre-tetanus baseline, to a
concurrently stimulated control pathway, or is induced in a pathway previously subject to successful
depotentiation.
In experiment 7.3, i.e.v. infusion of either 20 mM or 200 mM (R,5)-MCPG failed to cause a
significant reduction in the level of LTP up to 2 hr after tetanization. It is unlikely that this was due to
any failure of the drug infusion protocol as D-AP5 administered by the same route caused a total
block of LTP.
The bilateral stimulation and recording set-up used in experiment 7.4 confirmed that the baseline
changes induced by MCPG do not affect the level of potentiation 1-2 hr later (but see section 7.4.3 for
qualification of this argument). It appears, however, that the baseline fall caused by MCPG is more
marked after the induction of LTP followed by incomplete depotentiation (figure 7.6.1 A) than the fall
occurring after more effective depotentiation (figure 7.6.2A), or when MCPG is applied to an
untetanized pathway (figures 7.3.11A and 7.4.1A). It is conceivable that tetanization followed by 5
Hz stimulation results in a residual mGluR-dependent potentiation which returns to baseline after
MCPG application. However, MCPG has been shown to have no effect on LTP when applied after a
high frequency tetanus alone (Riedel et al., 1995a). Furthermore, inspection of the data from
individual rats suggests that the size of the fall in EPSP slope following MCPG infusion in
experiment 7.6 was independent of the amount of LTP remaining after tetanization and 5 Hz
stimulation (data not shown). This finding is inconsistent with the suggestion that the residual LTP
after depotentiation is mGluR-dependent. However, the reason for the difference in baseline changes
between experiments is not known.
Il is unlikely that changes in brain temperature had a significant effect on the relative level of LTP
recorded in experiments 7.3 and 7.4. In figure 7.3.6, the slight increase in brain temperature of
approximately 0.5°C associated with MCPG infusion appeared to be transient. No significant
temperature differences between groups were found 2 hr after tetanization, although the mean brain
temperature of MCPG-treated rats was about 0.4°C higher at this point than in vehicle-infused
controls. Nevertheless, it is unlikely that a block of LTP with 200 mM MCPG was masked by a small
temperature-dependent increase in EPSP slope in this group since in experiment 7.4, vehicle-infused
controls showed brain temperatures slightly (but again non-significantly) higher than MCPG-infused
animals 2 hours after tetanization (data not shown), yet a block of LTP was stili not obtained with
MCPG.
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It could be argued that the above results simply reflect an insufficient blockade of mGluR activation
in the dentate gyrus. Intraventricular infusion of a drug results in an unknown distribution and
concentration within the target structure; these are problems associated with most in vivo studies.
Nevertheless, in experiment 7.5, MCPG infusion was found to inhibit the rise in spontaneous activity
induced by infusion of the mGluR agonist, (1S,3R)-ACPD. Slow-onset potentiation such as that
described by Manahan-Vaughan and Reymann (1995a) was not observed after ACPD infusion (see
experiment 7.5). The fact that MCPG is effective in blocking an electrophysiological response to
ACPD confirms that the drug reaches ACPD-activated mGlu receptors. Nevertheless, this finding is
far from perfect as a positive control. For instance, it cannot conclusively be claimed that these
receptors are actually in the dentate, since MCPG may be blocking a network-mediated action of
ACPD originating elsewhere in the hippocampus or in other brain structures (see also experiment
7.5.4). However, an inhibition of the effects of ACPD does at least provide a crude assay for the
functional blockade of mGluRs by MCPG.
It has been suggested that mGluR activation may regulate plasticity by turning on a "molecular
switch" which eliminates the requirement for further mGluR activation in the induction of LTP; this
switch can be reset by depotentiating stimulation (Bortolotto et al., 1994). However, in experiment
7.6, MCPG remained ineffective in blocking LTP even after effective prior depotentiation (but see
experiment 7.6.4). Considering the controversy surrounding the phenomenon, it is interesting that a
period of 5 Hz stimulation given 2 min after tetanization results in significant depotentiation: 10 min
of this depotentiating stimulation resulted in a mean of only 5.6 ± 2.5% LTP after 1 hour, compared to
19.3 ±1.4% in tetanized-only controls. A more detailed experimental investigation of this
phenomenon is presented in the following chapter.
The failure of MCPG to block LTP in the dentate gyrus of urethane-anaesthetized rats is consistent
with the results of one recent study conducted under similar conditions (Bordi and Ugolini, 1995); an
earlier report described a reduction in the percentage EPSP slope potentiation after acute
intraventricular infusion, but no block of population spike potentiation (Richter-Levin et al., 1994). A
complete block of LTP was seen only during direct perfusion of MCPG into the dentate gyrus via a
push-pull cannula. However, it has been reported that urethane antagonizes the excitation induced by
application of excitatory amino acid agonists, including NMDA, in isolated spinal cord (Evans and
Smith, 1982). In another study, urethane anaesthesia was found to depress dentate gyrus granule cell
excitability and the strength of synaptic responses (Shirasaka and Wasterlain, 1995). The recent
finding that Thy-1 knockout mice show a complete block of dentate LTP under urethane anaesthesia,
but express significant LTP in the freely-moving state, demonstrates that the effects of anaesthesia
cannot be ignored (Nosten-Bertrand et al., 1996; Errington et al., 1997). Consistent with this result, it
is found that stronger tetanization parameters are required to induce LTP in area CA1 of urethane-
anaesthetized rats, compared to the freely-moving state (Riedel et al., 1994b). It has been reported that
MCPG does not block the LTP induced in area CA1 in vitro by strong tetanization protocols such as
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theta burst stimulation (Brown and Reymann, 1995). The weaker tetanization parameters necessary in
freely-moving rats may unmask a modulatory role of mGluRs, accounting for reports of a complete
block of LTP by MCPG under these circumstances (see Riedel et ah, 1995a).
An experiment to investigate the role of anaesthesia on the ability of MCPG to block LTP will be
carried out in the near future. Rats with chronically implanted stimulating and recording electrodes
will be infused with MCPG and tetanized either in the freely moving state, or under urethane
anaesthesia.
However, anaesthesia may be merely one of many factors influencing studies of MCPG and LTP.
Note that conflicting reports have been obtained under apparently similar conditions in the dentate
gyrus of urethane-anaesthetized rats (Richter-Levin et al., 1994; Bordi and Ugolini, 1995). A drug
whose effects on LTP are critically dependent on a range of experimental variables, many of them
unidentified, may not be a suitable tool to probe the relationship between LTP and learning. MCPG is
a very weak mGluR antagonist, with an uncertain profile of subtype selectivity (see chapter 3.6.3 &
3.10). As noted in the previous chapter, the quantity of MCPG that can be delivered is limited by
solubility of the drug, together with the need for small infusion volumes in vivo. These problems raise
questions about the suitability of MCPG for use the intact animal. In order adequately to characterize
the role of mGluRs in LTP, it is likely that antagonists with considerably greater subtype specificity
and potency than MCPG will be needed.
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Chapter Eight
Reversal of dentate LTP
by low frequency stimulation
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8.1 General introduction
Much attention has recently been devoted to the phenomena of long-term depression (LTD) and
depotentiation. LTD refers to the depression of naive pathways. Depotentiation refers to a reduction
in synaptic transmission from a previously potentiated level. The mechanisms of LTD induction were
discussed in chapter 2.5, and the following section will focus entirely on depotentiation.
Barrionuevo et al. (1980) found that the delivery of 1 Hz stimulation could reverse LTP in area CA1
of anaesthetized rats. A subsequent study in freely moving rats revealed that the phenomenon was
input-specific (Staubli and Lynch, 1990). A number of different laboratories have subsequently
obtained depotentiation in area CA1 in vitro using a continuous train of 1-5 Hz stimulation (Fujii et
al., 1991; Larson et ah, 1993; Bashir and Collingridge, 1994; ODell and Kandel, 1994; Doyle et al.,
1997), but others have failed to induce depotentiation under similar circumstances (Errington et ah,
1995). This discrepancy is discussed later.
The mechanistic relationship between LTD and depotentiation in area CA1 is unclear. Both
phenomena can be induced using the same trains of low frequency stimulation, and both are
generally found to be dependent on NMDA receptor activation (Dudek and Bear, 1992; Mulkey and
Malenka, 1992; Fujii et al., 1991; Wagner and Alger, 1995), although one group has reported that
depotentiation is NMDA receptor-independent, but depends on the activation of mGluRs (Bashir and
Collingridge, 1994). In addition, both LTD and depotentiation are blocked by protein phosphatase
inhibitors (Mulkey et al., 1993; O'Dell and Kandel, 1994). However, many studies have reported that
the same stimulation parameters that induce depotentiation in the adult CA1 region do not induce
LTD of naive synapses either in vitro (Fujii et al., 1991; O'Dell and Kandel, 1994; Bashir and
Collingridge, 1995; Otani and Connor, 1995; Wagner and Alger, 1995) or in vivo (Barrionuevo et al.,
1980; Staubli and Lynch, 1990; Staubli and Scafidi, 1997; Doyle et al., 1997; but see chapter 2.5).
This fact may be explained by the finding that LTD is more readily obtained in the immature rather
than the adult hippocampus (Dudek and Bear, 1993; Wagner and Alger, 1995), whereas the
susceptibility of CA1 synapses to depotentiation does not change in an age-dependent manner (at
least in area CA1 in vitro: see Errington et al., 1995)
It has been suggested that depotentiation represents a form of "primed LTD" (Wexler and Stanton,
1993; Wagner and Alger, 1996). According to this model, GABAA-mediated inhibition of NMDA
responses is too strong in the mature hippocampus to allow the induction of LTD (see Wagner and
Alger, 1995). However, tetanization results in an increase in the susceptibility for GABAa inhibition
to weaken during low frequency stimulation, thus facilitating the induction of depotentiation. The
successful induction of LTD in the immature hippocampus is attributed to the fact that GABAa-
mediated inhibition is weaker in young animals.
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Much of the work on LTD and depotentiation has focussed on area CA1 and relatively few studies of
dentate depotentiation have been carried out. However, heterosynaptic depotentiation is readily
induced in the dentate gyrus in vivo (e.g. Doyere et al., 1997), and homosynaptic depotentiation has
been successfully induced in slices taken from immature rats (O'Mara et al., 1995a,b). However,
homosynaptic depotentiation is generally not induced by the delivery of low frequency stimulation to
the medial perforant path—dentate gyrus projection of adult rats in vivo (Errington et al., 1995;
Abraham et al.. 1996; but see section 8.5 for further comments on the latter study).
In addition to the use of immature versus adult preparations, one factor that may be critical for the
successful induction of depotentiation is the interval between tetanization and low frequency
stimulation. A number of studies, including experiment 7.6, have reported that LTP is most readily
reversed when low frequency stimulation is delivered soon after tetanization (Barrionuevo et al.,
1980; Staubli and Lynch, 1990; Larson et al., 1993). A systematic investigation of this possibility in
area CA1 in vitro revealed that the percentage reversal of LTP declines steeply as the interval
between tetanus and 5 Hz is increased. Depotentiation was found to be most effective when 5 Hz
stimulation was delivered within minutes of tetanization (Staubli and Chun, 1996).
A number of additional studies have provided evidence that LTP is vulnerable to disruption for a
limited period after induction. For instance, brief cooling shocks and periods of anoxia have been
reported to cause a time-dependent reversal of LTP, presumably by the interruption of biochemical
cascades involved in the stabilization of LTP (Bittar and Muller, 1993; Arai et al., 1990a).
Subsequent studies have implicated adenosine A| receptors and integrins (a class of cell surface
receptor) in the time-dependent reversal of LTP (see section 8.5).
In experiment 7.6, it was reported that a 1 or 10 min period of 5 Hz stimulation results in a significant
reversal of dentate LTP in vivo when delivered 2 min after a high frequency tetanus. The aim of the
present study was to fully characterize the time-dependence of this effect. However, our interest in
the possibility of reversing LTP in a time-dependent manner was motivated by more than the mere
desire to characterize an electrophysiological phenomenon. The ability to selectively erase recently
induced potentiation in a synapse-specific manner, if successful, may provide a powerful tool for the
investigation of the relationship between LTP and learning.
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8.2 The effect of the interval between tetanus and 5 Hz stimulation on the reversal of LTP
8.2.1 Methods
Adult male Lister hooded rats obtained from the departmental breeding colony were used as subjects.
Animals were prepared for the recording of dentate field potentials as described in chapter 4.3.
Stimulation and recording were carried out unilaterally. Owing to difficulty experienced in inducing
LTP using tetanus parameters which had proved adequate throughout experiment 7, a new set of
parameters was adopted (see chapter 9.4).
Stimulation consisted of monophasic pulses, the intensity of which was adjusted to elicit a population
spike amplitude of 2-4 mV. The pulse width was 50 ps, except during a high frequency tetanus or 5
Hz stimulation, when the pulse-width was doubled; test pulses were delivered at 0.05 Hz throughout,
except during input / output curves, when this frequency was increased to 0.1 Hz.
Figure 8.2.1 shows an outline of the experimental design used in the present study. A baseline period
of variable duration (approx. 30-90 min) was initially recorded, until it was judged that evoked
responses had stabilized. This was followed by an I / O curve consisting of 4 pulses at each of 10
stimulation intensities, ranging from 0.1-1.0 mA. A further baseline period of 20 min was then
recorded before a high frequency tetanus was delivered. Tetanic stimulation consisted of 3 trains of
50 pulses of 100 ps duration, delivered at 250 Hz, with 10s between trains. A single test pulse of 100
ps duration was given 10s after the final tetanus train to provide an early measure of post-tetanic
potentiation. After a variable interval, measured from the final tetanus train, a 10 min period of 5 Hz
stimulation was delivered. The intervals tested were as follows: 10s (n = 7), 30s (n = 6), 2 min (n =
7), 10 min (n = 7), 30 min (n = 6). Control groups received either 5 Hz only, with no tetanus ("5 Hz
only" group; n = 6), or tetanic stimulation only, with no subsequent 5 Hz period ("LTP control"
group; n = 6). In the period between tetanus and 5 Hz, stimulation at the normal frequency and pulse
width was continued, except for those animals receiving 5 Hz as early as 10 s or 30 s after
tetanization, in which case no intervening stimulation was given. At the end of the 5 Hz stimulation
period, test pulses were again delivered at the normal frequency and duration until 1 hr had passed
since tetanization. A second I/O curve was then recorded.
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8.2.2 Results
8.2.2.1 Reversal of EPSP slope potentiation
Figure 8.2.2 shows the amount of EPSP slope potentiation at increasing delays between tetanus and 5
Hz stimulation. For reference, the "5 Hz only" and "tetanus only" control groups are included in each
individual graph. High-frequency tetanization alone reliably induced LTP; 5 Hz stimulation alone
had little effect, although a slight increase in slope was often observed. The efficacy of LTP reversal
declined as the interval between tetanus and 5 Hz increased; 5 Hz stimulation delivered 10 min or
more after tetanization had little effect other than a transient depression of responses, typically lasting
less than 10 min.
The mean percentage LTP in each group, measured over the final 10 min of the experiment (50-60
min after tetanization), is plotted in figure 8.2.3. An ANOVA revealed a highly significant overall
effect of group [F(6,38) = 10.2; p < 0.0001]. A significant reversal of LTP was only seen when less
than 10 min intervened between tetanus and 5 Hz [post-hoc Newman-Keuls pairwise comparisons of
the amount of LTP in the "tetanus only" control group versus LTP in all other groups; see figure
legend]. Delivery of 5 Hz starting 10s after tetanization resulted in a complete reversal of LTP. No
significant difference was found between the slight increase in EPSP slope seen with 5 Hz alone, and
that seen in the "10s" group. In fact, only the "10 min", "30 min" and "tetanus only" groups were
found to exhibit significant LTP relative to the "5 Hz only" condition [p < 0.01 in each case;
Newman-Keuls].
No significant group differences were found in absolute mean EPSP slope values over the 10 min
before tetanization (table 8.2.1). A measure of initial slope "PTP" was calculated for all tetanized
groups by dividing the value recorded 10 s after the final tetanus train by the value obtained from the
first pulse of the first tetanus train, then multiplying by 100. No group difference was found in this
measure of early slope PTP [figure 8.2.5A; F < 1], indicating that the initial potentiation induced by
tetanization was identical across groups (excluding the "5 Hz only" condition).
8.2.2.2 Reversal of population spike potentiation
The population spike data were generally consistent with the EPSP slope data. Figure 8.2.5 shows the
absolute increase in population spike amplitude at all intervals between tetanus and 5 Hz. "Tetanus
only" and "5 Hz only" control groups are again included in each individual graph. High-frequency
tetanization alone induced a lasting increase in population spike amplitude. However, 5 Hz
stimulation alone caused a small but lasting depression of the population spike.
The mean population spike increase over the final 10 min of the experiment is shown in figure 8.2.6.
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The "5 Hz only", "10s" and "30s" groups showed significantly less LTP than "tetanus only" controls
(see figure legend). Delivery of 5 Hz stimulation 2 min or more after tetanization caused only a
transient depression in population spike amplitude, which although outlasting the EPSP slope
depression, typically recovered within about 20 min.
No significant group differences were found in absolute baseline population spike amplitude over the
10 min prior to tetanization; the test pulse stimulation intensities required to elicit population spikes
of this amplitude did not differ across groups (table 8.2.1). An analysis of population spike "PTP"
recorded 10s after tetanization revealed no group differences in initial potentiation [figure 8.2.4B;
F(5,33)= 1.41;/? >0.2],







5 Hz only 286.7 ±33.1 4.63 ± 0.26 3.09 ±0.33
10 s 287.1 ± 14.8 4.55 ±0.23 3.17 ±0.52
30 s 298.3 ±36.8 5.10 ± 0.38 3.19 ±0.72
2 min 297.1 ±46.4 4.49 ±0.32 2.85 ±0.43
10 min 275.7 ±30.6 4.69 ± 0.22 2.14 ± 0.15
30 min 286.7 ±25.8 4.90 ±0.24 2.91 ±0.22
Tetanus only 280.0 ±43.9 4.34 ±0.36 2.54 + 0.50
ANOVA results F< 1 F< 1 F< 1
8.2.2.3 Changes in EPSP / spike (E-S) coupling induced by 5 Hz stimulation
Mean EPSP slope and population spike amplitude values were calculated for each stimulation
intensity sampled during both the initial and final I/O curves, i.e. 20 min before and 60 min after
tetanization. The maximum mean EPSP slope and population spike amplitude recorded during the
initial I/O curve were arbitrarily assigned values of 100 %, to which all other values were
normalized. An example of such I/O curves recorded from an animal in the tetanus only group is
shown in figure 8.2.7. In this example, EPSP slope and population spike LTP was observed over a
broad range of sampling intensities.
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For each rat, scatter plots relating EPSP slope to population spike amplitude were constructed from
the 1 / O curve data obtained both before and after tetanization and 5 Hz stimulation (or before and
after 5 Hz alone in the "5 Hz only" group). Figure 8.2.8 shows sample scatter plots constructed from
the I / O curves displayed in figure 8.2.7. Data points at which the population spike amplitude was
zero were excluded. Linear regression lines have been fitted to the scatter plots before and after
tetanization. After tetanization, data points exhibited an overall shift in a direction parallel to the pre-
tetanus regression line. This shift indicates that both population spike and EPSP slope LTP were
induced. In the absence of any changes in E-S coupling, regression lines should fall directly on top of
each other before and after tetanization, despite the shift along the regression line mentioned above.
However, the slight leftward shift in figure 8.2.8 indicates that population spike amplitude was
potentiated to a slightly greater extent than that predicted by the EPSP slope increase, i.e. modest E-S
potentiation occurred.
Figure 8.2.9 shows mean E-S plots for each group. For display purposes, data points have been
connected by interpolation. As indicated by the slight mean leftward shift in the E-S relationship,
LTP in "tetanus only" controls was accompanied by a slight E-S potentiation, consistent with the
example shown in figure 8.2.8. However, 5 Hz stimulation alone caused a rightward shift in the E-S
relationship, indicating a decrease in E-S coupling. Little change in E-S coupling was seen in any of
the groups that received a tetanus followed by 5 Hz stimulation (see below).
In order to analyse these data quantitatively, linear regression lines were fitted to the scatter plots
obtained from each individual animal, as in figure 8.2.8. All correlation coefficients were highly
significant with p values never exceeding 0.01 (data not shown). As illustrated in figure 8.2.8, the
spike amplitude elicited by an EPSP slope 75 % of the maximum value recorded during the pre-
tetanus I/O curve was interpolated from each regression equation. This value was compared before
and after tetanization (or before and after 5 Hz stimulation alone). A significant group by time point
interaction was found, revealing that groups showed differential changes in E-S coupling between the
initial and final I/O curves [F(6,38) = 3.96; p < 0.01; within-subject ANOVA], Subsequent analysis
of simple effects revealed no group differences in the spike amplitude elicited by a 75 % maximal
EPSP slope in the pre-tetanus I/O curve [F < 1], but the group difference was highly significant in
the final I/O curve [F(6,52) = 3.25; p < 0.01]. Significant E-S potentiation was found in the "tetanus
only" group [F(l,38) = 6.89; p < 0.05], and significant E-S depression in the "5 Hz only" group
[F(l,38) = 11.9; p < 0.01], No significant changes in E-S coupling were obtained in any group
receiving a tetanus followed by 5 Hz stimulation [10 s: F < 1; 30 s: F < 1; 2 min: F < 1; 10 min: F <
1; 30 min: F(l,38) = 2.92; p> 0.05],
Figure 8.2.10 shows the mean percentage increase or decrease in population spike amplitude elicited
by a 75 % maximal EPSP slope in the final I/O curve, compared to the value recorded in the initial I
/ O curve. In this way, the changes in E-S coupling analysed in the above ANOVA are represented by
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a single value. Positive values represent an increase in population spike in excess of that predicted by
the increase in EPSP slope, i.e. E-S potentiation. Negative values indicate a decrease in E-S coupling.
As revealed in the ANOVA, E-S potentiation and E-S depression were induced by tetanization and 5
Hz stimulation respectively. The non-significant trend towards E-S depression in the "30 min group"
was due to the fact that 5 Hz stimulation finished only 20 min before the second I / O curve in this
group. At this lime point, population spike amplitude had not recovered to pre-5 Hz levels, resulting
in an apparent slight E-S depression.
8.2.2.4 Epileptiform afterdischarges induced by 5 Hz stimulation
5 Hz stimulation was always accompanied by epileptiform activity characterized by seizure-like
afterdischarges and multiple population spikes. Fig. 8.1.11 shows a continuous polygraph record
during 5 Hz stimulation. The large negative deflections are positive-going EPSPs. In this example,
afterdischarges began within 10 s of the start of 5 Hz stimulation and persisted for approximately 1.5
min, after which no further episodes of afterdischarge activity were observed. Representative sample
EPSPs at three different time points are illustrated.
The afterdischarge onset latency and total duration were measured for each rat. Analysis of data from
all rats revealed that these two indices of the severity of afterdischarge activity were negatively
correlated, i.e. the more rapidly afterdischarges began, the longer they persisted [figure 8.2.12; r - -
0.41; p < 0.05]. However, no significant group difference was found in afterdischarge onset latency
[figure 8.2.13A; F(5,33) = 2.17; p > 0.05] or duration [figure 8.2.13B; F < 1], indicating that seizure¬
like activity was equally severe regardless of the interval between tetanus and 5 Hz, or indeed
regardless of whether a tetanus was delivered at all.
Similarly, there was no overall correlation between afterdischarge onset latency and the level of LTP
1 hr after tetanization [EPSP slope LTP: r - -0.14, NS; population spike LTP: r = -0.26, NS; data not
shown]. No correlation was found between afterdischarge duration LTP 1 hr after tetanization [EPSP
slope LTP: r = -0.05, NS; population spike LTP: r = -0.08, NS; data not shown]. These findings
indicate that the time window during which LTP is vulnerable to reversal cannot be explained as an
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2 x test pulse width
Fig. 8.2.1
Summary of experimental design. 5 Hz stimulation was delivered at
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Fig. 8.2.2
EPSP slope values normalized to the pre-tetanus baseline at increasing
delays between tetanization and 5 Hz stimulation. For reference, "tetanus
only" and "5 Hz only" groups are included in each individual panel.
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10s 30s 2 10 30 Tetanus
min min min only
Increasing interval between
tetanus and 5 Hz stimulation
Fig. 8.2.3
Mean EPSP slope values 50-60 min after tetanization. Asterisks
indicate groups showing significantly less LTP than "tetanus only"
controls (* p < 0.05; **p < 0.01).
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(A)
10s 30s 2 10 30 Tetanus
min min min only
Fig. 8.2.4
PTP recorded exhibited by a single test pulse delivered 10 s after the final
tetanus train. Data were normalized to the value recorded in response to
the first pulse of the first tetanus train (i.e. before potentiation was
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Fig. 8.2.5
Changes in population spike amplitude normalized to the pre-tetanus
baseline at increasing delays between tetanization and 5 Hz stimulation.








































10s 30s 2 10 30 Tetanus
min min min only
**
Increasing interval between
tetanus and 5 Hz stimulation
Fig. 8.2.6
Mean increase in population spike amplitude 50-60 min after tetanization.
Asterisks indicate groups showing significantly less LTP than "tetanus













—♦-- 20 min pre-tetanus
- 1 hr post-tetanus
0 0.1 0.2 0.3 0.4 0.5 0.6 0.7 0.8 0.9 1.0
Stimulation Intensity (mA)
Fig. 8.2.7
Input / output curves recorded before and after tetanization in a rat
receiving high frequency tetanization only. Both EPSP slope (A)
and population spike potention (B) are plotted.
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♦ 20 min pre-tetanus
☆ 1 hr post-tetanus
EPSP slope (% pre-tetanus max.)
Fig. 8.2.8
Scatter plots relating population spike amplitude to EPSP slope
20 min before and 1 hr after tetanization in a single rat from
the "tetanus only" group. The grey arrow and dotted lines
indicate the increase in population spike elicited by a 75 %
maximal EPSP slope after tetanization. E-S potentiation was
modest in this example.
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Fig. 8.2.9
Mean relationship between population spike amplitude and EPSP slope
at each point on the I / O curve recorded before and after tetanization.




Changes in population spike amplitude elicited by a fixed EPSP slope
before and after tetanization and / or 5 Hz stimulation. Asterisks




Sample polygraph record during 5 Hz stimulation. The large negative deflections
represent positive-going EPSPs. Epileptiform afterdischarges began abruptlywithin 10 s of the start of 5 Hz stimulation, and continued for approximately1.5 min before subsiding. Representative EPSPs recorded at 0, 15 and 100 s after
the start of 5 Hz stimulation are illustrated. The waveform recorded at 15 s
displays the multiple population spikes characteristic of afterdischarge activity.
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Afterdischarge onset latency (s)
Fig. 8.2.12










The latency to onset (A) and duration of afterdischarges (B) did not
differ across groups.
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8.3 The effect of (/?,S)-MCPG on the reversal of LTP by 5 Hz stimulation
8.3.1 Methods
Rats received intraventricular infusions of 200 mM (R,S)-MCPG (n = 3) prior to tetanization only (n
= 3) or tetanization followed 10 s later by 10 min of 5 Hz stimulation (n = 3). Intervals other than 10
s were not tested because this was found to be the optimal interval for reversing LTP in experiment
8.2.
Drug solutions were prepared and infusions were carried out as described in experiment 7.2.2. Drugs
were infused over 10 min, finishing 30 min before tetanization. All other aspects of the protocol were
identical to that described in experiment 8.2. Owing to the small group sizes, a statistical analysis of
the following data was not carried out.
8.3.2 Results
8.3.2.1 EPSP slope and population spike LTP
Figure 8.3A shows the EPSP slope data for this experiment, normalized to the pre-infusion baseline
owing to the slight fall in baseline induced by MCPG infusion (see chapter 7). Consistent with the
results presented in chapter 7, (R,S)-MCPG did not block LTP induced by tetanization 30 min after
the end of infusion. The reversal of LTP with 5 Hz stimulation delivered 10 s after tetanization was
also unaffected. Similar levels of EPSP slope PTP 10 s after tetanization were recorded in both
groups (table 8.3). Population spike LTP data followed a similar pattern to the EPSP slope results
(figure 8.3B). However, these data are less clear owing to the relatively poor LTP and large standard
errors in the tetanus only group.
8.3.2.2 Comparison with experiment 8.2
Table 8.3 shows the EPSP slope LTP and population spike LTP obtained in the present experiment,
compared to data obtained in the "tetanus only" and "10 s" groups in experiment 8.2, in which no
drug infusions were given. LTP data were all measured over the final 10 min of the experiment, 50-
60 min after tetanization. The level of slope PTP measured 10 s after the final tetanus train is also
compared. All measures of potentiation in both tetanus only and tetanus + 5 Hz conditions were
broadly similar in the presence or absence ofMCPG.
Note, however, that whereas data from experiment 8.2 are normalized to the pre-tetanus baseline,
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data from the present experiment are normalized to the pre-infusion baseline, on the assumption that
the MCPG-induced baseline fall is transient. However, this assumption may not be entirely valid (see
chapter 7.4.3), a possibility which might explain the apparent slight reduction in all measures of LTP
in the presence of MCPG.
Table 8.3 A comparison of the amount of LTP and depotentiation obtained in the present study after













No drug 127.1 ± 1.9 169.5 ±6.8 3.87 ± 0.42
MCPG 122.7 ±2.7 152.0 ±5.5 2.32 ± 1.10
Tetanus
+ 5 Hz
No drug 106.0 ±2.4 157.5 ±5.5 1.01 ±0.24
MCPG 104.6 ± 1.5 154.8 ±7.7 0.78 ±0.51
The values of baseline parameters (stimulation intensity, baseline EPSP slope, and baseline
population spike amplitude) were similar in the present experiment to those recorded in experiment
8.2 (data not shown).
8.3.2.3 MCPG and afterdischarge activity
MCPG has been reported to have anticonvulsant properties (Tebano et al., 1997; Burke and Hablitz,
1995; Arvanov et al., 1995). Hence it might be expected to inhibit the occurrence of afterdischarges
during 5 Hz stimulation. However, afterdischarges were always observed in the presence of MCPG,
and onset latency and duration were within the same range as the values obtained in experiment 8.2
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Fig. 8.3
(A) MCPG infusion failed to prevent the reversal of EPSP slope (A),
or population spike LTP (B) by 5 Hz stimulation starting 10 s after
tetanization.
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8.4 The effect of 1 Hz stimulation on LTP
8.4.1 Methods
The methods used were identical to those described in experiment 8.2, except that a 10 min period of
1 Hz stimulation was delivered instead of 5 Hz stimulation. Because a 10 s interval between tetanus
and 5 Hz stimulation was most effective in reversing LTP in experiment 8.2, this interval alone was
tested in the present experiment (n = 6). Owing to the fact that this study was carried out several
months after experiments 8.2 and 8.3, a new control group was deemed necessary. Hence, an
additional group of rats received a tetanus only (n = 6).
8.4.2 Results
8.4.2.1 Effect of 1 Hz stimulation on LTP
The delivery of a 10 min period of 1 Hz stimulation starting 10s after tetanization had no lasting
effect on EPSP slope LTP (figure 8.4.1A), although a transient depression lasting approximately 20
min was observed. The mean percentage slope LTP over the final 10 min of the experiment failed to
reveal a difference between tetanus + 1 Hz and tetanus only groups [F < 1], No difference in mean
population spike LTP was found over the same period [figure 8.4. IB; F(l,10) = 1.48; p > 0.2].
No group differences in EPSP slope PTP measured 10 s after the final tetanus train were found [F <
1; data not shown]. Stimulation intensity, baseline EPSP slope, and baseline population spike
amplitude were also equivalent in both groups [F< 1 in all cases; data not shown].
Despite the absence of a difference between 1 Hz + tetanus and tetanus only groups, the amount of
EPSP slope LTP in the latter group was significantly lower than that obtained under apparently
identical conditions in the tetanus only group of experiment 8.2 [115.3 ± 2.1 % and 127.0 ± 1.9 %
respectively; F(l,10) = 18.8; p < 0.01], However, no differences in population spike LTP [F < 1], or
EPSP slope PTP 10 s after the final tetanus train [F(l,10) = 1.30; p > 0.2] were found between the
two tetanus only control groups. The groups also did not differ significantly in terms of baseline
EPSP slope [F< 1], baseline population spike amplitude [F < 1], and test pulse stimulation intensity
|F(I,10) = 2.07; p > 0.1]. The reason for this difference in control LTP between experiments remains
unknown (but see chapter 9.4.6).
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8.4.2.2 Effect of 1 Hz stimulation on E-S coupling
Changes in E-S coupling were analyses as described in experiment 8.2. Figure 8.4.2A shows mean E-
S plots for the tetanus only group. A very slight E-S potentiation was observed. Little change in E-S
coupling was obtained after tetanization followed by 1 Hz stimulation (figure 8.4.2B).
Linear regression lines were fitted to scatter plots relating population spike amplitude to EPSP slope
before and after tetanization, as described in experiment 8.2. All correlation coefficients were highly
significant (p < 0.01 or less). An ANOVA of the population spike amplitude elicited by a 75 %
maximal EPSP slope before and after tetanization and / or 5 Hz stimulation revealed a significant
group by time point interaction [F(l,10) = 3.50; p < 0.05], demonstrating that the two groups showed
differential changes in E-S coupling between the initial and final I/O curves. However, an analysis
of simple effects failed to reveal significant E-S shifts in either group when analysed individually
[tetanus only: E(l,10) = 3.24; p > 0.1; tetanus + 5 Hz: F(l,10) = 2.09; p > 0.1]. Despite this, a
significant group difference in population spike amplitude elicited by a 75 % EPSP slope was found
after tetanization [F(l,14) = 7.08; p < 0.05], but not before \F < 1], These data provide weak
evidence that whilst 1 Hz stimulation does not reverse LTP, it may reverse E-S potentiation.
However, the fact that E-S potentiation did not reach significance in the tetanus only group means
that there is no adequate baseline against which a reversal of E-S potentiation can be judged. Owing
to the fact that 1 Hz stimulation was always delivered after a tetanus, the effects of 1 Hz alone on E-S
coupling are unknown.
8.4.2.3 Absence of afterdischarges during 1 Hz stimulation.
Afterdischarges were never observed during the delivery of 1 Hz stimulation, although a slight
depression of EPSPs was observed during the low frequency train (data not shown). Slope values
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Fig. 8.4.1
(A) A 10 min period of 1 Hz stimulation did not reverse EPSP slope
LTP when delivered starting 10 s after tetanization. (B) The population
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Mean relationship between population spike amplitude and EPSP slope
at each point on the I / O curve recorded before and after tetanization.
Data from both groups, i.e. tetanus only (A) and tetanus + 1 Hz (B) are
plotted (see text for details).
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8.5 General discussion
The present experiment reveals that dentate LTP in vivo exhibits a limited vulnerable phase, lasting
less than 10 min after induction, during which potentiation can be disrupted by 5 Hz stimulation.
Neither the induction of LTP, nor its reversal, was blocked by the application of the mGluR
antagonist, MCPG. Unlike the reversal of LTP, however, the reversal of tetanus-induced E-S
potentiation occurred in a time-independent manner, and 5 Hz stimulation alone resulted in E-S
depression.
8.5.1 The significance of theta frequency stimulation in LTP reversal
It may be significant that stimulation at 5 Hz, a frequency within the range of the hippocampal theta
rhythm (see chapter 2.4.8), was effective in reversing LTP, whilst 1 Hz stimulation had no effect. The
firing of neurons in area CA1 and the dentate gyrus of behaving rats is characterized either by high
frequency bursts known as complex spikes, or by the firing of single action potentials (Ranck Jr.,
1973). Both forms of activity are frequently phase-locked to the theta rhythm (Hill, 1978; Bland et
al., 1980; Otto et ah, 1991). It has been suggested that the firing of complex spikes may represent a
mechanism for the induction of a naturally occurring form of synaptic potentiation, whilst the firing
of single pulses phase-locked to theta may serve to reverse such potentiation (Larson et ah, 1993). In
fact, it has recently been reported that the exploration of a novel environment, a process that causes
an increase in power at theta frequencies, can reverse tetanically-induced dentate LTP (Xu et ah,
1998b).
However, stimulation at theta frequencies readily induces seizure-like afterdischarges (Ben-Ari et ah,
1979; Burdette et ah, 1996). In the present study, activity of this kind was always observed during 5
Hz stimulation, but never during 1 Hz stimulation. It is possible that theta frequency stimulation may
be effective in reversing LTP, not because such stimulation mimics endogenous patterns of
hippocampal activity, but because oscillatory circuits within the hippocampus are "tuned" to theta
frequencies, and can readily be driven to pathological states of activity by stimulation within this
frequency range. As such, it is possible that LTP reversal by 5 Hz stimulation, rather than being a
candidate mechanism for the active forgetting of information, may have more in common with
various neuropathological events. In this respect, it may be significant that the induction of seizures
has been reported to reverse LTP and to disrupt memory consolidation (Hesse and Teyler, 1976;
McGaugh. 1966).
Indeed, Abraham et al. (1996) reported that the delivery of 3 Hz stimulation starting 1 min after
tetanization resulted in an apparent depotentiation of dentate LTP in awake rats, only when
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accompanied by afterdischarge activity. No effect was obtained in one rat that did not exhibit
afterdischarge activity. Furthermore, this "depotentiation" was found to be transient, and was
interpreted as a non-specific depression of responses resulting from seizure generation. However, this
possibility cannot explain the results of the present study, as afterdischarges were equally severe
irrespective of the interval between tetanus and 5 Hz, yet no reversal of LTP could be induced 10 min
or 30 min after tetanization.
Despite the fact that a general depression of EPSPs cannot explain the time-dependent reversal of
LTP, it is impossible to rule out the possibility that afterdischarges play a necessary role in this
phenomenon, but are not in themselves sufficient to reverse LTP. This issue can only be resolved if a
means can be found of delivering a train of 5 Hz in vivo without inducing afterdischarges. For
instance, it may be possible in future experiments to gradually increase stimulation frequency to 5 Hz
without reaching the afterdischarge threshold. However, pilot studies using this technique have so far
proved unsuccessful. Alternatively, the stimulation intensity might be gradually increased during 5
Hz stimulation, without eliciting seizure-like activity.
Of course, the simplest method of eliminating afterdischarges would be to use a very low stimulation
intensity throughout 5 Hz stimulation. However, this method of stimulation would almost certainly
activate fewer of the afferent fibres than those recruited during a high frequency tetanus of sufficient
intensity to induce lasting LTP. Hence, it is likely that the use of very low stimulation currents during
5 Hz stimulation would fail to reverse LTP, and would provide no evidence about the role of
afterdischarges in this phenomenon.
8.5.2 Changes in E-S coupling
In the present study, tetanization resulted in a modest E-S potentiation, a phenomenon that is
routinely observed after tetanic induction of LTP, and has been attributed to a reduction in tonic
GABAergic inhibition (Chavez-Noriega et al., 1990) and an enhanced activation of dendritic voltage
sensitive calcium channels (Vida et ah, 1995). The delivery of 5 Hz stimulation following
tetanization reversed both LTP and E-S potentiation. The time-dependent reversal of LTP suggests
that this phenomenon is probably input-specific. However, the reversal of E-S potentiation occurred
in a time-independent fashion. Furthermore, the delivery of 5 Hz alone caused a decrease in E-S
coupling. This suggests that 5 Hz stimulation causes a decrease in granule cell excitability in response
to activity at both naive and potentiated synapses, an action which casts doubt upon the input
specificity of the time-independent reversal of E-S potentiation. The possible relevance of this finding
to the use of 5 Hz stimulation as an alternative to drug treatment in behavioural studies is discussed
below.
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8.5.3 The mechanism of time-dependent LTP reversal
II is possible that the time-dependent reversal of LTP by 5 Hz stimulation may be dependent on the
activation of adenosine A) receptors. 5 Hz stimulation is known to result in an increase in adenosine
release from hippocampal slices (Jonzon and Fredholm, 1985; Cunha et al., 1996). It has been
reported that the application of adenosine A] receptor antagonists to CA1 slices prevents the reversal
of LTP by 5 Hz or 1 Hz stimulation in CA1 slices (Larson et al., 1993; Fujii et al., 1997).
Furthermore, LTP can be reversed by the application of adenosine within 1 min, but not 5 min after
tetanization (Arai et al., 1990b). This time window is similar to the period during which LTP was
found to be vulnerable to reversal by 5 Hz stimulation in the present study. (However, Mitchell ct al.
(1993) have reported a failure to reverse CA1 LTP by the post-tetanus application of adenosine. The
reason for this discrepancy is unknown).
It has recently been reported that LTP induced by theta burst stimulation in CA1 slices can be
reversed in a time-dependent manner by the delivery of additional theta burst trains, a result which
explains the inverted U-shaped relationship between the number of theta burst trains in a tetanus and
the subsequent magnitude of LTP (Abraham and Huggett, 1997). As in the present study, the period
during which LTP was vulnerable to reversal lasted less than 10 min. The application of an adenosine
A, receptor antagonist prevented the reversal of LTP by excessive theta burst stimulation and allowed
LTP to develop normally.
Interestingly, it may be significant that both adenosine A, receptor activation and low frequency
stimulation are associated with a decrease in E-S coupling in area CA1 and the dentate gyrus,
respectively (Stone and O'Kane, 1997; Bramham and Srebro, 1987). These results are reminiscent of
the E-S depression reported here after the delivery of 5 Hz stimulation without prior tetanization.
The mechanism by which adenosine A| receptor activation can reverse LTP is unknown, although a
number of possibilities have been proposed (see Arai et al., 1990b; Abraham and Huggett, 1997). It is
unlikely that a presynaptic reduction in glutamate release resulting from A, receptor activation (see
Dunwiddie, 1985) could account for a time-dependent reversal of LTP. However, hippocampal A[
receptors are located both pre and postsynaptically (Deckert and Jorgensen, 1988). Furthermore, the
application of adenosine has been found to inhibit cAMP accumulation in CA1 pyramidal cells (van
Calker et al., 1979), a phenomenon subsequently found to be mediated by postsynaptic A, receptors.
(Dunwiddie and Fredholm, 1989). Hence, is possible that A, receptor activation disrupts postsynaptic
cAMP-dependent second messenger cascades known to be involved in the stabilization of LTP (Frey
et al., 1993; Huang and Kandel, 1994).
However, there is also evidence that adenosine receptor activation inhibits the activation of integrins,
a class of cell surface receptor (Thiel et al., 1996). In a recent study, an integrin antagonist was found
to induce a time-dependent reversal of LTP in CA1 slices: application of the drug 25 min or more
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after tetanization had no effect on potentiation (Staubli et al., 1998). Integrins are involved in the
control of morphological synaptic changes and the rearrangement of the postsynaptic membrane
environment following LTP induction. Previous studies have implicated these receptors in the
stabilization of LTP (Xiao et al., 1991; Bahr et al., 1997), and the inhibition of integrin activation
provides a potential mechanism for the depotentiation induced by low frequency stimulation.
Hence, the results of the present study might be explained by the possibility that activation of Ai
receptors in response to adenosine release during 5 Hz stimulation disrupts second messenger
cascades and / or integrin function during a vulnerable period of LTP stabilization, resulting in a
time-dependent reversal of potentiation.
However, a number of questions remain unanswered in this scheme. In particular, the role of NMDA
receptors in the time-dependent reversal of LTP is unknown. Furthermore, it is possible that the
reversal of established LTP reported by some groups (e.g. Bashir and Collingridge, 1994; Doyle et
al., 1997) is mechanistically distinct from the time-dependent reversal of LTP reported in the present
study and elsewhere (e.g. Larson et al., 1993; Staubli and Chun, 1996). One piece of evidence
suggests that this might indeed be the case. It was mentioned above that adenosine can reverse LTP if
applied within minutes of LTP induction, a phenomenon implicated in the time-dependent reversal of
LTP by low frequency stimulation (Arai et al., 1990b). However, endogenous adenosine has been
reported to attenuate both LTD and the depotentiation of established LTP in CA1 slices (de
Mendon§a et al., 1997). It is possible that the former result reflects a disruption of processes involved
in the stabilization of LTP, whilst the latter result may reflect an inhibition of mechanisms involved
in the induction of synaptic plasticity. Note that endogenous adenosine is found to inhibit LTP. in
addition to its effects on LTD and depotentiation (Mendoncja and Ribeiro, 1994).
It would be interesting to carry out a pharmacological characterization of the LTP reversal obtained
in the present study. Unfortunately, the limited time window during which dentate LTP can be
reversed would make such an undertaking very difficult. A ventricular infusion starting immediately
after tetanization would be unlikely to result in a sufficient hippocampal drug concentration 2 min
later. Direct intrahippocampal drug infusion might be possible, although it is likely that infusion at
the rapid rate necessary would result in a general depression of EPSPs, thus confounding the results.
Future studies will assess the practicality of such an approach.
8.5.4 LTP reversal by 5 Hz stimulation: physiological mechanism or experimental tool?
The physiological relevance of long trains of low frequency stimulation, such as a 10 min period of 5
Hz, is questionable. Nevertheless, the massive synchronous activation of afferent fibres occurring
during high frequency tetanization is similarly unnatural. However, brief periods of theta burst
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stimulation induce LTP and are physiologically plausible (see chapter 2.4.8). The possibility that LTP
induced using a more physiologically realistic tetanus might be reversed by a brief period of theta
stimulation remains a topic for future experiments. Nevertheless, regardless of the physiological
significance of the present findings, the ability to preferentially erase recently induced LTP, whilst
sparing established LTP, might provide a novel alternative to pharmacological intervention in future
behavioural studies of synaptic plasticity and learning.
In one possible version of such a study, a rat would be implanted with chronic stimulation and
recording electrodes, and trained in the watermaze delayed matching-to-place task (see Steele and
Morris, 1999). At variable intervals after the first trial of a session, 5 Hz stimulation would be
delivered. Retention of the platform position presented in the first trial would then be assessed. In this
way, it could be determined whether stimulation known to reverse LTP in a time-dependent manner
might also erase memory in a similar way.
However, there are several potential problems with the study proposed above. One such issue is the
difficulty of activating a large septotemporal portion of the hippocampus by perforant path
stimulation. It has been found that only a small residual fraction of the total hippocampal volume is
sufficient for normal watermaze learning, as long as this portion is located in the dorsal hippocampus
(Moser et al., 1993c, 1995). Hence, any treatment affecting a limited region of the hippocampus only
is unlikely to succeed. This problem has dogged research into the behavioural effects of LTP
saturation, but has recently been overcome by the implantation of recording electrodes into the dorsal
hippocampus following lesioning of the contralateral hippocampus (Moser et al., 1998). Tetanization
was delivered via an array of stimulating electrodes straddling the angular bundle of the perforant
path. Although laborious, such a technique would probably be necessary in a behavioural study of
memory erasure by 5 Hz stimulation.
A further issue concerns the synapse specificity of the LTP reversal effect. This was not conclusively
proven in the present study, although the time-dependent nature of LTP reversal provides some
support for this interpretation. However, the assumption that the effects of 5 Hz stimulation are
limited to the reversal of recently established LTP may not be strictly true. Ideally, this issue should
be resolved by the use of dual input studies prior to any behavioural exploitation of the LTP reversal
effect
The delivery of 5 Hz stimulation following tetanization reversed both LTP and E-S potentiation in the
present study. However, the reversal of E-S potentiation, unlike the reversal of LTP, occurred in a
time-independent fashion. Furthermore, the delivery of 5 Hz stimulation alone caused a decrease in
E-S coupling. This suggests that 5 Hz stimulation can cause a decrease in granule cell excitability in
response to activity at naive synapses, an action which casts doubt upon the input specificity of the
time-independent reversal of E-S potentiation following a tetanus. It is possible that a non input-
specific reduction in granule cell excitability might impair distant as well as recent memories.
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However, there is no reason to suppose that the degree of E-S depression would vary with the interval
between learning and 5 Hz stimulation. Indeed, the reversal of E-S potentiation induced by a tetanus
occurred in a time-independent manner as mentioned above. Hence the possibility that 5 Hz
stimulation might cause a decrease in E-S coupling in a behaving rat would not be likely to obscure a
delay-dependent effect on recall, even if an overall degradation of memory were found.
Finally, 5 Hz stimulation was always associated with epileptiform afterdischarges, phenomena which
may well have adverse physiological consequences in a behaving rat. It would be desirable to avoid
such pathological activity in any study of the effects of 5 Hz stimulation on learning.
In conclusion, the objections raised above do not rule out the possibility of using low frequency
stimulation as a way of preferentially erasing recent synaptic potentiation, although such a study
would be technically very demanding. However, the principle of looking for a tool which allows the




Factors associated with the magnitude of LTP
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9.1 Introduction
Throughout the period during which the work described in previous chapters was carried out,
intermittent problems with LTP induction were experienced. Typically, a tetanus that had previously
induced robust and lasting LTP would, a few months later, under apparently identical conditions,
induce only a short-term potentiation which would return to baseline within an hour. The problem
would spontaneously resolve itself again after another one or two months, with robust LTP being
obtained using the same recording and tetanization parameters. It was noticed that periods during
which LTP induction failed tended to occur in the winter, rather than the summer, an issue which is
discussed later. On a number of occasions, experiments were postponed after pilot studies revealed a
failure to induce lasting LTP of sufficient magnitude. In fact, the use of different tetanus parameters
in chapters 6, 7 and 8 was determined by the need to overcome difficulties in LTP induction.
Owing to the practical importance of this issue, efforts were made to identify some of the factors
governing the magnitude of LTP. Whilst this analysis did not entirely solve, or indeed explain, the
problems in LTP induction, it served to highlight the critical importance of a number of baseline
stimulation and tetanization parameters which are generally set at arbitrary values. The organization
of this chapter is partly chronological and partly thematic. This structure is necessary in order to
explain the rationale behind the data analysis and pilot studies carried out at each stage.
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9.2 The influence of initial EPSP magnitude on subsequent LTP: further analysis of data from
experiment 6.2
9.2.1 Introduction
In experiment 6.2, an attempt was made to determine the effects of MCPG on LTP induction.
However, this attempt was unsuccessful owing to the failure to induce lasting LTP in either drug-
treated or control groups. The tetanus used in this study (see chapter 6.2.1) had been successfully
used in studies of LTP in freely moving rats (Riedel et al. 1994a, 1995a). However, stronger
tetanization parameters may be needed to induce LTP under urethane anaesthesia (see chapter 3.10.5
& 7.7).
Nevertheless, during the study it appeared that the "better" the original EPSP after implantation of
electrodes, the less LTP was obtained after tetanization. In order to quantify this subjective
impression, the correlation between LTP magnitude and a range of baseline parameters was
investigated. Data from drug and control groups (total n = 24) were pooled for the following analysis,
because no significant differences between groups were observed.
There are a number of possible measures of "initial" EPSP slope magnitude that might be used, e.g.
the baseline EPSP slope recorded over the 10 min prior to tetanization, or the EPSP slope recorded at
a fixed stimulation intensity during the initial I/O curve before the start of the main experiment (see
chapter 6.2.1.5). In fact, the maximum EPSP slope recorded during this I/O curve was initially
chosen, although the pre-tetanus baseline EPSP slope was also analysed.
9.2.2 Results
Despite the adjustment of test pulse stimulation intensity, the pre-tetanus baseline EPSP slope was
very significantly correlated with the maximum EPSP slope elicited during the initial I/O curve
[figure 9.2.1; /- = 0.83; p < 0.01], suggesting that both measures are broadly equivalent. However, this
correlation indicates that the attempt to standardize EPSPs by adjusting the baseline stimulation
intensity was only partially successful.
Slope LTP was significantly negatively correlated with maximum initial slope when measured both
50-60 min post-tetanus [figure 9.2.2A; r = -0.55; p < 0.01] and 110-120 min post tetanus [figure
9.2.2B; r = -0.63; p < 0.01], confirming the initial suspicions that "good" potentials result in poor
LTP. No significant correlation was found between the level of EPSP slope PTP (0-4 min post
tetanus) and maximum initial EPSP slope [r = -0.18; NS; data not shown]. The baseline EPSP slope
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recorded over the 10 min before tetanization was also found to be significantly correlated with the
amount of EPSP slope LTP 50-60 min and 110-120 min after tetanization [r = -0.47; p < 0.05 and r =
0.44; p < 0.05 respectively; data not shown].
In addition to the above correlations, EPSP slope LTP measured 110-120 min after tetanization was
found to be negatively correlated with maximum initial population spike amplitude [figure 9.2.3A; r
= -0.58; p < 0.01] and maximum initial EPSP amplitude [figure 9.2.3B; r = -0.51; p < 0.02].
No significant correlations were found between the initial maximum values of each measure (EPSP
slope, population spike, or EPSP amplitude) and population spike PTP and LTP at any time point
(data not shown). No significant correlations were found between baseline stimulation intensity and
the PTP or LTP of any measure (data not shown). Similarly, baseline stimulation intensity was
correlated neither with the maximum EPSP slope obtained during the initial I/O curve, nor the pre-
tetanus baseline EPSP slope (data not shown).
In order to investigate the possible relationship between learning ability and the subsequent induction
of LTP, data from (-)-MCPG and 20 mM MCPG-treated rats were pooled (total n = 14), owing to the
absence of any difference in watermaze performance between these two groups. However, percentage
time in the training quadrant during the transfer test was not significantly correlated with the level of
EPSP slope LTP recorded either 1 hr or 2 hr after tetanization [/- = 0.03 and 0.08 respectively; data
not shown],
9.2.3 Discussion
The suspicion that "good" EPSPs result in poor LTP was confirmed by an analysis of the negative
correlation between various initial attributes of an EPSP, and the level of LTP subsequently induced.
It is possible that the initial size of an EPSP reflects naturally occurring synaptic enhancement as a
result of watermaze learning. If so, the failure to potentiate initially large EPSPs may be a
consequence of the fact that such EPSPs are already substantially potentiated above baseline levels.
However, this explanation predicts a negative correlation between watermaze learning and LTP. In
fact, no significant correlation was found between the percentage time spent in the training quadrant
during the transfer test, and the level of LTP 1 or 2 hr after tetanization.
However, it is likely that differences in the placement of stimulation and recording electrodes play a
role in determining the level of LTP induced. The accuracy with which the stimulating electrode is
lowered into the angular bundle of the perforant path will determine how many fibres are activated by
test pulse stimulation. An accurate electrode placement that activates a large number of fibres will
generate an EPSP with a large population spike and EPSP slope. This effect is not cancelled out by
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the adjustment of test pulse stimulation intensity in order to elicit a population spike 40 % of the
maximum obtainable. Pre-tetanus baseline EPSP slope values were still found to correlate
significantly with initial maximum values (figure 9.2.1).
Jeffery (1995) reported that if I / O curves were measured in freely moving rats, before and after
tetanization, the greatest amount of LTP was seen at the lowest test pulse intensities. It was suggested
that non-linear summation of post-synaptic potentials might explain this phenomenon. As more
perforant path fibres are recruited, the number of converging inputs to dentate granule cells increases,
which leads to a rise in non-linear summation. Thus, at high test pulse intensities, non-linear
summation may result in a smaller percentage EPSP slope increase than that observed using low test
intensities, at which non-linear summation is negligible. A similar phenomenon may explain why
large EPSPs, presumably entailing the activation of a high number of perforant path afferents, show
less LTP after tetanization than smaller EPSPs, in which considerably fewer converging inputs are
activated. However, it is unlikely that non-linear summation of EPSCs can account for a total failure
of LTP in a large proportion of cases. Ideally, plots of LTP across a range of test pulse intensities
should be constructed, in order to directly compare the present findings with those of Jeffery (1995).
However, this analysis is not possible using the present data, owing to I / O curves having been
recorded only at the start of the experiment. A more thorough analysis is presented below based on
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Fig 9.2.1
(A) Pre-tetanus baseline EPSP slope is highly correlated with the
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Fig. 9.2.2
(A) EPSP slope LTP 1 hr after tetanization is negatively correlated
with maximum EPSP slope during an initial I/O curve.
(B) EPSP slope LTP 2 hr after tetanization is also negatively
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Fig. 9.2.3
(A) EPSP slope LTP 2 hr after tetanization is negatively correlated
with maximum initial pop. spike amplitude
(B) EPSP slope LTP 2 hr after tetanization is also negatively
correlated with maximum initial EPSP amplitude.
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9.3 The effect of tetanus intensity and initial EPSP magnitude on EPSP slope LTP: pilot
studies and further analysis of data presented in experiment 7.3
9.3.1 Pilot studies
The failure to induce LTP at the end of watermaze testing in experiment 6.2 was solved by the use of
a different tetanus that induced lasting LTP in control rats (see experiments 7.3, 7.4 and 7.6).
However, during the autumn and winter following the completion of the work described in chapter 7,
this tetanus induced little or no LTP. Although the reasons for the change in effectiveness are
unknown, it is possible that a larger current during tetanization might result in greater afferent
cooperativity and hence greater LTP. Indeed, McNaughton et al. (1978) reported that a threshold
exists for the induction of LTP, and that even above this threshold, the amount of LTP increases as
the tetanization intensity is increased.
In order to examine whether a more intense high frequency tetanus might result in LTP, a number of
rats were tetanized either al double the baseline test pulse intensity (n = 6), or with a 1 mA tetanus
regardless of the test pulse intensity (n = 7). Potentiation was recorded for 1 hr after tetanization. The
tetanus and recording protocol used was otherwise identical to that described in experiment 7.3. In
both conditions, little or no lasting EPSP slope LTP was induced (figure 9.3.1 A). No group difference
in EPSP slope potentiation 1 hr after tetanization was found [F < 1 ]. Test pulse stimulation intensities
were equivalent between groups [E(l,l 1) = 1.09; p > 0.3; data not shown].
However, population spike amplitudes were still elevated 1 hr after tetanization (figure 9.3.IB). The
increase was modest (approximately 2 mV), and did not differ between groups [F < 1], It is
interesting that population spike potentiation was more robust than EPSP slope potentiation, a
phenomenon which was often noted in the course of LTP experiments. In fact, since almost no slope
LTP remained after 1 hr in the present study, the only persistent change in these animals was an E-S
potentiation. A similar transient potentiation of the EPSP slope, but a lasting potentiation of the
population spike has been reported by others under some circumstances (e.g. Pugliese et al., 1994).
Owing to the fact that I / O curves were recorded before and after tetanization in this study, it was
possible to examine the amount of LTP induced at a range of test pulse intensities, independently of
the test pulse stimulation intensity used throughout the main experiment. As mentioned above, this
analysis was not possible in experiment 6.2, owing to the fact that I/O curves were recorded before
tetanization only. Figure 9.3.2A shows the amount of LTP induced over the entire range of test pulse
intensities sampled in the I / O curves recorded 20 min before and 1 hr after tetanization. A detailed
account of this form of analysis is given in experiment 7.3. Little LTP was induced at any test
intensity in either group, but potentiation was lowest at the smallest test intensity, 0.1 mA (see section
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9.3.2).
The above data reveal that at times during which problems are experienced with LTP induction,
simply increasing the tetanus intensity does not provide a solution.
9.3.2 Further analysis of data from experiment 7.3: Effect of tetanus intensity on LTP across the I /
O curve
In order to investigate the phenomenon of EPSP slope depression at low test intensities in more
detail, it was decided to re-examine data from experiment 7.3. Note that in this experiment, I / O
curves were recorded 20 min before and 2 hr after tetanization. Owing to the absence of a difference
between drug and vehicle groups, data from all 20 rats in experiment 7.3 were pooled for the
following analysis. Figure 9.3.2B shows the mean EPSP slope potentiation over the entire range of
test intensities. Note the slight depression and increased standard error at a test intensity of 0.1 mA, a
phenomenon that is also observed in figure 9.3.2A.
Figure 9.3.3 shows sample plots relating LTP to test pulse intensity in three individual rats. In rat 1,
the greatest amount of potentiation was obtained at low test intensities. However the data from rats 2
and 3 are perhaps more typical. In these animals, the largest potentiation was seen at high test
intensities. In fact, tetanization caused a lasting depression of EPSP slope in rat 3 at the two lowest
test intensities. The raw I / O curve data from rats 1 and 3 are shown in figure 9.3.4. The percentage
LTP at each test intensity displayed in figure 9.3.3 was obtained simply by dividing the EPSP slope
value after tetanization by the value recorded before tetanization, then multiplying by 100. Note that
the pre- and post-tetanus I / O curves for rat 3 cross over at a test intensity of about 0.3 mA. Prior to
this point, EPSP slope values are depressed following tetanization, a phenomenon that is small in
absolute terms, but large in percentage terms.
Since baseline lest pulse intensities in experiment 7.3 were set at different values in each rat in order
to elicit a population spike amplitude of 2-4 mV, and since the tetanization current was always set at
double this value, a wide range of tetanus intensities was used. Hence, using I/O curve data, the
effect of tetanus intensity on the magnitude of LTP can be investigated over a range of test intensities.
In order to assess the overall relationship between tetanus intensity, test pulse intensity, and LTP
magnitude, scatter plots were constructed relating EPSP slope LTP to tetanus intensity at each test
pulse intensity sampled during the recording of I / O curves. Scatter plots of this relationship at 0.1
mA, 0.5 mA, and 1.0 mA are shown in figure 9.3.5. Significant correlations were revealed between
tetanus intensity and LTP magnitude only at the lowest test intensities. The change in the value of the
correlation coefficient, r, of the relationship between EPSP slope LTP and tetanus intensity as test
pulse intensity was increased is shown in figure 9.3.6A. The slope of this function became
280
progressively less negative as test pulse intensity was increased. Significant values of r are indicated
(see figure legend). At face value, this result suggests that tetanus intensity is negatively correlated
with LTP magnitude only at low test pulse intensities. However, the interpretation of these data is
complicated by the fact that tetanus intensity was found to be significantly negatively correlated with
initial maximum EPSP slope [r = -0.52; p < 0.05; figure 9.3.6B], i.e. small EPSPs were tetanized
more strongly than large EPSPs. This correlation is an artifact of the adjustment of test pulse
stimulation intensity to elicit a population spike of fixed amplitude. If the EPSP slope and population
spike amplitude were initially small, the baseline test pulse intensity was set at a high value in order
to elicit an EPSP of standard size. Since the tetanus intensity was always set at double the test pulse
intensity, small EPSPs were tetanized more intensely than large EPSPs. Note that no such
relationship was found in data taken from experiment 6.2, a finding which may be explained by the
use of different criteria for the setting of baseline test pulse intensity.
Because initial maximum EPSP slope is a factor likely to influence the level of LTP obtained (see
section 9.2), partial correlations were calculated. At each test pulse intensity, the relationship between
tetanus intensity and LTP was assessed, whilst controlling for the effects of initial maximum EPSP
slope. The partial correlation coefficient at each test pulse stimulation intensity is shown in figure
9.3.6C. Note that the correlation between tetanus intensity and LTP is now negative at all test pulse
intensities. A non-significant trend towards a negative correlation was obtained at several intensities,
and the correlation reached significance at 0.7 mA (see figure legend).
The present results reveal that, over the range tested, tetanization strength is inversely correlated with
the amount of EPSP slope LTP. Note that although the strength of the corrected negative correlation
was equivalent at all test intensities, an EPSP slope depression was only observed at the lowest test
intensities, and good LTP was usually obtained at high intensities (see figure 9.3.2B). The reason for
the depression of EPSPs at the low end of the I / O curve is not known. One possibility, however, is
that feed-forward inhibition may be potentiated after tetanization. It has been reported in area CA1
that at low stimulation levels, the magnitude of the IPSP dominates EPSP components, but that a
larger number of excitatory components than inhibitory components are recruited with increasing test
stimulation intensity (Turner, 1990). Hence, a potentiation of feed-forward inhibition would
preferentially cause a depression at low test intensities. Furthermore, if tetanization strength
determines the extent to which feed-forward inhibition is potentiated, the inverse correlation between
tetanus strength and percentage LTP might be explained.
Results consistent with those of the present analysis have been described in the dentate gyrus of
freely moving rats. Hodgson et al. (1997) found that a high intensity tetanus resulted in an EPSP
slope depression at low test intensities, but EPSP slope potentiation at high test intensities. Low
intensity tetanization, in contrast, resulted in LTP at low test pulse intensities. A potentiation of feed¬
forward inhibition by high intensity tetanization was suggested as an explanation for this pattern of
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results. It was argued that fibre damage was not the cause of the EPSP depression resulting from high
intensity tetanization, since depressed responses were found to recover over time. Furthermore, 4
weeks after the depression of EPSPs by high intensity tetanization, the application of a low intensity
tetanus was able to induce LTP at the low end of the I / O curve.
The results of the present study and those of Hodgson et al. (1997) are somewhat different from those
reported by Jeffery (1995) in freely moving rats. In the latter study, the effects of tetanus intensity
were not investigated. However, the greatest amount of LTP was always observed at low test pulse
intensities. Plots relating EPSP slope LTP to test pulse intensity generally resembled the data from rat
1 shown in figures 9.3.3 and 9.3.4 of the present study. It was found that after plotting percentage
EPSP slope LTP against the log of test pulse intensity for each rat, the data were well described by a
linear fit with negative slope. However, in the present study, such semi-log plots were found to be
positive in 13 out of 20 rats tested (data not shown), reflecting the fact that LTP was usually smallest
at low intensities. One possible reason for the discrepancies between studies is the fact that the
tetanus intensities used by Jeffery (1995) were typically about 0.3 mA, i.e. about half those used in
the present study. However, Jeffery (1995) used unanaesthetized rats, a factor which complicates
such comparisons. Nevertheless, the high intensity tetanus used by Hodgson et al. (1997) was set at a
current of 1.259 mA, higher than any tetanus used here.
Whatever the explanation for this phenomenon, in future experiments, baseline test pulse intensities
should be set at levels not lower than 0.2 mA, and that the use of high intensity tetani should be
avoided.
9.3.3 Further analysis of data from experiment 7.3: Effect of initial maximum EPSP slope on LTP
across the I/O curve
In section 9.2, it was reported that, paradoxically, large EPSPs show a smaller percentage LTP than
small EPSPs. Analysis of the relationship between maximum EPSP slope recorded during the initial I
/ O curve to percentage LTP at increasing test pulse intensities was carried out in exactly the same
way as described for tetanus intensity in section 9.3.2. Maximum initial EPSP slope values recorded
during the first I/O curve were highly correlated with pre-tetanus baseline EPSP slope values [r =
0.89; p < 0.001; data not shown], and with the EPSP slope recorded at all test pulse intensities [p <
0.01 or less in all cases; data not shown]. This result illustrates the fact that, as in section 9.3.2, the
maximum initial EPSP slope is broadly equivalent to all other alternative EPSP slope measures which
might have been chosen as independent variables in the following analysis.
Maximum initial slope values did not correlate significantly with EPSP slope LTP at any test pulse
intensity, although a weak, non-significant, positive association with EPSP slope LTP was observed
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at low test intensities, a relationship which became negative at higher test intensities (but see below
for analysis of partial correlations). Figure 9.3.7 shows scatter plots of the relationship between initial
EPSP slope and LTP at test intensities of 0.1 mA (A), 0.5 mA (B), and 1.0 mA (C). The change in the
correlation coefficient of the relationship between initial EPSP slope to percentage LTP is plotted in
figure 9.3.8A. However, as mentioned above, maximum initial EPSP slope was significantly
negatively correlated with tetanus intensity. Hence partial correlation coefficients were calculated
relating initial maximum EPSP slope to LTP at each test pulse intensity, whilst controlling for the
effects of tetanus intensity. The results are shown in figure 9.3.8B. Note that the corrected correlation
between initial EPSP slope and LTP is always negative, but becomes progressively stronger as the
test intensity is increased, reaching significance at 1.0 mA (see figure legend). The original weak
positive relationship between initial maximum EPSP slope and percentage LTP at low test intensities
was merely an artifact of the negative correlation between tetanus intensity and initial maximum
EPSP slope values.
However, because the maximum initial EPSP slope was recorded at or near a test intensity of 1 mA,
the fact that this measure is most strongly correlated with LTP at a 1 mA test intensity could be an
artifact. In order to rule out this possibility, partial correlations between the initial EPSP slope elicited
by stimulation at 0.1mA and percentage LTP at all test intensities were calculated, whilst controlling
for the effects of tetanus intensity. Consistent with the results obtained using initial maximum EPSP
slope, the strength of this correlation was greatest at high test intensities. Hence, the deleterious
effects on LTP of a large initial EPSP slope are genuinely most severe at high test intensities.
The finding that initial EPSP slope is negatively correlated with percentage LTP is consistent with the
results of section 9.2. It was suggested that the generation of a large EPSP is likely to involve the
activation of a larger number of perforant path fibres than the generation of a small EPSP. Owing to
the greater degree of postsynaptic convergence resulting from the activation of many afferent fibres,
large EPSPs may suffer from a greater masking of LTP by non-linear summation of postsynaptic
potentials than small EPSPs. According to this account, increasing the test pulse intensity would
make matters even worse, by recruiting even more afferent fibres. This may explain the present
observation that the negative correlation between initial EPSP slope and percentage LTP is strongest
at high test pulse stimulation intensities.
However, variability in the initial size of an EPSP is inevitable, and EPSP magnitude is not a factor
that can easily be manipulated. It was found in both the present section and section 9.2.2 that baseline
EPSP slope is still highly correlated with initial maximum EPSP slope, even after an attempt has been
made to standardize potentials by adjusting the test pulse stimulation intensity. Hence, even if a
relationship exists between initial EPSP magnitude and LTP, there is little that could be done except
to ensure that the mean initial EPSP slope is equivalent across experimental groups.
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Tetanization with 5 trains of 20 pulses at 250 Hz, 10 s between trains.
Stimulation intensity was set at either double the baseline intensity
(n = 6) or 1 mA (n = 7). No differences in EPSP slope LTP (A) or
population spike LTP (B) were observed.
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Fig. 9.3.2
Percentage EPSP slope LTP over the full range of test pulse
intensities. (A) LTP pilot study in which little or no LTP was
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Fig. 9.3.4
The absolute increase in EPSP slope across areange of test pulse
intensities. Rat 2 shows a slight depression in EPSP slope at low
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The relationship between EPSP slope LTP and tetanus intensity
at three different test pulse stimulation intensities. Data were
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Fig. 9.3.6
(A) Values of correlation coefficient, r, obtained from regression
lines relating percentage EPSP slope LTP to tetanus intensity over
the full range of test pulse stimulation intensities. (B) Tetanus
intensity is negatively correlated with initial maximum EPSP slope.
(C) Values of partial correlation coefficient, r, obtained by relating
EPSP slope LTP to tetanus intensity whilst controlling for the effects
of initial maximum EPSP slope. [ *p < 0.05; xp < 0.1]
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Fig. 9.3.7
The relationship between EPSP slope LTP and initial maximum
EPSP slope at three different test pulse stimulation intensities.
Data were calculated from I/O curves recorded 20 min before,
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Fig. 9.3.8
(A) Values of correlation coefficient, r, obtained from regression
lines relating percentage EPSP slope LTP to initial maximum EPSP
slope over the full range of test pulse stimulation intensities.
(B) Values of partial correlation coefficient, r, obtained by relating
EPSP slope LTP to initial maximum EPSP slope whilst controlling
for the effects of tetanus intensity. [*p < 0.05; xp < 0.1]
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9.4 Other variables associated with LTP magnitude
9.4.1 Introduction
This section begins with a description of a new set of baseline stimulation and tetanization parameters
that were found to induce robust LTP, despite the failure of previously adequate parameters (see
section 9.3.1). Possible reasons for the success of this protocol are discussed, after which a number of
additional issues relating to the induction of LTP, such as the strain of rat used, stress levels, and
seasonal variations in hormone levels are addressed.
9.4.2 The use ofnovel tetanus parameters: inter-train interval is only moderately important
The inability to induce robust LTP under conditions apparently identical to those of previous
experiments was again overcome by the use of a different set of baseline stimulation and tetanization
parameters. The parameters used were a modified version of those routinely used with success by
Errington and colleagues (e.g. Errington et al., 1995). Baseline test intensity was set, as before, at an
intensity sufficient to elicit a small population spike (2-4 mV), but pulse width was set at 50 ps,
rather than 100 ps as before, and monophasic rather than biphasic pulses were delivered. During
tetanization. the pulse width was doubled to 0.1 mA, but the stimulation intensity was not changed.
The tetanus consisted of 3 trains of 50 pulses at 250 Hz. In previous studies using this tetanus, an
inter-train interval of 1 min has typically been used. However, owing to the need to deliver low
frequency stimulation very soon after tetanization in experiment 8.2, pilots were carried out with an
interval of 20 s, and a 10 s inter-train interval was finally adopted.
There are several differences between the parameters described above and those used in previous
experiments, none of which were systematically investigated. For instance, monophasic stimulation
was adopted purely in order to replicate the conditions described by Errington and colleagues.
However, a number of other factors relating both to the new parameters are worth addressing, even if
conclusive data are unavailable.
It has been suggested, though never systematically studied, that optimal LTP is induced by widely
spaced tetanus trains. A potential mechanism for such an effect might be adenosine release during
tetanization, a phenomenon that might block further potentiation induced by subsequent trains
delivered in close succession (see Abraham and Huggett, 1997).
Figure 9.4.1 shows the amount of LTP induced by the tetanus described in the first paragraph of this
section, with either a 20 s inter-train interval (n = 6) or a 10 s interval (n = 6). The latter data are
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taken from the "tetanus only" control group of figure 8.2.2; The use of a 10 s inter-train interval did
not result in a significantly different level of EPSP slope LTP after 1 hr compared to a 20 s inter-train
interval [figure 9.4.1 A; F(l,10) = 2.44; p > 0.1]. However, a slightly reduced level of EPSP slope
PTP was seen in the 10 s condition [F(l,10) = 7.35; p < 0.05], A trend towards a difference in the
increase in population spike amplitude 1 hr after tetanization was also observed [figure 9.4.IB;
F(l,10) = 4.88; 0.1 > p > 0.05], and population spike PTP was significantly smaller in the 10 s
condition [F( 1,10) = 3.69; 0.1 > p > 0.05]. These data reveal a slight effect of inter-train interval.
However, the main finding is that robust LTP was induced in both conditions, after a period of failure
using previous tetanus parameters. Owing to the fact that the use of a 10 s inter-train interval resulted
in successful LTP in the present study, but very little LTP in section 9.3.3, this factor cannot explain
the failure of LTP induction.
It is worth noting that the tetanus intensity was fairly mild. Tetanic stimulation was delivered at an
intensity of less than 0.3 mA, with a pulse width of 100 ps, i.e. approximately half the intensity used
in experiment 7.3. Nevertheless, analysis of the first pulse of the first tetanus train in the "tetanus
only" group of experiment 8.2 revealed that stimulation at this intensity evoked a mean EPSP slope
of 5.39 ± 0.54 mV / ms, and a population spike amplitude of 7.65 ± 0.68 mV. It would be
inappropriate to describe such stimulation as "weak". Nevertheless, in view of the detrimental effects
of high tetanus intensities revealed in section 9.3.2, the use of a less intense tetanus may have
contributed to the respectable levels of LTP displayed in figure 9.4.1.
9.4.3 The effect ofbaseline test pulse width on the level ofLTP recorded
In experiment 8.2, baseline test pulse stimulation was delivered at a pulse width of 50 ps, half the
value used in previous experiments. Halving the duration of the stimulus pulse is not equivalent to
halving the current. For instance, a weak stimulating current would not be expected to activate as
many afferent fibres as a strong current, regardless of the duration of the pulse.
Owing to the fact that the characteristics of the test pulse with which potentiation is sampled are
critical in determining the level of LTP recorded (see section 9.3.2), pulse width I/O curves were
recorded over a range of stimulus intensities both before and after tetanization. The following data
were recorded from a single rat, a member of the 20 s inter-train interval group displayed in figure
9.4.1. During tetanization, pulses were delivered at 0.3 mA with a pulse width of 100 ps.
I / O curves were recorded both 20 min before and 1 hr after tetanization. Pulse widths ranged from
10 to 100 ps, and 4 different stimulation intensities were tested (0.1 mA, 0.2 mA, 0.4 mA, and 0.8
mA). Inspection of the raw data from the pre-tetanus I/O curve revealed that EPSP magnitude was
not determined by a simple multiplication of stimulation intensity with pulse width (i.e. total charge
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passed). The absolute EPSP slope elicited by a 0.8 mA test pulse of 10 ps duration was more than
double the size of that elicited by a 0.1 mA test pulse of 100 ps duration (data not shown).
Figure 9.4.2 shows the amount of EPSP slope LTP at increasing pulse width over the 4 different
stimulation intensities. Curves were constructed from the I / O data as described in experiment 7.3.
The most striking finding is the EPSP slope depression at small pulse widths during 0.1 mA test pulse
stimulation. Note that the scale has been extended in this panel. As in figures 9.3.3 & 9.3.4 (rat 3), the
depression in EPSP slope was small in absolute terms, but large in percentage terms. At pulse widths
lower than 50 ps, an EPSP slope of less than 1 mV / ms was elicited. The observed EPSP slope
depression at pulse widths between 20-50 ps reflects an absolute decrease of 0.2 mV / ms or less in
each case (data not shown).
As in figure 9.3.2, EPSP slope depression was only observed at a test pulse intensity of 0.1 mA. At a
test intensity of 0.2 mA, EPSP slope depression was not observed at any pulse width, but potentiation
was still greatest at high pulse widths. At 0.4 mA, an inverted U-shaped relationship between pulse
width and LTP was obtained, and at 0.8 mA, potentiation was found to be greatest at small pulse
widths, and declined as the pulse width was increased.
A scheme similar to that suggested in section 9.3.3 might also explain the present data. It is possible
that potentiation of feed-forward inhibition overcomes the potentiation of excitatory transmission
when test pulses of short duration are delivered at 0.1 mA. As the pulse width is increased, however,
increases in excitation may begin to dominate. However, as stimulation intensity is increased still
further, the effect of non-linear summation may become significant at long pulse durations, resulting
in the inverted U-shaped relationship at 0.4 mA. At high intensities, potentiation of feed forward
inhibition may no longer be a significant factor, but non-linear summation of postsynaptic potentials
may become increasingly important, resulting in maximal potentiation at short pulse widths, and a
gradual decline in LTP with increasing pulse width.
In conclusion, it seems that for this single rat at least, a pulse width of 50 ps was optimal over the
range of baseline test pulse settings used in experiment 8.2 (approximately 0.2-0.5 mA). The LTP
recorded with a pulse duration of 100 ps varied more as a function of stimulus current, being greater
at low intensities, but smaller at high intensities. However, the fact that lasting LTP was recorded
using test pulses of 100 ps in this example suggests that the difference in pulse width between
experiment 8.2 and section 9.3.1 cannot be blamed for the failure of LTP in the latter study.
9.4.4 The effect of the strain of rat used on LTP
The effects of rat strain on synaptic plasticity have rarely been investigated. However, the use of
Sprague-Dawley or Wistar rats is more common in LTP experiments than the use of Lister-hooded
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rats. The use of Lister-hooded rats in this laboratory is due simply to that fact that these animals have
good eyesight and are easy to track in the watermaze owing to the dark coloration of the head and
neck. It has been reported that CA1 LTD is more readily obtained in freely moving Wistar rats than
in Sprague-Dawley or Lister-hooded rats (Manahan-Vaughan and Reymann, 1997b). In fact, LTD
was never obtained in the latter strain. It has also been found that Sprague-Dawley rats exhibit greater
dentate PTP than Wistar-Kyoto rats (Diana et al., 1994). However, no differences in LTP were
reported.
In order to test whether the use of a different strain of rat might provide a solution to the LTP
problems experienced at the time when the experiment described in section 9.3.1 was carried out, a
number of pilot experiments were conducted using a tetanus similar or identical to that used in
experiment 7.3. Attempts were made to induce LTP in two Sprague-Dawley rats, and one male and
one female Cob Wistar. In none of these cases was robust LTP induced (data not shown). Hence,
although the influence of strain was not systematically investigated, the use of different strain did not
provide an immediate solution to the problem.
In order to test the possibility that rats obtained from the pharmacology breeding colony were
deficient in LTP, 4 Lister-hooded rats were obtained from a commercial supplier (Charles River U.K.
Ltd.). However, these animals showed no more LTP than those bred in our own colony (see section
9.4.5).
A more extensive pilot study was not carried out owing to the finding, described in section 9.4.2, that
a modified set of baseline and tetanization parameters resulted in robust LTP in Lister-hooded rats.
9.4.5 The effects ofstress on LTP induction
It has been known for some time that stress can impair hippocampal LTP (e.g. Foy et al., 1987).
Stress resulting from inescapable, rather than avoidable electric shock, appears to be particularly
detrimental (Shors et al., 1989). In fact, merely exposing a rat to a novel environment can block the
induction of LTP by a primed burst protocol (Diamond et al., 1990). It has recently been found that
stress not only inhibits LTP, but also enables the induction of LTD in vivo (Xu et al., 1997). The
effects of stress on synaptic plasticity are believed to be mediated largely by the release of
glucocorticoids such as corticosterone (Filipini et al., 1991; Diamond et al., 1992; Pavlides et al.,
1993; Xu et al., 1998a).
In all experiments from 7.4 onwards, rats were handled daily for approximately one week before LTP
was measured. This was done in an attempt to reduce stress levels associated with handling during
anaesthesia. However, before an experiment, rats were taken from the animal room to the surgery,
then placed in a halothane chamber before being injected with urethane. This procedure probably
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causes some degree of acute stress, owing to environmental novelty and the anaesthesia process itself.
In order to overcome this potential problem 4 rats obtained from a commercial supplier (the same 4
Charles River rats mentioned in section 9.4.4) were habituated to the surgery environment for a
period of 30 min over 8 consecutive days. This period included a brief daily spell in the anaesthetic
chamber. When anaesthetized prior to electrophysiological recording, these rats showed no evidence
of stress, such as vocalization or defecation. LTP was recorded as described in experiment 7.3.
Tetanization parameters were varied slightly between rats, but were in all cases similar to those used
in experiment 7.3. However, lasting EPSP slope potentiation was only induced in one rat, and even in
this case the increase was a mere 10 % after 1 hr.
Although the above evidence is clearly inadequate to make substantial claims about the role of stress
in LTP induction, it would seem that a simple habituation procedure does not provide an immediate
solution during periods when LTP induction routinely fails. However, the process of anaesthesia
itself may be stressful, and habituation to this procedure is clearly not feasible. Moreover, LTP is
successfully induced in many laboratories without extensive prior handling of the rats, habituation to
the surgical environment, or even halothane anaesthesia prior to intraperitoneal injection of
anaesthetic. Hence, it seems unlikely that stress is the critical factor underlying the intermittent failure
of LTP in this laboratory.
9.4.6 Seasonal variations in LTP
As mentioned above, problems with the induction of LTP tended to occur in the winter, rather than in
the spring or summer. Owing to the variety of tetanus and baseline stimulation parameters used
throughout the work described in this thesis, an overall analysis of seasonal effects is impossible.
However, the tetanus used in experiment 8.2 produced robust LTP in June / July when the main
experiment was conducted (figure 8.2.2; "tetanus only" control group), but resulted in modest LTP
when tested in December (figure 8.4.1; "tetanus only" control group for 1 Hz experiment). The
percentage EPSP slope LTP measured over the final 10 min of recording (50-60 min after
tetanization) is shown in figure 9.4.3. The difference in LTP between June / July and December was
highly significant [T(l,10) = 18.8; p < 0.01], although equivalent PTP over the 4 min after
tetanization was observed ]F(1,10) = 1.30; p > 0.2]. The population spike increase 1 hr after
tetanization was slightly, but non-significantly, smaller in December than in June / July [3.87 ± 0.42
mV and 3.12 ± 0.65 mV respectively; F < 1]. No group differences in baseline stimulation intensity
were found ]T(1,10) = 2.07; p > 0.1; data not shown].
The existence of seasonal changes in synaptic plasticity is surprising considering the use of male rats
housed from birth in a temperature-controlled environment with a fixed 12 hr light / 12 hr dark cycle.
Nevertheless, pronounced seasonal cycles in the levels of hypothalamic neuropeptides, such as
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corticotrophin releasing factor (CRF), have been reported in male Sprague-Dawley rats under
similarly uniform conditions (Bisette et al., 1995). The application of CRF is known to increase the
secretion of corticosterone (Yasuda et al., 1984), a hormone that has been found to inhibit LTP (see
section 9.4.5). Hence, seasonal changes in the secretion of neuromodulatory agents such as
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Fig. 9.4.1
Tetanization with 3 trains of 50 pulses at 250 Hz. An inter-train
interval of either 10 s or 20 s was used (see text for further details).
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Fig. 9.4.2
The relationship between EPSP slope LTP and test pulse width at a
range of different test pulse intensities indicated in the top left corner
of each panel. Scaling is equivalent in each case, although the y-axis






LTP induced by an identical tetanus in summer and in winter.
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9.5 General Discussion
The findings presented in this chapter represent an attempt to identify at least some of the factors
associated with the magnitude of LTP. However, apart from the suggestion that seasonal hormonal
rhythms might play some role, the reason for the intermittent failure of LTP induction remains
unknown. Nevertheless, in the course of this analysis, some intriguing and counterintuitive results
have been obtained.
Firstly, the size of an EPSP seems to be negatively correlated with the percentage EPSP slope LTP
induced, at least under some circumstances. The suspicion that "good" EPSPs exhibit poor
potentiation has been raised by others, but rarely investigated. Although by no means the only
possible explanation, it is suggested that non-linear summation of postsynaptic potentials may
underlie this paradoxical result.
Secondly, it was found that the use of a high intensity tetanus fails to induce robust potentiation
during periods of LTP failure. In fact, tetanus intensity was negatively correlated with the magnitude
of EPSP slope LTP over the range tested. This result is surprising, considering the well-established
concept of cooperativity, namely that the amount of LTP can increase as a function of the number of
perforant fibres activated during tetanization (McNaughton et ah, 1978). The reasons for this
discrepancy are unknown, but it is possible that the relationship reported by McNaughton and
colleagues only holds over a limited range of tetanus and / or test pulse intensities.
A more general issue arising from the results of this chapter concerns the use of input / output curves.
In many studies of LTP, potentiation is recorded at a single arbitrary test pulse intensity. Baseline test
pulse characteristics such as current, duration and the use of monophasic vs. biphasic stimulation vary
widely between laboratories, but are rarely recognized as critical factors in determining the level of
LTP recorded. In fact, as revealed in sections 9.2 and 9.3, results ranging from substantial LTD to
robust LTP can be observed in the same animal depending on the sampling intensity used. Owing to
the widespread failure to characterize changes in synaptic efficacy over a range of test intensities, it is
difficult or impossible to compare results obtained in different laboratories. It is possible that this
issue contributes substantially to a number of conflicting reports in the LTP literature.
However, a potential drawback with the recording of I / O curves is the possibility that high intensity
test pulses, delivered, at 0.1 Hz may themselves induce changes in synaptic efficacy. Indeed, a slight
rise in baseline EPSP slope was sometimes observed after an initial I / O curve (data not shown).
However, such changes were generally small, and hence unlikely to affect the level of LTP
subsequently obtained. Nevertheless, in future it would be wise to deliver I/O curve test pulses at
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0.05 Hz, and to randomize the order in which pulses of different intensities are presented, rather than
simply increasing the intensity in stepwise fashion.
A further methodological dilemma is presented by the question of which attribute of an EPSP to use
as an index of potentiation. Measurement of the population spike amplitude is favoured by some,
because it represents a physiologically relevant output, i.e. the firing of cells. However, population
spike amplitude reflects a confound of the number of cells firing, the degree of synchrony, and
possible changes in excitability due to neuromodulators. Owing to this problem, the change in EPSP
slope is more commonly used as a measure of LTP. It is generally believed that the early rising phase
of the EPSP slope provides a good index of fast synaptic transmission. However, as illustrated in
figures 9.3.1A and B, potentiation of population spike amplitude is not always accompanied by
lasting EPSP slope LTP. In fact, it is sometimes observed that after tetanization, despite lasting
changes in the amplitude and latency to onset of the population spike, and sometimes even changes in
the amplitude and overall shape of the EPSP, the EPSP slope remains unchanged. This is not an
argument for abandoning the use of EPSP slope as a measure of synaptic efficacy. The drawbacks
associated with alternative measures are even more severe. However, it should be remembered that
LTP is sometimes not manifested by a robust increase in EPSP slope.
One factor that has not been addressed in this chapter is anaesthesia. The possible role of urethane on
LTP induction was discussed in chapter 7.7. However, pilot studies not included in this thesis have
revealed that difficulties in the induction of LTP can be equally severe in freely moving as in
urethane-anaesthetized rats. In spite of these problems, the issue of anaesthesia remains of particular
relevance in studies of the role of mGluRs in LTP (see chapter 7.7).
To summarize, a number of factors have been identified which influence the amount of LTP recorded
after tetanization, although many sources of variability remain unexplained. The overall conclusion of
this investigation is that for anaesthetized rats in this laboratory, a test pulse stimulation intensity of
50 ps, at an intensity of 0.2-0.4 mA appears to be optimal. Tetanic stimulation should be delivered at
a modest intensity, in order to avoid the EPSP slope depression associated with intense tetanization.






The initial aim of this thesis was to investigate the role of NMDA receptors and mGluRs in spatial
learning. This led to a series of experiments investigating the role of mGluRs in LTP, followed by an
electrophysiological study of the time dependency of LTP reversal by 5 Hz stimulation. This
concluding section provides a brief summary of the experimental findings and their implications.
10.2 D-AP5 and spatial learning
The first experiment (chapter 5) was designed to address two main issues: (a) whether chronic
minipump infusion of D-AP5 causes brain damage; and (b) the effects of a specific behavioural
protocol described by Cain et al. (1996) on drug-induced sensorimotor disturbances. The results of
this study reveal that chronic AP5 infusion does not cause a persistent spatial learning deficit after
infusion has ended, such as that reported after MK-801 infusion in mice (Wozniak et al., 1996). In
addition, although acute intracerebral infusion of AP5 causes neuronal vacuolation (Labruyere et al.,
1989) no signs of neurotoxicity were observed in brains removed either during or after slow, chronic
AP5 infusion. These results provide convincing evidence that AP5-induced neuronal damage is not
the cause of the learning impairment resulting from infusion of this drug.
The sensorimotor disturbances caused by AP5 were mild at the start of training, but became
progressively more severe as testing progressed. Under these circumstances, the nature of the
performance deficit is impossible to assess. The massed-trial protocol of Cain et al. (1996) greatly
exacerbated the sensorimotor side effects of AP5 infusion, compared to those seen with 1 trial per
day training (Bannerman et al., 1995). It has been suggested that sensorimotor deficits are the cause
of the failure to learn a watermaze task after the delivery of AP5. However, it is also possible that an
initial AP5-induced failure to learn results in a progressive decline in sensorimotor aspects of
performance when coupled with multiple training trials in a task which for drug-treated animals is
insoluble.
The results of the above study do not provide definitive evidence that the AP5-induced impairment
results from a specific learning deficit. Nevertheless, a subsequent series of experiments carried out in
this laboratory by other members of the research group has provided positive evidence in support of
this notion. Rats were trained in a spatial discrimination task in the watermaze, in which a stable
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platform was placed in a fixed location, but an unstable platform was placed in a random location.
This study revealed that whereas AP5-induced sensorimotor deficits and abnormal behaviours
declined to control levels over the first few days of testing, discrimination performance remained
impaired in AP5-treated rats (R. G. M. Morris, R. J. Steele, S. J. Martin, and J. E. Bell, unpublished
observations). This indicates that the AP5-induced learning impairment is not inextricably linked
with the sensorimotor deficit. In addition, it has recently been found that AP5 causes a delay-
dependent impairment in a watermaze matching-to-place task, a result that is difficult to explain as
anything but a learning impairment (Steele and Morris, 1999). Hence, the balance of current evidence
suggests that AP5 does indeed cause a learning deficit in certain spatial tasks. Although AP5 infusion
does cause various non-mnemonic deficits, these cannot account for the poor performance of rats in
all learning and memory tasks.
10.3 The effects of MCPG on LTP and spatial learning
Few definitive conclusions can be drawn from the effects of the mGluR antagonist MCPG on
watermaze performance described in chapter 6. In the first experiment of this chapter, acute i.e.v.
infusion of MCPG caused a watermaze deficit that was limited to the transfer test, although a slight
initial deficit was also seen in a visible platform task. However, subsequent experiments revealed that
MCPG had no effect when chronically administered via a minipump, or when injected acutely into
the hippocampus. In a final study, there was a suggestion that diffusion of MCPG beyond the
hippocampus might be associated with a behavioural deficit. Whilst not ruling out the possibility of a
learning deficit specific to the blockade of hippocampal mGluRs, a non-hippocampal sensorimotor or
motivational account might also explain these data. Furthermore, it is possible that MCPG may be too
weak an mGluR antagonist to induce a reliable behavioural deficit, regardless of the nature of this
impairment. In addition, the subtype selectivity of MCPG is broad, and may include as yet
unidentified mGluRs. In future, it would be interesting to test the effects of a more potent and subtype
specific mGluR antagonist using a more powerful behavioural paradigm, such as the matching-to-
place task used by Steele and Morris (1999). As mentioned in chapter 6, pilot studies using AIDA are
currently underway.
MCPG had no effect on dentate LTP under urethane anaesthesia in vivo (chapter 7). This was true for
all experimental conditions, even when MCPG was applied after the reversal of prior LTP. Although
this last result is apparently inconsistent with the "molecular switch" hypothesis of Bortolotto et al.
(1994), there is reason to believe that the mechanism of LTP reversal by 5 Hz stimulation delivered 2
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min after tetanization may be different from the reversal of established LTP (see chapter 8.5.3).
Hence, no strong conclusions about the validity of the molecular switch hypothesis can be drawn
from the present data.
The MCPG studies presented in this thesis can therefore be summarized as follows: a drug that has no
effect on LTP has only modest effects on learning. This series of results unfortunately reveals very
little about the mechanistic relationship between LTP and learning, and the questionable efficacy of
MCPG as an mGluR antagonist prevents any strong negative conclusions about the role of mGluRs in
LTP and learning being made. However, a number of issues concerning the role of MCPG in LTP
remain unexplored. Perhaps the most important of these is the question of anaesthesia. It has been
reported that MCPG can completely block LTP in freely moving rats, whereas a partial block or no
effect is generally reported under urethane (see chapter 7.7). One possible explanation is that weaker
tetanization parameters may be sufficient to induce LTP in vivo (Riedel et al., 1994b). It has recently
been reported that MCPG is only effective in blocking the LTP induced by a weak tetanus (Wilsch et
al., 1998). However, pilot studies not included in this thesis have revealed that the induction of LTP
in freely moving rats tends to be even more problematic than the induction of LTP under urethane
(see chapter 9). Although, so far, it has not been possible to test the effect of MCPG on the LTP
induced by a weak tetanus in vivo, it is hoped that such an experiment may be carried out in the near
future.
10.4 Time-dependent reversal of LTP
It was reported in experiment 7.4 that low frequency stimulation could reverse dentate LTP in vivo
when delivered soon after tetanization. In chapter 8, a detailed characterization of the time-dependent
reversal of dentate LTP by 5 Hz stimulation was presented. It was found that 5 Hz stimulation was
only successful in reversing LTP when delivered within 2 min of tetanization. 5 Hz stimulation had
no effect on existing LTP when delivered 10 min or more after tetanization. It is worth noting that
this form of "depotentiation" may be very different from the reversal of established LTP. For reasons
discussed in chapter 8.5.3, it is likely that the present results represent a disruption of processes
involved in the stabilization of LTP, rather than a genuine depotentiation of existing LTP.
The investigation of LTP reversal was motivated by the possibility of using the phenomenon as a tool
in future behavioural experiments. The design of such an experiment is outlined in chapter 8.5.4.
However, there are a number of grounds for caution. In particular, 5 Hz stimulation alone was
associated with an E-S depression, consistent with a reduction in granule cell excitability.
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Furthermore, seizure-like afterdischarge activity was always associated with 5 Hz stimulation, a
phenomenon that is clearly undesirable and might constitute a serious problem in freely moving rats.
Nevertheless, if this problem can be overcome, it will be worthwhile conducting a pilot study to
assess the possible selective reversal of recent learning by the delivery of 5 Hz stimulation.
10.5 Conclusion
The role of NMDA receptors in LTP is well established, and the balance of current evidence suggests
that NMDA receptor activation is also necessary for spatial learning. The results of chapter 5 reveal
that the chronic application of AP5 is not neurotoxic, and that sensorimotor disturbances are not an
inevitable consequence of AP5 infusion. A subsequent study carried out by Steele and Morris (1999)
has revealed that AP5 infusion causes a delay-dependent deficit in watermaze matching-to-place
performance. This finding cannot be attributed to sensorimotor disturbances, and is difficult to
interpret as anything other than a memory impairment. Such a result, although not providing
definitive proof, is highly suggestive of a link between NMDA receptor-dependent synaptic plasticity
and spatial learning.
The role of mGluRs in both LTP and spatial learning is less clear, however. The antagonism of
mGluRs has been reported to block LTP under some circumstances, but not others (see chapter 7).
This result may simply reflect the inadequacy of MCPG as an tnGluR antagonist, but may also
indicate that mGluRs play a more subtle modulatory role in LTP than NMDA receptors. If so, then
the role of mGluR activation in naturally occurring synaptic plasticity, if such a thing exists, may not
be obligatory under all circumstances. Considering the difficulty in establishing a link between
NMDA receptor activation and learning, it may be even harder to establish such a link for a
modulatory class of receptor. Unfortunately, this gap between levels of analysis is only likely to be
bridged once a "circuit-level" understanding of hippocampal function is reached.
In the meantime, progress will require the thorough characterization of novel and subtype-selective
mGluR agonists and antagonists. However, the different mGluR subtypes have distinct physiological
actions, and it may not be sufficient simply to demonstrate an impairment or facilitation of spatial
learning resulting from the application of a novel pharmacological agent. Ultimately it is likely that
the development of new behavioural tasks will be necessary. An adequate task will need to provide a
rich characterization of behaviour, sufficient to identify the precise role of mGluRs, and indeed
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Summary—The effects of the metabotropic glutamate receptor antagonist (/?,S)-a-methyl-4-carboxyphenyl-
glycine (MCPG) on the induction of long-term potentiation (LTP) in the dentate gyrus were examined under
urethane anaesthesia in vivo. In experiment 1, bilateral intraventricular infusion of either 20 mM or 200 mM
(R.S)-MCPG (5 pi each side) failed to block LTP in the perforant path-granule cell projection, relative to
vehicle-infused controls; 30 mM D-AP5 (5 pi each side) infused in the same way as MCPG completely blocked
LTP. Experiment 2. in which the contralateral perforant path-dentate gyrus pathway was used as a non-
tetanized control, revealed that slight baseline changes induced by MCPG infusion were transient: again no
block of LTP was obtained. The efficacy of mGluR blockade was confirmed in experiment 3, in which MCPG
antagonized an increase in spontaneous activity induced by (l,S,3R)-I-aminocyclopentane-l,3-dicarboxylic
acid (ACPD). In experiment 4, significant depotentiation was induced by low frequency stimulation (5 Hz for
1 min) given 2 min after high frequency tetanization, but MCPG remained ineffective in blocking LTP after a
second tetanus. In experiment 5, increasing the period of low frequency stimulation from 1 to 10 min produced
greater depotentiation. but still did not unmask an MCPG-sensitive component of LTP. These experiments fail
to support a role for mGluRs in the induction of LTP in the dentate gyrus under urethane anaesthesia in vivo, nor
do they support the idea that a metabotropic switch controlling sensitivity to MCPG is reset by depotentiation.
© 1997 Elsevier Science Ltd.
Keywords—Hippocampus, MCPG, long-term potentiation (LTP), depotentiation. metabotropic giutamate
receptors.
Long-term potentiation (LTP) is a form of activity-
dependent synaptic plasticity which is widely cited as a
model of the cellular mechanisms underlying memory
formation (Bliss and Lomo. 1973; Morris et al„ 1990;
Bliss and Coilingridge. 1993). It is well established that
NMDA receptor activation is necessary for the induction
of LTP in the dentate gyrus and area CA1 of the rodent
hippocampus since potentiation is completely blocked,
both in vivo and in vitro, by application of the selective
NMDA antagonist AP5 (Coilingridge et al„ 1983; Harris
et til., 1984; Morris et al„ 1986; Errington et al„ 1987).
However, direct iontophoresis of NMDA in hippocampal
slice preparations induces only a short-lasting potentia¬
tion which decays back to baseline values within about
30 min (Collingridge et til., 1983; Kauer et al„ 1988). In
contrast, potentiation induced by a high frequency
tetanus consists of a short-lasting decremental phase
similar to that induced by NMDA, followed by a stable
*To whom correspondence should be addressed. Fax: (44)-131-
650-4579; e-mail: stevem@tattoo.ed.ac.uk
increase in synaptic efficacy which may remain above
baseline values for hours or even days. It has been
suggested that activation of metabotropic glutamate
receptors (mGluRs) may provide the necessary additional
trigger for the induction of stable NMDA receptor-
dependent LTP (Behnisch and Reymann, 1993).
The metabotropic glutamate receptor family currently
consists of eight subtypes (mGluRs 1-8) grouped into
three sub-classes based on sequence homology, pharma¬
cology and second messenger coupling. Class I com¬
prises mGluRs I and 5 which stimulate phosphoinositide
(PI) hydrolysis and intracellular calcium release. Class II
(mGluRs 2 and 3) and class III (mGluRs 4, 6, 7 and 8) are
negatively coupled to adenylate cyclase, but their
pharmacological profiles differ (Nakanishi, 1992; Pin
and Duvoisin, 1995). The most commonly used mGluR
agonist is (lS.3/?)-l-aminocyclopentane-l,3-dicar-
boxylic acid (ACPD) which stimulates both class I and
class II receptors: class III receptors are relatively
insensitive to ACPD. Early studies revealed that the
magnitude of tetanus-induced LTP in areaCAl in vitro is
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greatly increased by prior application of rrans-ACPD, a
mixture of (lSCR) and (1/?,3S)-ACPD (McGuinness et
al., 1991; Otani and Ben-Ari. 1991). It has since been
suggested that activation of mGluRs may in itself be
sufficient to induce a form of long-term potentiation.
Bortolotto and Collingridge (1993, 1995) reported that
the application of (1S.3R)-ACPD in vitro can induce a
slow-onset potentiation in area CA1 which occludes
totally with tetanus-induced LTP. However, Davis and
Laroche (1996) found that whereas (15,3/?)-ACPD
infusion in vivo caused a slow-onset potentiation in area
CA1, a dose-dependent biphasic effect was obtained in
the dentate gyrus, consisting of a short-term potentiation
induced by both 10 mM and 25 mM ACPD, followed in
the 25 mM group only, by a lasting depression of the
response. Since ACPD is a broad-spectrum agonist acting
at both class I and class II mGluR subtypes, it is possible
that the potentiation of the EPSP is mediated by class I
mGluRs coupled to PI hydrolysis, whereas the depression
is mediated by presynaptically located class II mGluRs.
The differential effects of ACPD in the dentate versus
CA1 may reflect the different mGluR subtype popula¬
tions within these two regions (Fotuhi et al., 1994).
Early studies of the role of mGluRs in LTP were
hampered by the lack of specific and potent mGluR
antagonists. However, since its discovery, the selective
mGluR antagonist (/?,S)-ct-methyl-4-carboxyphenylgly-
cine (MCPG) has been widely used (see Watkins and
Collingridge, 1994). MCPG, like ACPD, has been
reported to act on both class I and II mGluRs (see
Discussion). Nevertheless, studies of the effects of
mGluR antagonists on the induction of LTP have often
yielded contradictory results. For instance, Bashir et al.
(1993) found that application of (P.S)-MCPG blocked
LTP in rat CA1 hippocampal slices, but others have
failed to replicate this result (Chinestra et al.. 1993:
Manzoni et al.. 1994). MCPG has also been reported to
block LTP in the dentate gyrus in vivo. Riedel et al.
(1995) reported a complete block of LTP in freely-
moving rats, and Richter-Levin et al. (1994) reported a
reduction in EPSP slope potentiation following i.e.v.
infusion ofMCPG under urethane anaesthesia. However,
other workers have found no effect of MCPG on LTP in
urethane-anaesthetized animals (Bordi and Ugolini,
1995).
One potential explanation for these mixed results is
provided by the findings of Bortolotto et al. (1994) who
reported that in area CA1 in vitro. MCPG failed to block
LTP in pathways which had previously undergone
potentiation. However, low-frequency depotentiating
stimulation was found to re-establish the ability of
MCPG to block LTP following a second tetanus. These
data suggest that the activation of mGluRs turns on a
"molecular switch" which eliminates the requirement for
further mGluR activation in the induction of LTP.
Similarly, Wang et al. (1995) found that a block of
LTP with MCPG was attained only after low frequency
stimulation of afferent fibres. Negative results have.
however, been reported by Selig et al. (1995) and
Thomas and O'Dell (1995) who failed to see a block of
LTP in the presence of MCPG even after low frequency
stimulation of afferents. Nevertheless, the molecular
switch hypothesis has not, to our knowledge, been tested
in vivo. If, for unknown reasons, the switch is tonically
activated in vivo, blockade of LTP with MCPG might
become apparent only after low frequency stimulation
has induced depotentiation and so reset the switch.
The following series of experiments was carried out to
determine, initially, whether or not in our hands, MCPG
blocks LTP and reverses the electrophysiological effects
of ACPD under urethane anaesthesia in vivo. Additional
experiments were then conducted in order to address the
"molecular switch" hypothesis outlined above. However,
rather than simply giving low frequency stimulation
followed by MCPG infusion and LTP induction, it was
decided to follow the Bortolotto et al. (1994) protocol in
which LTP is first induced, then depotentiated using low




Adult male Lister hooded rats (250-500 g) were used
as subjects. They were given ad libitum access to food
and water and were maintained on a 12 hr light— 12 hr
dark cycle.
Electrophysiology
Experiments were conducted under urethane anaes¬
thesia (1.5 g/kg i.p.), with the rat mounted in a stereotaxic
frame (Kopf. Tujunga, CA, U.S.A.) with skull horizontal.
The animal's temperature was monitored by a rectal
probe and maintained at 36.2 ± 0.2°C. Teflon-coated
stainless steel electrodes were lowered into one or both
hippocampal formations in order to record positive-going
field potentials. A bipolar stimulating electrode was
positioned in the angular bundle of the perforant path
(AP = -7.5 mm, Lat = 4.0mm) and a monopolar re¬
cording electrode in the hilus of the dentate gyrus
(AP= —4.0 mm. Lat = 2.0mm). Two stainless steel
injection cannulae. connected by plastic tubing to
Hamilton syringes, were lowered into the left and right
lateral ventricles (AP= - 0.9 mm, Lat = ± 1.3 mm) and
in experiments 1-3, a thermistor was lowered into the
right dentate gyrus to monitor brain temperature. Field
EPSPs and thermistor readings were amplified using a
polygraph (Grass Instruments. Quincy, MA, U.S.A.); the
initial slope of the field EPSP (measured by linear
regression between two fixed time points) and the
population spike amplitude were monitored on-line by
an Acorn A5000 computer running specialized software.
Following the implantation of electrodes, stimulation
was turned off for 30 min to allow the brain tissue to
settle. After this period, a number of test pulses were
delivered and the stimulation intensity was adjusted to
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elicit a population spike amplitude of 2—4 mV. Recording
was started as soon as stable potentials had been
obtained. Throughout an experiment, perforant path test
stimulation consisted of biphasic pulses of 100 ps half-
pulse duration delivered at 0.05 Hz. Tetanic stimulation
consisted of five trains of 20 pulses at 250 Hz, with 10 sec
between trains: the stimulation intensity was set at twice
the baseline level.
Drugs
Two different concentrations of (F,S)-MCPG (Tocris,
Bristol, U.K.) were tested: 20 mM and 200 mM. Solu¬
tions were prepared by first dissolving the solid, crystal¬
line form of (/?,5)-MCPG in I M sodium hydroxide
solution to form an equimolar solution, then diluting with
phosphate buffered saline to achieve the desired
concentration. Despite the high concentration of NaOH
present, the pH of the 200 mM solution was found to be
7.28, i.e very nearly neutral. Two concentrations of
(1S,3F)-ACPD (1 mM and 4 mM; Tocris) were prepared
in the same way. A 100 mM stock solution of D-2-amino-
5-phosphopentanoate (D-AP5; Tocris) was made up in
equimolar NaOH. Spiking with small aliquots (1-2 ql) of
5 M NaOH was sometimes required to ensure that the
drug dissolved fully. A final concentration of 30 mM D-
AP5 was attained by dilution with the appropriate volume
of aCSF. Solutions were stored at —20°C in small
aliquots before use.
Statistics
All statistical comparisons were carried out using
analysis of variance (ANOVA) unless otherwise stated.
In general, statistical descriptions of the data are given in
the main body of the text, whereas numerical values are
included in the figure legends; such values are stated as
mean ±SEM throughout.
Examples of the actual initial values of a number of
measures such as EPSP slope, population spike amplitude
and brain temperature are given in the Results section of
experiment 1.
RESULTS
Experiment I: does MCPG block dentate LTP in vivo?
A 20-min baseline period was recorded, followed by a
10 pi bilateral drug infusion (i.e. 5 pi per ventricle) of
either 200 mM (/?,5)-MCPG (n = 7), 20 mM (R.S)-
MCPG (n = 6) or vehicle (phosphate buffered saline
(PBS); n = 7), delivered over a period of 10 min. Half an
hour after the end of this infusion, animals received a
high frequency tetanus. Field potentials were recorded for
a further 2 hr after tetanization. In order to test the drug
infusion system, a further control group was infused with
30 mM D-AP5 (n = 6). In two of these AP5-infused rats,
recordings were made bilaterally; only one pathway
received a high frequency tetanus.
EPSP slope LTP. Figure 1(A) shows the amount of
EPSP slope potentiation in the three main groups.
normalized to the mean value obtained during the
10 min prior to tetanization; neither dose of MCPG
caused a block of LTP. Separate ANOVAs of the mean
potentiation over different time periods revealed no
significant group differences in EPSP slope LTP 50-
60 min post-tetanus [F < 1] or 110-120 min post-tetanus
[F(2,17) = 1.21; /? > 0.3]. No group differences were
found in the percentage post-tetanic potentiation (PTP)
recorded 0-4 min after tetanization [F<1]. The mean
absolute slope of the pre-infusion baseline field EPSP did
not differ across groups [200 mM MCPG = 3.48 +
0.37 mV/msec; 20 mM MCPG = 3.61 ± 0.28 mV/msec:
vehicle = 3.61 ± 0.33 mV/msec; F < 1], nor did the test-
pulse stimulation intensity [200 mM MCPG = 282.9 ±
39.7 p.A; 20 mM MCPG = 291.7 ± 24.1 ^A; vehicle =
318.6 ± 39.8 pA; F< 1].
Infusion of 30 mM D-AP5 caused a complete block of
LTP. Figure 1(B) shows pooled data from the six rats
infused with AP5 compared with the vehicle-infused
controls. Mean non-tetanized control pathway data from
the two rats in which recordings were made bilaterally are
plotted alongside data from the six tetanized pathways.
Curiously, infusion of AP5 caused a slight increase in
EPSP slope, an effect noticeable in both tetanized and
control pathways and associated with a transient
temperature rise of approximately 0.5°C (data not
shown). However, the elevated pre-tetanus slope magni¬
tude appears to be maintained throughout the experiment.
Inspection of Fig. 1(B) suggests that this is most likely
due to the superposition of an EPSP slope increase
induced by AP5, upon a slight chronic baseline rise. (A
similar slight baseline rise was found in later experi¬
ments: see Fig. 2(A), control pathways.) Nevertheless,
equivalent changes were seen in both tetanized and non-
tetanized pathways. In the two rats which received
bilateral stimulation and recording, no differences were
found between tetanized and non-tetanized EPSP slope
values 1 hr after tetanization, relative to the pre-tetanus
baseline, indicating that LTP was indeed completely
blocked (individual traces not shown). Hence, in these
two animals at least, the possibility that a residual
potentiation is masked by baseline changes can be ruled
out.
Population spike LTP. Figure 1(C) shows the popula¬
tion spike potentiation expressed as the absolute change
in amplitude relative to the mean baseline value over the
10 min prior to tetanization. This method of analysis
results in a measure of change which is independent of
initial baseline values. (A percentage measure of
potentiation can result in misleading results if baseline
values fall to low levels prior to tetanization, as
occasionally happened.) No significant group differences
were found 50-60 min post-tetanus [F<1] or 110-
120 min post-tetanus [F< 1 ]. No group differences were
found in PTP 0—I min post-tetanus [Fell. The mean
absolute pre-infusion population spike amplitude did not
differ across groups [200 mM MCPG = 2.46 + 0.18 mV;
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Fig. 1. Single pathway study. (A) Intraventricular infusion (10 /d) of either 20 mM (n = 6) or 200 mM (R,S)-
MCPG (n = 7) had no effect on the percentage EPSP slope potentiation induced by a high frequency tetanus
delivered to the perforant path-dentate gyrus projection, relative to vehicle-infused controls (n = 7). Mean
percentage slope changes are plotted for each group, normalized to the baseline value over the 10 min prior to
tetanization. Representative sample waveforms recorded immediately before tetanization and 30 min afterwards
are shown. No group differences were found 50-60 min post tetanus [200 mM (R.Sj-MCPG = 119.9 ± 3.2%;
20 mM (R,S)-MCPG= 121.8 ± 3.5%; vehicie= 123.3 + 2.4%] or 110-120 min post-tetanus [200 mM (R.S)-
MCPG = 109.9 ± 4.0%; 20 mM (R,S)-MCPG = 116.3 ± 4.6%; vehicle = 116.9 ± 2.4%]. (B) Infusion of 10 jd
30 mM D-AP5 caused a complete block of EPSP slope LTP. Data from six animals infused with D-AP5 are plotted
against the vehicle-infused control data from the previous figure. Of the six rats infused with D-AP5, two received
bilateral stimulation and recording; mean data from the two control pathways are plotted alongside data from the
six tetanized pathways. 16.9 ± 2.4% LTP was seen in the vehicle-infused group 1 hr after tetanization, compared
to 1.7 + 2.8% in the D-AP5 tetanized group. A 3.9 ± 5.5% mean increase was seen in the 2 D-AP5 control
pathways. (C) Mean absolute increases in population spike amplitude relative to baseline levels are plotted. An
equivalent increase was seen in all groups 50-60 min post-tetanus [200 mM (R.Sj-MCPG = 3.10 ± 0.29 mV;
20 mM (R.S)-MCPG = 3.46 ± 0.36 mV; vehicle = 3.60 ± 0.76 mV] and 110-120 mins post tetanus [200 mM
(7?,S)-MCPG =1.81 ± 0.48 mV; 20 mM (R.S)-MCPG = 2.25 ± 0.48 mV; vehicle = 2.51 ± 0.58 mV]. (D) Infu¬
sion of both 20 mM and 200 mM (R.S)-MCPG caused a slight transient temperature rise relative to vehicle-infused
controls. The mean increase over the 30 min after drug infusion was calculated relative to the mean baseline
temperature over the 10 min before infusion [200 mM f/LSj-MCPG = 0.30 ± 0.04°C; 20 mM (/c,.S,)-MCPG =
0.47 ± 0.14°C; vehicle = 0.01 ± 0.09°C].
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20 mM MCPG = 2.92 ± 0.23 mV; vehicle = 2.51 ±
0.20 raV; F(2.17) = 1.55; p > 0.2],
Brain temperature. Figure 1(D) shows brain tempera¬
ture changes throughout the experiment normalized to the
mean temperature over the 10 min before infusion. An
ANOVA of the mean temperature change over the
30 min after drug infusion revealed a significant effect of
group [F(2,17) = 6.04; /?<0.05]. Individual Newman-
Keuis pairwise comparisons revealed small but signifi¬
cant temperature increases in both the 20 mM MCPG
(< 0.01) and 200 mM MCPG groups (/?<0.05). These
increases rarely exceeded 0.5°C. and no significant group
differences were found over the final 30 min of the
experiment [F < 1],
No significant differences were found in the absolute
baseline brain temperature recorded over the 10 min prior
to drug infusion [200 mM MCPG = 34.2 ± 0.4°C;
20 mM MCPG = 33.6 ± 0.2°C; vehicle = 32.5 ± 0.8°C;
F(2.17) = 2.80; /?>0.05] The non-significant trend to¬
wards a group difference is explained by the slightly
lower initial temperature recorded in the vehicle group:
this is an artefact due to the use of a slightly different
design of thermistor in three members of this group.
Experiment 2: does MCPG block LTP in vivo? A bilateral
study
Most procedures were identical to those described for
experiment 1. However, stimulating and recording
electrodes were placed in the right hippocampal forma¬
tion in addition to the left, and the thermistor was
positioned approximately 2 mm posterior and 1 mm
lateral to the right-hand recording electrode. The two
pathways were stimulated alternately, but only the left
perforant path was given a high frequency tetanus. Rats
received infusions of either 200 mM (^?,S)-MCPG (n = 5)
or vehicle (n = 7). Data from three animals in which a
seizure had occurred in one pathway during positioning
of the electrodes were discarded. Likewise, if the final
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Fig. 2. Dual pathway study. (A) Intracerebroventricular infusion of 10 /d 200 mM (R.S)-MCPG (n= 5) failed to
block EPSP slope LTP relative to vehicle-infused controls (n = 7). Tetanized pathways in each group showed
equivalent LTP 50-60 min post-tetanus [200 mM (R,S)-MCPG= 122.8 ± 2.6%; vehicle = 117.0 + 2.5%] and
110-120 min post-tetanus [200 mM (R,5)-MCPG= 116.7 + 3.7%; vehicle = 112.5 + 2.1%]. No group differ¬
ences were found in the untetanized control pathways 50-60 min post-tetanus [200 mM (R.S)-
MCPG= 105.4 + 1.5%; vehicle = 104.3 ± 4.1%] or 110-120min post-tetanus [200 mM (/?,S)-MCPG =
106.5 ± 3.1%; vehicle = 102.2 + 2.7%], indicating that despite the slight changes immediately after infusion,
(R,S)-MCPG did not cause a chronic fall in baseline values. (B) For every animal, the percentage EPSP slope value
obtained at each time point in the tetanized pathway was normalized to the value recorded in the control pathway
(i.e. tetanized/control x 100). This method of analysis smoothes out fluctuations in the raw data. No differences in
normalized LTP were found 50-60 min post-tetanus [200 mM (R.S)-MCPG = 116.6 + 1.3%; vehicle = 112.7 +
2.8%] or 110-120 min post-tetanus [200 mM (/?,5)-MCPG = 109.8 ± 3.6%; vehicle = 110.3 ± 1.8%]. (C)
200 mM (R.S)-MCPG failed to block population spike LTP. Absolute increases in spike amplitude relative to
baseline values are plotted for both tetanized and control pathways. Equivalent potentiation was seen in the
tetanized pathway for each group 50-60 min post-tetanus [200 mM (R.S)-MCPG = 3.02 ± 0.69 mV; vehi¬
cle = 2.78 4 0.49 mV] and 110-120 min post-tetanus [200 mM (R.S)-MCPG = 2.43 + 0.89 mV; vehi¬
cle = 1.99 + 0.30 mV], Untetanized pathways likewise did not differ 50—60 min post-tetanus [200 mM (R.S)-
MCPG = 0.08 + 0.10 mV; vehicle = 0.13 + 0.16 mV] or !10-120min post-tetanus [200 mM (R.S)-
MCPG = 0.43 + 0.19 mV; vehicle = 0.32 ± 0.15 mV. (D) For each animal, the spike increase in the tetanized
pathway was subtracted from that in the control pathway at each individual time point. No group differences in the
normalized data were found 50-60 min post-tetanus [200 mM (R.M-MCPG = 2.94 + 0.71 mV; vehicle =
2.65 r 0.46 mV] or 110-120 min post-tetanus [200 mM (R.M-MCPG = 2.0 + 0.94 mV; vehicle = 1.67 +
0.35 mV].





normalized slope baseline [(tetanized/controi) x 100]
changed by more than 10% during the hour before
tetantzation. the results were not included in the final
analysis.
EPSP slope LTP. MCPG infusion again failed to block
LTP. Figure 2(A) shows the data for both control and
tetanized pathways, normalized to the mean value 10 mtn
prior to tetanization. Separate ANOVAs at different time
points, in which tetanized and control pathway values
were entered as sub-groups within each drug treatment
group, revealed no significant drug group by pathway
interaction 50-60 min post-tetanus [F<1], or 110—
120 min fF<l], The tetanized pathways were still
significantly potentiated overall relative to the control
pathways 110-120 min post-tetanus |F(1,20) = 14.2:
/p < 0.01 ]. Post hoc pairwise comparisons at this time
point (Newman-Keuis) revealed that tetanized pathways
were significantly potentiated relative to control path¬
ways in each group (200 mM MCPG: p<0.05: vehicle:
p < 0.05); pairwise comparisons between the two teta¬
nized pathways revealed no significant differences in the.
level of LTP; no differences were found between the.
control pathway values. A similar analysis of the level of
PTP (0—4 min post-tetanus) also failed to reveal a group
by pathway interaction [F < 1].
An ANOVA of absolute mean EPSP slope values over
the 10 min before drug infusion, in which tetanized and
control pathways were entered as sub-groups revealed no
significant differences in initial slope values between
drug groups [F(l,20) = 3.64; >0.05] or between
tetanized and control pathways (FY 1.20) = 3.02;
p> 0.05]. A similar analysis of test-pulse stimulation
intensities revealed no significant differences between
groups [F< 1], or between pathways [F( 1,20)= 1.30;
P > 0.2].
In Fig. 2(B) the EPSP slope data are plotted using the
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non-tetanized pathway as a within-subject control at each
time point throughout the experiment, i.e. normalized
value = [(tetanized/control) x 100], Equivalent LTP was
seen in both groups: no significant group differences were
found 50-60 min post-tetanus [F(L10) = 1.22; p> 0.2],
or 110-120 min post-tetanus [F< 1].
The slight baseline changes noted in experiment 1
were observed in all animals infused with MCPG.
However, no significant differences in EPSP slope were
found between vehicle and MCPG control pathways 50—
60 min post-tetanus [F< 1], indicating that these changes
were transient and could not affect the level of LTP
obtained. Comparison of the baseline period in Fig. 2(A)
and (B) demonstrates that normalization of tetanized to
control values smoothes out these baseline fluctuations,
since both pathways are affected in the same way by
MCPG infusion.
Population spike LTP. Figure 2(C) shows the popula¬
tion spike increase for both control and tetanized
pathways, relative to the mean baseline value over the
10 min prior to tetanization: MCPG had no effect on the
induction of spike LTP. An ANOVA in which tetanized
and control pathways were entered as sub-groups
revealed no group by pathway interaction in the level
of LTP: 50-60 min post-tetanus [F < 1 ], 110-120 min
post tetanus [F < 1 ] or PTP: 0—t min post-tetanus [F < 1],
An ANOVA of mean absolute population spike
amplitudes over the 10 min prior to drug infusion, in
which tetanized and control pathways were entered as
within-subject factors, revealed no significant differences
between drug groups [F < 1 ], or between control and
tetanized pathways [F< 1],
At each time point, the population spike change in a
control pathway was subtracted from the corresponding
change in the tetanized pathway; the normalized data are
plotted in Fig. 2(D). MCPG and vehicle groups did not
differ either 50-60 min post-tetanus [F<1], or 110-
120 min post-tetanus [F< 1].
Brain temperature. Infusion of MCPG caused a slight
transient increase in brain temperature relative to vehicle-
infused controls, similar to that described in experiment
1. but the mean temperature increase over the 30 min
after drug infusion did not differ significantly between
groups on this occasion [200 mM MCPG = 0.36 ±
0.15°C; vehicle = 0.12 ± 0.08°C; F(l,10) = 2.51; p >
0.1],
Experiment 3: does MCPG antagonize the electrophysi¬
ological effects of the mGLuR agonist (1S.3R)-1-
aminocyclopentane-l,3-dicarboxylic acid (ACPD) in
vivo?
The recording set-up was identical to that used in
experiment I. A thermistor was placed in the dentate
gyrus contralateral to the stimulation and recording
electrodes in order to record brain temperature. Sponta¬
neous hippocampal activity was monitored by polygraph.
Following a 20-min baseline period, rats were infused
with 10 /d of either phosphate buffered saline (n = 8) or
200 mM (F.S)-MCPG (n = 8) over 10 min. Thirty
minutes later, a 10 /d infusion of 1 mM (1S.3F)-ACPD
was given, again over 10 min. A second infusion of
(1S,3F)-ACPD was given 2 hr after the start of the first
infusion of this drug in order to investigate the "wash¬
out" of (F.S)-MCPG. Recording was continued for a
further 50 min after the end of this infusion. At the end of
the experiment, six rats from each group were passively
warmed, and regression lines were calculated relating
EPSP slope to brain temperature. The experiment was
later repeated with infusions of 4 mM (lS.3/?)-ACPD
following an initial infusion of 200 mM (F.S)-MCPG
(n = 4) or PBS (n = 4). Brain temperature was not
monitored in these rats.
Changes in spontaneous activity of the dentate gyrus.
Figure 3(A) shows a representative polygraph trace
recorded during and after the first 1 mM ACPD infusion
in a rat previously infused with buffered saline: the rise in
spontaneous activity was characteristic of ACPD infu¬
sion. No changes in spontaneous activity were seen
during passive warming of animals. An equivalent
polygraph trace recorded from a rat previously infused
with 200 mM MCPG is shown in Fig. 3(B). On this
occasion, the increase in noise was completely blocked.
Figure 3(C) shows the mean increase in amplitude of
spontaneous activity in each group resulting from 1 mM
ACPD infusion, sampled at 2-min intervals. Values were
normalized to the mean amplitude 58-60 min after the
start of the experiment. Spontaneous activity was not
routinely recorded during infusion of PBS or 200 mM
MCPG, since previous pilot studies had already estab¬
lished that no changes in noise levels resulted from
infusion of these drugs (PBS: n = 3; 200 mM MCPG:
n- 5; data not shown). The maximum increase in
spontaneous activity from baseline values was
0.18 ± 0.29 mV in the MCPG pre-treated group, com¬
pared to 0.96 ± 0.22 mV in the PBS pre-treated group.
An ANOVA of all data points from 60 to 80 min after the
start of the experiment, in which time was entered as a
within-subject factor, revealed a significant group
difference [FG.14) = 7.39; /?<0.05], and a significant
group by time point interaction [F( 10.140) = 2.37:
p <0.051. Subsequent analysis of simple effects revealed
that spontaneous activity levels were significantly higher
in the PBS/ACPD group than in the MCPG/ACPD group
for a period 6 min after the start of ACPD infusion until
2 min after the end of infusion (see graph legend).
However, inspection of Fig. 3(C) suggests that prior
infusion of MCPG unmasked a slight initial depression in
spontaneous activity induced by ACPD.
The second infusion of 1 mM ACPD resulted in a
slightly greater, but still transient, increase in sponta¬
neous activity which was only partially blocked by prior
infusion of MCPG 180 min earlier, suggesting incom¬
plete wash-out of the drug (data not shown).
The increase in spontaneous activity resulting from the
first infusion of 4 mM ACPD is shown in Fig. 3(D). This
increase in noise was again blocked by MCPG: the
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Fig. 3. (A) Polygraph chart record during a 10 /d 1 mM (15.3f?)-ACPD infusion. 30 min after infusion of 10 id
phosphate buffered saline. The observed increase in spontaneous activity was characteristic of (15,3/?)-ACPD
infusion. (B) Polygraph chart record during a 10 /d 1 mM (15,3/?)-ACPD infusion. 30 min after infusion of 10 /d
200 mM (f?.S)-MCPG. The rise in spontaneous activity was completely blocked. (C) Mean increase in amplitude
(peak to trough) of spontaneous activity resulting from 10 fd 1 mM (15.3f?)-ACPD infusion measured directly
from polygraph chart records at 2-min intervals. Values are normalized to the mean amplitude 58-60 min after the
start of the experiment. Prior application of 10 id 200 mM (f?.5)-MCPG (n = 8) significantly reduced the increase
in spontaneous activity induced by infusion of 1 mM (15.3/?)-ACPD 30 min later, relative to vehicle pre-treated
controls (n = 8) (*p < 0.05; **p < 0.01). No changes in spontaneous activity levels were seen during either 200 mM
(f?.S)-MCPG or vehicle infusion (data not shown; see text). (D) Prior application of 10 /d 200 mM (/?,.S')-MCPG
[n = 4) significantly reduced the increase in spontaneous activity induced by infusion of 10 id 4 mM (lS.3f?)-
ACPD 30 min later, relative to vehicle-infused controls (n = 4) (*p<0.05; **p<0.01).
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Fig. 4. Low frequency stimulation (5 Hz for 1 min) given 2 min after a high frequency tetanus resulted in
significant EPSP slope depotentiation relative to controls given only the tetanus [EPSP slope 50-60 min post-
tetanus: control = 120.2 4 3.4% {n = 8V, depotentiated (vehicle and 200 mM (/?.5)-MCPG groups com¬
bined) = 111.5 ± 1.9% (n = 15)]. Subsequent infusion of 10 id 200 mM (R.S)-MCPG (n = 7) or vehicle (n - 8)
resulted in equivalent LTP after a second tetanus.
maximum increase in the MCPG pre-treated group was
0.14 + 0.25 mV. compared to 0.81 ± 0.44 mV in the
PBS pre-treated group. Analysis of all time points from
60 to 80 min after the start of the experiment revealed a
significant overall group difference between MCPG and
PBS treated rats [FY 1.6) = 12.01; p <0.05], together with
a significant group by time point interaction
[F(10,60) = 2.58: p < 0.05], Significant group differences
at individual time points are indicated in Fig. 4(D). The
slight depression in spontaneous activity unmasked by
ACPD infusion in the presence of MCPG appears more
marked after 4 mM ACPD infusion than after 1 mM
ACPD. Furthermore, the response to 4 mM ACPD in the
presence of PBS only appears to be biphasic, perhaps
reflecting the superposition of a smaller depression of
activity upon the larger increase in noise (see Discus¬
sion).
The second infusion of 4 mM ACPD resulted in a
slightly greater increase in spontaneous activity which
again was only partially blocked by by prior infusion of
MCPG 180 min earlier (data not shown). However, two
of the four rats initially infused with PBS showed
evidence of epileptiform activity during the second
ACPD infusion. Such activity was never observed in
rats initially infused with MCPG.
Changes in EPSP slope. Infusion of ACPD was
associated with a transient dose-dependent rise in EPSP
slope; an effect not blocked by MCPG (data not shown).
However, in those rats implanted with thermistors, the
rise in EPSP slope was typically accompanied by a small
rise in brain temperature whose time course paralleled
that of the increase in slope. Calculation of the expected
rise in slope based on the observed increase in
temperature in these rats revealed that the observed
slope increase was no greater than predicted by the
change in temperature alone.
Experiment 4: does prior depotentiation reveal an
MCPG-sensitive component of LTP in vivo ?
The recording set-up was identical to that used in
experiment 1. A 20-min baseline period was recorded,
followed by a high frequency tetanus. However. 2 min
after tetanization. a 1-min period of 5-Hz stimulation was
applied to most rats. One hour after the first tetanus, these
animals were infused with either 200 mM (F.S)-MCPG
(n = 7) or vehicle (n = 8). Half an hour after the end of
drug infusion, a second tetanus was given, and LTP was
followed for 1 hr. A control group <n= 8) also received
the first tetanus, but no depotentiating stimulation. LTP
was followed for 1 hr in these animals, and their
experiment ended at the point when drug infusion would
have begun for the other groups.
Tetanus I and depotentiation. Significant depotentia¬
tion was induced by 5-Hz stimulation given 2 min after
tetanization. An ANOVA of the amount of potentiation
50-60 min after the first tetanus, in which all depoten¬
tiated animals were compared with controls, revealed a
significant reduction in EPSP slope potentiation
[F(l.21) = 5.87: p < 0.05; Fig. 4], However, the depoten¬
tiation was incomplete; only two of the 15 rats receiving
5-Hz stimulation showed less than 5% LTP after 1 hr: all
control rats showed more than 5% LTP. No significant
group differences were found in the amount of PTP 0-
2 min post-tetanus [F<1], An analysis of population
spike depotentiation gave similar results (data not
shown).
No significant group differences were found in base¬
line stimulation intensity [F< 1]; initial spike amplitude
over the 10 min prior to tetanus 1 [F(2.20) = 1.19;
p > 0.3]; and absolute slope magnitude prior to tetanus
1 fF(2,20) = 2.02; p>0A].
Drug infusion and tetanus 2. Infusion of MCPG caused
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Fig. 5. (A) Low frequency stimulation (5 Hz for 10 min) given 2 min after a high frequency tetanus results in
significant EPSP slope depotentiation relative to controls given only the tetanus [EPSP slope 50-60 min post-
tetanus: control = 119.3 + 1.4% (n = 6); depotentiated (200 mM (F..S)-MCPG and vehicle groups com¬
bined) = 105.6 + 2.5% (n = 12)]. Subsequent infusion of 10 pi 200 mM (F.S)-MCPG (n = 6) or vehicle in = 6)
resulted in equivalent LTP after a second tetanus. (B) Infusion of 10 pi 200 mM (F.Si-MCPG did not block EPSP
slope potentiation, even in individual animals showing complete depotentiation. such as the example given here.
a marked fall in baseline slope values (see Discussion),
but failed to block LTP after the second tetanus. The
amount of potentiation 50-60 min after the second
tetanus, normalized to the original baseline, did not
differ between MCPG and vehicle groups [slope LTP:
F < 1; Fig. 4],
However, since depotentiation was not completely
effective, it might be more appropriate to re-normalize
the data to the slightly elevated baseline prior to the
second tetanus. The 10 min prior to drug infusion were
chosen, rather than the 10 min immediately before
tetanization, in order that MCPG-induced baseline
changes would not confound the results. Even when
analysed in this way, no significant differences in LTP
50—60 min after tetanus 2 were found between the two
groups [F< 1: data not shown].
Experiment 5: does a more effective depotentiation
protocol reveal an MCPG-sensitive component of LTP?
All procedures were identical to those described in
experiment 3, except that 5-Hz stimulation was continued
for 10 min instead of 1 min.
Tetanus I and depotentiation. An ANOVA of the
amount of EPSP slope LTP 50-60 min after tetanus 1. in
which all depotentiated animals (n = 12) were compared
with controls (n = 6), revealed a highly significant
reduction in the depotentiated group [F(1,I6) = 13.3;
pcO.Ol; Fig. 5(A)|. No significant differences were
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found in the amount of PTP 0-2 min post-tetanus [F < 1],
An analysis of population spike depotentiation gave
similar results (data not shown).
No group differences were found in baseline stimula¬
tion intensity [F< 1]; initial spike amplitude over the
10 min before tetanus 1 [F<1]; and absolute slope
magnitude before tetanus 1 [F< 1],
This protocol was slightly more effective than that
used previously. A comparison of the amount of EPSP
slope LTP following 5-Hz stimulation for 1 min (experi¬
ment 4) and the amount following 10 min (experiment 5)
revealed a trend towards greater depotentiation in the
latter [experiment 4=111.46+ 1.91%; experiment
5= 105.55 ± 2.25%; F(l,25) = 3.59: pcO.l], Further¬
more, EPSP slope values returned to within 5% of
baseline or less in seven of the 12 rats given 10 min of
5 Hz. compared to only two out of 15 given 1 min of low
frequency stimulation. No significant differences in non-
depotentiated control LTP were seen between experi¬
ments 4 and 5 [F < 1]; all controls showed more than 5%
LTP.
Drug infusion and tetanus 2. MCPG did not block LTP
following the second tetanus. The amount of potentiation
50-60 min after the second tetanus, normalized to the
original baseline, did not differ between MCPG and
vehicle groups [F< 1; Fig. 5(A)], This was true even in
individual cases where complete depotentiation was
achieved (Fig. 5(B)). The same result was obtained when
the results were re-normalized to the pre-infusion base¬
line (data not shown). These results confirm that the
inability of MCPG to block LTP is unaffected by prior
depotentiation.
DISCUSSION
The experiments described in this study have con¬
sistently revealed that intraventricular infusion of a high
dose of (F,S)-MCPG in urethane-anaesthetized rats does
not result in a block of LTP in the dentate gyrus. This
result holds whether or not LTP is assessed relative to a
pre-tetanus baseline, to a concurrently stimulated control
pathway, or is induced in a pathway previously subject to
depotentiation.
In experiment 1, i.e.v. infusion of either 20 mM or
200 mM (F.S)-MCPG failed to cause a significant
reduction in the level of LTP up to 2 hr after tetanization.
It is unlikely that this was due to any failure of the drug
infusion protocol as 30 mM D-AP5 administered by the
same route caused a total block of LTP. Surprisingly, the
infusion of AP5 resulted in a slight increase in the EPSP
slope baseline. AP5 is known to reduce population spike
amplitude in the dentate gyrus (Errington et ai, 1987), an
effect noted in the present study (data not shown).
Nevertheless, increases in EPSP slope have not been
reported previously. Although the reason for the increase
in EPSP slope associated with AP5 infusion is unknown,
data from two rats in which recordings were made
bilaterally reveal that the slope increase in untetanized
pathways persisted for the duration of the experiment and
rules out the possibility that a residual potentiation was
being masked.
Inspection of Fig. 1(A) reveals that slightly less LTP
was observed in the 200 mM MCPG group compared to
controls, though this effect was not found to be
statistically significant. However, prior to tetanization,
the baseline was falling in this group, an effect which,
though slight, was fairly consistent across animals and
may reflect a small metabotropic contribution to normal
synaptic transmission. It was recently found that MCPG
infusion into the basolateral amygdala causes a transient
depression of baseline responses (Keele et al.. 1995). The
authors attribute this to the action of MCPG as an agonist
at presynaptic mGluR "autoreceptors", but such effects
have not previously been described in the hippocampus.
Nevertheless, a chronic baseline fall might give rise to an
apparent block of LTP under some circumstances. In
order to control for this possibility experiment 2 was
conducted using bilateral stimulation and recording, with
the one pathway serving as an untetanized control. The
results confirm the finding of experiment 1, that MCPG is
ineffective in blocking LTP. Furthermore, the slight
baseline changes caused by MCPG are short-lasting and
could not contribute to the level of potentiation 2 hr after
tetanization. It appears, however, that the baseline fall
caused by MCPG is more marked after the induction of
LTP followed by incomplete depotentiation (Fig. 4) than
the fall occurring after more effective depotentiation
(Fig. 5(A)), or when MCPG is applied to an untetanized
pathway (Fig. 1(A), Fig. 2(A)]. It is conceivable that
tetanization followed by 5-Hz stimulation results in a
residual mGluR-dependent potentiation which returns to
baseline after MCPG application, although MCPG has
been shown to have no effect on LTP when applied after a
high frequency tetanus alone (Riedel et al.. 1995).
Nevertheless, inspection of the data from individual rats
suggests that the size of the fall in EPSP slope following
MCPG infusion in experiments 4 and 5 is independent of
the amount of LTP remaining after tetanization and 5-Hz
stimulation (data not shown). This finding is inconsistent
with the suggestion that the residual LTP after depoten¬
tiation is mGluR-dependent. However, the reason for the
difference in baseline changes between experiments is
not known.
It is unlikely that changes in brain temperature had a
significant effect on the relative level of LTP recorded in
experiments 1 and 2. In Fig. 1(D), the slight increase in
brain temperature of approximately 0.5°C associated
with MCPG infusion appeared to be transient. No
significant temperature differences between groups were
found 2 hr after tetanization, although the mean brain
temperature of MCPG-treated rats was about 0.4°C
higher at this point than in vehicle-infused controls.
Nevertheless, it is unlikely that a block of LTP with
200 mM MCPG was masked by a small temperature-
dependent increase in EPSP slope in this group since in
experiment 2, vehicle-infused controls showed brain
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temperatures slightly (but again non-significantly) higher
than MCPG-infused animals 2 hr after tetanization (data
not shown), yet a block of LTP was still not obtained with
MCPG.
It could be argued that the above results simply reflect
an insufficient blockade of mGluR activation in the
dentate gyrus. For instance, intraventricular infusion of a
drug results in an unknown distribution and concentration
within the target structure; these are problems associated
with most in vivo studies. Nevertheless, in experiment 3,
MCPG infusion was found to inhibit the rise in
spontaneous activity induced by infusion of the mGluR
agonist, (1S,3R)-ACPD. Previous studies have estab¬
lished that application of ACPD has a number of direct
excitatory effects on CA1 pyramidal cells, including
inhibition of the slow afterhyperpolarization current, and
blockade of spike frequency adaptation (Desai and Conn,
1991; Davies et al., 1995). A similar increase in the
excitability of dentate granule cells may underlie the rise
in spontaneous activity recorded in the present study. The
fact that MCPG is effective in blocking an electrophy¬
siological response to ACPD confirms that the drug
reaches ACPD-activated mGlu receptors. The blockade
was equally effective at both 1 mM and 4 mM doses of
ACPD. Note that the application of 4 mM (1S.3R)-ACPD
following 200 mM (7?,S)-MCPG reflects the agonist:
antagonist ratio typically used in vitro (e.g. 10 ;(M
(1S,3R)-ACPD: 500 mM (R.S)-MCPG; see Bashir et al..
1993). However, it is possible that the reduction in
ACPD-induced spontaneous activity may not reflect the
antagonism of mGluRs within the dentate gyrus, but that
MCPG may be blocking a network-mediated action of
ACPD originating elsewhere in the brain. It has also been
reported that MCPG exhibits greater potency in antag¬
onizing ACPD-mediated responses, compared to those of
glutamate (Brabet et al., 1995; Littman and Robinson,
1994). Hence, it might still be argued that glutamate
release during tetanic stimulation could be sufficient to
overcome the competitive antagonism of MCPG. How¬
ever, slice studies indicate that MCPG can block the LTP
induced by 100-Hz stimulation for 1 sec (i.e. 100 pulses;
see Bortolotto et al.. 1995), a protocol likely to result in
greater giutamate release than the 20 pulses per train used
in the present study.
Although MCPG successfully antagonized the increase
in spontaneous activity induced by ACPD, it unmasked a
dose-dependent depression (see Fig. 3(C) and (D)). This
may reflect a preferential antagonism of the excitatory
actions of class I mGluRs. revealing an inhibitory effect
of ACPD. perhaps mediated by class II mGluRs not
blocked by MCPG. The evidence in support of this is that
MCPG competitively inhibits ACPD-induced phosphoi-
nositide hydrolysis, but does not inhibit the agonist-
induced depression of forskoiin-stimulated cAMP for¬
mation in adult rat hippocampal slices (Riedel et al..
1995). The qualification of this argument is that MCPG
has been found to inhibit the latter effect in cortical brain
slices and in cells expressing mGluR2 (Kemp et al..
1994; Hayashi et al.. 1994). However, the results of
Riedel et al. (1995) suggest that it is the activation of
class I mGluRs which is necessary for the induction of
LTP, so the failure of MCPG to block a possible class II
mGluR-mediated effect of ACPD in the present study is
unlikely to account for the failure of MCPG to block
LTP.
Infusion of ACPD caused only a transient increase in
EPSP slope associated with a slight increase in brain
temperature. Slow-onset potentiation of the kind reported
by Manahan-Vaughan and Reymann (1995) using 4 mM
(1S,3R)-ACPD in the dentate gyrus in vivo was not seen.
However, the results of the present study are consistent
with those of Davis and Laroche (1996), who reported a
rapid-onset but transient rise in EPSP slope in the dentate
after infusion of 10 mM (lS.3/?)-ACPD.
It has been suggested that mGluR activation may
regulate plasticity by turning on a "molecular switch"
which eliminates the requirement for further mGluR
activation in the induction of LTP; this switch can be
reset by depotentiating stimulation (Bortolotto et al.,
1994). However, in experiment 4, MCPG remained
ineffective in blocking- - LTP even after significant
depotentiation. Nevertheless, 1 min of low frequency
stimulation did not completely erase LTP (potentiation
was reduced to within 5% of baseline in only two of 15
animals tested); it could be argued that a more effective
depotentiation protocol might produce a different result.
However, the results of experiment 5 confirm that the
inability of MCPG to block LTP is unaffected by prior
depotentiation. In this case. 10 min of 5-Hz stimulation
resulted in LTP of less than 5% in seven out of 12 animals
tested, but MCPG again failed to block LTP. even in
those individual animals showing complete depotentia¬
tion prior to drug infusion and re-tetanization. It is
conceivable that LTP reaches a ceiling after the second
tetanus, thus masking differences in potentiation between
the groups; LTP is of equal magnitude in the MCPG
group whose baseline is low prior to tetanus 2 and the
aCSF group whose pre-tetanus baseline is higher.
However, inspection of Fig. 2(A) suggests that these
baseline differences are likely to be transient. Moreover,
it is unlikely that LTP is saturated in Fig. 5(A), since the
EPSP slope 1 hr after tetanus 2 is only about 20% above
the baseline level prior to tetanus 1.
The above results are consistent with those of Selig et
al. (1995) and Thomas and O'Dell (1995) who failed to
replicate the molecular switch findings of Bortolotto and
Collingridge (1994) in area CA1 in vitro. Whilst the
results of the present study do not rale out the possibility
that the sensitivity of LTP to MCPG may, under certain
circumstances, be governed by the position of a
molecular switch, it is unlikely that such a possibility
can account for the negative results described here.
Nevertheless, it is interesting that a period of 5-Hz
stimulation given 2 min after tetanization results in
significant depotentiation: 10 min of this depotentiating
stimulation resulted in a mean of only 5.6 ± 2.5% LTP
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after 1 hr, compared to 19.3 ± 1.4% in tetanized-only
controls. Depotentiation has been reliably obtained in
area CA1 in vitro in a number of different laboratories
(Fujii et al., 1991; Larson et al., 1993; Bashir and
Collingridge, 1994; O'Dell and Kandei. 1994); it is
notable that low frequency stimulation in the theta range,
such as the 5 Hz used in the present study, has been found
to be optimal for reversing LTP. Initial reports suggested
that depotentiation could be obtained in area CA1 in vivo,
both in anaesthetized (Barrionuevo et al., 1980) and
freely-moving rats (Staubli and Lynch, 1990), but others
have failed to induce depotentiation in either the CA1
region or dentate gyrus under similar circumstances
(Errington et al., 1995). Recent work has demonstrated
that, at least in area CA1 in vitro, the percentage reversal
of LTP declines steeply as the interval between tetanus
and low frequency stimulation is increased; depotentia¬
tion is most effective when 5-Hz stimulation is given in
the first few minutes following tetanization (Staubli and
Chun, 1996). As the authors note, this timescale matches
the consolidation period (1-3 min) during which LTP is
susceptible to disruption by brief periods of hypoxia and
application of adenosine antugoniptr, (Arai et al„
1990a,b); it may be significant that low frequency
stimulation was given within this time-window in the
present study. The existence of a critical period for the
induction of depotentiation may explain the negative
results obtained by Errington et al„ as they allowed
30 min to intervene between tetanization and low
frequency stimulation. Further studies will be necessary
to determine whether depotentiation in the dentate gyrus
in vivo exhibits the same time-dependent properties as
those found in CA1 in vitro.
The failure ofMCPG to block LTP in the dentate gyrus
of urethane-anaesthetized rats is consistent with the
results of one recent study conducted under similar
conditions (Bordi and Ugolini, 1995); an earlier report
described a reduction in the percentage EPSP slope
potentiation after acute intraventricular infusion, but no
block of population spike potentiation (Richter-Levin et
al„ 1994). A complete block of LTP was seen only during
direct perfusion of MCPG into the dentate gyrus via a
push-pull cannula. However, it has been reported that
urethane antagonizes the excitation induced by applica¬
tion of excitatory amino acid agonists, including NMDA,
in isolated spinal cord (Evans and Smith, 1982). In
another study, urethane anaesthesia was found to depress
dentate gyrus granule cell excitability and the strength of
synaptic responses (Shirasaka and Wasterlain. 1995). The
recent finding that Thy-1 knockout mice show a complete
block of dentate LTP under urethane anaesthesia, but
express significant LTP in the freely-moving state,
demonstrates that the effects of anaesthesia cannot be
ignored (Nosten-Bertrand et al„ 1996; Errington et al..
1997). Consistent with this result, it is found that stronger
tetanization parameters are required to induce LTP in
area CA1 of urethane-anaesthetized rats, compared to the
freely-moving state (Riedel et al„ 1994). It has been
reported that MCPG does not block the LTP induced in
area CA1 in vitro by strong tetanization protocols, such
as theta burst stimulation (Brown et al., 1994). The
weaker tetanization parameters necessary in freely-
moving rats may unmask a modulatory role of mGluRs.
accounting for reports of a complete block of LTP by
MCPG under these circumstances (see Riedel et al.,
1996). It is worth noting, however, that the tetanus
parameters chosen in the current study were in fact quite
modest, typically yielding just over 15% LTP after 2 hr
(see experiment 1). Nevertheless, it will be necessary to
extend the experiments described here to freely-moving
animals before any firm conclusions about the involve¬
ment of mGluRs in LTP in vivo can be drawn.
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IELD potential recordings were made from the dentate
^rus of urethane-anaesthetized rats in order to inves-
^gate the ability of 5 Hz stimulation to reverse long-
im potentiation (LTP) induced by a high frequency
:tanus. A 10 min train of 5 Hz was found to reverse
TP in a time-dependent fashion: as the interval between
:tanus and 5 Hz was increased, LTP became progres-
vely less susceptible to reversal. If 10 min or 30 min
itervened between tetanization and 5 Hz stimulation,
TP was unaffected. These results indicate that dentate
TP in vivo exhibits a similar limited time window of
ulnerability to reversal by low frequency stimulation
3 that previously reported in area CA1 in vitro.
leuroReport 9: 3775-3781 © 1998 Lippincott Williams &
"Cilkins.
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kfter many years of research into the role of long-
erm potentiation (LTP) in learning,1-3 considerable
ittention has recently been devoted to the phenom-
:non of depotentiation, the activity-dependent
eversal of LTP. A number of laboratories have
obtained depotentiation in area CAl in vitro using a
;ontinuous train of 1- 5 Hz stimulation.4-8 However,
n vivo studies of the reversal of CAl LTP have
generated mixed results, with some authors reporting
>uccessful depotentiation using low frequency stim-
alation,9-11 and others failing to obtain any effect.12
In the dentate gyrus, heterosynaptic depotentia¬
tion has been observed in vivo13 and homosvnaptic
depotentiation has been successfully induced in slices
taken from immature rats.14 However, homosynaptic
depotentiation is generally not induced by the
delivery of low frequency stimulation to the medial
perforant path-dentate gyrus projection of adult rats
in vivo.12-15 One factor that may be critical for the
successful induction of depotentiation is the interval
between tetanization and low frequency stimulation.
A systematic investigation of this possibility in
area CAl in vitro revealed that the percentage reversal
of LTP declines steeply as the interval between
tetanus and low frequency stimulation is increased.4
Depotentiation was found to be most effective when
5 Hz stimulation was delivered within minutes of
tetanization.
I have previously reported that a 2 or 10 min
period of 5 Hz stimulation results in a significant
reversal of dentate LTP in vivo when delivered 2 min
after a high frequency tetanus.16 In the present study,
0959-4965 © 1998 Lippincott Williams & Wilkins
I investigated the possibility that dentate LTP in vivo,
like CAl LTP in vitro, exhibits a limited time
window of vulnerability to reversal by 5 Hz stimu¬
lation.
Materials and Methods
Adult male Lister-hooded rats (250-500 g) were given
ad. lib access to food and water and were maintained
on a 12:12 h lighndark cycle. Experiments were
conducted under urethane anaesthesia (1.5 g/kg, i.p.),
with the rat mounted in a stereotaxic frame (Kopf,
Tujunga, CA) with skull horizontal. The animal's
temperature was monitored by a rectal probe and
maintained at 36.2 ± 0.2°C using an isothermic
heating blanket. PTFE-coated, platmum/iridium elec¬
trodes were lowered into the left hippocampal forma¬
tion in order to record positive-going field potentials.
A bipolar stimulating electrode was positioned in the
angular bundle of the perforant path (AP = 7.5 mm;
L - 4.0 mm) and a monopolar recording electrode
in the hilus of the dentate gyrus (AP = 3.5 mm,
L = 2.0 mm). Field EPSPs were amplified using a
polygraph (Grass Instruments, Quincy, MA). The
initial slope of the field EPSP (measured by linear
regression between two fixed time points), and the
population spike amplitude, were monitored on-line
by an Acorn A5000 computer running specialized
software.
Stimulation consisted of monophasic pulses, the
intensity of which was adjusted to elicit a population
spike of 2—)■ mV. The pulse width was 50 p.s, except
during a high frequency tetanus or 5 Hz stimulation,
when the pulse width was doubled. Test pulses were
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delivered at 0.05 Hz throughout, except during the
recording of input/output (I/O) curves, when this
frequency was increased to 0.1 Hz.
Once stable EPSPs had been obtained, an I/O
curve was recorded, consisting of four pulses at
each of 10 stimulation intensities ranging from 0.1 to
1 mA. A baseline period of 20 min followed, after
which a high frequency tetanus was delivered. Tetanic
stimulation consisted of three trains of 50 pulses of
100 p-s duration, delivered at 250 Hz, with 10 s
between trains. A single test pulse of 100 p,s dura¬
tion was given 10 s after the final tetanus train to
provide an early measure of post-tetanic potentiation
(PTP). After a variable interval, measured from
the final tetanus train, a 10 min period of 5 Hz
stimulation was delivered. The intervals tested were
as follows: 10 s (n = 7); 30 s (n = 6); 2 mm (n = 7);
10 min (n = 7); 30 min (n = 6). Additional control
groups received either 5 Hz only, with no tetanus
(n - 6), or tetanic stimulation only, with no subse¬
quent 5 Hz period (n = 6). At the end of the 5 Hz
stimulation period, test pulse stimulation was
resumed until 1 h had passed since tetanization. A
second I/O curve was then recorded. The above
protocol is summarized in Fig. 1.
A further group of rats received 10 min of 1 Hz,
rather than 5 Hz, starting 10 s after tetanization
(.n = 6). Additional LTP controls were interleaved
with this 1 Hz group (n = 6). All other aspects of the
protocol were identical to that described above.
Separate groups of rats received intraventricular
infusions of 200 mM (i?,5)-o:-methyl-4-carboxy-
phenvlglycine (MCPG) prior to tetanization only
(n = 3), or tetanization followed 10 s later by 10 min
of 5 Hz stimulation (n = 3). In these animals, two
stainless steel injection cannulae connected by plastic
tubing to microsyringes, were lowered into the left
and right lateral ventricles (AP = -0.9 mm; L =
±1.3 mm). (A.S)-MCPG was dissolved in 1 M NaOH
to form an equimolar solution, then diluted with
phosphate buffered saline to achieve a concentration
of 200 mM. A total volume of 10 p.1 (5 p.1 per ventricle)
was infused over 10 min, starting 40 min prior to
tetanization. Otherwise, the protocol was identical
to that described above.
20 mm baseline


















FIG. 1. Summary of experimental design. 5 Hz stimulation was
delivered at intervals ranging from 10 s to 30 min following a high
freauency tetanus. See text for details.
All statistical comparisons were carried out using
analysis of variance (ANOVA) unless otherwise
stated. Numerical values are given as mean ± s.e.
throughout.
Results
Reversal of EPSP slope potentiation: Figure 2A
shows the amount of EPSP slope potentiation at
increasing delays between tetanus and 5 Hz stimula¬
tion, normalized to the mean value recorded over the
10 min prior to tetanization. For reference, the 5 Hz
only and tetanus only control groups are included in
each individual graph. High frequency tetanization
alone reliably induced LTP; 5 Hz stimulation alone
generally had little effect, although a slight increase
in EPSP slope was sometimes observed. The degree
of LTP reversal declined as the interval between
tetanus and 5 Hz was increased; 5 Hz stimulation
delivered 10 min or more after tetanization had little
effect other than causing a transient depression of
responses, typically lasting less than 10 min.
The mean percentage LTP in each group, measured
over the final 10 min of the experiment (50-60 min
after tetanization) is plotted in Fig. 2B. An ANOVA
revealed a highly significant overall effect of group
(F(6,38) = 10.24; p < 0.0001). A significant reversal of
LTP was only seen when less than 10 min intervened
between tetanus and 5 Hz {post-hoc Dunnett's pair-
wise comparisons between tetanus only and all other
groups; see figure legend). Delivery of 5 Hz starting
10 s after tetanization resulted in a complete reversal
of LTP. No significant difference was found between
the amount of LTP in this group and that in the
5 Hz only group (p > 0.9; post hoc Dunnett's pair-
wise comparison). In fact, only the 10 min, 30 min
and tetanus only groups exhibited significant LTP
relative to the 5 Hz only condition (p < 0.01 in each
case; Dunnett's).
No significant group differences were found in
absolute mean EPSP slope values over the 10 min
before tetanization (F < 1). A measure of initial slope
PTP was calculated for all tetanized groups by
dividing the value recorded 10 s after the final tetanus
train by the value obtained from the first pulse of
the first tetanus train, then multiplying by 100 (data
not shown). No group differences were found in this
measure of early slope PTP (F < 1), indicating that
the initial potentiation induced by tetanization was
identical across groups.
Reversal of population spike potentiation: The
population spike data were generally consistent with
the EPSP slope data. Figure 2C shows the absolute
increase in population spike amplitude relative to the
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FIG. 2. (A) EPSP slope values normalized to the pre-tetanus baseline at increasing delays between tetanization and 5 Hz stimulation. For
reference, tetanus only and 5 Hz only groups are included in each individual panel. (B) Mean EPSP slope values 50-60 min after tetaniza¬
tion. Asterisks indicate groups showing significantly less LTP than tetanus only controls (*p<0.05; **p<0.01). (C) Changes in population
spike amplitude normalized to the pre-tetanus baseiine. (D) Mean increase in population spike amplitude 50-60 min after tetanization. Asterisks
ndicate a significant reversal of LTP relative to tetanus only controls (*p<0.05; **p<0.01).
pre-tetanus baseline at all intervals between tetanus
and 5 Hz. Tetanus only and 5 Hz only control
groups are again included in each individual
graph. High frequency tetanization alone induced a
asting increase in population spike amplitude; 5 Hz
stimulation alone caused a small but lasting
depression of the population spike. Consistent with
the EPSP slope findings, the efficacy of population
spike LTP reversal declined as the interval between
tetanus and 5 Hz stimulation was increased. The
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deliver)' of 5 Hz starting 2 min or more after
tetanization caused only a transient depression in
population spike amplitude, which although out¬
lasting the EPSP slope depression, typically recov¬
ered within about 20 min.
The mean population spike increase 50-60 min
after tetanization is shown in Fig. 2D. The overall
effect of the group was highly significant (F(6,38) =
11.64; p< 0.0001). The 5 Hz only, 10 s and 30 s
groups showed significantly less LTP than tetanus
only controls {post-hoc Dunnett's pairwise compar¬
isons; see figure legend); deliver)' of 5 Hz stimula¬
tion 2 min or more after tetanization had no
significant effect.
No significant group differences were found in
absolute baseline population spike amplitude over the
10 min prior to tetanization (F < 1); the test pulse
stimulation intensities required to elicit population
spikes of this amplitude did not differ across
groups (F < 1). An analysis of population spike PTP
recorded 10 s after tetanization revealed no group
differences in initial potentiation (F(5,33) = 1.41;
p > 0.2).
Changes in EPSP-spike (E-S) coupling after 5 Hz
stimulation: Mean EPSP slope and population spike
amplitude values were calculated for each stimulation
intensity sampled during both the initial and final
I/O curves. The maximum mean EPSP slope and
population spike amplitude recorded during the
initial I/O curve were arbitrarily assigned values of
100%, to which all other values were normalized.
For each rat, scatter plots relating EPSP slope
to population spike amplitude were constructed
both before and after tetanization and/or 5 Hz stim¬
ulation.
Figure 3 shows mean E-S plots constructed from
the initial and final I/O curves, i.e. 20 min before and
60 min after tetanization. As indicated by the slight
leftward shift in the E-S relationship in Fig. 3A, LTP
in tetanus only controls was characterized by a
greater increase in the population spike amplitude
than that predicted by the increase in EPSP slope.
However, 5 Hz stimulation alone (Fig. 3B) caused a
rightward shift in the E-S relationship, indicating a
decrease in E-S coupling. No change in E-S coupling
was seen in any of the groups that received a tetanus
followed by 5 Hz stimulation, such as the 10 s group
shown in Fig. 3C.
Linear regression lines were fitted to the scatter
plots relating EPSP slope to population spike ampli¬
tude for each animal before and after tetanization (or
before and after 5 Hz stimulation in the case of the
5 Hz onlv group). The spike amplitude elicited by a
75% maximal EPSP slope was interpolated from each
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FIG. 3. Mean relationship between population spike amplitude and
EPSP slope at each point on the I/O curve recorded before and after
tetanization. (A) Tetanus only control group: the leftward shift indi¬
cates that tetanization induced a slight E-S potentiation. (B) 5 Hz
only group: the rightward shift indicates that 5 Hz stimulation alone
caused an E-S depression. (C) 10 s group: no change in E-S coupling
was observed in animals receiving both a tetanus and 5 Hz stimu¬
lation, such as the 10 s group illustrated here.
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id after tetanization (or before and after 5 Hz
imulation alone). A significant group by time point
.teraction was revealed (F(6,38) = 3.96; p < 0.01;
ithin-subject ANOVA). Subsequent analysis of
mple effects revealed significant E-S potentiation in
le tetanus only group (F(l,38) = 6.89; p < 0.05), and
-gnificant E-S depression in the 5 Hz only group
"(1,38) = 11.90; p < 0.01). No significant changes in
-S coupling were obtained in any group receiving
tetanus followed by 5 Hz stimulation (10 s: F < 1;
0 s: F < 1; 2 min: F < 1; 10 min: F < 1; 30 min:
(1,38) = 2.92; p > 0.05).
'pileptiform afterdischarges induced by 3 Hz stimu-
ition: 5 Hz stimulation was always accompanied
y epileptiform activity characterized by seizure-
ke afterdischarges and multiple population spikes,
'igure 4 shows a continuous polygraph record
uring 5 Hz stimulation. The large negative deflec-
10ns are positive-going EPSPs. In this example, after-
ischarges began within 10 s of the start of 5 Hz
timulation and persisted for -1.5 min, after which
io further episodes of afterdischarge activity were
ibserved. Representative sample EPSPs at three
iifferent time points are illustrated.
The afterdischarge onset latency and total duration
vere measured for each rat (data not shown).
Analysis of data from all rats revealed that these
wo indices of the severity of afterdischarge activitv
were negatively correlated, i.e. the more rapidly
afterdischarges began, the longer they persisted
(correlation coefficient, r = -0.41; p < 0.05). However,
no significant group difference was found in after-
discharge onset latency (F(5,33) = 2.17; p > 0.05) or
duration (F < 1), indicating that seizure-like activity
was equally severe regardless of the interval between
tetanus and 5 Hz, or indeed regardless of whether a
tetanus was delivered at all. Similarly, there was no
overall correlation between afterdischarge onset
latency or duration and the level of EPSP slope
or population spike LTP obtained 1 h after tetaniza¬
tion (data not shown). These findings indicate that
the time window during which LTP is vulnerable
to reversal cannot be explained as an artifact of
the severity of afterdischarges elicited by 5 Hz
stimulation.
Failure ofMCPG to block the reversal of LTP with
) Hz stimulation: Consistent with our previous
findings,16 (f?,5)-MCPG did not block LTP induced
by tetanization 30 min after the end of infusion
(n = 3; data not shown). The reversal of LTP with
5 Hz stimulation delivered 10 s after tetanization was
also unaffected (n = 3; data not shown).
Failure of 1 Hz stimulation to reverse LTP: The
delivery of a 10 min period of 1 Hz stimulation
starting 10 s after tetanization (n = 6) had no effect
Start of 5 Hz stimulation
Onset of afterdischarses
10 mV
10 s Hnd of afterdischaraes
5 mV
25 ms
(2) 15s (3) 100 s
G. 4. Sample polygraph record during 5 Hz stimulation. The large negative deflections represent positive-going EPSPs. Epileptiform after-
scharges began abruptly within 10 s of the start of 5 Hz stimulation, and continued for -1.5 min before subsiding. Representative EPSPs
corded at 0, 15 and 100 s after the start of 5 Hz stimulation (points 1, 2 and 3, respectively) are illustrated. The waveform recorded at
> s displays the multiple population spikes characteristic of afterdischarge activity.
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on either EPSP slope LTP or population spike LTP,
relative to controls (n - 6) carried out at the same
time (data not shown). Afterdischarges were never
observed during 1 Hz stimulation.
Discussion
The present experiment reveals that dentate LTP
in vivo exhibits a limited vulnerable phase, lasting
less than 10 min after induction, during which poten¬
tiation can be disrupted by 5 Hz stimulation. Neither
the induction of LTP, nor its reversal, was blocked
by the application of the mGluR antagonist, MCPG.
Despite the fact that tetanization alone resulted in E-
S potentiation, and 5 Hz stimulation alone resulted
in E-S depression, no changes in E-S coupling were
seen in any group receiving a high frequency tetanus
followed by 5 Hz stimulation. These results suggest
that, in contrast to its time-dependent effects on LTP,
5 Hz stimulation causes a time-independent reversal
of E-S potentiation, perhaps resulting from a non¬
specific depression of granule cell excitability.
The cellular mechanisms underlying the reversal of
LTP in the present study remain unknown. It may
be significant that stimulation at 5 Hz, a frequency
within the range of the hippocampal theta rhythm,
was effective in reversing LTP, whilst 1 Hz stimula¬
tion had no effect. The firing of neurons in area
CA1 and the dentate gyrus of behaving rats is char¬
acterized either by high frequency bursts known
as complex spikes, or by the firing of single action
potentials.17 Both forms of activity are frequently
phase-locked to the theta rhythm. It has been
suggested that the firing of complex spikes may repre¬
sent a mechanism for the induction of a naturally
occurring form of synaptic potentiation, whilst the
firing of single pulses phase-locked to theta may
serve to reverse such potentiation.6 It has recently
been reported that the exploration of a novel envi¬
ronment results in a complete reversal of CA1 LTP.18
Exploration was accompanied by an increase in
hippocampal EEG activity in the 6-8 Hz range, a
result still obtained after controlling for the level
of motor activity. Hence, hippocampal activity at
theta frequencies may be involved in the experience-
dependent erasure of synaptic enhancement, and as
such may represent an active forgetting mechanism,
working in concert with the storage of new infor¬
mation.
However, stimulation at theta frequencies readily
induces seizure-like afterdischarges.19'20 In the
present study, activity of this kind was always
observed during 5 Hz stimulation, but never during
1 Hz stimulation. As such, it is possible that LTP
reversal by 5 Hz stimulation, rather than being a
candidate mechanism for the active forgetting of
information, may have more in common with various
neuropathological events. One recent study reported
that the delivery of 3 Hz stimulation starting 1 min
after tetanization resulted in an apparent depotenti-
ation of dentate LTP in awake rats, but only when
accompanied by afterdischarge activity.15 However,
this depotentiation was found to be transient, and
was interpreted as a non-specific depression of
responses resulting from seizure generation. This
possibility cannot explain the results of the present
study, as afterdischarges were equally severe irre¬
spective of the interval between tetanus and 5 Hz,
yet no reversal of LTP could be induced 10 min or
30 min after tetanization.
It is possible that the time-dependent reversal of
LTP by 5 Hz stimulation may be dependent on
the activation of adenosine A, receptors. 5 Hz stim¬
ulation is known to result in an increase in adeno¬
sine release from hippocampal slices.21 It has been
reported that the application of adenosine A, receptor
antagonists to CA1 slices prevents the induction of
depotentiation,6-22 and the reversal of LTP by exces¬
sive theta burst stimulation.2-' Furthermore, LTP can
be reversed bv the application of adenosine within 1
min, but not 5 min after tetanization.24 This time
window is similar to the period during which LTP
was found to be vulnerable to reversal by 5 Hz
stimulation in the present study. Interestingly, it may
be significant that both adenosine A, receptor acti¬
vation and low frequency stimulation are associated
with a decrease in E-S coupling in area CA1 and
the dentate gyrus, respectively.26-26 These results are
reminiscent of the E-S depression reported here after
the delivery of 5 Hz stimulation without prior
tetanization.
The physiological relevance of long trains of low
frequency stimulation such as a 10 min period of
5 Hz is questionable. The possibility that LTP
induced using a more physiologically realistic tetanus
might be reversed by a brief period of theta stimu¬
lation remains a topic for future experiments.
Nevertheless, regardless of the physiological signifi¬
cance of the present findings, the ability to prefer¬
entially erase recently induced LTP, whilst sparing
established LTP, might provide a novel alternative to
pharmacological intervention in future behavioural
studies of synaptic plasticity and learning.
Conclusion
These results reveal that a 10 min train of 5 Hz
stimulation reverses dentate LTP in vivo only
when delivered up to 2 min after tetanization. This
finding is reminiscent of the effects of adenosine A,
receptor activation.24 However, the mechanism and
physiological significance of LTP reversal by 5 Hz
3780 Vol 9 No 17 1 December 1998
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imulation are currently unknown. Despite this, the
ulity to preferentially erase recently induced LTP
ight provide a useful tool for behavioural studies
the relationship between LTP and learning.
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